Please wait...
| ID | PMID | YEAR | Sequence | MAP | Name | C-ter MOD | N-ter MOD | Linear/Cyclic | Stereo-Chemistry | Modified | Length | Fuction | Activity | RBCs Source | Origin | Experimental structure | Non-Hemolytic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10924341 | 2000 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 100μg/ml | Rat | Indolicidin of bovine neutrophil | NA | NA | ||
| 10924341 | 2000 | ILPWKLPLLPLRR{ct:Amid} | IL4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0% hemolysis at 100μg/ml | Rat | Indolicidin analog of bovine neutrophil | NA | Non-hemolytic | ||
| 10924341 | 2000 | ILPLKLPWLPLRR{ct:Amid} | IL8 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0% hemolysis at 100μg/ml | Rat | Indolicidin analog of bovine neutrophil | NA | Non-hemolytic | ||
| 10924341 | 2000 | ILPLKLPLLPWRR{ct:Amid} | IL11 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0% hemolysis at 100μg/ml | Rat | Indolicidin analog of bovine neutrophil | NA | Non-hemolytic | ||
| 20969885 | 2011 | GIWSSIKNLASKAWNSDIGQSLRNKAAGAINKFVADKIGVTPSQAAS | Vejovine | Free | Free | Linear | L | None | 47 | Antibacterial | HC50 =100μM | Human | Vejovine (scorpion venom of Vaejovis mexicanus) | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid} | Peptide 1 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 3.1 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}{cyc:N-C}{ct:Amid} | Peptide 2 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 1.6 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:ACPC}-L-{nnr:APC}-K-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:APC}-L-{nnr:ACPC}-L-{nnr:ACPC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid} | Peptide 3 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 100 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}{cyc:N-C}{ct:Amid} | Peptide 4 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 100 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}{cyc:N-C}{ct:Amid} | Peptide 5 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 1.6 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-F-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-F-{nnr:APC}-F-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}{cyc:N-C}{ct:Amid} | Peptide 6 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 1.6 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-A-{nnr:APC}-A-{nnr:ACPC}-K-{nnr:ACPC}-A-{nnr:APC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid} | Peptide 7 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at >400 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:APC}-L-{nnr:ACPC}-A-{nnr:APC}-A-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:ACPC}-K-{nnr:ACPC}-A-{nnr:APC}{cyc:N-C}{ct:Amid} | Peptide 8 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at 100 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 17212422 | 2007 | {nnr:ACPC}-A-{nnr:APC}-K-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:APC}-A-{nnr:ACPC}-A-{nnr:ACPC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid} | Peptide 9 | Amidation | Free | Cyclic | L | APC = APC, ACPC = ACPC | 15 | Antibacterial | >10% hemolysis at >400 μg/ml | Human | Synthetic peptide | NA | NA | ||
| 18779649 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | L-Pleurocidin | Amidation | Free | Linear | L | None | 25 | Antibacterial | 77% hemolysis at 100 μM | Human | Skin mucous of the winter flounder (Pleuronectes americanus ) | α-helix | NA | ||
| 18779649 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | L-Pleurocidin | Amidation | Free | Linear | L | None | 25 | Antibacterial | 29% hemolysis at 50 μM | Human | Skin mucous of the winter flounder (Pleuronectes americanus ) | α-helix | NA | ||
| 18779649 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | L-Pleurocidin | Amidation | Free | Linear | L | None | 25 | Antibacterial | 0% hemolysis at 3.13-25 μM | Human | Skin mucous of the winter flounder (Pleuronectes americanus ) | α-helix | NA | ||
| 18779649 | 2008 | G{d}W{d}G{d}S{d}F{d}F{d}K{d}K{d}A{d}A{d}H{d}V{d}G{d}K{d}H{d}V{d}G{d}K{d}A{d}A{d}L{d}T{d}H{d}Y{d}L{d}{ct:Amid} | D-Pleurocidin | Amidation | Free | Linear | D | None | 25 | Antibacterial | 19% hemolysis at 100 μM | Human | Skin mucous of the winter flounder (Pleuronectes americanus ) | α-helix | NA | ||
| 18779649 | 2008 | G{d}W{d}G{d}S{d}F{d}F{d}K{d}K{d}A{d}A{d}H{d}V{d}G{d}K{d}H{d}V{d}G{d}K{d}A{d}A{d}L{d}T{d}H{d}Y{d}L{d}{ct:Amid} | D-Pleurocidin | Amidation | Free | Linear | D | None | 25 | Antibacterial | 0% hemolysis at 3.13-50 μM | Human | Skin mucous of the winter flounder (Pleuronectes americanus ) | α-helix | NA | ||
| 19399781 | 2009 | {nnr:Aib}-GL-{nnr:Aib}-GGL-{nnr:Aib}-GI-LOL{nt:Acet}{ct:leucinol} | Trichogin GA IV | 1,2-aminoalcohol, Lol (leucinol) | Acetylated by lipol (n-octanoyl) | Linear | L | Aib = α-aminoisobutyric acid | 11 | Antifungal and Antibacterial | 2% hemolysis at 15 μM | Human | Trichogin GA IV (Trichoderma longibrachiatum) | mixed 310/α-helical | NA | ||
| 19399781 | 2009 | {nnr:Aib}-GL-{nnr:Aib}-GGL-{nnr:Aib}-GIL{nt:Acet}{ct:Methoxy(Ome)} | Tric-OMe | Methoxy (Ome) | Acetylated by lipol (n-octanoyl) | Linear | L | Aib = α-aminoisobutyric acid | 11 | Antifungal and Antibacterial | 2% hemolysis at 15 μM | Human | Trichogin GA IV analogue (Trichoderma longibrachiatum) | mixed 310/α-helical | NA | ||
| 19399781 | 2009 | {nnr:Aib}-GGL-{nnr:Aib}-GIL{nt:Acet}{ct:Methoxy(Ome)} | Tric-8 | Methoxy (Ome) | Acetylated by lipol (n-octanoyl) | Linear | L | Aib = α-aminoisobutyric acid | 8 | Antifungal and Antibacterial | 0% hemolysis at 15 μM (non-hemolytic) | Human | Trichogin GA IV analogue (Trichoderma longibrachiatum) | mixed 310/α-helical | Non-hemolytic | ||
| 19399781 | 2009 | {nnr:Aib}-GIL{nt:Acet}{ct:Methoxy(Ome)} | Tric-4 | Methoxy (Ome) | Acetylated by lipol (n-octanoyl) | Linear | L | Aib = α-aminoisobutyric acid | 4 | Antifungal and Antibacterial | 0% hemolysis at 15 μM (non-hemolytic) | Human | Trichogin GA IV analogue (Trichoderma longibrachiatum) | mixed 310/α-helical | Non-hemolytic | ||
| 19703772 | 2009 | KLLLKLWLKLLK{nt:Acet}{ct:Amid} | KL1 | Amidation | Acetylation | Linear | L | None | 12 | Antibacterial | 100% hemolysis at >50μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 19703772 | 2009 | K{nnr:Ψ[CH2NH]}LLLKLWLKLLK{nt:Acet}{ct:Amid} | KL2 | Amidation | Acetylation | Linear | L | nnr:Ψ[CH2NH] | 12 | Antibacterial | 100% hemolysis at 150μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 19703772 | 2009 | KLLLKLWL{Ψ[CH2NH]}KLLK{nt:Acet}{ct:Amid} | KL3 | Amidation | Acetylation | Linear | L | nnr:Ψ[CH2NH] | 12 | Antibacterial | Low hemolysis upto 200μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 20176897 | 2010 | G-{nnr:ΔF}-RK-{nnr:ΔF}-HK-{nnr:ΔF}-WA{nt:Acet}{ct:Amid} | ΔFm | Amidation | Acetylation | Linear | L | ΔF = α,β-didehydrophenylalanine | 10 | Antibacterial | 0% hemolysis upto 1358μg/ml (non-hemolytic) | Human | Synthetic peptide | Helical | Non-hemolytic | ||
| 20176897 | 2010 | G-{nnr:ΔF}-RK-{nnr:ΔF}-KA-{nnr:ΔF}-WH{nt:Acet}{ct:Amid} | ΔFmscr | Amidation | Acetylation | Linear | L | ΔF = α,β-didehydrophenylalanine | 10 | Antibacterial | 0% hemolysis upto 679μg/ml (non-hemolytic) | Human | Synthetic peptide | helical | Non-hemolytic | ||
| 20195659 | 2011 | IDWLKLGKMVMDVL{ct:Amid} | Polybia MP3 | Amidation | Free | Linear | L | None | 14 | Antibacterial | EC50 =50 μM | Rabbit | Venom sac of the Polybia paulista | helical | NA | ||
| 20195659 | 2011 | INWLKLGKMVIDAL{ct:Amid} | Polybia MP2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | EC50 =50 μM | Rabbit | Venom sac of the Polybia paulista | helical | NA | ||
| 20195659 | 2011 | IDWKKLLDAAKQIL{ct:Amid} | Polybia MP1 | Amidation | Free | Linear | L | None | 14 | Antibacterial | Non-hemolytic | Rabbit | Venom sac of the Polybia paulista | helical | NA | ||
| 20195659 | 2011 | INWKKLLDAAKQIL{ct:Amid} | Polybia N2-MP1 | Amidation | Free | Linear | L | None | 14 | Antibacterial | EC50 =26 μM | Rabbit | Venom sac of the Polybia paulista | helical | NA | ||
| 20196123 | 2010 | ILPWKWPWWPWRR{ct:Amid} | Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 50μM | Human | Indolicidin (bovine) | Random-coil | NA | ||
| 20196123 | 2010 | ILPLKWPWWPWRR{ct:Amid} | [L4]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 73% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKLPWWPWRR{ct:Amid} | [L6]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 88% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPLWPWRR{ct:Amid} | [L8]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 63% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPWLPWRR{ct:Amid} | [L9]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 6% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPWWPLRR{ct:Amid} | [L11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 13% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPLKLPLLPLRR{ct:Amid} | [L4,6,8,9,11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPFKFPFFPFRR{ct:Amid} | [F4,6,8,9,11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 6% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPYKYPYYPYRR{ct:Amid} | [Y4,6,8,9,11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 4% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPLKLPWWPWRR{ct:Amid} | [L4,6]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 8% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPKKKPWWPWRR{ct:Amid} | [K4,6]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 8% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPLLPWRR{ct:Amid} | [L8,9]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 18% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPYLPWRR{ct:Amid} | [Y8,L9]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 60% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPKLPWRR{ct:Amid} | [K8,L9]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | Non-hemolytic | ||
| 20196123 | 2010 | ILPWKWPWLPLRR{ct:Amid} | [L9,11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 3% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPWLPYRR{ct:Amid} | [L9,Y11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 12% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPWLPKRR{ct:Amid} | [L9,K11]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 3% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPKKWPKLPWRR{ct:Amid} | [K4,8,L9]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 7% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKKPKLPWRR{ct:Amid} | [K6,8,L9]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 11% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | ILPWKWPWLPWKK{ct:Amid} | [L9,K12,13]Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 8% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | RRWPWWPWKWPLI{ct:Amid} | Retro-Ind | Amidation | Free | Linear | L | None | 13 | Antibacterial | 36% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | RRWPLLPWKWPLI{ct:Amid} | Retro-[L8,9]Indb | Amidation | Free | Linear | L | None | 13 | Antibacterial | 11% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | RRWPLKPWKKPLI{ct:Amid} | Retro-[K4,8,L9]Indb | Amidation | Free | Linear | L | None | 13 | Antibacterial | 9% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20196123 | 2010 | RRWPLKPKKWPLI{ct:Amid} | Retro-[K6,8,L9]Indb | Amidation | Free | Linear | L | None | 13 | Antibacterial | 7% hemolysis at 50μM | Human | Indolicidin analog (synthetic peptide) | Random-coil | NA | ||
| 20927512 | 2011 | MSVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK | Tmp1 | Free | Free | Linear | L | None | 34 | Antibacterial | 0% hemolysis at 50μM (non-hemolytic) | Sheep | Tmp1 (goat skin surface metagenome) | α Helix | Non-hemolytic | ||
| 20927512 | 2011 | LGFGTFVLMLLGLVVELIK | TMDSP | Free | Free | Linear | L | None | 19 | Antibacterial | Mild hemolytic activity at 50μM | Sheep | Tmp1 (goat skin surface metagenome) | α Helix | NA | ||
| 20927512 | 2011 | MLSVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1RM1 | Free | Free | Linear | L | None | 35 | Antibacterial | 0% hemolysis at 50μM (non-hemolytic) | Sheep | Tmp1 (goat skin surface metagenome) | α Helix | Non-hemolytic | ||
| 20927512 | 2011 | MVSVSVAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1RM2 | Free | Free | Linear | L | None | 35 | Antibacterial | 0% hemolysis at 50μM (non-hemolytic) | Sheep | Tmp1 (goat skin surface metagenome) | α Helix | Non-hemolytic | ||
| 20927512 | 2011 | MESVSVAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1RM3 | Free | Free | Linear | L | None | 35 | Antibacterial | 0% hemolysis at 50μM (non-hemolytic) | Sheep | Tmp1 (goat skin surface metagenome) | α Helix | Non-hemolytic | ||
| 20927512 | 2011 | MLSLSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1RM4 | Free | Free | Linear | L | None | 35 | Antibacterial | 0% hemolysis at 50μM (non-hemolytic) | Sheep | Tmp1 (goat skin surface metagenome) | α Helix | Non-hemolytic | ||
| 20927512 | 2011 | MESVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1SDM1 | Free | Free | Linear | L | None | 35 | Antibacterial | 0% hemolysis at 50μM (non-hemolytic) | Sheep | Tmp1 (goat skin surface metagenome) | α Helix | Non-hemolytic | ||
| 20927512 | 2011 | MESQSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1SDM2 | Free | Free | Linear | L | None | 35 | Antibacterial | 0% hemolysis at 50μM (non-hemolytic) | Sheep | Tmp1 (goat skin surface metagenome) | α Helix | Non-hemolytic | ||
| 20927512 | 2011 | MESQSNAVQLMLGFGTFVLMLLGLVVELIKNSNKK | T1SDM3 | Free | Free | Linear | L | None | 35 | Antibacterial | 0% hemolysis at 50μM (non-hemolytic) | Sheep | Tmp1 (goat skin surface metagenome) | α Helix | Non-hemolytic | ||
| 21184776 | 2011 | NGVQPKY | Leucrocin I | Free | Free | Linear | L | None | 7 | Antibacterial | 15.88% hemolysis upto 48.0μg | Human | Leucrocin (serum and plasma of Crocodylus siamensis) | 28.57% Extended strand 71.43% Random coil | NA | ||
| 21184776 | 2011 | NAGSLLSGWG | Leucrocin II | Free | Free | Linear | L | None | 10 | Antibacterial | 91.73% hemolysis at 10μg | Human | Leucrocin (serum and plasma of Crocodylus siamensis) | 44.44% Extended strand 55.56% Random coil | NA | ||
| 21184776 | 2011 | NAGSLLSGWG | Leucrocin II | Free | Free | Linear | L | None | 10 | Antibacterial | 11.63% hemolysis at 6.0μg | Human | Leucrocin (serum and plasma of Crocodylus siamensis) | 45.44% Extended strand 55.56% Random coil | NA | ||
| 14709550 | 2004 | K{d}GGGK{d}WGGK{d}GGK{d}{nt:Palmitoylation}{ct:Amid} | PA-D-G | Amidation | Palmitoylation | Linear | Mix | None | 12 | Antifungal and Antibacterial | >75% hemolysis at 100µM | Human | Synthetic peptide | Random coils | NA | ||
| 14709550 | 2004 | KAA{d}A{d}KWAA{d}KA{d}AK{nt:Palmitoylation}{ct:Amid} | PA-D-A | Amidation | Palmitoylation | Linear | Mix | None | 12 | Antifungal and Antibacterial | <25% hemolysis at 100µM | Human | Synthetic peptide | Random coils | NA | ||
| 14709550 | 2004 | KVV{d}V{d}KWVV{d}KV{d}VK{nt:Palmitoylation}{ct:Amid} | PA-D-V | Amidation | Palmitoylation | Linear | Mix | None | 12 | Antifungal and Antibacterial | 100% hemolysis at 100µM | Human | Synthetic peptide | β-aggregates | NA | ||
| 14709550 | 2004 | KLL{d}L{d}KWLL{d}KL{d}LK{nt:Palmitoylation}{ct:Amid} | PA-D-L | Amidation | Palmitoylation | Linear | Mix | None | 12 | Antifungal and Antibacterial | >75% hemolysis at 100µM | Human | Synthetic peptide | α-helical | NA | ||
| 15298176 | 2004 | GLFGVLAKVAAHVVPAIAEHF{ct:Amid} | Mac | Amidation | Free | Linear | L | None | 21 | Antibacterial | 100% hemolysis at 100µM | Rabbit | Maculatin 1.1 from dorsal glands of the tree frog Litoria genimaculata | α-helical | NA | ||
| 15298176 | 2004 | GLFGVLAKVAAHVVPAIAKHF{ct:Amid} | [K19]Mac | Amidation | Free | Linear | L | None | 21 | Antibacterial | 100% hemolysis at 100µM | Rabbit | Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata) | α-helical | NA | ||
| 15298176 | 2004 | GLFGVLAKVAAKVVPAIAKHF{ct:Amid} | [K12,19]Mac | Amidation | Free | Linear | L | None | 21 | Antibacterial | 100% hemolysis at 100µM | Rabbit | Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata) | α-helical | NA | ||
| 15298176 | 2004 | GLFGVLAKVAAHVVAAIAEHF{ct:Amid} | [A15]Mac | Amidation | Free | Linear | L | None | 21 | Antibacterial | 100% hemolysis at 100µM | Rabbit | Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata) | α-helical | NA | ||
| 15298176 | 2004 | LFGVLAKVAAHVVPAIAEHF{ct:Amid} | [∆1]Mac | Amidation | Free | Linear | L | None | 20 | Antibacterial | ~10% hemolysis at 100µM | Rabbit | Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata) | α-helical | NA | ||
| 15752569 | 2005 | FLSLIPHAINAVSAIAKHN{ct:Amid} | PS-1 | Amidation | Free | Linear | L | None | 19 | Antibacterial and Antiprotozoan | 1.98% hemolysis at 64µM | Human | Skin secretion of the Brazilian tree-frogs, Phyllomedusa hypochondrialis and Phyllomedusa oreades | α-helical | NA | ||
| 15752569 | 2005 | FLSLIPHAINAVSTLVHHF{ct:Amid} | PS-2 | Amidation | Free | Linear | L | None | 19 | Antibacterial and Antiprotozoan | 2.05% hemolysis at 64µM | Human | Skin secretion of the Brazilian tree-frogs, Phyllomedusa hypochondrialis and Phyllomedusa oreades | α-helical | NA | ||
| 16730857 | 2006 | KLKFKLKQ{cyc:N-C} | BPC8L | Free | Free | Cyclic | L | None | 8 | Antibacterial | 68±7.5% hemolysis at 360µM | Human | Synthetic peptide | NA | NA | ||
| 16730857 | 2006 | KLKLKFKLKQ{cyc:N-C} | BPC10L | Free | Free | Cyclic | L | None | 10 | Antibacterial | 81 ± 5.3% hemolysis at 360µM | Human | Synthetic peptide | NA | NA | ||
| 16940084 | 2006 | QRLFQVKGRR | PBP 10 | Free | Free | Linear | L | None | 10 | Antibacterial | >40% hemolysis at 40 µM | Human | Derived from the polyphosphoinositide binding site of gelsolin | NA | NA | ||
| 17067722 | 2006 | MKLGLLVVLAVAVLVPSLSEGQNVPSCQLKDPNQTPVEAGNMRNKREADDSSEESDLAEI | Pp B | Free | Free | Linear | L | None | 60 | Antibacterial | 3.2 HU/mg | Horse | Grammistins (Pogonoperca punctata) | NA | NA | ||
| 17067722 | 2006 | IGGIISFFKRLF | Gs B | Free | Free | Linear | L | None | 12 | Antibacterial | <10 HU/mg | Horse | Grammistins (Pogonoperca punctata) | NA | NA | ||
| 17067722 | 2006 | MKLGLLVVLAVAVLVPSLSEQDFPSCQLKEPNQTPVEAGNMRNKREADESSEEFDLAEM | Pp l | Free | Free | Linear | L | None | 60 | Antibacterial | 79 HU/mg | Horse | Grammistins (Pogonoperca punctata) | NA | NA | ||
| 17067722 | 2006 | VKRALSALKPKNKRFIGGIISFFKRLFG | Pp 2b | Free | Free | Linear | L | None | 28 | Antibacterial | 63 HU/mg | Horse | Grammistins (Pogonoperca punctata) | NA | NA | ||
| 17688900 | 2007 | FLSLALAALPKFLCLVFKKC | Brevinin-1DYa | Free | Free | Linear | L | None | 20 | Antibacterial | LC50 <5 µM | Human | brevinin family (Rana dybowskii) | NA | NA | ||
| 17688900 | 2007 | FLSLALAALPKLFCLIFKKC | Brevinin-1DYb | Free | Free | Linear | L | None | 20 | Antibacterial | LC50 <5 µM | Human | brevinin family (Rana dybowskii) | NA | NA | ||
| 17688900 | 2007 | FLPLLLAGLPKLLCLFFKKC | Brevinin-1DYc | Free | Free | Linear | L | None | 20 | Antibacterial | LC50 <5 µM | Human | brevinin family (Rana dybowskii) | NA | NA | ||
| 15055772 | 2004 | KWKLFKKIPKFLHLAKKF{ct:Amid} | P18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | Non-hemolytic | Human | cecropin A-magainin 2 hybrid | NA | Non-hemolytic | ||
| 15298176 | 2004 | FGVLAKVAAHVVPAIAEHF{ct:Amid} | [∆1,2]Mac | Amidation | Free | Linear | L | None | 19 | Antibacterial | 0%hemolysis at 100µM (non-hemolytic) | Rabbit | Analog of Maculatin 1.1 (Mac) | NA | Non-hemolytic | ||
| 16730857 | 2006 | KFKQ{cyc:N-C} | BPC4L | Free | Free | Cyclic | L | None | 4 | Antibacterial | 0% hemolysis at 360µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16730857 | 2006 | KF{d}KQ{cyc:N-C} | BPC4D | Free | Free | Cyclic | Mix | None | 4 | Antibacterial | 0% hemolysis at 360µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16730857 | 2006 | KF{d}KLKQ{cyc:N-C} | BPC6D | Free | Free | Cyclic | Mix | None | 6 | Antibacterial | 0% hemolysis at 360µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16730857 | 2006 | KLKLKLKE{cyc:N-C} | BPC8S2 | Free | Free | Cyclic | L | None | 8 | Antibacterial | 0% hemolysis at 360µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 16730859 | 2006 | VTLASHLPSDFTPAVHASLDKFLANVSTVLTSKYR | α107–141 | Free | Free | Linear | L | None | 35 | Antibacterial | Non-hemolytic | Bovine | Bovine hemoglobin | NA | Non-hemolytic | ||
| 16730859 | 2006 | TSKYR | α137–141 | Free | Free | Linear | L | None | 5 | Antibacterial | Non-hemolytic | Bovine | Bovine hemoglobin | NA | Non-hemolytic | ||
| 16730859 | 2006 | STVLTSKYR | α133–141 | Free | Free | Linear | L | None | 9 | Antibacterial | Non-hemolytic | Bovine | Bovine hemoglobin | NA | Non-hemolytic | ||
| 16730859 | 2006 | VTLASHLPSDFTPAVHASLDKFLANVSTVL | a107–136 | Free | Free | Linear | L | None | 30 | Antibacterial | Non-hemolytic | Bovine | Bovine hemoglobin | NA | Non-hemolytic | ||
| 16730859 | 2006 | QADFQKVVAGVANALAHRYH | β126-145 | Free | Free | Linear | L | None | 20 | Antibacterial | Non-hemolytic | Bovine | Bovine hemoglobin | NA | Non-hemolytic | ||
| 10819172 | 2000 | KLLLKLLLKLLK{ct:Amid} | S1 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 100% hemolysis at 200µg/ml | Mouse | Synthetic peptide | NA | NA | ||
| 10819172 | 2000 | KLLΨ[CH2OCONH]LKLLLKLLK{ct:Amid} | SC1 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 100% hemolysis at 200µg/ml | Mouse | Synthetic peptide | NA | NA | ||
| 10819172 | 2000 | KLLΨ[CH2OCONH]LKLLLΨ[CH2OCONH]KLLK{ct:Amid} | SC2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | ~90% hemolysis at 200µg/ml | Mouse | Synthetic peptide | NA | NA | ||
| 23430306 | 2013 | LRRLWLRANRL | LRR-1 | Free | Free | Linear | L | None | 11 | Antibacterial | 0% hemolysis at 128µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 23430306 | 2013 | LRRLWLRANRLLRRLWLRANRL | LRR-2 | Free | Free | Linear | L | None | 22 | Antibacterial | ~70% hemolysis at 128µM | Human | Synthetic peptide | NA | NA | ||
| 21168461 | 2011 | AMNSQLTLIVTIVLIFSSSRCERILDLRKTKKSCKNGEVLGCVSGHGPPGCSENECGGPRPKACFFDCHYGCCMCTGKLYRRKRDRKCVPKHECLL | Rhamp | Free | Free | Linear | L | None | 96 | Antibacterial | Very little hemolysis at 10µM | Rabbit | Rhamp from the salivary glands of female tick Rhipicephalus haemaphysaloides | NA | NA | ||
| 11168895 | 2000 | GWGSFFKKAAHVGKHVGKAALTHYL | Pleurocidin | Free | Free | Linear | L | None | 25 | Antibacterial | 6% hemolysis at 100µM | Rabbit | Pleurocidin isolated from the skin mucous secretions of the winter flounder(Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | GWGSFFKKAAHVGKHVGKAALTHYL | Pleurocidin | Free | Free | Linear | L | None | 25 | Antibacterial | 15% hemolysis at 100µM | Human | Pleurocidin isolated from the skin mucous secretions of the winter flounder(Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | AWASFFKKAAHVGKHVGKAALTHYL | [A1,3]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 4% hemolysis at 100µM | Rabbit | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | AWASFFKKAAHVGKHVGKAALTHYL | [A1,3]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 8% hemolysis at 100µM | Human | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | GWGSFFKKAAHVAKHVAKAALTHYL | [A13,17]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 50% hemolysis at 100µM | Rabbit | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | GWGSFFKKAAHVAKHVAKAALTHYL | [A13,17]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 93% hemolysis at 100µM | Human | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | AWASFFKKAAHVAKHVAKAALTHYL | [A1,3,13,17]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 45% hemolysis at 100µM | Rabbit | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | AWASFFKKAAHVAKHVAKAALTHYL | [A1,3,13,17]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 90% hemolysis at 100µM | Human | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | GWGSFFKKAAAVGKAVGKAALTAYL | [A11,15,23]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 15% hemolysis at 100µM | Rabbit | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | GWGSFFKKAAAVGKAVGKAALTAYL | [A11,15,23]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 45% hemolysis at 100µM | Human | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11226440 | 2001 | VLSAADKGNVKAAWGKVGGHAAE | α 1-23 peptide | Free | Free | Linear | L | None | 23 | Antibacterial | 0% hemolysis upto 2.013 mM (non-hemolytic) | Bovine | Peptic bovine hemoglobin hydrolysate | NA | Non-hemolytic | ||
| 11557475 | 2001 | GFKLKGMARISCLPNGQWSNFPPKCIRECAMVSS | S1 | Free | Free | Linear | L | None | 34 | Antibacterial | 0% hemolysis at 100 µg/ml (non-hemolytic) | Human | Synthetic peptide (Factor C Sushi Peptides) | NA | Non-hemolytic | ||
| 11557475 | 2001 | GFKLKGKAKISCLPNGQWSNFPPKCIRECAMVSS | S1Δ | Free | Free | Linear | L | None | 34 | Antibacterial | 0% hemolysis at 100 µg/ml (non-hemolytic) | Human | Synthetic peptide (Factor C Sushi Peptides) | NA | Non-hemolytic | ||
| 11557475 | 2001 | HAEHKVKIGVEQKYGQFPQGTEVTYTCSGNYFLM | S3 | Free | Free | Linear | L | None | 34 | Antibacterial | 8% hemolysis at 100 µg/ml | Human | Synthetic peptide (Factor C Sushi Peptides) | NA | NA | ||
| 11557475 | 2001 | HAEHKVKIKVKQKYGQFPQGTEVTYTCSGNYFLM | S3Δ | Free | Free | Linear | L | None | 34 | Antibacterial | 37% hemolysis at 100 µg/ml | Human | Synthetic peptide (Factor C Sushi Peptides) | NA | NA | ||
| 11892852 | 2001 | FLPLLAGLAANFLPKIFCKITRKC{cyc:N-C} | Brevinin 1E (B) | Free | Free | Cyclic | L | None | 24 | Antibacterial | 100% hemolysis at 0.7μM | Rat | Brevinin 1E from the skin secretions of Rana esculenta | NA | NA | ||
| 11892852 | 2001 | FLPLLAGLAANFLPKIFC-{nnr:Acm}-KITRKC-{nnr:Acm} | Brevinin1E linear (BL) | Free | Free | Linear | L | Acm = acetamidomethyl | 26 | Antibacterial | 100% hemolysis at 5μM | Rat | Synthetic brevinin 1E variants (Rana esculenta) | NA | NA | ||
| 11892852 | 2001 | FLPLLAGLCKITRKCAANFLPKIF{cyc:N-C} | Analog of brevinin 1E (BA) | Free | Free | Cyclic | L | None | 24 | Antibacterial | 100% hemolysis at 7μM | Rat | Synthetic brevinin 1E variants (Rana esculenta) | NA | NA | ||
| 11892852 | 2001 | FLPLLAGLC-{nnr:Acm}-KITRKC-{nnr:Acm}-AANFLPKIF | Linear analog of brevinin 1E (BAL) | Free | Free | Linear | L | Acm = acetamidomethyl | 26 | Antibacterial | Non-hemolytic | Rat | Synthetic brevinin 1E variants (Rana esculenta) | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWKFKKIPKFLHLAKKF{ct:Amid} | P18 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWKLFKKILKFLHLAKKF{ct:Amid} | [L9]-P18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 88.6% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKISKFLHLAKKF{ct:Amid} | [S9]-P18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50.4% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | WKLFKKIPKFLHLAKKF{ct:Amid} | N-1 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 10.1% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | FKLFKKIPKFLHLAKKF{ct:Amid} | N-2 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 0.6% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWFKKIPKFLHLAKKF{ct:Amid} | N-3 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 1.8% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | WFKKIPKFLHLAKKF{ct:Amid} | N-4 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 1.5% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | WKKIPKFLHLAKKF{ct:Amid} | N-5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWFKKIPKFLHLLKKF{ct:Amid} | N-3L | Amidation | Free | Linear | L | None | 16 | Antibacterial | 27.3% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | WFKKIPKFLHLLKKF{ct:Amid} | N-4L | Amidation | Free | Linear | L | None | 15 | Antibacterial | 28.8% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | WKKIPKFLHLLKKF{ct:Amid} | N-5L | Amidation | Free | Linear | L | None | 14 | Antibacterial | 9.4% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKIPFLHLAKKF{ct:Amid} | C-1 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 30.3% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKIPKFLHLAKK{ct:Amid} | C-2 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 19.8% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKIPLHLAKKF{ct:Amid} | C-3 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 4.7% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKIPKFLHLAK{ct:Amid} | C-4 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWKLFKKIPHLAKKF{ct:Amid} | C-5 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWKLFKKIPKFLHLA{ct:Amid} | C-6 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 6.7% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKIPLAKKF{ct:Amid} | C-7 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWKLFKKIPKFLHL{ct:Amid} | C-8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12005420 | 2001 | KWKLFKKIPLKKF{ct:Amid} | C-9 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 6.2% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12005420 | 2001 | KWKLFKKIPKFLH{ct:Amid} | C-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 7.6% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12054688 | 2002 | ILGKIWEGIKSLF{ct:Amid} | IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | ~30% hemolysis at 200μM | Sheep | IsCT (Isolated from the venom of scorpion Opisthacanthus madagascariensis) | NA | NA | ||
| 12054688 | 2002 | ILGKIWEGIKS | IsCTf | Free | Free | Linear | L | None | 11 | Antibacterial and Antifungal | ~0% hemolysis at 200μM (non-hemolytic) | Sheep | IsCT analogs (Isolated from the venom of scorpion Opisthacanthus madagascariensis) | NA | Non-hemolytic | ||
| 12054688 | 2002 | IFGAIWNGIKSLF{ct:Amid} | IsCT2 | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | <20% hemolysis at 200μM | Sheep | IsCT analogs (Isolated from the venom of scorpion Opisthacanthus madagascariensis) | NA | NA | ||
| 12054688 | 2002 | IFGAIWNGIKS | IsCT2f | Free | Free | Linear | L | None | 11 | Antibacterial and Antifungal | ~0% hemolysis at 200μM (non-hemolytic) | Sheep | IsCT analogs (Isolated from the venom of scorpion Opisthacanthus madagascariensis) | NA | Non-hemolytic | ||
| 12110678 | 2002 | LKLLKKLLKKLLKLL{ct:Amid} | Amphipathic-1L | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 100μM | Human | Synthetic peptide | NA | NA | ||
| 12110678 | 2002 | KLKLLKLLKLLKLLK{ct:Amid} | Scrambled-4L | Amidation | Free | Linear | L | None | 15 | Antibacterial | 82% hemolysis at 100 µM | Human | Synthetic peptide | NA | NA | ||
| 12110678 | 2002 | KKKLLLLLLLLLKKK{ct:Amid} | Segregated-5L | Amidation | Free | Linear | L | None | 15 | Antibacterial | 66% hemolysis at 100 µM | Human | Synthetic peptide | NA | NA | ||
| 12110678 | 2002 | LKL{d}LKK{d}LL{d}K{d}KLLK{d}LL{ct:Amid} | Amphipathic-1D | Amidation | Free | Linear | Mix | None | 15 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12110678 | 2002 | LLK{d}KLL{d}KL{d}L{d}LKLL{d}KK{ct:Amid} | Amphipathic-2D | Amidation | Free | Linear | Mix | None | 15 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12110678 | 2002 | LLK{d}LLK{d}KL{d}L{d}KKLL{d}KL{ct:Amid} | Amphipathic-3D | Amidation | Free | Linear | Mix | None | 15 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12110678 | 2002 | KLK{d}LLK{d}LL{d}K{d}LLKL{d}LK{ct:Amid} | Scrambled-4D | Amidation | Free | Linear | Mix | None | 15 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12110678 | 2002 | KKK{d}LLL{d}LL{d}L{d}LLLK{d}KK{ct:Amid} | Scrambled-5D | Amidation | Free | Linear | Mix | None | 15 | Antibacterial | 3% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 12110678 | 2002 | LLL{d}LLK{d}KK{d}K{d}KKLL{d}LL{ct:Amid} | Scrambled-6D | Amidation | Free | Linear | Mix | None | 15 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 12207877 | 2002 | VRRFPWWWPFLRR | Tritrpticin | Free | Free | Linear | L | None | 13 | Antibacterial and Antifungal | >80% hemolysis at 200µg/ml | Human | Tritrpticin | NA | NA | ||
| 12207877 | 2002 | VRRFGWWWGFLRR | TPG | Free | Free | Linear | L | None | 13 | Antibacterial and Antifungal | >60% hemolysis at 200µg/ml | Human | Tritrpticin analogs | NA | NA | ||
| 12207877 | 2002 | VRRFAWWWAFLRR | TPA | Free | Free | Linear | L | None | 13 | Antibacterial and Antifungal | ~ 90% hemolysis at 200µg/ml | Human | Tritrpticin analogs | NA | NA | ||
| 12207877 | 2002 | VRRFPFFFPFLRR | TWF | Free | Free | Linear | L | None | 13 | Antibacterial and Antifungal | 0% hemolysis at 200µg/ml (non-hemolytic) | Human | Tritrpticin analogs | NA | Non-hemolytic | ||
| 12207877 | 2002 | VRRFPAAAPFLRR | TWA | Free | Free | Linear | L | None | 13 | Antibacterial and Antifungal | 0% hemolysis at 200µg/ml (non-hemolytic) | Human | Tritrpticin analogs | NA | Non-hemolytic | ||
| 12207877 | 2002 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | ~ 80% hemolysis at 200µg/ml | Human | Indolicidin | NA | NA | ||
| 12297012 | 2002 | GSKKPVPIIYCNRRTGKCQRM | Thanatin | Free | Free | Linear | L | None | 21 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12297012 | 2002 | GSKKPVPIIYCNRRGKCQRM | Th1 | Free | Free | Linear | L | None | 20 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin analogs (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12297012 | 2002 | GSKKPVPIIYCNRRTKCQRM | Th2 | Free | Free | Linear | L | None | 20 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin analogs (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12297012 | 2002 | GSKKPVPIIYCNRRKCQRM | Th3 | Free | Free | Linear | L | None | 19 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin analogs (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12297012 | 2002 | GSKKPVPIIYCNRRATGKCQRM | Th4 | Free | Free | Linear | L | None | 22 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin analogs (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12297012 | 2002 | GSKKPVPIIYCNRRAATGKCQRM | Th5 | Free | Free | Linear | L | None | 23 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin analogs (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12297012 | 2002 | GSKKPVPIIYANRRTGKAQRM | Th6 | Free | Free | Linear | L | None | 21 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin analogs (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12354111 | 2002 | GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNLVAEKIGAATPS | Opistoporin 1 | Free | Free | Linear | L | None | 45 | Antibacterial and Antifungal | ~30% hemolysis at 100 μM | Human | Opistoporin 1(Isolated from venom of Opistophtalmus carinatus) | NA | NA | ||
| 12354111 | 2002 | FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ | Parabutoporin | Free | Free | Linear | L | None | 45 | Antibacterial and Antifungal | ~60% hemolysis at 100 μM | Human | Parabutoporin (Isolated from venom of Parabuthus schlechteri) | NA | NA | ||
| 12404639 | 2002 | LRLKYRRFKYRV{cyc:N-C} | Mimetic 1 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 27% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LRLQYRRFQYRV{cyc:N-C} | Mimetic 2 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 27% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LRLEYRRFEYRV{cyc:N-C} | Mimetic 3 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 14% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LRLKKRRWKYRV{cyc:N-C} | Mimetic 4 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 1% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LRLKKRRWKYRV{cyc:N-C} | Mimetic 5 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 13% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LCLKKRRWKYCV{cyc:N-C} | Mimetic 6 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 3% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12404639 | 2002 | LRCKKRRWKCRV{cyc:N-C} | Mimetic 7 | Free | Free | Cyclic | L | None | 12 | Antibacterial | 1% hemolysis at 100µg ml-1 | Human | Synthetic peptide | NA | NA | ||
| 12581207 | 2003 | FFGWLIKGAIHAGKAIHGLIHRRRH{ct:Amid} | Chrysophsin-1 | Amidation | Free | Linear | L | None | 25 | Antibacterial | 100% hemolysis at 1μM | Human | Synthetic peptide | NA | NA | ||
| 12581207 | 2003 | FFGWLIRGAIHAGKAIHGLIHRRRH{ct:Amid} | Chrysophsin-2 | Amidation | Free | Linear | L | None | 25 | Antibacterial | 100% hemolysis at 1 μM | Human | Synthetic peptide | NA | NA | ||
| 12581207 | 2003 | FIGLLISAGKAIHDLIRRRH{ct:Amid} | Chrysophsin-3 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 100% hemolysis at 5 μM | Human | Synthetic peptide | NA | NA | ||
| 12569105 | 2003 | FFHLHFH-{nnr:dcΔDOPA}{cyc:N-C} | Plicatamide | Free | Free | Cyclic | L | dcΔDOPA = decarboxy-(E)α,β-dehydro3,4-dihydroxyphenylalanine | 8 | Antibacterial | 100% hemolysis at ~40 μM | Human | Plicatamide (Styela plicata) | NA | NA | ||
| 12569105 | 2003 | FFHLHFH-{nnr:dcΔDOPA}{cyc:N-C} | Plicatamide | Free | Free | Cyclic | L | dcΔDOPA = decarboxy-(E)α,β-dehydro3,4-dihydroxyphenylalanine | 8 | Antibacterial | ~10% hemolysis at 80μM | Sheep | Plicatamide (Styela plicata) | NA | NA | ||
| 12712499 | 2003 | V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | Y{d}PY{d}P{cyc:N-C} | GS4 | Free | Free | Cyclic | Mix | None | 4 | Antibacterial and Antifungal | 100% hemolysis at >150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | KY{d}PKY{d}P{cyc:N-C} | GS6 | Free | Free | Cyclic | Mix | None | 6 | Antibacterial and Antifungal | 100% hemolysis at >150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKY{d}PKLY{d}P{cyc:N-C} | GS8 | Free | Free | Cyclic | Mix | None | 8 | Antibacterial and Antifungal | 100% hemolysis at >150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLY{d}PVKLY{d}P{cyc:N-C} | GS10 | Free | Free | Cyclic | Mix | None | 10 | Antibacterial and Antifungal | 100% hemolysis at 51–100 µg/mL | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKY{d}PKVKLY{d}P{cyc:N-C} | GS12 | Free | Free | Cyclic | Mix | None | 12 | Antibacterial and Antifungal | 100% hemolysis at >150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at <15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | V{d}KLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14V1 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/m | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14K2 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/m | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C} | GS14L3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at <15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at >150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C} | GS14V5 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 100–150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVYPLKVKLY{d}P{cyc:N-C} | GS14Y6 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/m | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}P{d}L{d}KVKLY{d}P{cyc:N-C} | GS14P7 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at <15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C} | GS14L8 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C} | GS14K9 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 51–100 µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLKV{d}KLY{d}P{cyc:N-C} | GS14V10 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at <15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C} | GS14K11 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 100–150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C} | GS14L12 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLKVKLYP{cyc:N-C} | GS14Y13 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at < 15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C} | GS14P14 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at < 15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKKLVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 K3L4 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 100–150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | LKLK{d}LF{d}PLKLKLF{d}P{cyc:N-C} | GS14K4 Y2/F2, V3/L3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at < 15µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | LKLK{d}LY{d}PLKLKLY{d}P{cyc:N-C} | GS14K4 V3/L3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLK{d}VF{d}PLKVKLF{d}P{cyc:N-C} | GS14K4 Y2/F2 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 15-50µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at > 150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | AKLK{d}AY{d}PLKAKLY{d}P{cyc:N-C} | GS14K4 V3/A3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at > 150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | VKAK{d}VY{d}PAKVKAY{d}P{cyc:N-C} | GS14K4 L3/A3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at > 150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12712499 | 2003 | AKAK{d}AY{d}PAKAKAY{d}P{cyc:N-C} | GS14K4 V3L3/A6 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at > 150µg/ml | Human | Gramicidin S analogs | NA | NA | ||
| 12963031 | 2003 | HVDKKVADKVLLLKQLRIMRLLTRL | Spinigerin | Free | Free | Linear | L | None | 25 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Spinigerin isolated from the fungus-growing termite Pseudacanthotermes spiniger | NA | Non-hemolytic | ||
| 12963031 | 2003 | KKVADKVLLLKQLRIMRL | Spinigerin (4–21) | Free | Free | Linear | L | None | 18 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Spinigerin truncate isolated from the fungus-growing termite Pseudacanthotermes spiniger | NA | Non-hemolytic | ||
| 14514057 | 2003 | KWKLFKKIGIGKFLHSAKKF{ct:Amid} | CA-MA | Amidation | Free | Linear | L | None | 20 | Antibacterial and Antitumor | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14514057 | 2003 | KWKKLLKKPLLKKLLKKL{ct:Amid} | CA-MA analogue P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial and Antitumor | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14514057 | 2003 | KWKLKPLLKKLLKKL{ct:Amid} | P6 | Amidation | Free | Linear | L | None | 15 | Antibacterial and Antitumor | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14514057 | 2003 | KWKKLLKKPLKLKL{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 14 | Antibacterial and Antitumor | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14514057 | 2003 | KPLLKKLLKKL{ct:Amid} | P8 | Amidation | Free | Linear | L | None | 11 | Antibacterial and Antitumor | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14514057 | 2003 | KLLKKPLKLKL{ct:Amid} | P9 | Amidation | Free | Linear | L | None | 11 | Antibacterial and Antitumor | 0% hemolysis at 100µM (non-hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 14531844 | 2003 | FLPILASLAAKFGPKLFCLVTKKC | Brevinin-1BYa | Free | Free | Linear | L | None | 24 | Antibacterial | HC50 = 4µM | Human | Brevinin-1B analog | NA | NA | ||
| 14531844 | 2003 | FLPILASLAAKLGPKLFCLVTKKC | Brevinin-1BYb | Free | Free | Linear | L | None | 24 | Antibacterial | HC50 = 4µM | Human | Brevinin-1B analog | NA | NA | ||
| 14531844 | 2003 | FLPILASLAATLGPKLLCLITKKC | Brevinin-1BYc | Free | Free | Linear | L | None | 24 | Antibacterial | Non-hemolytic | Human | Brevinin-1B analog(Rana boylii) | α-helix | Non-hemolytic | ||
| 14531844 | 2003 | GILSTFKGLAKGVAKDLAGNLLDKFKCKITGC | Ranatuerin-2BYa | Free | Free | Linear | L | None | 32 | Antibacterial | HC50 = 120µM | Human | Ranatuerin-2B analog | NA | NA | ||
| 14531844 | 2003 | GIMDSVKGLAKNLAGKLLDSLKCKITGC | Ranatuerin-2BYb | Free | Free | Linear | L | None | 28 | Antibacterial | HC50 >200µM | Human | Ranatuerin-2B analog | NA | NA | ||
| 14531844 | 2003 | FLPIIAKVLSGLL{ct:Amid} | Temporin-1BYa | Amidation | Free | Linear | L | None | 13 | Antibacterial | Non-hemolytic | Human | Temporin-1B analog(Rana boylii) | NA | Non-hemolytic | ||
| 15019213 | 2003 | AKKVFKRLEKLFSKIQNDK | HP (2–20) | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal | <20% hemolysis at 2.15 to 215µM | Human | N-terminus of Helicobacter pylori ribosomal protein 1, HpRpL1 | NA | NA | ||
| 14642822 | 2003 | GYGCPFNQYQCHSHCSGIRGYKGGYCKGTFKQTCKCY | Ornithodoros defensin A | Free | Free | Linear | L | None | 37 | Antibacterial | EC50 >100 (µg/ml) | Human | Synthetic peptide | NA | NA | ||
| 14642822 | 2003 | GYGCPFNQYQCHSHCSGIRGYKGGYCKGTFKQTCKCY | Ornithodoros defensin A | Free | Free | Linear | L | None | 37 | Antibacterial | EC50 >100 (µg/ml) | Rabbit | Synthetic peptide | NA | NA | ||
| 14642822 | 2003 | LTCDLLSFEAKGFAANHSLCAAHCLAIGRKGGACQNGVCVCRR | Oryctes defensin | Free | Free | Linear | L | None | 43 | Antibacterial | EC50 >100 (µg/ml) | Human | Synthetic peptide | NA | NA | ||
| 14642822 | 2003 | LTCDLLSFEAKGFAANHSLCAAHCLAIGRKGGACQNGVCVCRR | Oryctes defensin | Free | Free | Linear | L | None | 43 | Antibacterial | EC50 >100 (µg/ml) | Rabbit | Synthetic peptide | NA | NA | ||
| 14596922 | 2003 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial | HC10 = 1.78 μg/ml | Human | Melittin | NA | NA | ||
| 14596922 | 2003 | GLPALISWIKRKRQQ{ct:Amid} | Mel(12-26) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 4500 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | LLPALISWIKRKRQQ{ct:Amid} | Mel(12-26,L1) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 192 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GSPALISWIKRKRQQ{ct:Amid} | Mel(12-26,S2) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 1588 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLLALISWIKRKRQQ{ct:Amid} | Mel(12-26,L3) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 35.2 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLSALISWIKRKRQQ{ct:Amid} | Mel(12-26,S3) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 44 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPLLISWIKRKRQQ{ct:Amid} | Mel(12-26,L4) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 203 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPASISWIKRKRQQ{ct:Amid} | Mel(12-26,S5) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 3840 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPALSSWIKRKRQQ{ct:Amid} | Mel(12-26,S6) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 650 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPALILWIKRKRQQ{ct:Amid} | Mel(12-26,L7) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 15.4 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPALISLIKRKRQQ{ct:Amid} | Mel(12-26,L8) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 9350 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPALISSIKRKRQQ{ct:Amid} | Mel(12-26,S8) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 13800 μg/ml | Human | Melittin analogs | NA | NA | ||
| 14596922 | 2003 | GLPALISWSKRKRQQ{ct:Amid} | Mel(12-26,S9) | Amidation | Free | Linear | L | None | 15 | Antibacterial | HC10 = 6140 μg/ml | Human | Melittin analogs | NA | NA | ||
| 15752569 | 2005 | FLSLIPHAINAVSAIAKHN{ct:Amid} | PS-1 | Amidation | Free | Linear | L | None | 19 | Antibacterial and Antiprotozoa | 1.98% hemolysis at 64µM | Human | Phylloseptin analogs isolated from the skin secretion of the Brazilian tree-frogs, Phyllomedusa hypochondrialis and Phyllomedusa oreades | NA | NA | ||
| 15752569 | 2005 | FLSLIPHAINAVSTLVHHF{ct:Amid} | PS-2 | Amidation | Free | Linear | L | None | 19 | Antibacterial and Antiprotozoa | 2.05% hemolysis at 64µM | Human | Phylloseptin analogs isolated from the skin secretion of the Brazilian tree-frogs, Phyllomedusa hypochondrialis and Phyllomedusa oreades | NA | NA | ||
| 15581850 | 2004 | SIGSALKKALPVAKKIGKIALPIAKAALPVAAGLVG | CtxA | Free | Free | Linear | L | None | 36 | Antibacterial | Hemolytic at 110 µM | Human | Ceratotoxins are α-helical cationic peptides isolated from the medfly Ceratitis capitata | NA | NA | ||
| 15581850 | 2004 | SLGGVISGAKKVAKVAIPIGKAVLPVVAKLVG | CtxC | Free | Free | Linear | L | None | 32 | Antibacterial | Hemolytic 645µM | Human | Ceratotoxins are α-helical cationic peptides isolated from the medfly Ceratitis capitata | NA | NA | ||
| 15581850 | 2004 | SIGTAVKKAVPIAKKVGKVAIPIAKAVLSVVGQLVG | CtxD | Free | Free | Linear | L | None | 36 | Antibacterial | Hemolytic at 84µM | Human | Ceratotoxins are α-helical cationic peptides isolated from the medfly Ceratitis capitata | NA | NA | ||
| 15581850 | 2004 | SIGSALKKALPVAKKIGKIALPIAKAALP | CtxA1–29 | Free | Free | Linear | L | None | 29 | Antibacterial | Hemolytic at 960µM | Human | Ceratotoxins are α-helical cationic peptides isolated from the medfly Ceratitis capitata | NA | NA | ||
| 15328096 | 2004 | CVKVKVKVGSGVKVKVKVC{cyc:N-C}{nt:Acet}{ct:Amid} | V1 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 880000 nM | Human | Synthetic peptide | NA | NA | ||
| 15328096 | 2004 | CVKVSVKVGSGVKVSVKVC{cyc:N-C}{nt:Acet}{ct:Amid} | V2 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 5,89,000 nM | Human | Synthetic peptide | NA | NA | ||
| 15328096 | 2004 | CVKVRVKVGSGVKVRVKVC{cyc:N-C}{nt:Acet}{ct:Amid} | V3 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 590000 nM | Human | Synthetic peptide | NA | NA | ||
| 15328096 | 2004 | CVKVQVKVGSGVKVQVKVC{cyc:N-C}{nt:Acet}{ct:Amid} | V4 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 3226000 nM | Human | Synthetic peptide | NA | NA | ||
| 15328096 | 2004 | CAKAKAKAGSGAKAKAKAC{cyc:N-C}{nt:Acet}{ct:Amid} | V5 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 1055000 nM | Human | Synthetic peptide | NA | NA | ||
| 15328096 | 2004 | CFKFKFKFGSGFKFKFKFC{cyc:N-C}{nt:Acet}{ct:Amid} | V6 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 35000 nM | Human | Synthetic peptide | NA | NA | ||
| 15328096 | 2004 | CWKWKWKWGSGWKWKWKWC{cyc:N-C}{nt:Acet}{ct:Amid} | V7 | Amidation | Acetylation | Cyclic | L | None | 19 | Antibacterial | EC50 = 45000 nM | Human | Synthetic peptide | NA | NA | ||
| 12081622 | 2002 | ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE | CRAMP | Free | Free | Linear | L | None | 38 | Antibacterial | 0% hemolysis at 50 µM (non-hemolytic) | Human | CRAMP (Mouse femoral marrow cells) | NA | Non-hemolytic | ||
| 12147359 | 2002 | AKKVFKRLEKLFSKIQNWK | Anal 1 | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal and Anticancer | 0% hemolysis at 100μM (non-hemolytic) | Human | HP (2 – 20) analogs (Helicobacter pylori) | NA | Non-hemolytic | ||
| 12147359 | 2002 | AKKVFKRLEKLFSKIWNDK | Anal 2 | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal and Anticancer | 0% hemolysis at 100μM (non-hemolytic) | Human | HP (2 – 20) analogs (Helicobacter pylori) | NA | Non-hemolytic | ||
| 12147359 | 2002 | AKKVFKRLEKLFSKIWNWK | Anal 3 | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal and Anticancer | 0% hemolysis at 100μM (non-hemolytic) | Human | HP (2 – 20) analogs (Helicobacter pylori) | NA | Non-hemolytic | ||
| 12147359 | 2002 | AKKVFKRLEKSFSKIQNDK | Anal 4 | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal and Anticancer | 0% hemolysis at 100μM (non-hemolytic) | Human | HP (2 – 20) analogs (Helicobacter pylori) | NA | Non-hemolytic | ||
| 12147359 | 2002 | AKKVSKRLEKLFSKIQNDK | Anal 5 | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal and Anticancer | 0% hemolysis at 100μM (non-hemolytic) | Human | HP (2 – 20) analogs (Helicobacter pylori) | NA | Non-hemolytic | ||
| 15572194 | 2004 | SADLVKKIWDNPAL{nt:Acet}{ct:Amid} | Polybine-I | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 0% hemolysis at 100μM (non-hemolytic) | Rat | Polybine-I (From venom of Polybia paulista) | NA | Non-hemolytic | ||
| 15572194 | 2004 | SVDMVMKGLKIWPL{nt:Acet}{ct:Amid} | Polybine-II | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 0% hemolysis at 100μM (non-hemolytic) | Rat | Polybine-II (From venom of Polybia paulista) | NA | Non-hemolytic | ||
| 15546886 | 2005 | GCRFCCNCCPNMSGCGVCCRF | Bass Hepcidin | Free | Free | Linear | L | None | 21 | Antibacterial and Antifungal | 0% hemolysis at 100 µg/ml (non-hemolytic) | Rat | Bass hepcidin (Morone chrysops x Morone saxatilis) | NA | Non-hemolytic | ||
| 15358153 | 2004 | AKKVFKRLEKLFSKIQNDK{ct:Amid} | HP (2–20) | Amidation | Free | Linear | L | None | 19 | Antibacterial | 0% hemolysis at 140µg/ml (non-hemolytic) | Human | HP (2–20) (Helicobacter pylori) | NA | Non-hemolytic | ||
| 15369808 | 2004 | ILGKIWEGIKSLF{ct:Amid} | IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | 80% hemolysis at 100µM | Human | IsCT | NA | NA | ||
| 15369808 | 2004 | ILGKIAEGIKSLF{ct:Amid} | [A6]-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | 0% hemolysis at 100µM (non-hemolytic) | Human | IsCT analogs (Opisthacanthus madagascariensis) | NA | Non-hemolytic | ||
| 15369808 | 2004 | ILGKILEGIKSLF{ct:Amid} | [L6]-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | ~20% hemolysis at 100µM | Human | IsCT analogs (Opisthacanthus madagascariensis) | NA | NA | ||
| 15369808 | 2004 | ILGKIWKGIKSLF{ct:Amid} | [K7]-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | ~50% hemolysis at 100µM | Human | IsCT analogs (Opisthacanthus madagascariensis) | NA | NA | ||
| 15369808 | 2004 | ILGKILKGIKKLF{ct:Amid} | [L6, K11]-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial and Antifungal | ~20% hemolysis at 100µM | Human | IsCT analogs (Opisthacanthus madagascariensis) | NA | NA | ||
| 15369808 | 2004 | ILGKIWKIKKLF{ct:Amid} | [K7, P8, K11]-IsCT | Amidation | Free | Linear | L | None | 12 | Antibacterial and Antifungal | 0% hemolysis at 100µM (non-hemolytic) | Human | IsCT analogs (Opisthacanthus madagascariensis) | NA | Non-hemolytic | ||
| 12878508 | 2003 | WLNALLHHGLNCAKGVLA{ct:Amid} | 18Hc | Amidation | Free | Linear | L | None | 18 | Antibacterial | ~20% hemolysis at 100µg/ml | Human | Synthetic Analogs of Halocidin (Tunicate Halocynthia aurantium) | NA | NA | ||
| 12878508 | 2003 | WLNALLKKGLNCAKGVLA{ct:Amid} | 18HcKK | Amidation | Free | Linear | L | None | 18 | Antibacterial | <10% hemolysis at 100µg/ml | Human | Synthetic Analogs of Halocidin (Tunicate Halocynthia aurantium) | NA | NA | ||
| 12878508 | 2003 | KWLNALLHHGLNCAKGVLA{ct:Amid} | K19Hc | Amidation | Free | Linear | L | None | 19 | Antibacterial | ~10% hemolysis at 100µg/ml | Human | Synthetic Analogs of Halocidin (Tunicate Halocynthia aurantium) | NA | NA | ||
| 12878508 | 2003 | KWLNALLKKGLNCAKGVLA{ct:Amid} | K19HcKK | Amidation | Free | Linear | L | None | 19 | Antibacterial | <10% hemolysis at 100µg/ml | Human | Synthetic Analogs of Halocidin (Tunicate Halocynthia aurantium) | NA | NA | ||
| 12878508 | 2003 | KWKLFKKIPKFLHLAKKF{ct:Amid} | P18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | <0% hemolysis at 100µg/ml | Human | P18 (Halocynthia aurantium) | NA | Non-hemolytic | ||
| 11846794 | 2002 | RLYR | RLYR | Free | Free | Linear | L | None | 4 | Antibacterial and Antifungal | EC50 = 5200µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRRLYR | (RLYR)2 | Free | Free | Linear | L | None | 8 | Antibacterial and Antifungal | EC50 = 1950µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRRLYRRLYRRLYR | (RLYR)4 | Free | Free | Linear | L | None | 16 | Antibacterial and Antifungal | EC50 = 338µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRRLYRRLYRRLYRRLYRRLYRRLYRRLYR | (RLYR)8 | Free | Free | Linear | L | None | 32 | Antibacterial and Antifungal | EC50 = 48µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRRLYRK | (RLYR)2-[K] | Free | Free | Linear | L | None | 19 | Antibacterial and Antifungal | EC50 = 3700µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRRLYRRLYRRLYRKKK | (RLYR)4-[K2K] | Free | Free | Linear | L | None | 35 | Antibacterial and Antifungal | EC50 = 1510µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRRLYRRLYRRLYRRLYRRLYRRLYRKKKKK | (RLYR)8-([K2K]2K) | Free | Free | Linear | L | None | 8 | Antibacterial and Antifungal | EC50 = 1514µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRKVYG{cyc:N-C} | RLYRKVYG | Free | Free | Cyclic | L | None | 17 | Antibacterial and Antifungal | EC50 = 3950µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRKVYGRLYRKVYGK{cyc:N-C} | (RLYRKVYG)2-[K] | Free | Free | Cyclic | L | None | 17 | Antibacterial and Antifungal | EC50 = 1420µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGKKK{cyc:N-C} | (RLYRKVYG)4-[K2K] | Free | Free | Cyclic | L | None | 35 | Antibacterial and Antifungal | EC50 = 610µM | Human | Synthetic peptide | NA | NA | ||
| 11846794 | 2002 | RLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGKKKKK{cyc:N-C} | (RLYRKVYG)8 (K2K)2K | Free | Free | Cyclic | L | None | 63 | Antibacterial and Antifungal | EC50 = 112µM | Human | Synthetic peptide | NA | NA | ||
| 10819172 | 2000 | KLLLKLLLKLLK{cyc:N-C}{ct:Amid} | S1 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial | 100% hemolysis at 200µg/ml | Mouse | Synthetic peptide | NA | NA | ||
| 10819172 | 2000 | KLLLKLLLKLLK{cyc:N-C}{ct:Amid} | SC1 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial | 100% hemolysis at 200µg/ml | Mouse | Synthetic peptide | NA | NA | ||
| 10819172 | 2000 | KLLLKLLLKLLK{cyc:N-C}{ct:Amid} | SC2 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial | ~90% hemolysis at 200µg/ml | Mouse | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | VKLKVY{d}PLKVKLY{d}P{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 1.5µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | LKLK{d}LF{d}PLKLKLF{d}P{cyc:N-C} | Y2/F2, V3/L3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 12.5µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | LKLK{d}LY{d}PLKLKLY{d}P{cyc:N-C} | V3/L3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 25µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | VKLK{d}VF{d}PLKVKLF{d}P{cyc:N-C} | Y2/F2 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 40µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C} | GS14K4 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at 200µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | AKLK{d}AY{d}PLKAKLY{d}P{cyc:N-C} | V3/A3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at >800µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | VKAK{d}VY{d}PAKVKAY{d}P{cyc:N-C} | L3/A3 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at >800µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11682479 | 2002 | AKAK{d}AY{d}PAKAKAY{d}P{cyc:N-C} | V3L3/A6 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial and Antifungal | 100% hemolysis at >800µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11779154 | 2002 | RIIDLLWRVRRPQKPKFVTVWVR | PMAP-23 | Free | Free | Linear | L | None | 23 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Porcine myeloid antibacterial peptide | NA | Non-hemolytic | ||
| 12168695 | 2002 | GIGAVLKVLTTGLP{d}ALISWIKRKRQQ{ct:Amid} | Melittin-1 | Amidation | Free | Linear | Mix | None | 26 | Antibacterial | 50% hemolysis at >200µg/ml | Human | Melittin analogs | NA | NA | ||
| 12168695 | 2002 | GIGAVLKVLTTGLP{d}ALISWIKFKRQQ{ct:Amid} | Melittin-2 | Amidation | Free | Linear | Mix | None | 26 | Antibacterial | 50% hemolysis at >80µg/ml | Human | Melittin analogs | NA | NA | ||
| 12168695 | 2002 | GIGAVLKVLTTGLP{d}ALISWIKXXKRQQ{ct:Amid} | Melittin-1P | Amidation | Free | Linear | Mix | None | 27 | Antibacterial | 50% hemolysis at >18µg/ml | Human | Melittin analogs | NA | NA | ||
| 12168695 | 2002 | GIGAVLKVLTTGLP{d}ALISWIKXKRQQ{nt:Acet}{ct:Amid} | Melittin-A1P | Amidation | Acetylation | Linear | Mix | None | 26 | Antibacterial | 50% hemolysis at >200µg/ml | Human | Melittin analogs | NA | NA | ||
| 12168695 | 2002 | GIGAVLKVLTTGLP{d}ALISWIKRKRQQ{nt:Acet}{ct:Amid} | Melittin-A1 | Amidation | Acetylation | Linear | Mix | None | 26 | Antibacterial | 50% hemolysis at >200µg/ml | Human | Melittin analogs | NA | NA | ||
| 12429503 | 2002 | GIFPKIIGKGIVNGIKSLAKGVGMKVFKAGLNNIGNTGCNNRDEC | Palustrin-3AR | Free | Free | Linear | L | None | 45 | Antibacterial | HC50 = 200µM | Human | Palustrin-3 analog (Rana areolata) | NA | NA | ||
| 12429503 | 2002 | GIFSKINKKKAKTGLFNIIKTVGKEAGMDVIRAGIDTISCKIKGEC | Esculentin-1ARa | Free | Free | Linear | L | None | 46 | Antibacterial | HC50 = 180µM | Human | Esculentin-1 analog (Rana areolata) | NA | NA | ||
| 12429503 | 2002 | GLFPKFNKKKVKTGIFDIIKTVGKEAGMDVLRTGIDVIGCKIKGEC | Esculentin-1ARb | Free | Free | Linear | L | None | 46 | Antibacterial | HC50 = 120µM | Human | Esculentin-1 analog (Rana areolata) | NA | NA | ||
| 12429503 | 2002 | GLMDTVKNAAKNLAGQLLDTIKCKMTGC | Ranatuerin-2ARa | Free | Free | Linear | L | None | 28 | Antibacterial | HC50 = 100µM | Human | Ranatuerin-2 analog (Rana areolata) | NA | NA | ||
| 12429503 | 2002 | GILDTIKNAAKTVAVGLLEKIKCKMTGC | Ranatuerin-2ARb | Free | Free | Linear | L | None | 28 | Antibacterial | HC50 = 150µM | Human | Ranatuerin-2 analog (Rana areolata) | NA | NA | ||
| 12429503 | 2002 | GFISTVKNLATNVAGTVIDTIKCKVTGGC | Palustrin-2AR | Free | Free | Linear | L | None | 29 | Antibacterial | HC50 > 300µM | Human | Palustrin-2 analog (Rana areolata) | NA | NA | ||
| 12429503 | 2002 | FLPIVGRLISGLL{ct:Amid} | Temporin-1AR | Amidation | Free | Linear | L | None | 13 | Antibacterial | HC50 = 210µM | Human | Temporin-1 analog (Rana areolata) | NA | NA | ||
| 22083756 | 2012 | CLRIGMRGRELMGGIGKTM | pCM19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0.109% hemolytic at 100 μg/mL | Human | Peptide of hGlyrichin,corresponding to amino acids 42 to 60 (Homo sapien) | NA | NA | ||
| 22083756 | 2012 | CLRIGMRGRELMGGIGKTM | pCM19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0.119% hemolytic at 3000 μg/mL | Human | Peptide of hGlyrichin,corresponding to amino acids 42 to 60 (Homo sapien) | NA | NA | ||
| 21664395 | 2011 | GIGKFLHSAGKFGKAFIGEIMKS | Magainin-M1 | Free | Free | Linear | L | None | 23 | Antibacterial | LC50 =180μM | Human | Derived from skin secretions of Xenopus muelleri | NA | NA | ||
| 21664395 | 2011 | WCPPMIPLCSRF{cyc:N-C}{ct:Amid} | Tigerinin-M1 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial | LC50 >500μM | Human | Derived from skin secretions of Xenopus muelleri | NA | NA | ||
| 21664395 | 2011 | GIGKFLHSAGKFGKAFLGEVMKS | Magainin-MW1 | Free | Free | Linear | L | None | 23 | Antibacterial | LC50 >200μM | Human | Derived from skin secretions of Xenopus muelleri West | NA | NA | ||
| 21664395 | 2011 | GMASKAGSVLGKITKIALGAL{ct:Amid} | PGLa-MW1 | Amidation | Free | Linear | L | None | 21 | Antibacterial | LC50 >200μM | Human | Derived from skin secretions of Xenopus muelleri West | NA | NA | ||
| 21664395 | 2011 | GLGSLLGKAFKFGLKTVGKMMGGAPREQ | CPF-MW1 | Free | Free | Linear | L | None | 28 | Antibacterial | LC50 =70μM | Human | Derived from skin secretions of Xenopus muelleri West | NA | NA | ||
| 21664395 | 2011 | GLGSLLGKAFKFGLKTVGKMMGGAPREE | CPF-MW2 | Free | Free | Linear | L | None | 28 | Antibacterial | LC50 =105μM | Human | Derived from skin secretions of Xenopus muelleri West | NA | NA | ||
| 23026014 | 2013 | WFRKQLKW | L10 | Free | Free | Linear | L | None | 8 | Antibacterial and Antifungal | No hemolysis upto 800μg/ml | Human | Derived from modified N-terminal domain of bovine lactoferrin | NA | Non-hemolytic | ||
| 1362637 | 1992 | PKLLETFLSKWIG | SPF | Free | Free | Linear | L | None | 13 | Antibacterial | 10% hemolysis at 9μM | Rat | Seminalplasmin derivative | NA | NA | ||
| 1362637 | 1992 | PKLLKTFLSKWIG | SPFK | Free | Free | Linear | L | None | 13 | Antibacterial | 10% hemolysis at 9μM | Rat | SPF analog | NA | NA | ||
| 2253768 | 1990 | G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d} | All-D-Magainin-2 | Free | Free | Linear | D | None | 23 | Antibacterial and Antifungal | 0% hemolysis upto 80μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 2253768 | 1990 | G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d} | All-D-Magainin-2 | Free | Free | Linear | D | None | 23 | Antibacterial and Antifungal | 1% hemolysis at 100μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 2253768 | 1990 | G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d} | All-D-Magainin-2 | Free | Free | Linear | D | None | 23 | Antibacterial and Antifungal | 2% hemolysis at 200μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 2253768 | 1990 | GIGKFLHSAKKFGKAFVGEIMNS | All-L-Magainin-2 | Free | Free | Linear | L | None | 23 | Antibacterial and Antifungal | 0% hemolysis at 25μg/ml (non hemolytic) | Human | Derived from skin of Xenopus laevis | NA | Non-hemolytic | ||
| 2253768 | 1990 | GIGKFLHSAKKFGKAFVGEIMNS | All-L-Magainin-2 | Free | Free | Linear | L | None | 23 | Antibacterial and Antifungal | 1% hemolysis at 80μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 2253768 | 1990 | GIGKFLHSAKKFGKAFVGEIMNS | All-L-Magainin-2 | Free | Free | Linear | L | None | 23 | Antibacterial and Antifungal | 2% hemolysis at 200μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 9273892 | 1997 | LALILRKIVTAL{nt:Fmoc}{ct:Amid} | FCR(3A) | Amidation | Fmoc | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 8μg | Rat | Crabrolin (Vespa crabro) | NA | NA | ||
| 9273892 | 1997 | LALILRKIVTAL{ct:Amid} | CR(3A) | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~90% hemolysis at 80μg | Rat | Crabrolin (Vespa crabro) | NA | NA | ||
| 9273892 | 1997 | LKLIPRKIVTAL{nt:Fmoc}{ct:Amid} | FCR(3K,6P) | Amidation | Fmoc | Linear | L | None | 13 | Antibacterial | ~60% hemolysis at 80μg | Rat | Crabrolin (Vespa crabro) | NA | NA | ||
| 9273892 | 1997 | LKLIPRKIVTAL{ct:Amid} | CR(3K,6P) | Amidation | Free | Linear | L | None | 13 | Antibacterial | Non-hemolytic | Rat | Crabrolin (Vespa crabro) | NA | Non-hemolytic | ||
| 9273892 | 1997 | LPLILRKIVTAL{nt:Fmoc}{ct:Amid} | FCR | Amidation | Fmoc | Linear | L | None | 13 | Antibacterial | ~80% hemolysis at 8μg | Rat | Crabrolin (Vespa crabro) | NA | NA | ||
| 9273892 | 1997 | LPLILRKIVTAL{ct:Amid} | CR | Amidation | Free | Linear | L | None | 13 | Antibacterial | Non-hemolytic | Rat | Crabrolin (Vespa crabro) | NA | Non-hemolytic | ||
| 1605597 | 1992 | GIGKFLHSAKKFGKAFVGEIMNS | Peptide-1 | Free | Free | Linear | L | None | 23 | Antibacterial | 0% hemolysis upto 100μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | GIGKFLHSAKKFGKAFVGEIMNS | Peptide-1 | Free | Free | Linear | L | None | 23 | Antibacterial | 1% hemolysis upto 200μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS | Peptide-3 | Free | Free | Linear | L | None | 33 | Antibacterial | 0% hemolysis upto 200μg/ml (non hemolytic) | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | Non-hemolytic | ||
| 1605597 | 1992 | AAAAAAAAAAGIGKFLHSAKKFGKAFVGEIMNS | Peptide-4 | Free | Free | Linear | L | None | 33 | Antibacterial | 2% hemolysis upto 100μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | AAAAAAAAAAGIGKFLHSAKKFGKAFVGEIMNS | Peptide-4 | Free | Free | Linear | L | None | 33 | Antibacterial | 9% hemolysis upto 200μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS | Peptide-5 | Free | Free | Linear | L | None | 33 | Antibacterial | 0% hemolysis at 25μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS | Peptide-5 | Free | Free | Linear | L | None | 33 | Antibacterial | 1% hemolysis at 50μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS | Peptide-5 | Free | Free | Linear | L | None | 33 | Antibacterial | 2% hemolysis at 100μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS | Peptide-5 | Free | Free | Linear | L | None | 33 | Antibacterial | 4% hemolysis at 200μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS | Peptide-6 | Free | Free | Linear | L | None | 43 | Antibacterial | 1% hemolysis at 25μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS | Peptide-6 | Free | Free | Linear | L | None | 43 | Antibacterial | 2% hemolysis at 50μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS | Peptide-6 | Free | Free | Linear | L | None | 43 | Antibacterial | 6% hemolysis at 100μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS | Peptide-6 | Free | Free | Linear | L | None | 43 | Antibacterial | 14% hemolysis at 200μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | GIGKFLHSAKKFGKAFVGEIMNSKKKKKKKKKK | Peptide-7 | Free | Free | Linear | L | None | 33 | Antibacterial | 0% hemolysis upto 100μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | GIGKFLHSAKKFGKAFVGEIMNSKKKKKKKKKK | Peptide-7 | Free | Free | Linear | L | None | 33 | Antibacterial | 1% hemolysis at 200μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKFLHSAKKWLKAFVKLKKNW | Peptide-8 | Free | Free | Linear | L | None | 21 | Antibacterial | 3% hemolysis at 25μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKFLHSAKKWLKAFVKLKKNW | Peptide-8 | Free | Free | Linear | L | None | 21 | Antibacterial | 16% hemolysis at 50μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKFLHSAKKWLKAFVKLKKNW | Peptide-8 | Free | Free | Linear | L | None | 21 | Antibacterial | 29% hemolysis at 100μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKFLHSAKKWLKAFVKLKKNW | Peptide-8 | Free | Free | Linear | L | None | 21 | Antibacterial | 41% hemolysis at 200μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | GIGKLFLHAAKKFAKAFVAEKMNS | Peptide-9 | Free | Free | Linear | L | None | 24 | Antibacterial | 0% hemolysis upto 200μg/ml (non hemolytic) | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | Non-hemolytic | ||
| 1605597 | 1992 | KKKKKKKKKKGIGKLFLHAAKKFAKAFVAEKMNS | Peptide-10 | Free | Free | Linear | L | None | 34 | Antibacterial | 0% hemolysis at 100μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKKKKKKKKKGIGKLFLHAAKKFAKAFVAEKMNS | Peptide-10 | Free | Free | Linear | L | None | 34 | Antibacterial | 2% hemolysis at 200μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 10604598 | 1999 | PKLLKTFLSKWIG | SPFK | Free | Free | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 65μg/ml | Rat | Synthetic peptide | NA | NA | ||
| 10604598 | 1999 | CKLLKTFLSKWIC{cyc:N-C} | SC | Free | Free | Cyclic | L | None | 13 | Antibacterial | 100% hemolysis at 40μg/ml | Rat | Synthetic peptide | NA | NA | ||
| 10604598 | 1999 | CKLLKTFLSKWIC{cyc:N-C}{ct:Amid} | SAC | Amidation | Free | Cyclic | L | None | 13 | Antibacterial | 100% hemolysis at 5μg/ml | Rat | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLALKALKAALKLA | KLAL | Free | Free | Linear | L | None | 18 | Antibacterial | EC50 = 10μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | K{d}L{d}ALKLALKALKAALKLA | k1/l2 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 7μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLA{d}L{d}KLALKALKAALKLA | a3/l4 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 33μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALK{d}L{d}ALKALKAALKLA | k5/l6 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 160μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLA{d}L{d}KALKAALKLA | a7/l8 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 180μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLALK{d}A{d}LKAALKLA | k9/a10 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 56μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLALKAL{d}K{d}AALKLA | l11/k12 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 540μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLALKALKA{d}A{d}LKLA | a13/a14 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 260μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLALKALKAAL{d}K{d}LA | l15/k16 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 210μM | Human | Synthetic peptide | NA | NA | ||
| 8823199 | 1996 | KLALKLALKALKAALKL{d}A{d} | l17/a18 | Free | Free | Linear | Mix | None | 18 | Antibacterial | EC50 = 70μM | Human | Synthetic peptide | NA | NA | ||
| 19109988 | 2010 | GFLSALKKYLPIVLKHV | Osmin | Free | Free | Linear | L | None | 17 | Antibacterial and Antifungal | Weak hemolytic activity i.e. 5.0HU/mg | Human | Osmin (venom from the solitary bee Osmia rufa) | NA | NA | ||
| 19109988 | 2010 | GFLSALKKYLPIVLKHV{ct:Amid} | Osmin | Amidation | Free | Linear | L | None | 17 | Antibacterial and Antifungal | Hemolytic activity i.e. 16.6HU/mg | Human | Osmin (venom from the solitary bee Osmia rufa) | NA | NA | ||
| 9166783 | 1997 | GLGKFLHSAKRFGKAFVGEAMNS{ct:Amid} | L2R11A20-M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC50 >1000μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GLGKFLHSAKRFGKAFVGEAMNS{ct:Amid} | L2R11A20-M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | 12% hemolysis at 150μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC50 =430μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | 30% hemolysis at 150μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GIGKFIHSAKKFGKLFVGEIMNS{ct:Amid} | I6L15-M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC50 =260μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GIGKFIHSAKKFGKLFVGEIMNS{ct:Amid} | I6L15-M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | 40% hemolysis at 150μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GIGKFIHAAKKFGKLFIGEIMNS{ct:Amid} | I6A8L15I17-M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC50 =32μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GIGKFIHAAKKFGKLFIGEIMNS{ct:Amid} | I6A8L15I17-M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | 98% hemolysis at 150μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 12581207 | 2003 | FFGWLIKGAIHAGKAIHGLIHRRRH{ct:Amid} | Chrysophsin-1 | Amidation | Free | Linear | L | None | 25 | Antibacterial | ~40% hemolysis at 1μM | Human | Chrysophsin (the gills of red sea bream Chrysophrys major) | NA | NA | ||
| 12581207 | 2003 | FFGWLIKGAIHAGKAIHGLIHRRRH{ct:Amid} | Chrysophsin-1 | Amidation | Free | Linear | L | None | 25 | Antibacterial | 100% hemolysis at 100μM | Human | Chrysophsin (the gills of red sea bream Chrysophrys major) | NA | NA | ||
| 12581207 | 2003 | FFGWLIRGAIHAGKAIHGLIHRRRH{ct:Amid} | Chrysophsin-2 | Amidation | Free | Linear | L | None | 25 | Antibacterial | >40% hemolysis at 1μM | Human | Chrysophsin (the gills of red sea bream Chrysophrys major) | NA | NA | ||
| 12581207 | 2003 | FFGWLIRGAIHAGKAIHGLIHRRRH{ct:Amid} | Chrysophsin-2 | Amidation | Free | Linear | L | None | 25 | Antibacterial | 100% hemolysis at 100μM | Human | Chrysophsin (the gills of red sea bream Chrysophrys major) | NA | NA | ||
| 12581207 | 2003 | FIGLLISAGKAIHDLIRRRH{ct:Amid} | Chrysophsin-3 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 0% hemolysis at 1μM | Human | Chrysophsin (the gills of red sea bream Chrysophrys major) | NA | NA | ||
| 12581207 | 2003 | FIGLLISAGKAIHDLIRRRH{ct:Amid} | Chrysophsin-3 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 100% hemolysis at 100μM | Human | Chrysophsin (the gills of red sea bream Chrysophrys major) | NA | NA | ||
| 8223491 | 1993 | IIGPVLGLVGSALGGLLKKI{ct:Amid} | Peptide B | Amidation | Free | Linear | L | None | 20 | Antibacterial | Lethal concentration =17.0μM | Human | Synthetic peptide | NA | NA | ||
| 2689223 | 1989 | KWKLFKKIEKVGQNIRDGIIKAGPGIGAVLKVLTTGL{ct:Amid} | CA(1-24)M(1-13) | Amidation | Free | Linear | L | None | 37 | Antibacterial and Antiparasitic | Lethal concentration calculated from zone of inhibition >200μM | Sheep | Cercropin-melittin hybrids | NA | NA | ||
| 2689223 | 1989 | KWKLFKKIEKVGQGIGAVLKVLTTGL{ct:Amid} | CA(1-13)M(1-13) | Amidation | Free | Linear | L | None | 26 | Antibacterial and Antiparasitic | Lethal concentration calculated from zone of inhibition >200μM | Sheep | Cercropin-melittin hybrids | NA | NA | ||
| 2689223 | 1989 | AVAVVGQATQIAKKWKLFKKIEKVGQ{ct:Amid} | CA(25-37)CA(1-13) | Amidation | Free | Linear | L | None | 26 | Antibacterial and Antiparasitic | Lethal concentration calculated from zone of inhibition >300μM | Sheep | Cercropin-melittin hybrids | NA | NA | ||
| 2689223 | 1989 | GIGAVLKVLTTGLKWKLFKKIEKVGQ{ct:Amid} | M(1-13)CA(1-13) | Amidation | Free | Linear | L | None | 26 | Antibacterial and Antiparasitic | Lethal concentration calculated from zone of inhibition 80μM | Sheep | Cercropin-melittin hybrids | NA | NA | ||
| 2689223 | 1989 | LISWIKRKRQQGIGAVLKVLTTGL{ct:Amid} | M(16-26)M(1-13) | Amidation | Free | Linear | L | None | 24 | Antibacterial and Antiparasitic | Lethal concentration calculated from zone of inhibition >200μM | Sheep | Cercropin-melittin hybrids | NA | NA | ||
| 9048567 | 1997 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial | 100% hemolysis at 50μM | Human | Melittin ( venom of the honey bee Apis mellifera) | NA | NA | ||
| 9048567 | 1997 | GIGAV{d}LKV{d}LTTGLPALI{d}SWIK{d}RKRQQ{ct:Amid} | [D]-V5,8,I17,K21-melittin | Amidation | Free | Linear | Mix | None | 26 | Antibacterial | 0% hemolysis at 50μM | Human | Melittin diastereomers ( venom of the honey bee Apis mellifera) | NA | Non-hemolytic | ||
| 9048567 | 1997 | GIGAV{d}LKV{d}LTTGLPALI{d}SWIK{d}RKRQQ | [D]-V5,8,I17,K21-melittin | Free | Free | Linear | Mix | None | 26 | Antibacterial | ~1-2% hemolysis at 50μM | Human | Melittin diastereomers (Apis mellifera) | NA | NA | ||
| 9335545 | 1997 | GVAKFGKAAAHFGKGWIKEMLNS{ct:Amid} | 80°M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC25=307μM | Human | Synthetic peptide | NA | NA | ||
| 9335545 | 1997 | GIAKFGKAAAHFGKKWVGELMNS{ct:Amid} | 100°M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC25=159μM | Human | Synthetic peptide | NA | NA | ||
| 9335545 | 1997 | GIGKFLHSAKKFGKAWVGEIMNS{ct:Amid} | 120°M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC25=271μM | Human | Synthetic peptide | NA | NA | ||
| 9335545 | 1997 | GIGKFLHTLKTFGKKWVGEIMNS{ct:Amid} | 140°M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC25=15μM | Human | Synthetic peptide | NA | NA | ||
| 9335545 | 1997 | GIGKFLHKVKSFGKSWIGEIMNS{ct:Amid} | 160°M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC25=20μM | Human | Synthetic peptide | NA | NA | ||
| 9335545 | 1997 | GIGKFLHKVGSFIKSWKGEIMNS{ct:Amid} | 180°M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC25=24μM | Human | Synthetic peptide | NA | NA | ||
| 8849687 | 1996 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~90% hemolysis at 20µM | Rat | Derived from cytoplasmic granules of bovine neutrophils, | NA | NA | ||
| 8849687 | 1996 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~100% hemolysis at 30µM | Rat | Derived from cytoplasmic granules of bovine neutrophils, | NA | NA | ||
| 8849687 | 1996 | ILAWKWAWWAWRR{ct:Amid} | ILA | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~20% hemolysis at 5µM | Rat | Indolicidin analog | NA | NA | ||
| 8849687 | 1996 | ILAWKWAWWAWRR{ct:Amid} | ILA | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100% hemolysis at 20µg/ml | Rat | Indolicidin analog | NA | NA | ||
| 8849687 | 1996 | ILPFKFPFFPFRR{ct:Amid} | ILF | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~20% hemolysis upto 80µg/ml | Rat | Indolicidin analog | NA | NA | ||
| 8843284 | 1996 | KFFKFFKFF | Synthetic peptide | Free | Free | Linear | L | None | 9 | Antibacterial | Strongly hemolytic at 40µg/ml | Human | Synthetic peptide | NA | NA | ||
| 8810288 | 1996 | F{d}PV{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C} | GS | Free | Free | Cyclic | Mix | O = L-Ornithine | 10 | Antibacterial | 100% hemolysis at 39µg/ml | Human | Gramicidin S (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | Y{d}PY{d}P{cyc:N-C} | GS4 | Free | Free | Cyclic | Mix | None | 4 | Antibacterial | 100% hemolysis at >800µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | Y{d}PKY{d}PK{cyc:N-C} | GS6 | Free | Free | Cyclic | Mix | None | 6 | Antibacterial | 100% hemolysis at >1600µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | Y{d}PVKY{d}PKL{cyc:N-C} | GS8 | Free | Free | Cyclic | Mix | None | 8 | Antibacterial | 100% hemolysis at >1600µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | Y{d}PVKLY{d}PVKL{cyc:N-C} | GS10 | Free | Free | Cyclic | Mix | None | 10 | Antibacterial | 100% hemolysis at 67µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | Y{d}PVKLKY{d}PKVKL{cyc:N-C} | GS12 | Free | Free | Cyclic | Mix | None | 12 | Antibacterial | 100% hemolysis at 250µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | Y{d}PVKLKVY{d}PLKVKL{cyc:N-C} | GS14 | Free | Free | Cyclic | Mix | None | 14 | Antibacterial | 100% hemolysis at 6µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | Y{d}PLKVKY{d}PKLKV{cyc:N-C} | GS12LV | Free | Free | Cyclic | Mix | None | 12 | Antibacterial | 100% hemolysis at 92µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | F{d}PVKLKF{d}PKVKL{cyc:N-C} | GS12F | Free | Free | Cyclic | Mix | None | 12 | Antibacterial | 100% hemolysis at 400µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | F{d}PV{nnr:O}L{nnr:O}F{d}P{nnr:O}V{nnr:O}L{cyc:N-C} | GS12FO | Free | Free | Cyclic | Mix | O = L-Ornithine | 12 | Antibacterial | 100% hemolysis at 160µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8810288 | 1996 | F{d}PL{nnr:O}L{nnr:O}F{d}P{nnr:O}L{nnr:O}L{cyc:N-C} | GS12FO/LL | Free | Free | Cyclic | Mix | O = L-Ornithine | 12 | Antibacterial | 100% hemolysis at 170µg/ml | Human | Gramicidin S analog (Bacillus brevis) | NA | NA | ||
| 8620888 | 1996 | GFFALIPKIISSPLFKTLLSAVGSALSSSGG | Pardaxin | Free | Free | Linear | L | None | 31 | Antibacterial | >20% hemolysis at 25µM | Human | Pardaxin (Pardachirus marmoratus) | NA | NA | ||
| 8620888 | 1996 | GFFALIPKIISSPLFKTLLSAVGSALSSSGG | Pardaxin | Free | Free | Linear | L | None | 31 | Antibacterial | >50% hemolysis at 50µM | Human | Pardaxin (Pardachirus marmoratus) | NA | NA | ||
| 8620888 | 1996 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE{ct:[NH(CH2)2NH2]2} | Pardaxin- [NH(CH2)2NH2]2 | [NH(CH2)2NH2]2 | Free | Linear | L | None | 33 | Antibacterial | >100% hemolysis at 12µM | Human | Pardaxin analog (Pardachirus marmoratus) | NA | NA | ||
| 8620888 | 1996 | GFFALIPKIISSPLFKTLLSAV | Des-(23-33)-pardaxin | Free | Free | Linear | L | None | 22 | Antibacterial | >100% hemolysis at 10µM | Human | Pardaxin analog (Pardachirus marmoratus) | NA | NA | ||
| 8620888 | 1996 | GFFALIPKIISSPLFKTLLSAV{ct:[NH(CH2)2NH2]2} | Des-(23-33)-pardaxin-[NH(CH2)2NH2]2 | [NH(CH2)2NH2]2 | Free | Linear | L | None | 22 | Antibacterial | <20% hemolysis at 50µM | Human | Pardaxin analog (Pardachirus marmoratus) | NA | NA | ||
| 8620888 | 1996 | KGFFALIPKIISSPLFKTLLSAV{ct:[NH(CH2)2NH2]2} | Lys-des-(23- 33)-pardaxin-[NH(CH2)2NH2]2 | [NH(CH2)2NH2]2 | Free | Linear | L | None | 23 | Antibacterial | No hemolysis (Non hemolytic) | Human | Pardaxin analog (Pardachirus marmoratus) | NA | Non-hemolytic | ||
| 8620888 | 1996 | ISSPLFKTLLSAVGSALSSSGGQE | Des-(I -9)-pardaxin | Free | Free | Linear | L | None | 24 | Antibacterial | No hemolysis (Non hemolytic) | Human | Pardaxin analog (Pardachirus marmoratus) | NA | Non-hemolytic | ||
| 8620888 | 1996 | ISSPLFKTLLSAVGSALSSSGGQE{ct:[NH(CH2)2NH2]2} | Des-(I -9)-pardaxin-[NH(CH2)2NH2]2 | [NH(CH2)2NH2]2 | Free | Linear | L | None | 24 | Antibacterial | No hemolysis (Non hemolytic) | Human | Pardaxin analog (Pardachirus marmoratus) | NA | Non-hemolytic | ||
| 8620888 | 1996 | GFFALIPKIIS | Des-(12-33)-pardaxin | Free | Free | Linear | L | None | 11 | Antibacterial | No hemolysis (Non hemolytic) | Human | Pardaxin analog (Pardachirus marmoratus) | NA | Non-hemolytic | ||
| 8620888 | 1996 | GFFALIPKIIS{ct:[NH(CH2)2NH2]2} | Des-(I 2-33)-pardaxin-[NH(CH2)2NH2]2 | [NH(CH2)2NH2]2 | Free | Linear | L | None | 11 | Antibacterial | No hemolysis (Non hemolytic) | Human | Pardaxin analog (Pardachirus marmoratus) | NA | Non-hemolytic | ||
| 19540868 | 2009 | KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC{cyc:N-C} | Bactridine 1 | Free | Free | Cyclic | L | None | 61 | Antibacterial | 0.2% hemolysis at 90µM | Human | Derived from venom of Tityus discrepans | NA | NA | ||
| 19540868 | 2009 | KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC{cyc:N-C} | Bactridine 1 | Free | Free | Cyclic | L | None | 61 | Antibacterial | 1.0% hemolysis at 180µM | Human | Derived from venom of Tityus discrepans | NA | NA | ||
| 19540868 | 2009 | KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR{cyc:N-C} | Bactridine 2 | Free | Free | Cyclic | L | None | 64 | Antibacterial | 7.6% hemolysis at 90µM | Human | Derived from venom of Tityus discrepans | NA | NA | ||
| 19540868 | 2009 | KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR{cyc:N-C} | Bactridine 2 | Free | Free | Cyclic | L | None | 64 | Antibacterial | 21.0% hemolysis at 180µM | Human | Derived from venom of Tityus discrepans | NA | NA | ||
| 8353519 | 1993 | SIGSALKKALPVAKKIGKIALPIAKAALP | Ceratotoxin A | Free | Free | Linear | L | None | 29 | Antibacterial | Area of inhibition ~25mm2 at 5 nmol | Human | Derived from secretion of the female reproductive accessory glands of Ceratitis capitata | NA | NA | ||
| 19056441 | 2009 | IFGAILPLALGALKNLIK{ct:Amid} | Hy-a1 | Amidation | Free | Linear | L | None | 18 | Antibacterial | HC50 =18µM | Human | Derived from skin secretion of Hypsiboas albopunctatus | NA | NA | ||
| 12354111 | 2002 | GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNLVAEKIGATPS | Opistoporin 1 | Free | Free | Linear | L | None | 44 | Antibacterial and Antifungal | 30% hemolysis at 100µM | Human | Opistoporin (Opistophtalmus carinatus) | NA | NA | ||
| 12354111 | 2002 | FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ | Parabutoporin | Free | Free | Linear | L | None | 45 | Antibacterial and Antifungal | <10% hemolysis upto 5µM | Human | Parabutoporin (Opistophtalmus carinatus) | NA | NA | ||
| 12354111 | 2002 | FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ | Parabutoporin | Free | Free | Linear | L | None | 45 | Antibacterial and Antifungal | 50% hemolysis at 38µM | Human | Parabutoporin (Opistophtalmus carinatus) | NA | NA | ||
| 12354111 | 2002 | INLKALAALAKKIL | Mastoparan | Free | Free | Linear | L | None | 14 | Antibacterial and Antifungal | ~10% hemolysis at 100µM | Human | Mastoparan (wasp) | NA | NA | ||
| 15639237 | 2005 | GLGSVFGRLARILGRVIPKV{ct:Amid} | Peptide P1 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 20% hemolysis at 10µM | Human | Pilosulin 1 analog(Myrmecia pilosula) | NA | NA | ||
| 15639237 | 2005 | GLGSVFGRLARILGRVIPKV{ct:Amid} | Peptide P1 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 100% hemolysis at 100µM | Human | Pilosulin 1 analog(Myrmecia pilosula) | NA | NA | ||
| 15639237 | 2005 | GLLSKFGRLARKLARVIPKV{ct:Amid} | Peptide P2 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 15% hemolysis at 10µM | Human | Pilosulin 1 analog(Myrmecia pilosula) | NA | NA | ||
| 15639237 | 2005 | GLLSKFGRLARKLARVIPKV{ct:Amid} | Peptide P2 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 40% hemolysis at 100µM | Human | Pilosulin 1 analog(Myrmecia pilosula) | NA | NA | ||
| 10632060 | 1999 | KKVVFKVKFKK{ct:Amid} | MP | Amidation | Free | Linear | L | None | 11 | Antifungal and Antibacterial | 0% hemolysis upto 500 μg/mL (Non hemolytic) | Mouse | Synthetic peptide | NA | Non-hemolytic | ||
| 10632060 | 1999 | K{d}{Ψ[CH2NH]}KVVFKVKFKK{d}{ct:Amid} | MP1 | Amidation | Free | Linear | Mix | None | 11 | Antifungal and Antibacterial | 0% hemolysis upto 500 μg/mL (Non hemolytic) | Mouse | Synthetic peptide | NA | Non-hemolytic | ||
| 10632060 | 1999 | K{Ψ[CH2OCONH]}KVVFKVKFKK{d}{ct:Amid} | MP6 | Amidation | Free | Linear | Mix | None | 11 | Antifungal and Antibacterial | 0% hemolysis upto 500 μg/mL (Non hemolytic) | Mouse | Synthetic peptide | NA | Non-hemolytic | ||
| 12110678 | 2002 | LKLLKKLLKKLLKLL{ct:Amid} | Amphipathic-1L | Amidation | Free | Linear | L | None | 15 | Antibacterial | 100% hemolytic at 100μM | Human | Synthetic peptide | NA | NA | ||
| 12110678 | 2002 | KLKLLKLLKLLKLLK{ct:Amid} | Scrambled-4L | Amidation | Free | Linear | L | None | 15 | Antibacterial | 82% hemolytic at 100μM | Human | Synthetic peptide | NA | NA | ||
| 12110678 | 2002 | KKKLLLLLLLLLKKK{ct:Amid} | Segregated-5L | Amidation | Free | Linear | L | None | 15 | Antibacterial | 66% hemolytic at 100μM | Human | Synthetic peptide | NA | NA | ||
| 15298176 | 2004 | FGVLAKVAAHVVPAIAEHF{ct:Amid} | [∆1,2]Mac | Amidation | Free | Linear | L | None | 19 | Antibacterial | 0% hemolysis upto 100µM | Rabbit | Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata) | α-helical | Non-hemolytic | ||
| 23935838 | 2013 | AKKVFKRLPKLFSKIWNWK{ct:Amid} | Anal 3-Pro | Amidation | Free | Linear | L | None | 19 | Antibacterial/ Antifungal | 0 % Hemolysis at ~100 µM | Human | Helicobacter Pylori | Helix-hinge-Helix | Non-hemolytic | ||
| 24307932 | 2013 | KRIVQRIKDFLR{ct:Amid} | KR-12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 10.6 % Hemolysis at 100 µM | Human | Human Cathelicidin Ll-37 | Helical | NA | ||
| 23831136 | 2013 | NGVQPKY | Luecrocin I | Free | Free | Linear | L | None | 7 | Antibacterial | 0 % Hemolysis at 91 μg/mL | Human | White Blood Cells Of Crocodylus Siamensis | α-Helical | Non-hemolytic | ||
| 23831136 | 2013 | NGVQPKYKWWKWWKKWW{ct:Amid} | KT2 | Amidation | Free | Linear | L | None | 17 | Antibacterial | <20 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPKYRWWRWWRRWW{ct:Amid} | RT2 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 10 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPKYKWWKWWKKWWW{ct:Amid} | KT3 | Amidation | Free | Linear | L | None | 18 | Antibacterial | <60 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPKYRWWRWWRRWW | CRT2 | Free | Free | Linear | L | None | 17 | Antibacterial | 20 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPKYRWWRWWRRWWW | CRT3 | Free | Free | Linear | L | None | 18 | Antibacterial | <30 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPWYKWWKWWKKWW{ct:Amid} | KWKT2 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 60 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | NGVQPKYRWWRWWRRWWWW{ct:Amid} | RT4 | Amidation | Free | Linear | L | None | 19 | Antibacterial | <60 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | RWWRWWRRWW{ct:Amid} | RW2 | Amidation | Free | Linear | L | None | 10 | Antibacterial | <70 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 23831136 | 2013 | RWWRWWRRWWW{ct:Amid} | RW3 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <90 % Hemolysis at 91 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | A{d}L{d}L{d}L | 0 | Free | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 4 | Antibacterial | 15.6 ± 3.2 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LLLLL | 1 | Free | Free | Linear | L | None | 5 | Antibacterial | 6.9 ± 1.8 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LLLLD | 2 | Free | Free | Linear | L | None | 5 | Antibacterial | 6.0 ± 0.5 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LLLDL | 3 | Free | Free | Linear | L | None | 5 | Antibacterial | 2.7 ± 0.1 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LLDLL | 4 | Free | Free | Linear | L | None | 5 | Antibacterial | 2.7 ± 1.4 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LDLLL | 5 | Free | Free | Linear | L | None | 5 | Antibacterial | 4.2 ± 0.6 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DLLLL | 6 | Free | Free | Linear | L | None | 5 | Antibacterial | 4.2 ± 0.8 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LLLDD | 7 | Free | Free | Linear | L | None | 5 | Antibacterial | 5.1 ± 2.3 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LLDLD | 8 | Free | Free | Linear | L | None | 5 | Antibacterial | 1.3 ± 0.2 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LDLLD | 9 | Free | Free | Linear | L | None | 5 | Antibacterial | 1.4 ± 1.5 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DLLLD | 10 | Free | Free | Linear | L | None | 5 | Antibacterial | 2.4 ± 0.8 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LLDDL | 11 | Free | Free | Linear | L | None | 5 | Antibacterial | 3.7 ± 1.7 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LDLDL | 12 | Free | Free | Linear | L | None | 5 | Antibacterial | 1.9 ± 2.2 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DLLDL | 13 | Free | Free | Linear | L | None | 5 | Antibacterial | 3.7 ± 0.3 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LDDLL | 14 | Free | Free | Linear | L | None | 5 | Antibacterial | 0.5 ± 0.5 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DLDLL | 15 | Free | Free | Linear | L | None | 5 | Antibacterial | 1.6 ± 0.6 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DDLLL | 16 | Free | Free | Linear | L | None | 5 | Antibacterial | 4.1 ± 0.9 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LLDDD | 17 | Free | Free | Linear | L | None | 5 | Antibacterial | 6.2 ± 0.4 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LDLDD | 18 | Free | Free | Linear | L | None | 5 | Antibacterial | 0–0.9 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DLLDD | 19 | Free | Free | Linear | L | None | 5 | Antibacterial | 0.5 ± 0.5 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LDDLD | 20 | Free | Free | Linear | L | None | 5 | Antibacterial | 0.8 ± 0.1 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DLDLD | 21 | Free | Free | Linear | L | None | 5 | Antibacterial | 0–0.6 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DDLLD | 22 | Free | Free | Linear | L | None | 5 | Antibacterial | 8 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LDDDL | 23 | Free | Free | Linear | L | None | 5 | Antibacterial | 3.3 ± 0.3 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DLDDL | 24 | Free | Free | Linear | L | None | 5 | Antibacterial | 1.0 ± 0.7 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DDLDL | 25 | Free | Free | Linear | L | None | 5 | Antibacterial | 3.5 ± 1.2 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DDDLL | 26 | Free | Free | Linear | L | None | 5 | Antibacterial | 5.3 ± 0.3 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | LDDDD | 27 | Free | Free | Linear | L | None | 5 | Antibacterial | 1.3 ± 0.2 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DLDDD | 28 | Free | Free | Linear | L | None | 5 | Antibacterial | 0–1.4 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DDLDD | 29 | Free | Free | Linear | L | None | 5 | Antibacterial | 3.1 ± 1.1 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DDDLD | 30 | Free | Free | Linear | L | None | 5 | Antibacterial | 0–3.1 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DDDDL | 31 | Free | Free | Linear | L | None | 5 | Antibacterial | 8.5 ± 3.8 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 24147906 | 2013 | DDDDD | 32 | Free | Free | Linear | L | None | 5 | Antibacterial | 15 ± 2.2 % Hemolysis at 142 µM | Human | Synthetic | α-Helical | NA | ||
| 23860860 | 2014 | SGKLCCRRKK{ct:Amid} | D0 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 2.2 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 23860860 | 2014 | SGKLYYRRKK{ct:Amid} | D1 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 2 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 23860860 | 2014 | SGKLWWRRKK{ct:Amid} | D2 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 2.5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 23860860 | 2014 | SGKRWWRRKK{ct:Amid} | D3 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 23860860 | 2014 | RGKRWWRRKK{ct:Amid} | D4 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 55 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 23860860 | 2014 | RWKRWWRRKK{ct:Amid} | D5 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 6.5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 23860860 | 2014 | RKKRWWRRKK{ct:Amid} | D6 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 6.5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 24176194 | 2014 | AKKVFKRLEKLFSKIWNWK{ct:Amid} | HPA3 | Amidation | Free | Linear | L | None | 19 | Antibacterial | 10 % Hemolysis at 49.2 µM | Human | Helicobacter Pylori | α-Helix | NA | ||
| 24176194 | 2014 | AKKVFKRLPKLFSKIWNWK{ct:Amid} | HPA3P | Amidation | Free | Linear | L | None | 19 | Antibacterial | 10 % Hemolysis at >800 µM | Human | Helicobacter Pylori | α-Helix | NA | ||
| 24176194 | 2014 | AKKVFKRLPKLPSKIWNWK{ct:Amid} | HPA3P2 | Amidation | Free | Linear | L | None | 19 | Antibacterial | 10 % Hemolysis at >800 µM | Human | Helicobacter Pylori | α-Helix | NA | ||
| 24176194 | 2014 | AKKVFKRLEKLFSKIWNWK{ct:Amid} | HPA3 | Amidation | Free | Linear | L | None | 19 | Antibacterial | 50 % Hemolysis at 397.7 µM | Human | Helicobacter Pylori | α-Helix | NA | ||
| 24176194 | 2014 | AKKVFKRLPKLFSKIWNWK{ct:Amid} | HPA3P | Amidation | Free | Linear | L | None | 19 | Antibacterial | 50 % Hemolysis at >800 µM | Human | Helicobacter Pylori | α-Helix | NA | ||
| 24176194 | 2014 | AKKVFKRLPKLPSKIWNWK{ct:Amid} | HPA3P2 | Amidation | Free | Linear | L | None | 19 | Antibacterial | 50 % Hemolysis at >800 µM | Human | Helicobacter Pylori | α-Helix | NA | ||
| 24161537 | 2014 | LIAGLAANFLPKLFCKITK{ct:Amid} | B1CTcu1 | Amidation | Free | Linear | L | None | 19 | Antibacterial | 1 % Hemolysis at 10 µg/ml | Rabbit | Indian Ranid Frog Clinotarsus Curtipes | α-Helix | Non-hemolytic | ||
| 24161537 | 2014 | FLPLLAGLAANFLPKIFCKITRK{ct:Amid} | B1CTcu2 | Amidation | Free | Linear | L | None | 23 | Antibacterial | 17.8 % Hemolysis at 10 µg/ml | Rabbit | Indian Ranid Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 24161537 | 2014 | LPLLAGLAANFLPKIFCKITRK{ct:Amid} | B1CTcu3 | Amidation | Free | Linear | L | None | 22 | Antibacterial | 45 % Hemolysis at 10 µg/ml | Rabbit | Indian Ranid Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 24161537 | 2014 | FLPFIAGMAAKFLPKIFCAISKK{ct:Amid} | B1CTcu4 | Amidation | Free | Linear | L | None | 23 | Antibacterial | 54.8 % Hemolysis at 10 µg/ml | Rabbit | Indian Ranid Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 24161537 | 2014 | LIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 37.5 % Hemolysis at 10 µg/ml | Rabbit | Indian Ranid Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 24859674 | 2014 | MGWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKGLADG KILHNQNVNSWGPITVTPTTDGGETRFDGQIIVQMENDPVVAKAAANL AGKHAESSVVVQLDSDGNYRVVYGDPSKLDGKLRWQLVGHGRDHSET NNTRLSGYSADELAVKLAKFQQSFNQAENINNKPDHISIVGCSLVSDDKQ KGFMGWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKGLADG KILHNQNVNSWGPITVTPT | GWKL-LUCILIN-CPD-His8 | Free | Free | Linear | L | None | 257 | Antibacterial | 0 % Hemolysis at 56.4 µM | Human | Recombinant Protein | Random coils | Non-hemolytic | ||
| 24168384 | 2014 | GFFLNALKNFAKTAGKRLKSLLNHASCKLSGQC | Cyanophlyctin b | Free | Free | Linear | L | None | 33 | Antibacterial | 0.7 % Hemolysis at 500 µg/ml | Human | Skin Secretions Of Euphlyctis Cyanophlyctis | α-Helix | Non-hemolytic | ||
| 24168384 | 2014 | VIPFVASVAAEMMQHIFCAASRKC | Brevini-Eu | Free | Free | Linear | L | None | 24 | Antibacterial | 1.9 % Hemolysis at 500 µg/ml | Human | Skin Secretions Of Euphlyctis Cyanophlyctis | α-Helix | Non-hemolytic | ||
| 24871991 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | M(melittin) | Free | Free | Linear | L | None | 26 | Antibacterial | 50 % Hemolysis at 8 μg/ml | Sheep | Bee Venom | α-Helix | NA | ||
| 24953028 | 2014 | W-{nnr:3-ABA}-R{ct:Amid} | 1a | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 3 | Antibacterial | 10 % Hemolysis at 400 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | W-{nnr:3-ABA}-R{ct:Amid} | 1a | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 3 | Antibacterial | 50 % Hemolysis at >500 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WW-{nnr:3-ABA}-R{ct:Amid} | 2a | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 4 | Antibacterial | 10 % Hemolysis at 100 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WW-{nnr:3-ABA}-R{ct:Amid} | 2a | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 4 | Antibacterial | 50 % Hemolysis at 240 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RW-{nnr:3-ABA}-R{ct:Amid} | 2b | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 4 | Antibacterial | 10 % Hemolysis at 205 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RW-{nnr:3-ABA}-R{ct:Amid} | 2b | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 4 | Antibacterial | 50 % Hemolysis at 500 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WR-{nnr:3-ABA}-R{ct:Amid} | 2c | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 4 | Antibacterial | 10 % Hemolysis at 300 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WR-{nnr:3-ABA}-R{ct:Amid} | 2c | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 4 | Antibacterial | 50 % Hemolysis at >500 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WW-{nnr:3-ABA}-RR{ct:Amid} | 3a | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 5 | Antibacterial | 10 % Hemolysis at 150 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WW-{nnr:3-ABA}-RR{ct:Amid} | 3a | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 5 | Antibacterial | 50 % Hemolysis at 400 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RW-{nnr:3-ABA}-RR{ct:Amid} | 3b | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 5 | Antibacterial | 10 % Hemolysis at 350 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RW-{nnr:3-ABA}-RR{ct:Amid} | 3b | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 5 | Antibacterial | 50 % Hemolysis at >500 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WR-{nnr:3-ABA}-RR{ct:Amid} | 3c | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 5 | Antibacterial | 10 % Hemolysis at 325 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WR-{nnr:3-ABA}-RR{ct:Amid} | 3c | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 5 | Antibacterial | 50 % Hemolysis at >500 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WR-{nnr:3-ABA}-WR{ct:Amid} | 3d | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 5 | Antibacterial | 10 % Hemolysis at 220 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WR-{nnr:3-ABA}-WR{ct:Amid} | 3d | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 5 | Antibacterial | 50 % Hemolysis at 400 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RW-{nnr:3-ABA}-WR{ct:Amid} | 3e | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 5 | Antibacterial | 10 % Hemolysis at 250 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RW-{nnr:3-ABA}-WR{ct:Amid} | 3e | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 5 | Antibacterial | 50 % Hemolysis at 410 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WWR-{nnr:3-ABA}-RR{ct:Amid} | 4a | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 200 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WWR-{nnr:3-ABA}-RR{ct:Amid} | 4a | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 380 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RWR-{nnr:3-ABA}-WR{ct:Amid} | 4b | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 210 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RWR-{nnr:3-ABA}-WR{ct:Amid} | 4b | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 400 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RWW-{nnr:3-ABA}-RR{ct:Amid} | 4c | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 255 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RWW-{nnr:3-ABA}-RR{ct:Amid} | 4c | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 420 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WRR-{nnr:3-ABA}-WR{ct:Amid} | 4d | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 190 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WRR-{nnr:3-ABA}-WR{ct:Amid} | 4d | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 380 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WRW-{nnr:3-ABA}-RR{ct:Amid} | 4e | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 140 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WRW-{nnr:3-ABA}-RR{ct:Amid} | 4e | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 370 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RRW-{nnr:3-ABA}-WR{ct:Amid} | 4f | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 100 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RRW-{nnr:3-ABA}-WR{ct:Amid} | 4f | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 355 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WRW-{nnr:3-ABA}-WR{ct:Amid} | 4g | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 80 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WRW-{nnr:3-ABA}-WR{ct:Amid} | 4g | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 310 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | OW-{nnr:3-ABA}-WO{ct:Amid} | 3f | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 5 | Antibacterial | 10 % Hemolysis at 190 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | OW-{nnr:3-ABA}-WO{ct:Amid} | 3f | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 5 | Antibacterial | 50 % Hemolysis at >500 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | OWW-{nnr:3-ABA}-OO{ct:Amid} | 4h | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 150 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | OWW-{nnr:3-ABA}-OO{ct:Amid} | 4h | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 440 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WOO-{nnr:3-ABA}-WO{ct:Amid} | 4i | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 170 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WOO-{nnr:3-ABA}-WO{ct:Amid} | 4i | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 500 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WOW-{nnr:3-ABA}-OO{ct:Amid} | 4j | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 175 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WOW-{nnr:3-ABA}-OO{ct:Amid} | 4j | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 450 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | OOW-{nnr:3-ABA}-WO{ct:Amid} | 4k | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 120 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | OOW-{nnr:3-ABA}-WO{ct:Amid} | 4k | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 450 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WOW-{nnr:3-ABA}-WO{ct:Amid} | 4l | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 100 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WOW-{nnr:3-ABA}-WO{ct:Amid} | 4l | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 390 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RRF-{nnr:3-ABA}-FR{ct:Amid} | 4m | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 130 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RRF-{nnr:3-ABA}-FR{ct:Amid} | 4m | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 375 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | FRF-{nnr:3-ABA}-FR{ct:Amid} | 4n | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 125 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | FRF-{nnr:3-ABA}-FR{ct:Amid} | 4n | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 310 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | OOF-{nnr:3-ABA}-FO{ct:Amid} | 4o | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 210 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | OOF-{nnr:3-ABA}-FO{ct:Amid} | 4o | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 490 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | FOF-{nnr:3-ABA}-FO{ct:Amid} | 4p | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 10 % Hemolysis at 180 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | FOF-{nnr:3-ABA}-FO{ct:Amid} | 4p | Amidation | Free | Linear | L | 3-ABA = 3-amino benzoic acid | 6 | Antibacterial | 50 % Hemolysis at 400 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RRWWR{ct:Amid} | 5a | Amidation | Free | Linear | L | None | 5 | Antibacterial | 10 % Hemolysis at 90 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | RRWWR{ct:Amid} | 5a | Amidation | Free | Linear | L | None | 5 | Antibacterial | 50 % Hemolysis at 240 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WRWWR{ct:Amid} | 5b | Amidation | Free | Linear | L | None | 5 | Antibacterial | 10 % Hemolysis at 60 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WRWWR{ct:Amid} | 5b | Amidation | Free | Linear | L | None | 5 | Antibacterial | 50 % Hemolysis at 200 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | OOWWO{ct:Amid} | 5c | Amidation | Free | Linear | L | None | 5 | Antibacterial | 10 % Hemolysis at 100 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | OOWWO{ct:Amid} | 5c | Amidation | Free | Linear | L | None | 5 | Antibacterial | 50 % Hemolysis at 310 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WOWWO{ct:Amid} | 5d | Amidation | Free | Linear | L | None | 5 | Antibacterial | 10 % Hemolysis at 65 μg/ml | Human | Synthetic | NA | NA | ||
| 24953028 | 2014 | WOWWO{ct:Amid} | 5d | Amidation | Free | Linear | L | None | 5 | Antibacterial | 50 % Hemolysis at 220 μg/ml | Human | Synthetic | NA | NA | ||
| 24842084 | 2014 | FLSHIAGFLSNLF{ct:Amid} | Temporin-SHc(Temp-SHc) | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at >80 µM | Human | Skin Of Pelophylax Saharica | α-Helix | NA | ||
| 24842084 | 2014 | FLSHLAGFLSNLF{ct:Amid} | L5 temp-SHc | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at >80 µM | Human | Analogue Of Temp-Shc, Skin Of Pelophylax Saharica | α-Helix | NA | ||
| 24842084 | 2014 | HSLFLAGFLSNLF{ct:Amid} | (4-1)L5temp-SHc | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 2 µM | Human | Analogue Of Temp-Shc, Skin Of Pelophylax Saharica | α-Helix | NA | ||
| 24952979 | 2014 | IRCRRRFCRI{ct:Amid} | IR1 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | IRIRCRRRFCRIRI{ct:Amid} | IR2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 128 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | FRCRRRFCRF{ct:Amid} | FR1 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | FRFRCRRRFCRFRF{ct:Amid} | FR2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 64 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | WRCRRRFCRW{ct:Amid} | WR1 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | WRWRCRRRFCRWRW{ct:Amid} | WR2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 64 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | PRCRRRFCRP{ct:Amid} | PR1 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | PRPRCRRRFCRPRP{ct:Amid} | PR2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide, Porcine Leukocytes | β-Sheet | NA | ||
| 24952979 | 2014 | RGGRLCYCRRRFCVCVGR{ct:Amid} | Protegrin-1(PG-1) | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 2 µM | Human | Porcine Leukocytes | β-Sheet | NA | ||
| 24981062 | 2014 | SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW | AvBD103b | Free | Free | Linear | L | None | 38 | Antibacterial | 0 % Hemolysis at 0.75 µM | Human | King Penguin (Aptenodytes Patagonicus) | α-Helix/β-Sheet | Non-hemolytic | ||
| 24981062 | 2014 | SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW | AvBD103b | Free | Free | Linear | L | None | 38 | Antibacterial | 0.84 % Hemolysis at 1.5 µM | Human | King Penguin (Aptenodytes Patagonicus) | α-Helix/β-Sheet | NA | ||
| 24981062 | 2014 | SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW | AvBD103b | Free | Free | Linear | L | None | 38 | Antibacterial | 1.01 % Hemolysis at 3 µM | Human | King Penguin (Aptenodytes Patagonicus) | α-Helix/β-Sheet | NA | ||
| 24981062 | 2014 | SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW | AvBD103b | Free | Free | Linear | L | None | 38 | Antibacterial | 1.18 % Hemolysis at 6 µM | Human | King Penguin (Aptenodytes Patagonicus) | α-Helix/β-Sheet | NA | ||
| 24981062 | 2014 | SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW | AvBD103b | Free | Free | Linear | L | None | 38 | Antibacterial | 1.37 % Hemolysis at 12 µM | Human | King Penguin (Aptenodytes Patagonicus) | α-Helix/β-Sheet | NA | ||
| 24981062 | 2014 | SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW | AvBD103b | Free | Free | Linear | L | None | 38 | Antibacterial | 2.61 % Hemolysis at 48 µM | Human | King Penguin (Aptenodytes Patagonicus) | α-Helix/β-Sheet | NA | ||
| 25445609 | 2014 | GRRRRSVQWCA{nt:NH3} | human lactoferrin (1-11) | Free | NH3 | Linear | L | None | 11 | Antibacterial and Antifungal | 0 % Hemolysis at 1 mM | Rabbit | Human Lactoferrins | NA | Non-hemolytic | ||
| 25445609 | 2014 | GRRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQEIQA{nt:NH3} | human lactoferricin | Free | NH3 | Linear | L | None | 49 | Antibacterial and Antifungal | 0 % Hemolysis at 1 mM | Rabbit | Human Lactoferrins | NA | Non-hemolytic | ||
| 25445609 | 2014 | WNLLRQAQEKFGKDKSPK{nt:NH3} | human lactoferrampin | Free | NH3 | Linear | L | None | 18 | Antibacterial and Antifungal | 0 % Hemolysis at 1 mM | Rabbit | Human Lactoferrins | NA | Non-hemolytic | ||
| 25445609 | 2014 | APRKNVRWCTI{nt:NH3} | bovine lactoferrin (1-11) | Free | NH3 | Linear | L | None | 11 | Antibacterial and Antifungal | 0 % Hemolysis at 1 mM | Rabbit | Bovine Lactoferrins | NA | Non-hemolytic | ||
| 25445609 | 2014 | MFKCRRWQWRMKKLGAPSITCVRRAF{nt:NH3} | bovine lactoferricin | Free | NH3 | Linear | L | None | 26 | Antibacterial and Antifungal | 0 % Hemolysis at 1 mM | Rabbit | Bovine Lactoferrins | NA | Non-hemolytic | ||
| 25445609 | 2014 | DLIWKLLSKAQEKFGKNKSR{nt:NH3} | bovine lactoferrampin | Free | NH3 | Linear | L | None | 20 | Antibacterial and Antifungal | 0 % Hemolysis at 1 mM | Rabbit | Bovine Lactoferrins | NA | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIFRGIVHVGKTIHRLVTG | Pis-1 | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | ~100 % Hemolysis at 100 µM | Human | Mast Cells Of Aquacultured Hybrid Striped Bass | α-Helical | NA | ||
| 25473836 | 2014 | AFHHIFRGIVHVGKTIHRLVTG | PisF1A | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 100 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FAHHIFRGIVHVGKTIHRLVTG | PisF2A | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | >12 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FFHHIARGIVHVGKTIHRLVTG | PisF6A | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 29 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | KFHHIFRGIVHVGKTIHRLVTG | PisF1K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 50 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FKHHIFRGIVHVGKTIHRLVTG | PisF2K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIKRGIVHVGKTIHRLVTG | PisF6K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIFRGIKHVGKTIHRLVTG | PisV10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 50 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIFRGIKHVGKTIHRLVTG | PisV10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 20 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | KFHHIFRGIKHVGKTIHRLVTG | Pis-F1K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FKHHIFRGIKHVGKTIHRLVTG | Pis-F2K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIKRGIKHVGKTIHRLVTG | Pis-F6K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | KFHHIFRGIKHVGKTIHRLVTG | Pis-F1K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | <20 % Hemolysis at 200 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FFHHIKRGIKHVGKTIHRLVTG | Pis-F6K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 19 % Hemolysis at 400 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FFHHIKRGIKHVGKTIHRLVTG | Pis-F2K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 400 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25200682 | 2014 | GIGAVLKVLTTGLCALISWIKRKRQQ | MLT-P14C | Free | Free | Linear | L | None | 26 | Antibacterial | 50 % Hemolysis at 2.5 µM | Human | Analog Of Melittin, Bee Venom | α-Helix | NA | ||
| 25200682 | 2014 | GIGAVLKVLTTGLCALISWIKRKRQQGIGAVLKVLTTGLCALISWIKRKRQQ | Dimer-MLT-P14C | Free | Free | Linear | L | None | 52 | Antibacterial | 50 % Hemolysis at 1 µM | Human | Analog Of Melittin, Bee Venom | α-Helix | NA | ||
| 25209888 | 2014 | MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid} | Scolopendin 1 | Amidation | Free | Linear | L | None | 48 | Antibacterial, Antifungal | 0 % Hemolysis at 80 µM | Human | Centipede Scolopendra Subspinipes Mutilans | NA | Non-hemolytic | ||
| 25209888 | 2014 | MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid} | Scolopendin 1 | Amidation | Free | Linear | L | None | 48 | Antibacterial, Antifungal | 0 % Hemolysis at 40 µM | Human | Centipede Scolopendra Subspinipes Mutilans | NA | Non-hemolytic | ||
| 25209888 | 2014 | MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid} | Scolopendin 1 | Amidation | Free | Linear | L | None | 48 | Antibacterial, Antifungal | 0 % Hemolysis at 20 µM | Human | Centipede Scolopendra Subspinipes Mutilans | NA | Non-hemolytic | ||
| 25209888 | 2014 | MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid} | Scolopendin 1 | Amidation | Free | Linear | L | None | 48 | Antibacterial, Antifungal | 0 % Hemolysis at 10 µM | Human | Centipede Scolopendra Subspinipes Mutilans | NA | Non-hemolytic | ||
| 25209888 | 2014 | MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid} | Scolopendin 1 | Amidation | Free | Linear | L | None | 48 | Antibacterial, Antifungal | 0 % Hemolysis at 5 µM | Human | Centipede Scolopendra Subspinipes Mutilans | NA | Non-hemolytic | ||
| 25209888 | 2014 | MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid} | Scolopendin 1 | Amidation | Free | Linear | L | None | 48 | Antibacterial, Antifungal | 0 % Hemolysis at 2.5 µM | Human | Centipede Scolopendra Subspinipes Mutilans | NA | Non-hemolytic | ||
| 25209888 | 2014 | MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA{ct:Amid} | Scolopendin 1 | Amidation | Free | Linear | L | None | 48 | Antibacterial, Antifungal | 0 % Hemolysis at 1.3 µM | Human | Centipede Scolopendra Subspinipes Mutilans | NA | Non-hemolytic | ||
| 24952727 | 2014 | APKAMKLLKKLLKLQKKGI | SHAP1 | Free | Free | Linear | L | None | 19 | Wound healing, Antibacterial, Antifungal | 0 % Hemolysis at 1 µM | Human | Synthetic Peptide | α-Helical | Non-hemolytic | ||
| 24952727 | 2014 | APKAMKLLKKLLKLQKKGI | SHAP1 | Free | Free | Linear | L | None | 19 | Wound healing, Antibacterial, Antifungal | 0 % Hemolysis at 10 µM | Human | Synthetic Peptide | α-Helical | Non-hemolytic | ||
| 24952727 | 2014 | APKAMKLLKKLLKLQKKGI | SHAP1 | Free | Free | Linear | L | None | 19 | Wound healing, Antibacterial, Antifungal | 0 % Hemolysis at 100 µM | Human | Synthetic Peptide | α-Helical | Non-hemolytic | ||
| 24952727 | 2014 | APKAMKLLKKLLKLQKKGI | SHAP1 | Free | Free | Linear | L | None | 19 | Wound healing, Antibacterial, Antifungal | <5 % Hemolysis at 200 µM | Human | Synthetic Peptide | α-Helical | Non-hemolytic | ||
| 25016054 | 2014 | ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD | GM1 | Free | Free | Linear | L | None | 39 | Antibacterial, Anti-infective | 0 % Hemolysis at 100 μg/ml | Human | Galleria Mellonella Native | NA | Non-hemolytic | ||
| 25016054 | 2014 | ENFFKEKERKGQRIRDAIISRRPRVETLAQAQKIIKGGD | ΔGm1 | Free | Free | Linear | L | None | 39 | Antibacterial, Anti-infective | 0 % Hemolysis at 100 μg/ml | Human | Galleria Mellonella Native Analogue | NA | Non-hemolytic | ||
| 24101243 | 2014 | VDNANDLLSKVKKDKSD | A1 | Free | Free | Linear | L | None | 17 | Antibacterial | 0 % Hemolysis at 500 μg/ml | Human | Human C8Α Complement System Peptide | α-Helix | Non-hemolytic | ||
| 24101243 | 2014 | TSFLNELNKYNEKKFI | A2 | Free | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 500 μg/ml | Human | Human C8Α Complement System Peptide | α-Helix | Non-hemolytic | ||
| 24101243 | 2014 | VIDKAKMESLGITSRDTT | A3 | Free | Free | Linear | L | None | 18 | Antibacterial | 0 % Hemolysis at 500 μg/ml | Human | Human C8Α Complement System Peptide | α-Helix | Non-hemolytic | ||
| 24101243 | 2014 | KKFGGGKTERARKAMAVE | A4 | Free | Free | Linear | L | None | 18 | Antibacterial | 0 % Hemolysis at 500 μg/ml | Human | Human C8Α Complement System Peptide | α-Helix | Non-hemolytic | ||
| 25421112 | 2015 | LLSNVAGLLKQFAK | XPF2 | Free | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 256 μg/ml | Human | Silurana Tropicalis | α-Helix | NA | ||
| 25421112 | 2015 | LLRRVAGLLKQFAK | XPF4 | Free | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 256 μg/ml | Human | Silurana Tropicalis | α-Helix | Low hemolytic | ||
| 25421112 | 2015 | LLRRVARLLKRFAK | XPF6 | Free | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 128 μg/ml | Human | Silurana Tropicalis | α-Helix | Low hemolytic | ||
| 25433327 | 2015 | GIGKFLHSAGKFGKAFVGEIMKS | Magainin-G1 | Free | Free | Linear | L | None | 23 | Antibacterial | 50 % Hemolysis at >160 µM | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GMASKAGAIAGKIAKVALKAV{ct:Amid} | PGLa-G2 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at >160 µM | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GWASKIGQTLGKMAKVGLQELIQPK | XPF-G1 | Free | Free | Linear | L | None | 25 | Antibacterial | 50 % Hemolysis at >160 µM | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GFGSFLGKALKAALKIGANALGGAPQQ | CPF-G2 | Free | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GFGSFLGKALKAALKIGANALGGAPEQ | CPF-G3 | Free | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at 85 µM | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GFGSVLGKLFKTAVKIIPSLLPSKQE | CPF-G4 | Free | Free | Linear | L | None | 26 | Antibacterial | 50 % Hemolysis at 35 µM | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GLASFLGKALKAGLKIGANLLGGAPQQ | CPF-G5 | Free | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GFGSFLGKALKAALKVGANMLGGAPQQ | CPF-G6 | Free | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at 60 µM | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 26688811 | 2015 | KWKYPKLLKKLLK | KW-13 | Free | Free | Linear | L | None | 13 | Antibacterial | <1 % Hemolysis at 10 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 26688811 | 2015 | KWKYPKLLKKLLK | KW-13 | Free | Free | Linear | L | None | 13 | Antibacterial | <1 % Hemolysis at 40 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 26688811 | 2015 | KWKYPKLLKKLLK | KW-13 | Free | Free | Linear | L | None | 13 | Antibacterial | <1 % Hemolysis at 160 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 26688811 | 2015 | KWKYPKLLKKLLK | KW-13 | Free | Free | Linear | L | None | 13 | Antibacterial | <1 % Hemolysis at 640 μg/ml | Human | Synthetic Peptide | α-Helix | NA | ||
| 25172690 | 2015 | GLSRLFTALK | ACWWP1 | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibacterial | 0 % Hemolysis at 512 μg/ml | Mouse | Boiled–Dried Anchovies Cooking Wastewater | α-Helix | Non-hemolytic | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 5.3 ± 0.8 % Hemolysis at 5 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 8.9 ± 1.2 % Hemolysis at 10 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 14.5 ± 2.1 % Hemolysis at 25 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 19.7 ± 2.5 % Hemolysis at 50 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 24.7 ± 1.9 % Hemolysis at 100 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 28.5 ± 1.5 % Hemolysis at 150 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 33.6 ± 2.4 % Hemolysis at 200 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | AWNTYDYMKREHSLVKPYQG | MrMBL-N20 | Free | Free | Linear | L | None | 20 | Antibacterial | 37.4 ± 2.0 % Hemolysis at 250 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 7.9 ± 1.4 % Hemolysis at 5 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 11.5 ± 1.3 % Hemolysis at 10 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 18.7 ± 2.5 % Hemolysis at 25 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 25.4 ± 2.2 % Hemolysis at 50 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 31.4 ± 3.5 % Hemolysis at 100 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 36.8 ± 1.7 % Hemolysis at 150 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 41.5 ± 2.5 % Hemolysis at 200 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25575476 | 2015 | GGLFYVKHKEQQRKRF | MrMBL-C16 | Free | Free | Linear | L | None | 16 | Antibacterial | 46.5 ± 2.2 % Hemolysis at 250 µM | Human | Freshwater Prawn Macrobrachium Rosenbergii | α-Helix/Random coil | NA | ||
| 25311453 | 2015 | YSKSLPLSVLNP | Synthesized AN5-1 | Free | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 256 μg/ml | Human | Fermentation Broth Of Paenibacillus Alvei | NA | Low hemolytic | ||
| 25311453 | 2015 | YSKSLPLSVLNP | Biosynthesized AN5-1 | Free | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 256 μg/ml | Human | Fermentation Broth Of Paenibacillus Alvei | NA | Low hemolytic | ||
| 25680229 | 2015 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 53 % Hemolysis at 512 μg/ml | Human | Skin Of The African Clawed Frog | α-Helix | NA | ||
| 25680229 | 2015 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 25 % Hemolysis at 256 μg/ml | Human | Skin Of The African Clawed Frog | α-Helix | NA | ||
| 25680229 | 2015 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 13 % Hemolysis at 128 μg/ml | Human | Skin Of The African Clawed Frog | α-Helix | NA | ||
| 25680229 | 2015 | GIGKFLKKAKKF{ct:Amid} | CEM1 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibacterial | 0 % Hemolysis at 0-512 μg/ml | Human | Pexiganan, Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 25680229 | 2015 | IGKFLKKAKKFG{ct:Amid} | CEM2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibacterial | 0 % Hemolysis at 0-512 μg/ml | Human | Pexiganan, Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 25735802 | 2015 | RFRRLRWKTRWRLKKI{ct:Amid} | PRW4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRCKTRCRLKKI{ct:Amid} | K4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRDKTRDRLKKI{ct:Amid} | K4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRIKTRIRLKKI{ct:Amid} | K4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRPKTRPRLKKI{ct:Amid} | K4 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRW{d}KTRW{d}RLKKI{ct:Amid} | PRW4-d | Amidation | Free | Linear | Mix | w = Wd (D-Trp-substituted) | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | RFRRLRWRTRWRLRRI{ct:Amid} | PRW4-R | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 25735802 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 16 | Antimicrobial, Antibacterial | 5 % Hemolysis at 0.25 µM | Human | Control,Bee Venom | α-Helix | NA | ||
| 25997127 | 2015 | LIAGLAANFLPQILCKIARKC{ct:Amid} | linear B1CTcu5 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 37 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LIAGLAANFLPQILCKIARKC{cyc:N-C}{ct:Amid} | Cyclic B1CTcu5 | Amidation | Free | Cyclic | L | None | 21 | Antibacterial | 40 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | IAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5-L | Amidation | Free | Linear | L | None | 20 | Antibacterial | 30.5 % Hemolysis at 50 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | AGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5-LI | Amidation | Free | Linear | L | None | 19 | Antibacterial | 26 % Hemolysis at 50 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | GLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5-LIA | Amidation | Free | Linear | L | None | 18 | Antibacterial | 26.5 % Hemolysis at 100 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LAANFLPQILCKIARKC{ct:Amid} | B1CTcu5-LIAG | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 30 % Hemolysis at 12.5 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | KIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5K | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 15 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | WIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5W | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 39.11 % Hemolysis at 100 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | RIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5R | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 19.4 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | HIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5H | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 30.4 % Hemolysis at 50 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LGGGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5LGG | Amidation | Free | Linear | L | None | 21 | Antibacterial | 23.4 % Hemolysis | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LIAGLAANFLPQILCKIARK{ct:Amid} | B1CTcu5-C | Amidation | Free | Linear | L | None | 20 | Antibacterial | 13 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LIAGLAANFLPQILC(AC{d}M{d})KIARKC{ct:Amid} | B1CTcu5C (Acm) | Amidation | Free | Linear | L | None | 21 | Antibacterial | 25 % Hemolysis at 12.5 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LIAGLAANFLPQILC{ct:Amid} | B1CTcu5-Rana | Amidation | Free | Linear | L | None | 15 | Antibacterial | NA | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | Non-hemolytic | ||
| 25997127 | 2015 | LIAGLAANFL{ct:Amid} | B1CTcu5L1-L10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | NA | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | Non-hemolytic | ||
| 25997127 | 2015 | PQILCKIARKC{ct:Amid} | B1CTcu5P11-C21 | Amidation | Free | Linear | L | None | 11 | Antibacterial | NA | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | Non-hemolytic | ||
| 25997127 | 2015 | LIAGLAANFLPQILCKIARKC{ct:Amid} | DB1CTcu5 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 40.22 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25807936 | 2015 | {nnr:6#}IK{ct:Amid} | P1 | Amidation | Free | Linear | L | 6# = BDZ,benzodiazepine scaffold | 2 | Antibacterial | 50 % Hemolysis at >1000 μg/ml | Human | Bdz Peptidomimetic Compounds | α-Helix | NA | ||
| 25807936 | 2015 | K{nnr:6#}CK{ct:Amid} | P2 | Amidation | Free | Linear | L | 6# = BDZ,benzodiazepine scaffold | 3 | Antibacterial | 50 % Hemolysis at >1000 μg/ml | Human | Bdz Peptidomimetic Compounds | α-Helix | NA | ||
| 25807936 | 2015 | K{d}{nnr:6#}K{d}{ct:Amid} | P3 | Amidation | Free | Linear | D | 6# = BDZ,benzodiazepine scaffold | 2 | Antibacterial | 50 % Hemolysis at >1000 μg/ml | Human | Bdz Peptidomimetic Compounds | α-Helix | NA | ||
| 25807936 | 2015 | K{nnr:6#}VH{ct:Amid} | P4 | Amidation | Free | Linear | L | 6# = BDZ,benzodiazepine scaffold | 3 | Antibacterial | 50 % Hemolysis at >1000 μg/ml | Human | Bdz Peptidomimetic Compounds | α-Helix | NA | ||
| 25807936 | 2015 | K{nnr:6#}K{ct:Amid} | P5 | Amidation | Free | Linear | L | 6# = BDZ,benzodiazepine scaffold | 2 | Antibacterial | 50 % Hemolysis at >1000 μg/ml | Human | Bdz Peptidomimetic Compounds | α-Helix | NA | ||
| 25807936 | 2015 | K{nnr:6#}KC{ct:Amid} | P6 | Amidation | Free | Linear | L | 6# = BDZ,benzodiazepine scaffold | 3 | Antibacterial | 50 % Hemolysis at >1000 μg/ml | Human | Bdz Peptidomimetic Compounds | α-Helix | NA | ||
| 25807936 | 2015 | K{nnr:6#}FK{ct:Amid} | P7 | Amidation | Free | Linear | L | 6# = BDZ,benzodiazepine scaffold | 3 | Antibacterial | 50 % Hemolysis at >1000 μg/ml | Human | Bdz Peptidomimetic Compounds | α-Helix | NA | ||
| 25807936 | 2015 | K{d}{nnr:6#}F{d}K{d}{ct:Amid} | P8 | Amidation | Free | Linear | D | 6# = BDZ,benzodiazepine scaffold | 3 | Antibacterial | 50 % Hemolysis at >1000 μg/ml | Human | Bdz Peptidomimetic Compounds | α-Helix | NA | ||
| 25807936 | 2015 | K{nnr:6#}LK{ct:Amid} | P9 | Amidation | Free | Linear | L | 6# = BDZ,benzodiazepine scaffold | 3 | Antibacterial | 50 % Hemolysis at >1000 μg/ml | Human | Bdz Peptidomimetic Compounds | α-Helix | NA | ||
| 25807936 | 2015 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antibacterial | 50 % Hemolysis at 120 μg/ml | Human | Magainin Analogue | α-Helix | Non-hemolytic | ||
| 26046345 | 2015 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial | 56.98 % Hemolysis at 250 μg/ml | Human | Neutrophil Blood Cells Of Cows | α-Helix | NA | ||
| 26046345 | 2015 | LLPWKWPWWKWRR{ct:Amid} | IN1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 3.6 % Hemolysis at 250 μg/ml | Human | Indolicidin Analog | α-Helix | Low hemolytic | ||
| 26046345 | 2015 | RRPWRWPWWPWRR{ct:Amid} | IN2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 15.39 % Hemolysis at 250 μg/ml | Human | Indolicidin Analog | α-Helix | NA | ||
| 26046345 | 2015 | RRPWRWPRWPWRR{ct:Amid} | IN3 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 2.39 % Hemolysis at 250 μg/ml | Human | Indolicidin Analog | α-Helix | Low hemolytic | ||
| 26046345 | 2015 | FLGGLIKIVPAMICAVTKKC{ct:OH} | Ranalexin | OH | Free | Linear | L | None | 20 | Antibacterial | <15 % Hemolysis at 250 μg/ml | Human | Bullfrog (Rana Catesbeiana) Skin | α-Helix | NA | ||
| 26046345 | 2015 | FLGGLIKWWPWRR{ct:Amid} | RN7-IN6 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antipneumococcal | 0 % Hemolysis at 15.62 μg/ml | Human | Indolicidin Ranalexin Hybrid Peptide | α-Helix | Non-hemolytic | ||
| 26046345 | 2015 | FLGGLIKPWWPWRR{ct:Amid} | RN7-IN7 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <10 % Hemolysis at 250 μg/ml | Human | Indolicidin Ranalexin Hybrid Peptide | α-Helix | Non-hemolytic | ||
| 26046345 | 2015 | FLGGLIKWPWWPWRR{ct:Amid} | RN7-IN8 | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antipneumococcal | 0 % Hemolysis at 15.62 μg/ml | Human | Indolicidin Ranalexin Hybrid Peptide | α-Helix | Non-hemolytic | ||
| 26046345 | 2015 | FLGGLIKKWPWWPWRR{ct:Amid} | RN7-IN9 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antipneumococcal | 0 % Hemolysis at 15.62 μg/ml | Human | Indolicidin Ranalexin Hybrid Peptide | α-Helix | Non-hemolytic | ||
| 26046345 | 2015 | FLGGLIKWKWPWWPWRR{ct:Amid} | RN7-IN10 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antipneumococcal | 5.9 % Hemolysis at 15.62 μg/ml | Human | Indolicidin Ranalexin Hybrid Peptide | α-Helix | NA | ||
| 25966444 | 2015 | Q(L)R{nt:C18-aliphatic chain}{ct:Amid} | LP1 | Amidation | C18-aliphatic chain | Linear | L | C18 = aliphatic chain | 3 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | QLR{nt:C18-aliphatic chain}{ct:Amid} | LP2 | Amidation | C18-aliphatic chain | Linear | L | C18 = aliphatic chain | 3 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | CGCQ(L)R{nt:C18-aliphatic chain}{ct:Amid} | LP3 | Amidation | C18-aliphatic chain | Linear | L | C18 = aliphatic chain | 6 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | CGCQLR{nt:C18-aliphatic chain}{ct:Amid} | LP4 | Amidation | C18-aliphatic chain | Linear | L | C18 = aliphatic chain | 6 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | {nnr:βA}{nnr:βA}KIAKLKAKIQKLKQKIAKLK{nt:C12-aliphatic chain}{ct:Amid} | LH | Amidation | C12-aliphatic domain,βA- 2 spacer | Linear | L | C12 = aliphatic domain, βA = 2 spacer | 22 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | Q(L)R{nt:C18-aliphatic chain}{ct:Amid} | LP1 | Amidation | C18-aliphatic chain | Linear | L | C18 = aliphatic chain | 3 | Antibacterial | 50 % Hemolysis at >100 µM | Bovine | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | QLR{nt:C18-aliphatic chain}{ct:Amid} | LP2 | Amidation | C18-aliphatic chain | Linear | L | C18 = aliphatic chain | 3 | Antibacterial | 50 % Hemolysis at >100 µM | Bovine | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | CGCQ(L)R{nt:C18-aliphatic chain}{ct:Amid} | LP3 | Amidation | C18-aliphatic chain | Linear | L | C18 = aliphatic chain | 6 | Antibacterial | 50 % Hemolysis at >100 µM | Bovine | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | CGCQLR{nt:C18-aliphatic chain}{ct:Amid} | LP4 | Amidation | C18-aliphatic chain | Linear | L | C18 = aliphatic chain | 6 | Antibacterial | 50 % Hemolysis at >100 µM | Bovine | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | {nnr:βA}{nnr:βA}KIAKLKAKIQKLKQKIAKLK{nt:C12-aliphatic chain}{ct:Amid} | LH | Amidation | C12-aliphatic domain,βA- 2 spacer | Linear | L | C12 = aliphatic domain, βA = 2 spacer | 22 | Antibacterial | 50 % Hemolysis at >100 µM | Bovine | Host Defence Peptides | α-Helix | NA | ||
| 25826179 | 2015 | FKKLKKLFSKLWNWK{nt:Acet}{ct:Amid} | HPRP-A1 | Amidation | Acetylation | Linear | L | None | 15 | Antibacterial | MHC % Hemolysis at 32 µM | Human | N-Terminus Of Ribosomal Protein L1 Of Helicobacter Pylori | α-Helix | NA | ||
| 25826179 | 2015 | FKKLKKLFSKLKNWW{nt:Acet}{ct:Amid} | HPRP-A2 | Amidation | Acetylation | Linear | L | None | 15 | Antibacterial | MHC % Hemolysis at 16 µM | Human | Analog Of Hprp-A1 | α-Helix | NA | ||
| 25826179 | 2015 | KFLKLKWLKSWKNFK{nt:Acet}{ct:Amid} | HPRP-A3 | Amidation | Acetylation | Linear | L | None | 15 | Antibacterial | MHC % Hemolysis at 250 µM | Human | Analog Of Hprp-A1 | α-Helix | NA | ||
| 25826179 | 2015 | FKLKLKFSNKLKWKW{nt:Acet}{ct:Amid} | HPRP-B | Amidation | Acetylation | Linear | L | None | 15 | Antibacterial | MHC % Hemolysis at 64 µM | Human | Analog Of Hprp-A1 | β-Sheets | NA | ||
| 25826179 | 2015 | LFKKNKLWFKSKKWL{nt:Acet}{ct:Amid} | HPRP-C | Amidation | Acetylation | Linear | L | None | 15 | Antibacterial | MHC % Hemolysis at 500 µM | Human | Analog Of Hprp-A1 | Random coil | NA | ||
| 26028561 | 2015 | FKRLKKLISWIKRKRQQ{ct:Amid} | Hn-Mc | Amidation | Free | Linear | L | None | 17 | Antibacterial | 1.1 % Hemolysis at 250 µM | Rat | Hybrid Peptide | α-Helix | Low hemolytic | ||
| 25620367 | 2015 | GFGCNGPWNEDDLRCHNHCKSIKGYKGGYCAKGGFVCKCY | NZ2114 | Free | Free | Linear | L | None | 40 | Antibacterial | <0.05 % Hemolysis at 128 μg/ml | Human | Variant Of Nz2114 | α-Helix | Low hemolytic | ||
| 25620367 | 2015 | GFGCNGPWQEDDVKCHNHCKSIKGYKGGYCAKGGFVCKCY | MP1102 | Free | Free | Linear | L | None | 40 | Antibacterial | <0.05 % Hemolysis at 128 μg/ml | Human | Pseudoplectania Nigrella | α-Helix | Low hemolytic | ||
| 26238108 | 2015 | KWKSFLKTFKSAKKTVLHTLLKAISS | A20L | Free | Free | Linear | L | None | 26 | Antibacterial | MHC % Hemolysis at 213.33 μg/ml | Human | Derivative Of V13K | α-Helix | NA | ||
| 26204061 | 2015 | GIIKKIIKKIIKKI{ct:Amid} | FITC | Amidation | Free | Linear | L | None | 14 | Antibacterial and Anticancer | 50 % Hemolysis at 256 µM | Human | Synthetic Amphiphiles | α-Helix | Low hemolytic | ||
| 26204061 | 2015 | IIKKIIKKIIKKI{ct:Amid} | 1 | Amidation | Free | Linear | L | None | 13 | Antibacterial and Anticancer | 50 % Hemolysis at 256 µM | Human | Synthetic Amphiphiles | α-Helix | Low hemolytic | ||
| 26204061 | 2015 | GIIKKIIKKIIKK{ct:Amid} | 2 | Amidation | Free | Linear | L | None | 13 | Antibacterial and Anticancer | 50 % Hemolysis at 500 µM | Human | Synthetic Amphiphiles | α-Helix | Low hemolytic | ||
| 26204061 | 2015 | IIKKIIKKIIKK{ct:Amid} | Rhodamine | Amidation | Free | Linear | L | None | 12 | Antibacterial and Anticancer | 50 % Hemolysis at >1000 µM | Human | Synthetic Amphiphiles | α-Helix | Low hemolytic | ||
| 26041027 | 2015 | RPHGAGEGIDRVPAGPSPSEVGLAIPSGK{ct:Amid} | Pep-7 | Amidation | Free | Linear | L | None | 29 | Antibacterial | 0.1 ± 0.1 % Hemolysis at 1.7 µM | Human | Porphyromonas Gingivalis | NA | NA | ||
| 26041027 | 2015 | RPHGAGEGIDRVPAGPSPSEVGLAIPSGK{ct:Amid} | Pep-7 | Amidation | Free | Linear | L | None | 29 | Antibacterial | 0.1 ± 0.1 % Hemolysis at 3.4 µM | Human | Porphyromonas Gingivalis | NA | NA | ||
| 26041027 | 2015 | RPHGAGEGIDRVPAGPSPSEVGLAIPSGK{ct:Amid} | Pep-7 | Amidation | Free | Linear | L | None | 29 | Antibacterial | 0.3 ± 0.1 % Hemolysis at 6.8 µM | Human | Porphyromonas Gingivalis | NA | NA | ||
| 26149664 | 2015 | RWK({nnr:N3}){nt:H}{ct:Amid} | 3 a | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 3 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | RWK({nnr:N3}){nt:H}{ct:Amid} | 3 b | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 3 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | RWK({nnr:N3}){nt:H}{ct:Amid} | 3 c | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 3 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | WRK({nnr:N3}){nt:H}{ct:Amid} | 4 a | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 3 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | WRK({nnr:N3}){nt:H}{ct:Amid} | 4b | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 3 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | WRK({nnr:N3}){nt:H}{ct:Amid} | 4c | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 3 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | RWRK({nnr:N3}){nt:H}{ct:Amid} | 5a | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 4 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | RWRK({nnr:N3}){nt:H}{ct:Amid} | 5b | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 4 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | RWRK({nnr:N3}){nt:H}{ct:Amid} | 5c | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 4 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | WRWK({nnr:N3}){nt:H}{ct:Amid} | 6a | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 4 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | WRWK({nnr:N3}){nt:H}{ct:Amid} | 6b | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 4 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | WRWK({nnr:N3}){nt:H}{ct:Amid} | 6c | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 4 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | RWRWRWK({nnr:N3}){nt:H}{ct:Amid} | 7a | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 7 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | RWRWRWK({nnr:N3}){nt:H}{ct:Amid} | 7b | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 7 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26149664 | 2015 | RWRWRWK({nnr:N3}){nt:H}{ct:Amid} | 7c | Amidation | H | Linear | L | N3 = 1,2,3-triazol-4-methoxy | 7 | Antibacterial | <1 % Hemolysis at <100 µM | Human | Arg-Trp-Based Peptides | α-Helix | Non-hemolytic | ||
| 26160494 | 2015 | KKYRYHLKPFSKK{nt:NH3+}{ct:Carboxyl (COO-)} | p-(Ser11)-BthTX-I(COO-) | Carboxyl (COO-) | NH3+ | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >128 µmol/L | Human | Analogues Bothropstoxin-I (Bthtx-I) | α-Helix | NA | ||
| 26160494 | 2015 | KKYRYHLKPFSKK{nt:NH3+}{ct:Amid} | [p-(Ser11)-BthTX-I(CONH2)] | Amidation | NH3+ | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >128 µmol/L | Human | Analogues Bothropstoxin-I (Bthtx-I) | α-Helix | NA | ||
| 26160494 | 2015 | KKYRYHLKPFCKK{nt:NH3+}{ct:Carboxyl (COO-)} | p-BthTX-I | Carboxyl (COO-) | NH3+ | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >128 µmol/L | Human | Bothropstoxin-I (Bthtx-I) | α-Helix | NA | ||
| 26160494 | 2015 | KKYRYHLKPFCKKKKYRYHLKPFCKK{nt:NH3+}{ct:Carboxyl (COO-)} | (p-BthTX-I)2 | Carboxyl (COO-) | NH3+ | Linear | L | None | 26 | Antibacterial | 50 % Hemolysis at >128 µmol/L | Human | Analogues Bothropstoxin-I (Bthtx-I) | α-Helix | NA | ||
| 26461841 | 2015 | MFTLKKSLFLVLILGMVSLSLCRPQSLADKETSDDPTEEENTAGDEESVEKRDLGKASYPIAYS | Spinosan-A | Free | Free | Linear | L | None | 64 | Antibacterial, Antioxidative | 2.36±0.023 % Hemolysis at 80 μg/ml | Rabbit | Paa Spinosa | α-Helix | NA | ||
| 26461841 | 2015 | MFTLKKSLFLILILGMVSLSLCGQRSLADKETSNDPTGEENTAGDEEGGEEGNLEMRRDYCKPEECDYYFSFPI | Spinosan-B | Free | Free | Linear | L | None | 74 | Antibacterial, Antioxidative | 2.11±0.023 % Hemolysis at 80 μg/ml | Rabbit | Paa Spinosa | α-Helix | NA | ||
| 26461841 | 2015 | MFTLKKSLFLVLILGMVSLSLCRGRSLADKETSNDPTGEENTAGDEESGEKRDLSMMRKAGSNIVCGLNGLC | Spinosan-C | Free | Free | Linear | L | None | 72 | Antibacterial, Antioxidative | 2.94±0.023 % Hemolysis at 80 μg/ml | Rabbit | Paa Spinosa | α-Helix | NA | ||
| 26461841 | 2015 | MFTLKKSLFLVLILGMVSLSLCQQESNADKETTKEVTGEANTAGNVEIVEVAEVEKEMEELYKEIDDCVNYGNCKTLKLM | Spinosan-D | Free | Free | Linear | L | None | 80 | Antibacterial, Antioxidative | 3.94±0.023 % Hemolysis at 80 μg/ml | Rabbit | Paa Spinosa | α-Helix | NA | ||
| 26235946 | 2015 | KAAKAAKKAAKAAWK{nt:Acet}{ct:Amid} | Ac-UM-14W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | <1 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKA{nnr:X}KKAAKAAWK{nt:Acet}{ct:Amid} | Ac-SS-14W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | <1 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKA{nnr:X}KK{nnr:X}AKA{nnr:X}WK{nt:Acet}{ct:Amid} | Ac-DS-14W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 38.8 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKA{nnr:X}KK{nnr:X}AKW{nnr:X}AK{nt:Acet}{ct:Amid} | Ac-DS-12W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 42.5 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Acet}{ct:Amid} | Ac-DS-3W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 42.5 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}WKA{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Acet}{ct:Amid} | Ac-DS-5W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 38.5 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Succinylated}{ct:Amid} | Su-DS-5W | Amidation | Succinylated | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 32.6 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:H}{ct:Amid} | H-DS-5W | Amidation | H | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 25.5 % Hemolysis at 25 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | KAAKAAKKAAKAAWK{nt:Acet}{ct:Amid} | Ac-UM-14W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | <1 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKA{nnr:X}KKAAKAAWK{nt:Acet}{ct:Amid} | Ac-SS-14W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | <1 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKA{nnr:X}KK{nnr:X}AKA{nnr:X}WK{nt:Acet}{ct:Amid} | Ac-DS-14W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 22.1 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKA{nnr:X}KK{nnr:X}AKW{nnr:X}AK{nt:Acet}{ct:Amid} | Ac-DS-12W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 25.3 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Acet}{ct:Amid} | Ac-DS-3W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 28.9 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}WKA{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Acet}{ct:Amid} | Ac-DS-5W | Amidation | Acetylation | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 22 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:Succinylated}{ct:Amid} | Su-DS-5W | Amidation | Succinylated | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 19.5 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26235946 | 2015 | K{nnr:X}AKW{nnr:X}KK{nnr:X}AKA{nnr:X}AK{nt:H}{ct:Amid} | H-DS-5W | Amidation | H | Linear | L | X = residues cross-linked by an oct-4-enyl staple | 15 | Antibacterial | 13.5 % Hemolysis at 12.5 µM | Human | Doubly-Stapled Alanine/Lysine-Based Peptides | α-Helix | NA | ||
| 26152423 | 2015 | MRLVKVSAAVILVLLAVSAS | Rhamp1- His | Free | Free | Linear | L | None | 22 | Antibacterial | Hemolysis at 10 µM | Rabbit | Rhipicephalus Haemaphysaloides | NA | NA | ||
| 26159095 | 2015 | GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C} | cMnALF24 | Free | Free | Cyclic | L | None | 24 | Antibacterial | ~10 % Hemolysis at 0.67 µM | Rabbit | Macrobrachium Nipponense | β-Sheets | Low hemolytic | ||
| 26159095 | 2015 | GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C} | cMnALF24 | Free | Free | Cyclic | L | None | 24 | Antibacterial | ~10 % Hemolysis at 3.35 µM | Rabbit | Macrobrachium Nipponense | β-Sheets | Low hemolytic | ||
| 26159095 | 2015 | GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C} | cMnALF24 | Free | Free | Cyclic | L | None | 24 | Antibacterial | ~10 % Hemolysis at 6.7 µM | Rabbit | Macrobrachium Nipponense | β-Sheets | Low hemolytic | ||
| 26159095 | 2015 | GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C} | cMnALF24 | Free | Free | Cyclic | L | None | 24 | Antibacterial | ~10 % Hemolysis at 33.5 µM | Rabbit | Macrobrachium Nipponense | β-Sheets | Low hemolytic | ||
| 26159095 | 2015 | GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C} | cMnALF24 | Free | Free | Cyclic | L | None | 24 | Antibacterial | 22 % Hemolysis at 67 µM | Rabbit | Macrobrachium Nipponense | β-Sheets | Low hemolytic | ||
| 26311041 | 2015 | FVQWFSKFLGRIL{ct:Amid} | TL | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 15.4 µM | Human | Amphibian Skin Temporins | α-Helix | NA | ||
| 26311041 | 2015 | FVQWWSKWLGRIL{ct:Amid} | TL-1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 21.4 µM | Human | Analog Of Tl | α-Helix | NA | ||
| 26311041 | 2015 | FVRWWSKWLRRIL{ct:Amid} | TL-2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 8.5 µM | Human | Analog Of Tl | α-Helix | NA | ||
| 26311041 | 2015 | FVRWWSRWLRRIL{ct:Amid} | TL-3 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 8 µM | Human | Analog Of Tl | α-Helix | NA | ||
| 26311041 | 2015 | FVKWWSKWLKKIL{ct:Amid} | TL-4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 15.9 µM | Human | Analog Of Tl | α-Helix | NA | ||
| 26489599 | 2015 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | 23 ± 1 % Hemolysis at 100 µM | Human | Derivative Of Indolicidin From Bovine Neutrophils | NA | NA | ||
| 26489599 | 2015 | BRBR{ct:Amid} | 23 | Amidation | Free | Linear | L | None | 4 | Antibacterial | <1 % Hemolysis at 100 µM | Human | Tetrapeptide | NA | Low hemolytic | ||
| 26656394 | 2015 | GLRKKFRKTRKRIQKLGRKIGKTGRKVWKAWREYGQIPYPCRI | Cap11 | Free | Free | Linear | L | None | 43 | Antibacterial | 4 ± 0 % Hemolysis at 64 μg/ml | Horse | Mammalian, Guinea Pig, Neutrophils | α-Helical | NA | ||
| 26656394 | 2015 | KLRKLFRKLLKLIRKLLR | Cap11-1-18m2 | Free | Free | Linear | L | None | 18 | Antibacterial | 52 ± 6 % Hemolysis at 64 μg/ml | Horse | Truncated Derivative Of Cap11 | α-Helical | NA | ||
| 26656394 | 2015 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY | Cap18 | Free | Free | Linear | L | None | 37 | Antibacterial | 1 ± 0 % Hemolysis at 64 μg/ml | Horse | Mammalian, Rabbit, Neutrophils | α-Helical | NA | ||
| 26656394 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial | 110 ± 1 % Hemolysis at 128 μg/ml | Horse | Insects, Honey Bee | α-Helical | NA | ||
| 26656394 | 2015 | ILPWKWPWWPWR | Indolicidin | Free | Free | Linear | L | None | 12 | Antibacterial | 12 ± 0 % Hemolysis at 128 μg/ml | Horse | Mammalian, Bovine Neutrophils | Extended | NA | ||
| 26656394 | 2015 | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR | Cecropin P1 | Free | Free | Linear | L | None | 31 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Mammalian, Pig, Small Intestine | α-Helical | Non-hemolytic | ||
| 26656394 | 2015 | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG{ct:Amid} | Cecropin B | Amidation | Free | Linear | L | None | 36 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Insects, Giant Silk Moth, Pupae | α-Helical | Non-hemolytic | ||
| 26656394 | 2015 | RLARIVVIRVAR | Bac2A | Free | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Non-Amidated Version Of Bac2A-Nh2 | α-Helical/β-Sheet | Non-hemolytic | ||
| 26656394 | 2015 | RLARIVVIRVAR{ct:Amid} | Bac2A-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Linear Variant Of Bactenecin From Bovine Neutrophils | NA | Non-hemolytic | ||
| 26656394 | 2015 | RRWKIVVIRWRR{ct:Amid} | Sub5-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Synthetic Variant Of Bac2A-Nh2 | NA | Non-hemolytic | ||
| 26656394 | 2015 | GIHDILKYGKPS | Myxinidin | Free | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Fish, Epidermal Mucus Of Hagfish | NA | Non-hemolytic | ||
| 26656394 | 2015 | GIHDILKYGKPS{ct:Amid} | Myxinidin-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Amidated Form Of Myxinidin | NA | Non-hemolytic | ||
| 26656394 | 2015 | VDKGSYLPRPTPPRPIYNRN | Pyrrhocoricin | Free | Free | Linear | L | None | 20 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Insects, Pyrrhocoris Apterus | NA | Non-hemolytic | ||
| 26656394 | 2015 | GNNRPVYIPQPRPPHPRI | Apidaecin IA | Free | Free | Linear | L | None | 18 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Insects, Honey Bee | Extended, proline rich | Non-hemolytic | ||
| 26656394 | 2015 | VDKPDYRPRPRPPNM | Metalnikowin I | Free | Free | Linear | L | None | 15 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Insects, Palomena Prasina | NA | Non-hemolytic | ||
| 26680226 | 2015 | NLCASLRARHTIPQCRKFGRR{ct:Amid} | mBjAMP1 | Amidation | Free | Linear | L | None | 21 | Antibacterial | little Hemolysis at 100 μg/ml | Human | Vaguely Eel Amphioxus Branchiostoma Japonicum | α-Helical | Low hemolytic | ||
| 26680226 | 2015 | NLCASLRARHTIPQCRKFGRR{ct:Amid} | mBjAMP1 | Amidation | Free | Linear | L | None | 21 | Antibacterial | little Hemolysis at 50 μg/ml | Human | Vaguely Eel Amphioxus Branchiostoma Japonicum | α-Helical | Low hemolytic | ||
| 26680226 | 2015 | NLCASLRARHTIPQCRKFGRR{ct:Amid} | mBjAMP1 | Amidation | Free | Linear | L | None | 21 | Antibacterial | little Hemolysis at 25 μg/ml | Human | Vaguely Eel Amphioxus Branchiostoma Japonicum | α-Helical | Low hemolytic | ||
| 26680226 | 2015 | NLCASLRARHTIPQCRKFGRR{ct:Amid} | mBjAMP1 | Amidation | Free | Linear | L | None | 21 | Antibacterial | little Hemolysis at 12.5 μg/ml | Human | Vaguely Eel Amphioxus Branchiostoma Japonicum | α-Helical | Low hemolytic | ||
| 26606380 | 2015 | IKIPSFFRNILKKVGKEAVSLIAGALKQS | pseudhymenochirin-1Pb | Free | Free | Linear | L | None | 29 | Antibacterial, Cytotoxicity | 30 ± 5 % Hemolysis at >100 µM | Mouse | Merlin’S Clawed Frog, Pseudhymenochirus Merlini | α-Helical | NA | ||
| 26606380 | 2015 | GIFPIFAKLLGKVIKVASSLISKGRTE | pseudhymenochirin-2Pa | Free | Free | Linear | L | None | 27 | Antibacterial, Cytotoxicity | 7 ± 2 % Hemolysis at >100 µM | Mouse | Merlin’S Clawed Frog, Pseudhymenochirus Merlini | α-Helical | NA | ||
| 26295533 | 2015 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 21 % Hemolysis at 0.25 mg/ml | Human | Bovine Cathelicidin | α-Helical | NA | ||
| 26295533 | 2015 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | ~10 % Hemolysis at 0.1 mg/ml | Human | Bovine Cathelicidin | α-Helical | NA | ||
| 26295533 | 2015 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 5 % Hemolysis at 0.05 mg/ml | Human | Bovine Cathelicidin | α-Helical | NA | ||
| 26295533 | 2015 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 6 % Hemolysis at 0.025 mg/ml | Human | Bovine Cathelicidin | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVVIRVAR{cyc:N-C}{ct:Amid} | Bac2A | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.25 mg/ml | Human | Bovine Host Defense Peptide Variant | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVVIRVAR{cyc:N-C}{ct:Amid} | Bac2A | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.1 mg/ml | Human | Bovine Host Defense Peptide Variant | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVVIRVAR{cyc:N-C}{ct:Amid} | Bac2A | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.05 mg/ml | Human | Bovine Host Defense Peptide Variant | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVVIRVAR{cyc:N-C}{ct:Amid} | Bac2A | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.025 mg/ml | Human | Bovine Host Defense Peptide Variant | α-Helical | NA | ||
| 26295533 | 2015 | RLRRIVVIRVAR{cyc:N-C}{ct:Amid} | R3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.25 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLRRIVVIRVAR{cyc:N-C}{ct:Amid} | R3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.1 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLRRIVVIRVAR{cyc:N-C}{ct:Amid} | R3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.05 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLRRIVVIRVAR{cyc:N-C}{ct:Amid} | R3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.025 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVPIRVAR{cyc:N-C}{ct:Amid} | P7 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.25 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVPIRVAR{cyc:N-C}{ct:Amid} | P7 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.1 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVPIRVAR{cyc:N-C}{ct:Amid} | P7 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.05 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RLARIVPIRVAR{cyc:N-C}{ct:Amid} | P7 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.025 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | VRWRIRVAVIRA{cyc:N-C}{ct:Amid} | W3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 10 % Hemolysis at 0.25 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | VRWRIRVAVIRA{cyc:N-C}{ct:Amid} | W3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 5 % Hemolysis at 0.1 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | VRWRIRVAVIRA{cyc:N-C}{ct:Amid} | W3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | >5 % Hemolysis at 0.05 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | VRWRIRVAVIRA{cyc:N-C}{ct:Amid} | W3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.025 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RRWRIVVIRVRR{cyc:N-C}{ct:Amid} | Sub3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <10 % Hemolysis at 0.25 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RRWRIVVIRVRR{cyc:N-C}{ct:Amid} | Sub3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 10 % Hemolysis at 0.1 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RRWRIVVIRVRR{cyc:N-C}{ct:Amid} | Sub3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 5 % Hemolysis at 0.05 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | RRWRIVVIRVRR{cyc:N-C}{ct:Amid} | Sub3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | <5 % Hemolysis at 0.025 mg/ml | Human | Bac2A Derivative | α-Helical | NA | ||
| 26295533 | 2015 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid} | LL-37 | Amidation | Free | Linear | L | None | 37 | Antibacterial, Antifungal | <5 % Hemolysis at 0.25 mg/ml | Human | Human Cathelicidin | α-Helical | NA | ||
| 26295533 | 2015 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid} | LL-37 | Amidation | Free | Linear | L | None | 37 | Antibacterial, Antifungal | <5 % Hemolysis at 0.1 mg/ml | Human | Human Cathelicidin | α-Helical | NA | ||
| 26295533 | 2015 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid} | LL-37 | Amidation | Free | Linear | L | None | 37 | Antibacterial, Antifungal | <5 % Hemolysis at 0.05 mg/ml | Human | Human Cathelicidin | α-Helical | NA | ||
| 26295533 | 2015 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid} | LL-37 | Amidation | Free | Linear | L | None | 37 | Antibacterial, Antifungal | <5 % Hemolysis at 0.025 mg/ml | Human | Human Cathelicidin | α-Helical | NA | ||
| 26100634 | 2015 | GLFGVLAKVAAHVVPAIAEHF{ct:Amid} | Maculatin 1.1 | Amidation | Free | Linear | L | None | 21 | Anticancer, Antibacterial Gram- | 50 % Hemolysis at 29.5 ± 1.0 µM | Human | Australian Tree Frog Litoria Genimaculata | α-Helical | NA | ||
| 26100634 | 2015 | GIGAVLKVTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Anticancer, Antibacterial Gram- | 50 % Hemolysis at 1.2± 0.1 µM | Human | Bee Venom | α-Helical | NA | ||
| 25982541 | 2015 | FIGAAARLASKIF{ct:Amid} | BmKn2A1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 0-100 μg/mL | Human | Analogs Of The Scorpion Venom Bmkn Peptides | α-Helical | Non-hemolytic | ||
| 25982541 | 2015 | FIGAVARLVSKIF{ct:Amid} | BmKn2V1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <100 % Hemolysis at 100 μg/mL | Human | Analogs Of The Scorpion Venom Bmkn Peptides | α-Helical | NA | ||
| 25982541 | 2015 | FIGALARLLSKIF{ct:Amid} | BmKn2L1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <100 % Hemolysis at 100 μg/mL | Human | Analogs Of The Scorpion Venom Bmkn Peptides | α-Helical | NA | ||
| 25982541 | 2015 | FIGAIAKLLKKIF{ct:Amid} | BmKn2K7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <100 % Hemolysis at 100 μg/mL | Human | Analogs Of The Scorpion Venom Bmkn Peptides | α-Helical | NA | ||
| 25982541 | 2015 | FIGAVKGLLSKIF{ct:Amid} | BmKn1-6Lys | Amidation | Free | Linear | L | None | 13 | Antibacterial | <60 % Hemolysis at 100 μg/mL | Human | Analogs Of The Scorpion Venom Bmkn Peptides | α-Helical | NA | ||
| 25982541 | 2015 | FKGALAGLLSKKF{ct:Amid} | BmKn1L2K2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 0-100 μg/mL | Human | Analogs Of The Scorpion Venom Bmkn Peptides | α-Helical | Non-hemolytic | ||
| 25891396 | 2015 | AGYLLGKINLKALAALAKKIL{ct:Amid} | TP10 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 80 % Hemolysis at 512 μg/mL | Human | Deletion Analogue Of The Cpp Transportan | α-Helical-50% TFE solution | NA | ||
| 25891396 | 2015 | AGYLLGKINLKPLAALAKKIL{ct:Amid} | TP10-2 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 512 μg/mL | Human | Transportan 10 Analogues | α-Helical | Non-hemolytic | ||
| 25891396 | 2015 | AAYLLAKINLKALAALAKKIL{ct:Amid} | TP10-3 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 39.57 % Hemolysis at 512 μg/mL | Human | Transportan 10 Analogues | α-Helical | NA | ||
| 25891396 | 2015 | AGYLLGKINLKKLAKL({nnr:Aib})KKIL{ct:Amid} | TP10-5 | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid | 21 | Antibacterial, Antibiofilm | 80 % Hemolysis at 512 μg/mL | Human | Transportan 10 Analogues | α-Helical | NA | ||
| 25891396 | 2015 | AGYLLGKINLKPLAKL({nnr:Aib})KKIL{ct:Amid} | TP10-7 | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid | 21 | Antibacterial, Antibiofilm | 59.45 % Hemolysis at 512 μg/mL | Human | Transportan 10 Analogues | α-Helical | NA | ||
| 25891396 | 2015 | AGYLLPKINLKPLAKLPKKIL{ct:Amid} | TP10-8 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 512 μg/mL | Human | Transportan 10 Analogues | α-Helical | Non-hemolytic | ||
| 25839356 | 2015 | FIHHIIGWISHGVRAIHRAIH{ct:Amid} | Gad-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram- | 50 % Hemolysis at 43 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FIHHIIGWISHGVRAIHRAIH{ct:Amid} | Gad-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | 100 % Hemolysis at 100 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FIHHIIGWISHGVRAIHRAIH{ct:Amid} | Gad-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | 100 % Hemolysis at 200 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FIHHIIGWISHGVRAIHRAIH{ct:Amid} | Gad-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | 100 % Hemolysis at 400 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FLHHIVGLIHHGLSLFGDR{ct:Amid} | Gad-2 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | 50 % Hemolysis at 56 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FLHHIVGLIHHGLSLFGDR{ct:Amid} | Gad-2 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | <90 % Hemolysis at 100 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FLHHIVGLIHHGLSLFGDR{ct:Amid} | Gad-2 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | 100 % Hemolysis at 200 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FLHHIVGLIHHGLSLFGDR{ct:Amid} | Gad-2 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | 100 % Hemolysis at 400 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAGLLSKIF{ct:Amid} | BmKn1OR | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAGLLSKIF{ct:Amid} | BmKn1OR | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAIARLLSKIF{ct:Amid} | BmKn2OR | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAIARLLSKIF{ct:Amid} | BmKn2OR | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAAAGLASKIF{ct:Amid} | BmKn1A1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAAAGLASKIF{ct:Amid} | BmKn1A1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAGLVSKIF{ct:Amid} | BmKn1V1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAGLVSKIF{ct:Amid} | BmKn1V1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGALAGLLSKIF{ct:Amid} | BmKn1L1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGALAGLLSKIF{ct:Amid} | BmKn1L1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAKLLKKIF{ct:Amid} | BmKn1K7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <100 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAKLLKKIF{ct:Amid} | BmKn1K7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <100 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | NA | ||
| 25451872 | 2015 | FIGAVAELLEKIF{ct:Amid} | BmKn1E7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 50 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | Non-hemolytic | ||
| 25451872 | 2015 | FIGAVAELLEKIF{ct:Amid} | BmKn1E7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 100 μg/mL | Human | Analogs Of Peptides From Buthus Martensii Scorpion Venom | α-Helical | Non-hemolytic | ||
| 25640709 | 2015 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5N | Amidation | Free | Linear | L | None | 20 | Antibacterial | 20 % Hemolysis at 90 µM | Human | Synthetic Homologue Of Maximin H5 | α-Helical | NA | ||
| 25640709 | 2015 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5N | Amidation | Free | Linear | L | None | 20 | Antibacterial | <12 % Hemolysis at <25 µM | Human | Synthetic Homologue Of Maximin H6 | α-Helical | NA | ||
| 25640709 | 2015 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5N | Amidation | Free | Linear | L | None | 20 | Antibacterial | 15 % Hemolysis at >450 µM | Human | Synthetic Homologue Of Maximin H7 | α-Helical | NA | ||
| 25640709 | 2015 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5C | Amidation | Free | Linear | L | None | 20 | Antibacterial | 12 % Hemolysis at 180 µM | Human | Isoform Of Mh5N | α-Helical | NA | ||
| 25640709 | 2015 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5C | Amidation | Free | Linear | L | None | 20 | Antibacterial | <12 % Hemolysis at <25 µM | Human | Isoform Of Mh5N | α-Helical | NA | ||
| 25640709 | 2015 | ILGPVLGLVSDTLDDVLGIL{ct:Amid} | MH5C | Amidation | Free | Linear | L | None | 20 | Antibacterial | 25 % Hemolysis at >450 µM | Human | Isoform Of Mh5N | α-Helical | NA | ||
| 26144972 | 2015 | VARGWKRKCPLFGKGG | VG16KRKP | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 0.12 % Hemolysis at 25 µM | Human | Analogue Of Vg16 | Loop-type | Non-hemolytic | ||
| 26144972 | 2015 | VARGWKRKCPLFGKGG | VG16KRKP | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | <0.12 % Hemolysis at 50 µM | Human | Analogue Of Vg16 | Loop-type | Non-hemolytic | ||
| 26144972 | 2015 | VARGWKRKCPLFGKGG | VG16KRKP | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 0.1 % Hemolysis at 100 µM | Human | Analogue Of Vg16 | Loop-type | Non-hemolytic | ||
| 26144972 | 2015 | VARGWKRKCPLFGKGG | VG16KRKP | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 0.09 % Hemolysis at 150 µM | Human | Analogue Of Vg16 | Loop-type | Non-hemolytic | ||
| 26144972 | 2015 | VARGWKRKCPLFGKGG | VG16KRKP | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | <0.12 % Hemolysis at 200 µM | Human | Analogue Of Vg16 | Loop-type | Non-hemolytic | ||
| 26144972 | 2015 | VARGWKRKCPLFGKGG | VG16KRKP | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 0.1 % Hemolysis at 250 µM | Human | Analogue Of Vg16 | Loop-type | Non-hemolytic | ||
| 25530580 | 2015 | GLLTRIKTLL{ct:Amid} | 4T | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLL{nnr:Hser}RIKTLL{ct:Amid} | 4Hser | Amidation | Free | Linear | L | HSer = homoserine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLSRIKTLL{ct:Amid} | 4S | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Solitary Spider Wasp, Anoplius Samariensis | α-Helical | NA | ||
| 25530580 | 2015 | GLL{nnr:O}RIKTLL{ct:Amid} | 4Orn | Amidation | Free | Linear | L | O = L-Ornithine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKRIKSLL{ct:Amid} | 8S | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLL{nnr:Dab}RIKTLL{ct:Amid} | 4Dab | Amidation | Free | Linear | L | Dab = 2,4-diaminobutanoic acid | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLL{nnr:Dap}RIKTLL{ct:Amid} | 4Dap | Amidation | Free | Linear | L | Dap = 2,3-diaminopropanoic acid | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKKIKKLL{ct:Amid} | 5K8K | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKRIKKLL{ct:Amid} | 8K | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLL{nnr:Dab}RIK{nnr:Dab}LL{ct:Amid} | 4,8Dab | Amidation | Free | Linear | L | Dab = 2,4-diaminobutanoic acid | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G({nnr:O-Me-Ser})({nnr:O-Me-Ser})KRIKT({nnr:O-Me-Ser})({nnr:O-Me-Ser}){ct:Amid} | 2,3,9,10(O-Me-Ser) | Amidation | Free | Linear | L | O-Me-Ser = O-methyl-serine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G({nnr:O-Me-Ser})LKRIKTL({nnr:O-Me-Ser}){ct:Amid} | 2,10(O-Me-Ser) | Amidation | Free | Linear | L | O-Me-Ser = O-methyl-serine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GVVKRIKTVV{ct:Amid} | 2,3,9,10V | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GMMKRIKTMM{ct:Amid} | 2,3,9,10M | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G({nnr:O-Me-Ser})LKRIKTLL{ct:Amid} | 2(O-Me-Ser) | Amidation | Free | Linear | L | O-Me-Ser = O-methyl-serine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GNV{d}A{d}NV{d}A{d}KRIKTNV{d}A{d}NV{d}A{d}{ct:Amid} | 2,3,9,10Nva | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GVLKRIKTLV{ct:Amid} | 2,10V | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLMKRIKTML{ct:Amid} | 3,9M | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GMLKRIKTLM{ct:Amid} | 2,10M | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Nva}LKRIKTL{nnr:Nva}{ct:Amid} | 2,10Nva | Amidation | Free | Linear | L | Nva = Norvaline | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GMLKRIKTLL{ct:Amid} | 2M | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 400 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Nle}LKRIKTL{nnr:Nle}{ct:Amid} | 2,10Nle | Amidation | Free | Linear | L | Nle = Norleucine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Nle}{nnr:Nle}KRIKT{nnr:Nle}{nnr:Nle}{ct:Amid} | 2,3,9,10Nle | Amidation | Free | Linear | L | Nle = Norleucine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Epa}LKRIKTL{nnr:Epa}{ct:Amid} | 2,10Epa | Amidation | Free | Linear | L | Epa = 2-amino,3-ethylpentanoic acid | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Hle}LKRIKTL{nnr:Hle}{ct:Amid} | 2,10Hle | Amidation | Free | Linear | L | Hle = homoleucine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Cha}LKRIKTLL{ct:Amid} | 2Cha | Amidation | Free | Linear | L | Cha = 3- cyclohexylalanine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKRIKTL{nnr:Cha}{ct:Amid} | 10Cha | Amidation | Free | Linear | L | Cha = 3- cyclohexylalanine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:βNal}KRIKTLL{ct:Amid} | 2(βNal) | Amidation | Free | Linear | L | βNal = 3(2-naphtyl)alanine | 10 | Antibacterial | 50 % Hemolysis at >500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Hle}{nnr:Hle}KRIKT{nnr:Hle}{nnr:Hle}{ct:Amid} | 2,3,9,10Hle | Amidation | Free | Linear | L | Hle = homoleucine | 10 | Antibacterial | 50 % Hemolysis at 380 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Aoc}LKRIKTL{nnr:Aoc}{ct:Amid} | 2,10Aoc | Amidation | Free | Linear | L | Aoc = 2-aminooctanoic acid | 10 | Antibacterial | 50 % Hemolysis at 500 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Cha}LKRIKT{nnr:Cha}L{ct:Amid} | 2,9Cha | Amidation | Free | Linear | L | Cha = 3- cyclohexylalanine | 10 | Antibacterial | 50 % Hemolysis at 350 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Cha}LKRIKTL{nnr:Cha}{ct:Amid} | 2,10Cha | Amidation | Free | Linear | L | Cha = 3- cyclohexylalanine | 10 | Antibacterial | 50 % Hemolysis at 300 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Aoc}{nnr:Aoc}KRIKT{nnr:Aoc}{nnr:Aoc}{ct:Amid} | 2,3,9,10Aoc | Amidation | Free | Linear | L | Aoc = 2-aminooctanoic acid | 10 | Antibacterial | 50 % Hemolysis at 125 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GALKR{nnr:βNal}KTLA{ct:Amid} | 2,10A6(βNal) | Amidation | Free | Linear | L | βNal = 3(2-naphtyl)alanine | 10 | Antibacterial | 50 % Hemolysis at 71 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Nva}{nnr:Nva}KR{nnr:βNal}KT{nnr:Nva}{nnr:Nva}{ct:Amid} | 2,3,9,10Nva6(βNal) | Amidation | Free | Linear | L | Nva = Norvaline, βNal = 3(2-naphtyl)alanine | 10 | Antibacterial | 50 % Hemolysis at 120 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | G{nnr:Nva}LKR{nnr:βNal}KTL{nnr:Nva}{ct:Amid} | 2,10Nva6(βNal) | Amidation | Free | Linear | L | Nva = Norvaline, βNal = 3(2-naphtyl)alanine | 10 | Antibacterial | 50 % Hemolysis at 100 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GL{nnr:Nva}KR{nnr:βNal}KT{nnr:Nva}L{ct:Amid} | 3,9Nva6(βNal) | Amidation | Free | Linear | L | Nva = Norvaline, βNal = 3(2-naphtyl)alanine | 10 | Antibacterial | 50 % Hemolysis at 20 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKKIKWLL{ct:Amid} | 5K8W | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 130 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKKIKWLL{ct:Amid} | 5W | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 20 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25530580 | 2015 | GLLKFIKWLL{ct:Amid} | 5F8W | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 2 µM | Human | Anoplin Analogues | α-Helical | NA | ||
| 25728268 | 2015 | MLIFVHIIAPVISGCAIAFFSYWLSRRNTK{ct:Amid} | PepA1 | Amidation | Free | Linear | L | None | 30 | Antibacterial | 50 % Hemolysis at 70 µM | Human | Bacteria S. Aureus | α-Helical | NA | ||
| 25728268 | 2015 | MLIFVHIIAPVISGC{ct:Amid} | Pep N-ter | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 300-900 µM | Human | Derived From Pepa1 | NA | NA | ||
| 25728268 | 2015 | AIAFFSYWLSRRNTK{ct:Amid} | Pep C-ter | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 420 µM | Human | Derived From Pepa2 | NA | NA | ||
| 25728268 | 2015 | FFSYWLSRRNTK{ct:Amid} | Pep1 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 50 % Hemolysis at 300-900 µM | Human | Derived From Pepa3 | NA | NA | ||
| 25728268 | 2015 | FFSYWLSRRTK{ct:Amid} | Pep2 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 50 % Hemolysis at 300-900 µM | Human | Derived From Pepa4 | NA | NA | ||
| 25728268 | 2015 | FFSWLSRRTK{ct:Amid} | Pep3 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 300-900 µM | Human | Derived From Pepa5 | NA | NA | ||
| 25728268 | 2015 | FFWLSRRTK{ct:Amid} | Pep4 | Amidation | Free | Linear | L | None | 9 | Antibacterial | 50 % Hemolysis at 300-900 µM | Human | Derived From Pepa6 | NA | NA | ||
| 25728268 | 2015 | FFWLSRTK{ct:Amid} | Pep5 | Amidation | Free | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at 300-900 µM | Human | Derived From Pepa7 | NA | NA | ||
| 25728268 | 2015 | FFWLSRRTK{cyc:N-C} | Pep6 | Free | Free | Cyclic | L | None | 9 | Antibacterial | 50 % Hemolysis at 5 µM | Human | Derived From Pepa8 | NA | NA | ||
| 25728268 | 2015 | FFWSRRTK{cyc:N-C} | Pep7 | Free | Free | Cyclic | L | None | 8 | Antibacterial | 50 % Hemolysis at 14 µM | Human | Derived From Pepa9 | NA | NA | ||
| 25728268 | 2015 | FFWRRTK{cyc:N-C} | Pep8 | Free | Free | Cyclic | L | None | 7 | Antibacterial | 50 % Hemolysis at 160 µM | Human | Derived From Pepa10 | NA | NA | ||
| 25728268 | 2015 | FFWLRR{nnr:aza-β3Hyt}K{ct:Amid} | Pep9 | Amidation | Free | Linear | L | aza-β3Hyt = aza-b3 -homohydroxythreonine | 8 | Antibacterial | 50 % Hemolysis at 300-900 µM | Human | Derived From Pepa11 | NA | NA | ||
| 25728268 | 2015 | FFWLRR{nnr:aza-β3Hyt}K{cyc:N-C} | Pep10 | Free | Free | Cyclic | L | aza-b3 = homohydroxythreonine | 8 | Antibacterial | 50 % Hemolysis at 150 µM | Human | Derived From Pepa12 | NA | NA | ||
| 25728268 | 2015 | FFWRR{nnr:aza-β3Hyt}K{cyc:N-C} | Pep11 | Free | Free | Cyclic | L | aza-b3 = homohydroxythreonine | 7 | Antibacterial | 50 % Hemolysis at 840 µM | Human | Derived From Pepa13 | NA | NA | ||
| 25683050 | 2015 | RWTWRGSGRWTWR{nt:Acet}{ct:Amid} | l-RW | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 8-500 μg/mL | Rabbit | Synthetic | NA | Non-hemolytic | ||
| 25941665 | 2015 | MKILCFFIVLLFVAVHGAVGFSRSPRYHM QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL{nt:Acet} | AvBD-4 | Free | Acetylation | Linear | L | None | 64 | Antibacterial, Antifungal | 1 % Hemolysis at 12.5 μg/mL | Chicken | Synthetic Chicken Β-Defensin | NA | Low hemolytic | ||
| 25941665 | 2015 | MKILCFFIVLLFVAVHGAVGFSRSPRYHM QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL{nt:Acet} | AvBD-4 | Free | Acetylation | Linear | L | None | 64 | Antibacterial, Antifungal | <3 % Hemolysis at 25 μg/mL | Chicken | Synthetic Chicken Β-Defensin | NA | Low hemolytic | ||
| 25941665 | 2015 | MKILCFFIVLLFVAVHGAVGFSRSPRYHM QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL{nt:Acet} | AvBD-4 | Free | Acetylation | Linear | L | None | 64 | Antibacterial, Antifungal | <4 % Hemolysis at 50 μg/mL | Chicken | Synthetic Chicken Β-Defensin | NA | Low hemolytic | ||
| 25941665 | 2015 | MKILCFFIVLLFVAVHGAVGFSRSPRYHM QCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL{nt:Acet} | AvBD-4 | Free | Acetylation | Linear | L | None | 64 | Antibacterial, Antifungal | 6 % Hemolysis at 100 μg/mL | Chicken | Synthetic Chicken Β-Defensin | NA | Low hemolytic | ||
| 25941665 | 2015 | MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ{nt:Acet} | AvBD-10 | Free | Acetylation | Linear | L | None | 69 | Antibacterial, Antifungal | 1 % Hemolysis at 12.5 μg/mL | Chicken | Synthetic Chicken Β-Defensin | NA | Low hemolytic | ||
| 25941665 | 2015 | MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ{nt:Acet} | AvBD-10 | Free | Acetylation | Linear | L | None | 69 | Antibacterial, Antifungal | <3 % Hemolysis at 25 μg/mL | Chicken | Synthetic Chicken Β-Defensin | NA | Low hemolytic | ||
| 25941665 | 2015 | MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ{nt:Acet} | AvBD-10 | Free | Acetylation | Linear | L | None | 69 | Antibacterial, Antifungal | <3 % Hemolysis at 50 μg/mL | Chicken | Synthetic Chicken Β-Defensin | NA | Low hemolytic | ||
| 25941665 | 2015 | MKILCLLFAVLLFLFQAAPGSADPLFPDTVACRT QGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ{nt:Acet} | AvBD-10 | Free | Acetylation | Linear | L | None | 69 | Antibacterial, Antifungal | <6 % Hemolysis at 100 μg/mL | Chicken | Synthetic Chicken Β-Defensin | NA | Low hemolytic | ||
| 26574006 | 2015 | MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC | penisin | Free | Free | Linear | L | None | 61 | Antibacterial | 0 % Hemolysis at 5 µM | Rabbit | Paenibacillus Sp. Strain A3 | Random coil | Non-hemolytic | ||
| 26574006 | 2015 | MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC | penisin | Free | Free | Linear | L | None | 61 | Antibacterial | 0 % Hemolysis at 10 µM | Rabbit | Paenibacillus Sp. Strain A3 | Random coil | Non-hemolytic | ||
| 26574006 | 2015 | MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC | penisin | Free | Free | Linear | L | None | 61 | Antibacterial | 0 % Hemolysis at 20 µM | Rabbit | Paenibacillus Sp. Strain A3 | Random coil | Non-hemolytic | ||
| 26574006 | 2015 | MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC | penisin | Free | Free | Linear | L | None | 61 | Antibacterial | 2 % Hemolysis at 40 µM | Rabbit | Paenibacillus Sp. Strain A3 | Random coil | NA | ||
| 26574006 | 2015 | MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC | penisin | Free | Free | Linear | L | None | 61 | Antibacterial | <4 % Hemolysis at 80 µM | Rabbit | Paenibacillus Sp. Strain A3 | Random coil | NA | ||
| 26574006 | 2015 | MANNVFDLDVEVKSVNSVNQNIGLFTSTCFSSQCFSSKFTDTFSSNCFTGRHQCGYTHGSC | penisin | Free | Free | Linear | L | None | 61 | Antibacterial | <4 % Hemolysis at 100 µM | Rabbit | Paenibacillus Sp. Strain A3 | Random coil | NA | ||
| 25581614 | 2015 | HLNKRVQRELIGWLDWLK | AmyI-1-18 | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 20 % Hemolysis at 1000 µM | Sheep | Α-Amylase (Amyi-1) Of Rice (Oryza Sativa L. Japonica) | α-Helical | Non-hemolytic | ||
| 25773522 | 2015 | ILGKIWEGIKSLF{ct:Amid} | IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~86 % Hemolysis at 90 µM | Human | Scorpion, Opisthacanthus Madagascariensis | α-Helical | NA | ||
| 25773522 | 2015 | ILGKIWKGIKSLF{ct:Amid} | E7K-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 48 % Hemolysis at 90 µM | Human | Isct Designed Analogs | α-Helical | NA | ||
| 25773522 | 2015 | ILGKIWEGKKSLF{ct:Amid} | I9K-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0.4 % Hemolysis at 90 µM | Human | Isct Designed Analogs | α-Helical | Non-hemolytic | ||
| 25773522 | 2015 | ILGKIWKGKKSLF{ct:Amid} | E7K,I9K-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0.14 % Hemolysis at 90 µM | Human | Isct Designed Analogs | α-Helical | Non-hemolytic | ||
| 25773522 | 2015 | ILGKIWEGIKSLF{ct:Amid} | IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 43.59 µM | Human | Scorpion, Opisthacanthus Madagascariensis | α-Helical | NA | ||
| 25773522 | 2015 | ILGKIWKGIKSLF{ct:Amid} | E7K-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 92.17 µM | Human | Isct Designed Analogs | α-Helical | NA | ||
| 25773522 | 2015 | ILGKIWEGKKSLF{ct:Amid} | I9K-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 500 µM | Human | Isct Designed Analogs | α-Helical | Non-hemolytic | ||
| 25773522 | 2015 | ILGKIWKGKKSLF{ct:Amid} | E7K,I9K-IsCT | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 500 µM | Human | Isct Designed Analogs | α-Helical | Non-hemolytic | ||
| 25583073 | 2015 | VDIHVWDGVVDIHVWDGV | PIP-18[59–76] | Free | Free | Linear | L | None | 18 | Antibacterial, Wound healing activity | <20 % Hemolysis at 100 μg/mL | Human | Python Reticulatus Serum Protein | α-Helical | Low hemolytic | ||
| 25583073 | 2015 | LGRVDIHVWDGVYIRGR | [D-Ala66]-PNT.II | Free | Free | Linear | L | None | 17 | Antibacterial | <30 % Hemolysis at 100 μg/mL | Human | Python Reticulatus Serum Protein | α-Helical | NA | ||
| 25583073 | 2015 | CVDIHVWDGVC{cyc:N-C} | Cyclic C-PIP[57-67]C | Free | Free | Cyclic | L | None | 11 | Antibacterial | 30 % Hemolysis at 100 μg/mL | Human | Python Reticulatus Serum Protein | β or Helical | NA | ||
| 25583073 | 2015 | VEIHVWEGV | D60,65E-PIP[59-67] | Free | Free | Linear | L | None | 9 | Antibacterial | <30 % Hemolysis at 100 μg/mL | Human | Python Reticulatus Serum Protein | α-Helical | NA | ||
| 25583073 | 2015 | VDIHVWDGV | β-Asp65-PIP[59-67] | Free | Free | Linear | L | None | 9 | Antibacterial, Wound healing activity | <20 % Hemolysis at 100 μg/mL | Human | Python Reticulatus Serum Protein | α-Helical | Low hemolytic | ||
| 26456194 | 2016 | SPAIWGCDSFLGYCRLACFAHEA | defensin-TK | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1.5 % Hemolysis at 50 μg/ml | Human | Frog Theloderma Kwangsiensis | α-Helix/β-Sheet | NA | ||
| 26456194 | 2016 | SPAIWGCDSFLGYCRLACFAHEA | defensin-TK | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 2.7 % Hemolysis at 100 μg/ml | Human | Frog Theloderma Kwangsiensis | α-Helix/β-Sheet | NA | ||
| 26456194 | 2016 | SPAIWGCDSFLGYCRLACFAHEA | defensin-TK | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 6.2 % Hemolysis at 200 μg/ml | Human | Frog Theloderma Kwangsiensis | α-Helix/β-Sheet | NA | ||
| 26385363 | 2016 | AAKAAAKAAAKAA{ct:Amid} | KL0A10 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at >256 µM | Human | Mirror-Like Peptides | α-Helix | NA | ||
| 26385363 | 2016 | LLKAAAKAAAKLL{ct:Amid} | KL4A6 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at >256 µM | Human | Mirror-Like Peptides | α-Helix | NA | ||
| 26385363 | 2016 | AAKLLLKLLLKAA{ct:Amid} | KL6A4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at 8 µM | Human | Mirror-Like Peptides | α-Helix | NA | ||
| 26385363 | 2016 | LLKLLLKLLLKLL{ct:Amid} | KL10A0 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at 2 µM | Human | Mirror-Like Peptides | α-Helix | NA | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:iPr})({nnr:Boc}){ct:OH} | gA3K(iPr) | OH | Free | Linear | Mix | K{d} = D-lysine, fmoc = 9-fluorenylmethoxycarbonyl, iPr = Isopropyl group, Boc = ε-amino group of the lysine side chain | 15 | Antibacterial | 0 % Hemolysis at 10 µM | Human | Bacillus Brevis | β-Helix | Non-hemolytic | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:Cy})({nnr:Boc}){ct:OH} | gA3K(Cy) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, Cy = Cyclohexyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | 55 % Hemolysis at 20 µM | Human | Bacillus Brevis | β-Helix | NA | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:CyMe})({nnr:Boc}){ct:OH} | gA3K(CyMe) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, CyMe = Cyclohexylmethyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | <90 % Hemolysis at 10 µM | Human | Bacillus Brevis | β-Helix | NA | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:Bn})({nnr:Boc}){ct:OH} | gA3K(Bn) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, Bn = Benzyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | <90 % Hemolysis at 10 µM | Human | Bacillus Brevis | β-Helix | NA | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:2pyr})({nnr:Boc}){ct:OH} | gA3K(2pyr) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, 2pyr = 2-Pyridyl group, Boc = ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | 0 % Hemolysis at 10 µM | Human | Bacillus Brevis | β-Helix | Non-hemolytic | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:3pyr})({nnr:Boc}){ct:OH} | gA3K(3pyr) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, 3pyr = 3-Pyridyl group, Boc = ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | 0 % Hemolysis at 10 µM | Human | Bacillus Brevis | β-Helix | Non-hemolytic | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:4pyr})({nnr:Boc}){ct:OH} | gA3K(4pyr) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, 4pyr = 4-Pyridyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | 0 % Hemolysis at 10 µM | Human | Bacillus Brevis | β-Helix | Non-hemolytic | ||
| 26918268 | 2016 | {nnr:Fmoc}-K{d}({nnr:4AMBn})({nnr:Boc}){ct:OH} | gA3K(4AMBn) | OH | Free | Linear | Mix | fmoc = 9-fluorenylmethoxycarbonyl, 4AMBn = 4-Aminomethylbenzyl group, Boc=ε-amino group of the lysine side chain, K{d} = D-Lys | 15 | Antibacterial | <25 % Hemolysis at 75 µM | Human | Bacillus Brevis | β-Helix | NA | ||
| 26876358 | 2016 | GEGFLGMLLHGVGHAIHGLIHGK | Rbpisc | Free | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at <63 µM | Fish | Oplegnathus Fasciatus | Helix-Loop-Helix | NA | ||
| 26876358 | 2016 | GEGFLGMLLHGVGHAIHGLIHGK | Rbpisc | Free | Free | Linear | L | None | 15 | Antibacterial | 13 % Hemolysis at 125 µM | Fish | Oplegnathus Fasciatus | Helix-Loop-Helix | NA | ||
| 26876358 | 2016 | GEGFLGMLLHGVGHAIHGLIHGK | Rbpisc | Free | Free | Linear | L | None | 15 | Antibacterial | 28.9 % Hemolysis at 250 µM | Fish | Oplegnathus Fasciatus | Helix-Loop-Helix | NA | ||
| 26876358 | 2016 | GEGFLGMLLHGVGHAIHGLIHGK | Rbpisc | Free | Free | Linear | L | None | 15 | Antibacterial | 70.13 % Hemolysis at 500 µM | Fish | Oplegnathus Fasciatus | Helix-Loop-Helix | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 2.3 % Hemolysis at 25 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 5.6 % Hemolysis at 50 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 18.7 % Hemolysis at 100 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 29.5 % Hemolysis at 200 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 3.9 % Hemolysis at 25 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 13.7 % Hemolysis at 50 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 27.7 % Hemolysis at 100 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 45.3 % Hemolysis at 200 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 3.1 % Hemolysis at 25 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 7.3 % Hemolysis at 50 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 20.5 % Hemolysis at 100 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FLKGCWTKWYSLKPKCPF{ct:Amid} | Megin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 32.9 % Hemolysis at 200 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 5.6 % Hemolysis at 25 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 15.2 % Hemolysis at 50 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 36.2 % Hemolysis at 100 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 50.3 % Hemolysis at 200 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 26998557 | 2016 | GIMSSLMKKLAAHIAK{ct:Amid} | HYL | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Hylaeus Signatus | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLKAHIAK{ct:Amid} | HYL-1 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLAKHIAK{ct:Amid} | HYL-2 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLAAHIKK{ct:Amid} | HYL-3 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLKKHIAK{ct:Amid} | HYL-4 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMISLMKKLAAHIAK{ct:Amid} | HYL-5 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 320 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLAAIIAK{ct:Amid} | HYL-6 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 93 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLAKIIAK{ct:Amid} | HYL-7 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLKKIIAK{ct:Amid} | HYL-8 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | G{d}I{d}M{d}S{d}S{d}L{d}M{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid} | HYL-9 | Amidation | Free | Linear | D | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLAKIIKK{ct:Amid} | HYL-10 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIMSSLMKKLKKIIKK{ct:Amid} | HYL-11 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 284 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSLLKKLKKIIAK{ct:Amid} | HYL-12 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 333 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | G{d}I{d}L{d}S{d}S{d}L{d}L{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid} | HYL-13 | Amidation | Free | Linear | D | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 373 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GI{nnr:X}SSL{nnr:X}KKLKKIIAK{ct:Amid} | HYL-14 | Amidation | Free | Linear | L | X = norleucine | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILKSLLKKLKKIIAK{ct:Amid} | HYL-15 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSKLLKKLKKIIAK{ct:Amid} | HYL-16 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 364 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | KILSSLLKKLKKIIAK{ct:Amid} | HYL-17 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 165 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GIWSSLLKKLKKIIAK{ct:Amid} | HYL-18 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSWLKKLKKIIAK{ct:Amid} | HYL-19 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 197 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSLWKKLKKIIAK{ct:Amid} | HYL-20 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 191 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | G{d}I{d}L{d}S{d}S{d}L{d}W{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid} | HYL-21 | Amidation | Free | Linear | D | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GKLSSLWKKLKKIIAK{ct:Amid} | HYL-22 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSLLKKWKKIIAK{ct:Amid} | HYL-23 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 115 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSLLKKLKKWIAK{ct:Amid} | HYL-24 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 57 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSLWKKLKKWIAK{ct:Amid} | HYL-25 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | GILSSLWKKPKKIIAK{ct:Amid} | HYL-26 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 27128941 | 2016 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial | <10 % Hemolysis at 6.25 µM | Human | Chinese Wolf Spider Lycosa Singoriensis | α-Helix | NA | ||
| 27128941 | 2016 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial | <10 % Hemolysis at 12.5 µM | Human | Chinese Wolf Spider Lycosa Singoriensis | α-Helix | NA | ||
| 27128941 | 2016 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial | <10 % Hemolysis at 25 µM | Human | Chinese Wolf Spider Lycosa Singoriensis | α-Helix | NA | ||
| 27128941 | 2016 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial | 20 % Hemolysis at 50 µM | Human | Chinese Wolf Spider Lycosa Singoriensis | α-Helix | NA | ||
| 27128941 | 2016 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial | <20 % Hemolysis at 100 µM | Human | Chinese Wolf Spider Lycosa Singoriensis | α-Helix | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 7 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 15 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 29 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 59 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 118 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 235 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 470 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <30 % Hemolysis at 940 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <50 % Hemolysis at 1880 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 26837216 | 2016 | RRRQKRIVVRRRLIR | P3 | Free | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Cell-Penetrating Peptides | α-Helix | Non-hemolytic | ||
| 26837216 | 2016 | RRWRRWNRFNRRRCR | P8 | Free | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Cell-Penetrating Peptides | α-Helix | Non-hemolytic | ||
| 26849911 | 2016 | RRLIWLILRLLR{ct:Amid} | RR12Wpolar | Amidation | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 5 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIWLILRLLR{ct:Amid} | RR12Wpolar | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 10 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIRLILRLLR{ct:Amid} | RR12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 25 µM | mouse | Synthetic | α-Helix | NA | ||
| 26849911 | 2016 | RRLIWLILRLLR{ct:Amid} | RR12Wpolar | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 25 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIRLWLRLLR{ct:Amid} | RR12Whydro | Amidation | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 25 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIRLILRLLR{ct:Amid} | RR12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 50 µM | mouse | Synthetic | α-Helix | NA | ||
| 26849911 | 2016 | RRLIWLILRLLR{ct:Amid} | RR12Wpolar | Amidation | Free | Linear | L | None | 12 | Antibacterial | <60 % Hemolysis at 50 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIRLWLRLLR{ct:Amid} | RR12Whydro | Amidation | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 50 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIRLILRLLR{ct:Amid} | RR12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 100 µM | mouse | Synthetic | α-Helix | NA | ||
| 26849911 | 2016 | RRLIWLILRLLR{ct:Amid} | RR12Wpolar | Amidation | Free | Linear | L | None | 12 | Antibacterial | <80 % Hemolysis at 100 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26849911 | 2016 | RRLIRLWLRLLR{ct:Amid} | RR12Whydro | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 100 µM | mouse | Analogs Of Rr12 | α-Helix | NA | ||
| 26896660 | 2016 | RIVQRIKKWLLKWKKLGY{ct:Amid} | peptide 5 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 8 ± 2 % Hemolysis at 55 µM | Human | Cationic Amps | α-Helix | NA | ||
| 26896660 | 2016 | RIVQRILKWLKKWYKLGK{ct:Amid} | peptide 8 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 85 ± 12 % Hemolysis at 55 µM | Human | Cationic Amps | α-Helix | NA | ||
| 26896660 | 2016 | RIVQRIAKWAKKWYKAGK{ct:Amid} | peptide 8.1 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 5 ± 1 % Hemolysis at 55 µM | Human | Cationic Amps | α-Helix | NA | ||
| 26902768 | 2016 | KRFWPLVPVAINTVAAGINLYKAIRRK{ct:Amid} | Fow-3 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 88.1 % Hemolysis at 256 µM | Human | Chicken Cathelicidin | Random coil- sodium phosphate buffer/α-Helical structure-SDS and TFE buffer | Non-hemolytic | ||
| 26902768 | 2016 | KRFWPLVPVAINTVA{ct:Amid} | Fow-3(1-15) | Amidation | Free | Linear | L | None | 15 | Antibacterial | <5 % Hemolysis at 256 µM | Human | Truncated Peptides Of Fowlicidin-3 | α-Helix | NA | ||
| 26902768 | 2016 | KRFWPLVPVAINTVAA{ct:Amid} | Fow-3(1-19) | Amidation | Free | Linear | L | None | 19 | Antibacterial | 38.9 % Hemolysis at 256 µM | Human | Truncated Peptides Of Fowlicidin-3 | α-Helix | NA | ||
| 26902768 | 2016 | LYKAIRRK{ct:Amid} | Fow-3(20-27) | Amidation | Free | Linear | L | None | 8 | Antibacterial | <5 % Hemolysis at 256 µM | Human | Truncated Peptides Of Fowlicidin-3 | α-Helix | NA | ||
| 26902768 | 2016 | KRFWPLVPVAINTVAL{ct:Amid} | Fow-3(1-15-20-27) | Amidation | Free | Linear | L | None | 23 | Antibacterial | <5 % Hemolysis at 256 µM | Human | Truncated Peptides Of Fowlicidin-3 | Random coil- sodium phosphate buffer/α-Helical structure-SDS and TFE buffer | Non-hemolytic | ||
| 27033467 | 2016 | AATKPKKAGAEAAPKKPAKKQTKKKPAKKAGGKKKPKRAGAKKAKK{ct:Amid} | hdMolluscidin | Amidation | Free | Linear | L | None | 46 | Antibacterial | 0 % Hemolysis at 100 μg/ml | Human | Marine Snail Haliotis Discus | α-Helix | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}W{nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api793 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 20 | Antibacterial Gram- | 1.3 ± 0.4 % Hemolysis at 0.1 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}W{nnr:O}W{nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api794 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 22 | Antibacterial Gram- | 1.7 ± 0.2 % Hemolysis at 0.1 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}I{nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api795 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 20 | Antibacterial Gram- | −0.8 ± 0.4 % Hemolysis at 0.1 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}I{nnr:O}I{nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api796 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 22 | Antibacterial Gram- | −0.8 ± 0.2 % Hemolysis at 0.1 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}W{nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api793 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 20 | Antibacterial Gram- | 1.6 ± 0.5 % Hemolysis at 0.6 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}W{nnr:O}W{nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api794 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 22 | Antibacterial Gram- | 1.9 ± 0.3 % Hemolysis at 0.6 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}I{nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api795 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 20 | Antibacterial Gram- | 0.0 ± 0.7 % Hemolysis at 0.6 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}I{nnr:O}I{nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api796 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 22 | Antibacterial Gram- | −0.1 ± 0.8 % Hemolysis at 0.6 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27187467 | 2016 | GMWSKIKETAMAAAKEAAKAAGKTISDMIKQ{ct:Amid} | Dermaseptin-PD-1 | Amidation | Free | Linear | L | None | 30 | Antibacterial, Antifungal, Anticancer | 100 % Hemolysis at >156.8 µM | Horse | Pachymedusa Dacnicolor | α-Helix | Low hemolytic | ||
| 27187467 | 2016 | GMWSKIKNAGKAAAKAAAKAAGKAALDAVSEAI{ct:Amid} | Dermaseptin-PD-2 | Amidation | Free | Linear | L | None | 32 | Antibacterial, Antifungal, Anticancer | 100 % Hemolysis at >161.6 µM | Horse | Pachymedusa Dacnicolor | α-Helix | Low hemolytic | ||
| 26802742 | 2016 | FIGALLRPALKLLA{ct:Amid} | Pxt-2 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 2 % Hemolysis at 50 µM | Rat | X. Tropicalis Skin | α-Helix | NA | ||
| 26802742 | 2016 | FIGALLGPLLNLLK{ct:Amid} | Pxt-5 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 69.8 % Hemolysis at 50 µM | Rat | X. Tropicalis Skin | α-Helix | NA | ||
| 26802742 | 2016 | NLLGSLLKTGLKVGSNLL{ct:Amid} | Pxt-12 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 0 % Hemolysis at 50 µM | Rat | X. Tropicalis Skin | α-Helix | Non-hemolytic | ||
| 26802742 | 2016 | ALLKLAPRLLAGIF{ct:Amid} | Reverse Pxt-2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 1.5 % Hemolysis at 50 µM | Rat | X. Tropicalis Skin | α-Helix | NA | ||
| 26802742 | 2016 | KLLNLLPGLLAGIF{ct:Amid} | Reverse Pxt-5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 5.2 % Hemolysis at 50 µM | Rat | X. Tropicalis Skin | α-Helix | NA | ||
| 26802742 | 2016 | INLKALAALAKKIL{ct:Amid} | Mastoparan | Amidation | Free | Linear | L | None | 14 | Antibacterial | 13.5 % Hemolysis at 50 µM | Rat | Wasp Venom | α-Helix | NA | ||
| 26802742 | 2016 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial | 100 % Hemolysis at 10 µM | Rat | Bee Venom | α-Helix | NA | ||
| 26854372 | 2016 | GSNFCDSKCKLCSKAGLADRCLKYCGICCEECKCVPSGTYGNKHECPCYRDKKNSKGKSKCP | Snakin-1(SN-1) | Free | Free | Linear | L | None | 63 | Antibacterial | little hemolysis % Hemolysis at 0-128 µM | Sheep | Potato Solanum Tuberosum | α-Helix | NA | ||
| 26920749 | 2016 | IDGLKAIWKKVADLLKNT{ct:Amid} | L1A | Amidation | Free | Linear | L | None | 18 | Antibacterial | 4 % Hemolysis at 148 µM | Human | Synthetic Peptide | α-Helix | NA | ||
| 26920749 | 2016 | IDGLKAIWKKVADLLKNT{nt:Acet}{ct:Amid} | Ac-L1A | Amidation | acetylation | Linear | L | None | 18 | Antibacterial | 5 % Hemolysis at 145 µM | Human | Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 26920749 | 2016 | IDGLKAIVKKVADLLKNT{nt:Abz = ortho-aminobenzoic acid}{ct:Amid} | Abz-L1A-W8V | Amidation | Abz = ortho-aminobenzoic acid | Linear | L | None | 18 | Antibacterial | 46 % Hemolysis at 140 µM | Human | Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 7 % Hemolysis at 1.25 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 9 % Hemolysis at 2.5 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 13 % Hemolysis at 5 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 18 % Hemolysis at 10 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 36 % Hemolysis at 20 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 59 % Hemolysis at 40 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 80 % Hemolysis at 80 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKYL{ct:Amid} | BP100-PP | Amidation | Free | Linear | L | None | 11 | Antibacterial | 92 % Hemolysis at 160 µM | Human | Parent Peptide | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 9 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 13 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 26 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 43 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 65 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | {nnr:X}KLFKKILKYL{ct:Amid} | BP100K1A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 87 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 11 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 9 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 15 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 20 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 31 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | K{nnr:X}LFKKILKYL{ct:Amid} | BP100K2A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 48 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KK{nnr:X}FKKILKYL{ct:Amid} | BP100L3A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 12 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 3 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 10 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 10 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKL{nnr:X}KKILKYL{ct:Amid} | BP100F4A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 5 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 18 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 40 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 69 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLF{nnr:X}KILKYL{ct:Amid} | BP100K5A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 93 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 5 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 14 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 36 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 64 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFK{nnr:X}ILKYL{ct:Amid} | BP100K6A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 91 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 1 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 3 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 3 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 5 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKK{nnr:X}LKYL{ct:Amid} | BP100I7A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 3 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 9 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 8 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 11 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 11 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 10 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 11 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKI{nnr:X}KYL{ct:Amid} | BP100L8A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 16 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 12 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 11 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 13 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 22 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 38 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKIL{nnr:X}YL{ct:Amid} | BP100K9A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 57 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 5 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 12 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 13 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 23 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILK{nnr:X}L{ct:Amid} | BP100Y10A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 37 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 1 % Hemolysis at 1.25 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 2.5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 5 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 7 % Hemolysis at 10 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 5 % Hemolysis at 20 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 5 % Hemolysis at 40 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 4 % Hemolysis at 80 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 26975251 | 2016 | KKLFKKILKY{nnr:X}{ct:Amid} | BP100L11A | Amidation | Free | Linear | L | X = Ala-d3(3,3,3-2H3-Ala) | 11 | Antibacterial | 6 % Hemolysis at 160 µM | Human | Bp100 Analogues | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLKSLLGWKRKRFG{ct:Amid} | LG21 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 8.5 % Hemolysis at 100 µM | Mouse | Hybrid Amp Consisted Of Temporin B (Tb) And Lps Binding Motif. | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGALLKSLLGWKRKRFG{ct:Amid} | LG21N7A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLASLLGWKRKRFG{ct:Amid} | LG21K10A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 12 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLKALLGWKRKRFG{ct:Amid} | LG21S11A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLKSLLGWARKRFG{ct:Amid} | LG21K16A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 25 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLKSLLGWKAKRFG{ct:Amid} | LG21R17A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 38 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLKSLLGWKRARFG{ct:Amid} | LG21K18A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 28 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27015761 | 2016 | LLPIVGNLLKSLLGWKRKAFG{ct:Amid} | LG21R19A | Amidation | Free | Linear | L | None | 20 | Antibacterial | 25 % Hemolysis at 100 µM | Mouse | Lg21 Ala Variant Peptides | α-Helix | NA | ||
| 27046192 | 2016 | RWWRWWRRWWR | WR12 | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 20 µM | Human | Cationic Antibiotic Peptides (Ecaps) | α-Helix | NA | ||
| 27046192 | 2016 | KWWKWWKKWWK | WK12 | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 20 µM | Human | Cationic Antibiotic Peptides (Ecaps) | α-Helix | NA | ||
| 27129462 | 2016 | RGSALTHLP | RP9 | Free | Free | Linear | L | None | 9 | Antibacterial, Anticancer | 3.3 ± 0.5 % Hemolysis at 61.2 µM | Human | Crocodile Leukocyte Extract | α-Helix | NA | ||
| 27129462 | 2016 | RGSALTHLP | RP9 | Free | Free | Linear | L | None | 9 | Antibacterial, Anticancer | 5.7 ± 0.2 % Hemolysis at 122.4 µM | Human | Crocodile Leukocyte Extract | α-Helix | NA | ||
| 27197902 | 2016 | GLRRALLRLLRSLRRLLLRA | P7 | Free | Free | Linear | L | None | 20 | Antibacterial, Antitumor, Antifungal | 0 % Hemolysis at 4-32 µM | Mouse | Cell-Penetrating Peptide Pptg20 | α-Helix | Non-hemolytic | ||
| 27251456 | 2016 | GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG{ct:Amid} | PMAP-36 | Amidation | Free | Linear | L | None | 36 | Antibacterial, Antifungal | 5 % Hemolysis at 4 µM | Human | Cathelicidin-Related | α-Helix(50% TFE and 30 mM SDS) | NA | ||
| 27251456 | 2016 | RRLRKKTRKRLKKIGKVLKWI{ct:Amid} | RI21 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 5 % Hemolysis at 32 µM | Human | Pmap-36 Analogues | α-Helix(50% TFE and 30 mM SDS) | NA | ||
| 27251456 | 2016 | RKKTRKRLKKIGKVLKWI{ct:Amid} | RI18 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 5 % Hemolysis at 128 µM | Human | Pmap-36 Analogues | α-Helix(50% TFE and 30 mM SDS) | NA | ||
| 27251456 | 2016 | TRKRLKKIGKVLKWI{ct:Amid} | TI15 | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 5 % Hemolysis at >128 µM | Human | Pmap-36 Analogues | α-Helix(50% TFE and 30 mM SDS) | NA | ||
| 27251456 | 2016 | RLKKIGKVLKWI{ct:Amid} | RI12 | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antifungal | 5 % Hemolysis at >128 µM | Human | Pmap-36 Analogues | α-Helix(50% TFE and 30 mM SDS) | NA | ||
| 27271216 | 2016 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial | 10 % Hemolysis at 0.78 µM | Human | Bee Venom | α-Helix | NA | ||
| 27271216 | 2016 | RIGVLLARLPKLFSLFKLMGKKV{ct:Amid} | RV-23 | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 6.25 µM | Human | Rana Draytonii | α-Helix | NA | ||
| 27271216 | 2016 | AIGSILGALAKGLPTLISWIKNR{ct:Amid} | AR-23 | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 3.12 µM | Human | Rana Tagoi | α-Helix | NA | ||
| 27271216 | 2016 | RIGSILGALAKGLPTLISWIKNR{ct:Amid} | A(A1R) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 3.12 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | AIGSILGRLAKGLPTLISWIKNR{ct:Amid} | A(A8R) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 3.12 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | AIGSILGALAKGLPTLKSWIKNR{ct:Amid} | A(I17K) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 50 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | AIGSILGALAKGLPTLRSWIKNR{ct:Amid} | A(I17R) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 25 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | RIGSILGRLAKGLPTLISWIKNR{ct:Amid} | A(A1R, A8R) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 6.25 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | RIGSILGALAKGLPTLKSWIKNR{ct:Amid} | A(A1R, I17K) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 100 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | AIGSILGRLAKGLPTLKSWIKNR{ct:Amid} | A(A8R, I17K) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 100 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | RIGSILGRLAKGLPTLKSWIKNR{ct:Amid} | A(A1R, A8R, I17K) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 200 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | RIGSILGRLAKGLPTLRSWIKNR{ct:Amid} | A(A1R, A8R, I17R) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 100 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27331141 | 2016 | GFCWYVCVYRNGVRVCYRRCN | arenicin-3 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 4.4 ± 1.1 % Hemolysis at 300 μg/ml | Human | Coelomocytes Of Marine Polychaeta Lugworm Arenicola Marina | β-Hairpin | NA | ||
| 27331141 | 2016 | KWCFRVCYRGICYRRCR{ct:Amid} | tachyplesin-1 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antifungal | 27.8 ± 3.9 % Hemolysis at 300 μg/ml | Human | Hemocyte Debris Of Tachypleus Tridentatus | β-Hairpin | NA | ||
| 27331141 | 2016 | RRWCFRVCYRGFCYRKCR{ct:Amid} | polyphemusin-1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 29.6 ± 2.4 % Hemolysis at 300 μg/ml | Human | Hemocyte Debris Of Limulus Polyphemus | β-Hairpin | NA | ||
| 27331141 | 2016 | ZCRRLCYKQRCVTYCRGR{nt:Z= N- terminal pyroglutamic acid}{ct:Amid} | gomesin | Amidation | Z= N- terminal pyroglutamic acid | Linear | L | None | 18 | Antibacterial, Antifungal | 4.4 ± 0.1 % Hemolysis at 300 μg/ml | Human | Hemocytes Of The Spider Acanthoscurria Gomesiana | β-Hairpin | NA | ||
| 27331141 | 2016 | RGGRLCYCRRRFCVCVGR{ct:Amid} | protegrin-1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 64.8 ± 3.5 % Hemolysis at 300 μg/ml | Human | Porcine Neutrophils | β-Hairpin | NA | ||
| 27331141 | 2016 | GSKKPVPIIYCNRRTGKCQRM{ct:Amid} | thanatin | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 1.3 ± 0.4 % Hemolysis at 300 μg/ml | Human | Spined Soldier Bug, Podisus Maculiventris | β-Hairpin | NA | ||
| 27367675 | 2016 | KWKLFKKIFKRIVQRIKDFLRN | C-L | Free | Free | Linear | L | None | 22 | Antibacterial | 50 % Hemolysis at 221 ± 3.27 µg/mL | Sheep | Hybrid Peptide | α-Helix | NA | ||
| 27367675 | 2016 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | L | Free | Free | Linear | L | None | 37 | Antibacterial | 50 % Hemolysis at 32 ± 0.68 µg/mL | Sheep | Human Leukocytes And Epithelia | α-Helix | NA | ||
| 27367675 | 2016 | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | C-L | Free | Free | Linear | L | None | 37 | Antibacterial | 50 % Hemolysis at 169 ± 15.1 µg/mL | Sheep | Hyalophora Cecropia | α-Helix | NA | ||
| 26952034 | 2016 | ASKAGAIAGKIAKVALKAL | XLAsp-P1 | Free | Free | Linear | L | None | 19 | Antibacterial, Anticancer | 0 % Hemolysis at 8 µg/mL | Rabbit | Skin Of Xenopus Laevis | α-Helix | Low hemolytic | ||
| 26952034 | 2016 | ASKAGAIAGKIAKVALKAL | XLAsp-P2 | Free | Free | Linear | L | None | 19 | Antibacterial, Anticancer | 0 % Hemolysis at 16 µg/mL | Rabbit | Skin Of Xenopus Laevis | α-Helix | Low hemolytic | ||
| 26952034 | 2016 | ASKAGAIAGKIAKVALKAL | XLAsp-P3 | Free | Free | Linear | L | None | 19 | Antibacterial, Anticancer | 0 % Hemolysis at 32 µg/mL | Rabbit | Skin Of Xenopus Laevis | α-Helix | Low hemolytic | ||
| 26952034 | 2016 | ASKAGAIAGKIAKVALKAL | XLAsp-P4 | Free | Free | Linear | L | None | 19 | Antibacterial, Anticancer | 6.4 % Hemolysis at 64 µg/mL | Rabbit | Skin Of Xenopus Laevis | α-Helix | Low hemolytic | ||
| 26952034 | 2016 | ASKAGAIAGKIAKVALKAL | XLAsp-P5 | Free | Free | Linear | L | None | 19 | Antibacterial, Anticancer | <20 % Hemolysis at 128 µg/mL | Rabbit | Skin Of Xenopus Laevis | α-Helix | Low hemolytic | ||
| 27311856 | 2016 | #ERROR! | Kunitzin-RE | Free | Free | Linear | L | None | 17 | Antibacterial | little hemolysis % at 120 µM | Horse | European Frog, Rana Esculenta | Loop | Low hemolytic | ||
| 27311856 | 2016 | AVNIPFKVHLRCKAAFC | Kunitzin-OS | Free | Free | Linear | L | None | 12 | Antibacterial | little hemolysis % at 120 µM | Horse | Chinese Frog, Odorrana Schmackeri | Loop | Low hemolytic | ||
| 27617260 | 2016 | RWRWRW{ct:Amid} | MP196 | Amidation | Free | Linear | L | None | 6 | Antibacterial | 14 % Hemolysis at 250 µg/mL | Mouse | Synthetic | α-Helix | NA | ||
| 27617260 | 2016 | RWRWRW{ct:Amid} | MP196 | Amidation | Free | Linear | L | None | 6 | Antibacterial | 23 % Hemolysis at 500 µg/mL | Mouse | Synthetic | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 2 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 4 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 1 % Hemolysis at 8 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 9 % Hemolysis at 16 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 20 % Hemolysis at 32 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 33 % Hemolysis at 64 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 62 % Hemolysis at 128 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 105 % Hemolysis at 256 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 107 % Hemolysis at 512 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 2 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1 % Hemolysis at 4 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1 % Hemolysis at 8 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 6 % Hemolysis at 16 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 26 % Hemolysis at 32 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 54 % Hemolysis at 64 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 75 % Hemolysis at 128 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 93 % Hemolysis at 256 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 100 % Hemolysis at 512 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 0 % Hemolysis at 2 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1 % Hemolysis at 4 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1 % Hemolysis at 8 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 2 % Hemolysis at 16 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 6 % Hemolysis at 32 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 24 % Hemolysis at 64 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 59 % Hemolysis at 128 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 83 % Hemolysis at 256 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 96 % Hemolysis at 512 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27606830 | 2016 | KGGK{nt:16C- palmitate}{ct:Amid} | C16-KGGK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 5 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KGGK{nt:16C- palmitate}{ct:Amid} | C16-KGGK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 10 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KGGK{nt:16C- palmitate}{ct:Amid} | C16-KGGK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | 20 % Hemolysis at 20 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KGGK{nt:16C- palmitate}{ct:Amid} | C16-KGGK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | >40 % Hemolysis at 50 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KGGK{nt:16C- palmitate}{ct:Amid} | C16-KGGK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <80 % Hemolysis at 100 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KkK{nt:16C- palmitate}{ct:Amid} | C16-KKK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 3 | Antibacterial and Antibiofilm | <20 % Hemolysis at 5 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KkK{nt:16C- palmitate}{ct:Amid} | C16-KKK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 3 | Antibacterial and Antibiofilm | 20 % Hemolysis at 10 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KkK{nt:16C- palmitate}{ct:Amid} | C16-KKK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 3 | Antibacterial and Antibiofilm | >20 % Hemolysis at 20 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KkK{nt:16C- palmitate}{ct:Amid} | C16-KKK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 3 | Antibacterial and Antibiofilm | 40 % Hemolysis at 50 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KkK{nt:16C- palmitate}{ct:Amid} | C16-KKK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 3 | Antibacterial and Antibiofilm | <60 % Hemolysis at 100 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KAaK{nt:16C- palmitate}{ct:Amid} | C16-KAAK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 5 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KAaK{nt:16C- palmitate}{ct:Amid} | C16-KAAK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 10 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KAaK{nt:16C- palmitate}{ct:Amid} | C16-KAAK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 20 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KAaK{nt:16C- palmitate}{ct:Amid} | C16-KAAK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | 20 % Hemolysis at 50 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KAaK{nt:16C- palmitate}{ct:Amid} | C16-KAAK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <40 % Hemolysis at 100 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KLlK{nt:16C- palmitate}{ct:Amid} | C16-KLLK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 5 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KLlK{nt:16C- palmitate}{ct:Amid} | C16-KLLK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 10 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KLlK{nt:16C- palmitate}{ct:Amid} | C16-KLLK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | 20 % Hemolysis at 20 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KLlK{nt:16C- palmitate}{ct:Amid} | C16-KLLK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <40 % Hemolysis at 50 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KLlK{nt:16C- palmitate}{ct:Amid} | C16-KLLK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <50 % Hemolysis at 100 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 26952110 | 2016 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 100 μg/mL | Human | Scorpion Heterometrus Petersii | α-Helical | NA | ||
| 26952110 | 2016 | GILGKLWKGVKSIF{ct:Amid} | K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 100 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | LILGKLWKGVKSIF{ct:Amid} | L1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 100 μg/mL | Human | Hp1404 Derivative | α-Helical | Non-hemolytic | ||
| 26952110 | 2016 | SILGKLWKGVKSIF{ct:Amid} | S1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 100 μg/mL | Human | Hp1404 Derivative | α-Helical | Non-hemolytic | ||
| 26952110 | 2016 | FILGKLWKGVKSIF{ct:Amid} | F1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <5 % Hemolysis at 100 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | KILGKLWKGVKSIF{ct:Amid} | K1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 100 μg/mL | Human | Hp1404 Derivative | α-Helical | Non-hemolytic | ||
| 26952110 | 2016 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <50 % Hemolysis at 200 μg/mL | Human | Scorpion Heterometrus Petersii | α-Helical | NA | ||
| 26952110 | 2016 | GILGKLWKGVKSIF{ct:Amid} | K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <50 % Hemolysis at 200 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | LILGKLWKGVKSIF{ct:Amid} | L1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 200 μg/mL | Human | Hp1404 Derivative | α-Helical | Non-hemolytic | ||
| 26952110 | 2016 | SILGKLWKGVKSIF{ct:Amid} | S1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 200 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | #ERROR! | F1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <40 % Hemolysis at 200 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | KILGKLWKGVKSIF{ct:Amid} | K1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 200 μg/mL | Human | Hp1404 Derivative | α-Helical | Non-hemolytic | ||
| 26952110 | 2016 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <100 % Hemolysis at 400 μg/mL | Human | Scorpion Heterometrus Petersii | α-Helical | NA | ||
| 26952110 | 2016 | GILGKLWKGVKSIF{ct:Amid} | K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <80 % Hemolysis at 400 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | LILGKLWKGVKSIF{ct:Amid} | L1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 400 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | SILGKLWKGVKSIF{ct:Amid} | S1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 50 % Hemolysis at 400 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | FILGKLWKGVKSIF{ct:Amid} | F1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <80 % Hemolysis at 400 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 26952110 | 2016 | KILGKLWKGVKSIF{ct:Amid} | K1K8 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 11.5 % Hemolysis at 400 μg/mL | Human | Hp1404 Derivative | α-Helical | NA | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 8 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 15.6 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 31.2 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 62.5 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 125 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 250 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 500 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | <10 % Hemolysis at 1000 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28230992 | 2017 | LRRLRRRWRRRLRRL{ct:Amid} | 1 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | ARRARRRWRRRARRA{ct:Amid} | 2 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | FRRFRRRWRRRFRRF{ct:Amid} | 3 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | WRRWRRRWRRRWRRW{ct:Amid} | 4 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | LRRLRRRWLRRLRRR{ct:Amid} | 5 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | LRRLRRRLRRLRRRWRRRLRRLRRRLRRL{ct:Amid} | 6 | Amidation | Free | Branched | L | None | 29 | Antibacterial | 10 % Hemolysis at 64 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | LRRLRRRLRRLRRRLRRLRRRWRRRLRRLRRRLRRLRRRLRRL{ct:Amid} | 7 | Amidation | Free | Branched | L | None | 43 | Antibacterial | 10 % Hemolysis at 64 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | LRRLRRRWWRRRLRRL{ct:Amid} | 8 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at 256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | LRRLRRRWWWRRRLRR{ct:Amid} | 9 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at >256 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28254375 | 2017 | ASVVNKLTGGVAGLLK | TP | Free | Free | Linear | L | None | 16 | Antibacterial | <10 % Hemolysis at 1.25-160 µM | Mouse | Tibetan Swine | α-Helix | NA | ||
| 28254375 | 2017 | ASVVNKLTGGVAGLLK | TP | Free | Free | Linear | L | None | 16 | Antibacterial | 9.4 ± 1.01 % Hemolysis at 320 µM | Mouse | Tibetan Swine | α-Helix | NA | ||
| 28299865 | 2017 | ASKAGAIAG | XLAsp-P2 | Free | Free | Linear | L | None | 9 | Antibacterial | 0 % Hemolysis at 8 μg/ml | Rabbit | Xenopus Laevis Skin | Double Helix | Non-hemolytic | ||
| 28299865 | 2017 | ASKAGAIAG | XLAsp-P2 | Free | Free | Linear | L | None | 9 | Antibacterial | <10 % Hemolysis at 16 μg/ml | Rabbit | Xenopus Laevis Skin | Double Helix | NA | ||
| 28299865 | 2017 | ASKAGAIAG | XLAsp-P2 | Free | Free | Linear | L | None | 9 | Antibacterial | <10 % Hemolysis at 32 μg/ml | Rabbit | Xenopus Laevis Skin | Double Helix | NA | ||
| 28299865 | 2017 | ASKAGAIAG | XLAsp-P2 | Free | Free | Linear | L | None | 9 | Antibacterial | <10 % Hemolysis at 64 μg/ml | Rabbit | Xenopus Laevis Skin | Double Helix | NA | ||
| 28299865 | 2017 | ASKAGAIAG | XLAsp-P2 | Free | Free | Linear | L | None | 9 | Antibacterial | <40 % Hemolysis at 128 μg/ml | Rabbit | Xenopus Laevis Skin | Double Helix | NA | ||
| 28347740 | 2017 | RWKIFKKIERVGQNVRDGIIKAGPAIQVLGTAKALGK | ABP-dHC-Cecropin A | Free | Free | Linear | L | None | 37 | Antibacterial | 0 % Hemolysis at 1-800 µM | Human | Drury (Hyphantria Cunea) (Dhc) | α-Helix | Non-hemolytic | ||
| 28347740 | 2017 | RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK | ABP-dHC-Cecropin A-K(24) | Free | Free | Linear | L | None | 37 | Antibacterial | 0 % Hemolysis at 1-800 µM | Human | Abp-Dhc-Cecropin A Analog | α-Helix | Non-hemolytic | ||
| 28657596 | 2017 | ILGKIWEGIKSLF{ct:Amid} | IsCT1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~100 % Hemolysis at 50 μg/ml | Human | Scorpion Opithancatus Madagascariensis | α-Helix | NA | ||
| 28657596 | 2017 | ILGKIWEGIKSLF{ct:Amid} | IsCT1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~100 % Hemolysis at 100 μg/ml | Human | Scorpion Opithancatus Madagascariensis | α-Helix | NA | ||
| 28657596 | 2017 | IFGAIWNGIKSLF{ct:Amid} | IsCT2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~100 % Hemolysis at 50 μg/ml | Human | Scorpion Opithancatus Madagascariensis | α-Helix | NA | ||
| 28657596 | 2017 | IFGAIWNGIKSLF{ct:Amid} | IsCT2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~100 % Hemolysis at 100 μg/ml | Human | Scorpion Opithancatus Madagascariensis | α-Helix | NA | ||
| 28657596 | 2017 | ILGKAWEGAKSLF{ct:Amid} | IsCT1A1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28657596 | 2017 | ILGKVWEGVKSLF{ct:Amid} | IsCT1V1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28657596 | 2017 | ILGKLWEGLKSLF{ct:Amid} | IsCT1L1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 80 % Hemolysis at 50 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28657596 | 2017 | ILGKLWEGLKSLF{ct:Amid} | IsCT1L1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <100 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28657596 | 2017 | ILGKIWKGIKSLF{ct:Amid} | IsCT1K7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 50 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28657596 | 2017 | ILGKIWKGIKSLF{ct:Amid} | IsCT1K7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <70 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28657596 | 2017 | ILGKIWEGIESLF{ct:Amid} | IsCT1E7 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | Non-hemolytic | ||
| 28657596 | 2017 | ILGAAWNGAKSLF{ct:Amid} | IsCT2A1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | Non-hemolytic | ||
| 28657596 | 2017 | ILGAVWNGVKSLF{ct:Amid} | IsCT2V1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 20 % Hemolysis at 100 μg/ml | Human | Analogs Of Scorpion Venom Isct Peptides | α-Helix | NA | ||
| 28661457 | 2017 | DLRDSWKVIGSDKK | AI-Hemocidin 2 | Free | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at >500 μg/ml | Human | Arca Inflata | α-Helix | NA | ||
| 28661457 | 2017 | DLRDSWKVIGSDKK | AI-Hemocidin 2 | Free | Free | Linear | L | None | 14 | Antibacterial | 10.27 ± 0.42 % Hemolysis at 500 μg/ml | Human | Arca Inflata | α-Helix | NA | ||
| 28731688 | 2017 | WWWLRRIW{ct:Amid} | WT | Amidation | Free | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at 35 µM | Human | Motif Of A Short Trp-Rich | α-Helix | NA | ||
| 28731688 | 2017 | RWWLRRIW{ct:Amid} | W1R | Amidation | Free | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at >200 µM | Human | Motif Of A Short Trp-Rich | α-Helix | NA | ||
| 28731688 | 2017 | WRWLRRIW{ct:Amid} | W2R | Amidation | Free | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at 100 µM | Human | Motif Of A Short Trp-Rich | α-Helix | NA | ||
| 28731688 | 2017 | WWRLRRIW{ct:Amid} | W3R | Amidation | Free | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at >200 µM | Human | Motif Of A Short Trp-Rich | α-Helix | NA | ||
| 28731688 | 2017 | WWWRRRIW{ct:Amid} | L4R | Amidation | Free | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at >200 µM | Human | Motif Of A Short Trp-Rich | α-Helix | NA | ||
| 28731688 | 2017 | WWWLRRRW{ct:Amid} | I7R | Amidation | Free | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at 150 µM | Human | Motif Of A Short Trp-Rich | α-Helix | NA | ||
| 28731688 | 2017 | WWWLRRIR{ct:Amid} | W8R | Amidation | Free | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at >200 µM | Human | Motif Of A Short Trp-Rich | α-Helix | NA | ||
| 28894233 | 2017 | IFGAILPLALGALKNLIK | RGD-Hylin a1 | Free | Free | Linear | L | None | 18 | Antibacterial | 30 % Hemolysis at 12.5 μg/ml | Human | Skin Of South American Tree Frogs | NA | NA | ||
| 28894233 | 2017 | IFGAILPLALGALKNLIK | RGD-Hylin a1 | Free | Free | Linear | L | None | 18 | Antibacterial | 76 % Hemolysis at 25 μg/ml | Human | Skin Of South American Tree Frogs | NA | NA | ||
| 28894233 | 2017 | IFGAILPLALGALKNLIK | RGD-Hylin a1 | Free | Free | Linear | L | None | 18 | Antibacterial | 82 % Hemolysis at 37 μg/ml | Human | Skin Of South American Tree Frogs | NA | NA | ||
| 28894233 | 2017 | IFGAILPLALGALKNLIK | RGD-Hylin a1 | Free | Free | Linear | L | None | 18 | Antibacterial | 99 % Hemolysis at 50 μg/ml | Human | Skin Of South American Tree Frogs | NA | NA | ||
| 28656506 | 2017 | GKPRPYSPRPTSHPRPIRV | n-drosocin | Free | Free | Linear | L | None | 19 | Antibacterial | <10 % Hemolysis at 200 µM | Rat | Drosophila Melanogaster | Random coil | NA | ||
| 28656506 | 2017 | GKPRPYSPRPTSHPRPIRV | M-drosocin | Free | Free | Linear | L | None | 19 | Antibacterial | <10 % Hemolysis at 200 µM | Rat | Drosophila Melanogaster | Random coil | NA | ||
| 28656506 | 2017 | GKPRPYSPRPTSHPRPIRV | Di-drosocin | Free | Free | Linear | L | None | 19 | Antibacterial | <10 % Hemolysis at 200 µM | Rat | Drosophila Melanogaster | Random coil | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}GRIL{ct:Amid} | 1 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 21(±4) % Hemolysis at 50 µM | Human | Amphibian Temporins | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}GRIL{ct:Amid} | 1 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 7(±3) % Hemolysis at 25 µM | Human | Amphibian Temporins | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}GRIL{ct:Amid} | 1 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 6(±3) % Hemolysis at 12.5 µM | Human | Amphibian Temporins | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}GRIL{ct:Amid} | 1 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 3(±2) % Hemolysis at 6.25 µM | Human | Amphibian Temporins | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}GRIL{ct:Amid} | 1 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 1(±1) % Hemolysis at 3.125 µM | Human | Amphibian Temporins | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | 9 | Amidation | Free | Linear | Mix | l = D-Leucine, k = D-Lys | 13 | Antibacterial | 7(±4) % Hemolysis at 50 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | 9 | Amidation | Free | Linear | Mix | l = D-Leucine, k = D-Lys | 13 | Antibacterial | 5(±3) % Hemolysis at 25 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | 9 | Amidation | Free | Linear | Mix | l = D-Leucine, k = D-Lys | 13 | Antibacterial | 5(±2) % Hemolysis at 12.5 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | 9 | Amidation | Free | Linear | Mix | l = D-Leucine, k = D-Lys | 13 | Antibacterial | 1(±2) % Hemolysis at 6.25 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | 9 | Amidation | Free | Linear | Mix | l = D-Leucine, k = D-Lys | 13 | Antibacterial | 0(±1) % Hemolysis at 3.125 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}WRIL{ct:Amid} | 10 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 37(±1) % Hemolysis at 50 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}WRIL{ct:Amid} | 10 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 20(±3) % Hemolysis at 25 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}WRIL{ct:Amid} | 10 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 7(±1) % Hemolysis at 12.5 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}WRIL{ct:Amid} | 10 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 4(±2) % Hemolysis at 6.25 µM | Human | Tl Analogue | α-Helix | NA | ||
| 28863356 | 2017 | FVPWFSKFL{d}WRIL{ct:Amid} | 10 | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial | 2(±1) % Hemolysis at 3.125 µM | Human | Tl Analogue | α-Helix | NA | ||
| 29185466 | 2017 | GFGMALKLLKKVL{ct:Amid} | Macropin | Amidation | Free | Linear | L | None | 13 | Anti-bioflm, Antibacterial | 5 % Hemolysis at 25 µM | Human | Macropis Fulvipes Venom | α-Helical | NA | ||
| 28904355 | 2017 | NPEKALEPLIAIQIAIKGMLNGWFTGVGFRRKR | LysAB2 P0 | Free | Free | Linear | L | None | 33 | Antibacterial | 63.2 % Hemolysis at 64 µM | Human | Acinetobacter Baumannii Phage Endolysin Lysab2 | α-Helix | NA | ||
| 28904355 | 2017 | NPEKALEPLIAIQIAIKGMLNGWFTGVGFRRKR | LysAB2 P0 | Free | Free | Linear | L | None | 33 | Antibacterial | 100 % Hemolysis at 128 µM | Human | Acinetobacter Baumannii Phage Endolysin Lysab3 | α-Helix | NA | ||
| 28904355 | 2017 | EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR | LysAB2 P1 | Free | Free | Linear | L | None | 31 | Antibacterial | 50 % Hemolysis at 32 µM | Human | Acinetobacter Baumannii Phage Endolysin Lysab4 | α-Helix | NA | ||
| 28904355 | 2017 | EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR | LysAB2 P1 | Free | Free | Linear | L | None | 31 | Antibacterial | 60 % Hemolysis at 64 µM | Human | Acinetobacter Baumannii Phage Endolysin Lysab5 | α-Helix | NA | ||
| 28904355 | 2017 | EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR | LysAB2 P1 | Free | Free | Linear | L | None | 31 | Antibacterial | 80 % Hemolysis at 128 µM | Human | Acinetobacter Baumannii Phage Endolysin Lysab6 | α-Helix | NA | ||
| 28904355 | 2017 | EKALEKLIAIQKAIKGMLAGWFTGVGARRKR | LysAB2 P2 | Free | Free | Linear | L | None | 31 | Antibacterial | 90 % Hemolysis at 128 µM | Human | Acinetobacter Baumannii Phage Endolysin Lysab7 | α-Helix | NA | ||
| 28904355 | 2017 | NPEKALEKLIAIQKAIKGMLNGWFTGVGFRRKR | LysAB2 P3 | Free | Free | Linear | L | None | 33 | Antibacterial | 1.97 % Hemolysis at 4 µM | Human | Acinetobacter Baumannii Phage Endolysin Lysab8 | α-Helix | NA | ||
| 28904355 | 2017 | NPEKALEKLIAIQKAIKGMLNGWFTGVGFRRKR | LysAB2 P3 | Free | Free | Linear | L | None | 33 | Antibacterial | <10 % Hemolysis at 256 µM | Human | Acinetobacter Baumannii Phage Endolysin Lysab9 | α-Helix | NA | ||
| 38802469 | 2024 | AFCGGRCRGFRRRLFCTKAC | AMP | Free | Free | Linear | L | None | 20 | Antibacterial and Antibioflm | <1 % Hemolysis at 1.5625-100 μg/mL | Human | Synthetic | expanded conformation | Non-hemolytic | ||
| 38287360 | 2024 | RWCVYAYVRVRGVLVRYRRCW | Ar-1 | Free | Free | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RWCVYAYVRVRGVLVRYRRCW | Ar-1 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 20.2±1.8 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RW-{nnr:Abu}-VYAYVRVRGVLVRYRR-{nnr:Abu}-W | Ar-1-Abu | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RW-{nnr:Abu}-VYAYVRVRGVLVRYRR-{nnr:Abu}-W | Ar-1-Abu | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 10 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RWCVYAYVRIRGVLVRYRRCW | Ar-2 | Free | Free | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at 29.2±2.4 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RWCVYAYVRIRGVLVRYRRCW | Ar-2 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 4.9±0.7 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RW-{nnr:Abu}-VYAYVRIRGVLVRYRR-{nnr:Abu}-W | Ar-2-Abu | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RW-{nnr:Abu}-VYAYVRIRGVLVRYRR-{nnr:Abu}-W | Ar-2-Abu | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 10 % Hemolysis at 15.4±1.0 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GFCWYVCVYRNGVRVCYRRCN | Ar-3 | Free | Free | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GFCWYVCVYRNGVRVCYRRCN | Ar-3 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 30.3±2.5 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GF-{nnr:Abu}-WYV-{nnr:Abu}-VYRNGVRV-{nnr:Abu}-YRR-{nnr:Abu}-N | Ar-3-Abu | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GF-{nnr:Abu}-WYV-{nnr:Abu}-VYRNGVRV-{nnr:Abu}-YRR-{nnr:Abu}-N | Ar-3-Abu | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 10 % Hemolysis at 39.3±3.2 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GFCWYV-{nnr:Abu}-VYRNGVRV-{nnr:Abu}-YRRCN | Ar-3(3–20) | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GFCWYV-{nnr:Abu}-VYRNGVRV-{nnr:Abu}-YRRCN | Ar-3(3–20) | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 10 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GF-{nnr:Abu}-WYVCVYRNGVRVCYRR-{nnr:Abu}-N | Ar-3(7–16) | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GF-{nnr:Abu}-WYVCVYRNGVRVCYRR-{nnr:Abu}-N | Ar-3(7–16) | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 10 % Hemolysis at 41.1±4.3 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38328670 | 2024 | MAKRRKKAKKKAKKAKKRRRRR | MR-22 | Free | Free | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 2-256 μg/mL | Human | Synthetic | Helix/coil | Non-hemolytic | ||
| 38578302 | 2024 | KYWKKYWKKYWK{ct:Amid} | KK12YW | Amidation | Free | Linear | L | None | 11 | Antibacterial | 0 % Hemolysis at 0.44-229.27 μg/mL | Fish | Synthetic | α-Helical | Non-hemolytic | ||
| 38578302 | 2024 | KYWKKYWKKYWK{ct:Amid} | KK12YW | Amidation | Free | Linear | L | None | 11 | Antibacterial | 25 % Hemolysis at 458.55 μg/mL | Fish | Synthetic | α-Helical | NA | ||
| 38578302 | 2024 | KYWKKYWKKYWK{ct:Amid} | KK12YW | Amidation | Free | Linear | L | None | 11 | Antibacterial | <50 % Hemolysis at 917.1 μg/mL | Fish | Synthetic | α-Helical | NA | ||
| 38578302 | 2024 | KYWKKYWKKYWK{ct:Amid} | KK12YW | Amidation | Free | Linear | L | None | 11 | Antibacterial | <50 % Hemolysis at 1834.21 μg/mL | Fish | Synthetic | α-Helical | NA | ||
| 38578302 | 2024 | KYWKKYWKKYWK{ct:Amid} | KK12YW | Amidation | Free | Linear | L | None | 11 | Antibacterial | <50 % Hemolysis at 3668.42 μg/mL | Fish | Synthetic | α-Helical | NA | ||
| 38578302 | 2024 | KYWKKYWKKYWK{ct:Amid} | KK12YW | Amidation | Free | Linear | L | None | 11 | Antibacterial | 51.2 % Hemolysis at 7336.84 μg/mL | Fish | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 2 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 4 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 8 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 16 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 32 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 64 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 128 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 4 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 8 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 16 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 32 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 64 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <40 % Hemolysis at 128 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 4 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 8 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 16 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <30 % Hemolysis at 32 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <50 % Hemolysis at 64 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <80 % Hemolysis at 128 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 4 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <40 % Hemolysis at 8 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <70 % Hemolysis at 16 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <120 % Hemolysis at 32 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <120 % Hemolysis at 64 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <120 % Hemolysis at 128 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 4 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 8 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 16 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 32 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 64 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 128 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <40 % Hemolysis at 4 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <70 % Hemolysis at 8 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <120 % Hemolysis at 16 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <120 % Hemolysis at 32 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <120 % Hemolysis at 64 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <120 % Hemolysis at 128 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 37992185 | 2024 | YGKAAAAK‐{nnr:Aic}‐AAAKAAAAK | peptideA | Free | Free | Linear | L | Aic = 2−aminoindane‐2‐carboxylicacid | 18 | Antibacterial | 0 % Hemolysis at | Human | Synthetic | NA | Non-hemolytic | | ||
| 37734650 | 2024 | KLKSKLMVVCNKIGLLKSLCRKFVKSH | NKL-WT | Free | Free | Linear | L | None | 27 | Antibacterial and Anticancer | 16.3 % Hemolysis at 40 µM | Rabbit | Antarctic Teleost Trematomus Bernacchii | α-Helical | NA | ||
| 37734650 | 2024 | KLKSKLMVVCNKIGLLKSLCRKFVKSH | NKL-WT | Free | Free | Linear | L | None | 27 | Antibacterial and Anticancer | 40.5 % Hemolysis at 80 µM | Rabbit | Antarctic Teleost Trematomus Bernacchii | α-Helical | NA | ||
| 37734650 | 2024 | KLKSKLMVVANKIGLLKSLARKFVKSH | NKL-MUT | Free | Free | Linear | L | None | 27 | Antibacterial and Anticancer | 0.9 % Hemolysis at 5 µM | Rabbit | Antarctic Teleost Trematomus Bernacchii | α-Helical | NA | ||
| 37734650 | 2024 | KLKSKLMVVANKIGLLKSLARKFVKSH | NKL-MUT | Free | Free | Linear | L | None | 27 | Antibacterial and Anticancer | 2.6 % Hemolysis at 80 µM | Rabbit | Antarctic Teleost Trematomus Bernacchii | α-Helical | NA | ||
| 37760693 | 2024 | FLWRISKFLGKKL{ct:Amid} | HRZN-13 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 0.7 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | Non-hemolytic | ||
| 37760693 | 2024 | FLWRISKFLGRKL{ct:Amid} | HRZN-14 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 5.6 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | Non-hemolytic | ||
| 37760693 | 2024 | FLPWISKFLGKIL{ct:Amid} | HRZN-15 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 100 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | FLPWISKFLGKIL{ct:Amid} | HRZN-15 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 8.6 % Hemolysis at 10 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | FLKKIWKLLGKLL{ct:Amid} | HRZN-16 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 100 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | FLKKIWKLLGKLL{ct:Amid} | HRZN-16 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 67 % Hemolysis at 10 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | KLWKLLKKLGRLL{ct:Amid} | HRZN-17 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 18 % Hemolysis at 10 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | KLWKLLKKLGRLL{ct:Amid} | HRZN-17 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 74 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 39 | Antibacterial/ Antibiofilm | 5.4 % Hemolysis at 10 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 39 | Antibacterial/ Antibiofilm | 22 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 29568446 | 2017 | ACLLQSLLCPYSTHRCG{cyc:N-C} | P8-d-C10 | Free | Free | Bicyclic | L | None | 17 | Antibacterial | 6 % Hemolysis at 32 μg/mL | Sheep | Peptide Phage | NA | Low hemolytic | ||
| 29568446 | 2017 | ACLLQSLLCPYSTHACG{cyc:N-C} | P8-d-(R15A)-C10 | Free | Free | Bicyclic | L | None | 17 | Antibacterial | 0 % Hemolysis at 32 μg/mL | Sheep | Peptide Phage | NA | Non-hemolytic | ||
| 29568446 | 2017 | ACLLQSLLCPYSTARCG{cyc:N-C} | P8-d-(H14R, R15A)-C10 | Free | Free | Bicyclic | L | None | 17 | Antibacterial | 2 % Hemolysis at 32 μg/mL | Sheep | Peptide Phage | NA | Low hemolytic | ||
| 29568446 | 2017 | ACLLQSLLCAYSTHRCG{cyc:N-C} | P8-d-(P10R, R15A)-C10 | Free | Free | Bicyclic | L | None | 17 | Antibacterial | 0 % Hemolysis at 32 μg/mL | Sheep | Peptide Phage | NA | Non-hemolytic | ||
| 29568446 | 2017 | ACLLQALLCPYSTHRCG{cyc:N-C} | P8-d-(S6R, R15A)-C10 | Free | Free | Bicyclic | L | None | 17 | Antibacterial | 0 % Hemolysis at 32 μg/mL | Sheep | Peptide Phage | NA | Non-hemolytic | ||
| 29568446 | 2017 | ACLLQALLCPYSTHRCG{cyc:N-C} | P8-L-(S6R, R15A)-C10 | Free | Free | Bicyclic | L | None | 17 | Antibacterial | 0 % Hemolysis at 32 μg/mL | Sheep | Peptide Phage | NA | Non-hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R1}{ct:Amid} | C6-Pat | Amidation | R1 = hexanoyl | Linear | Mix | R1 = hexanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 0.61 ± 0.25 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2}{ct:Amid} | C7-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 1.77 ± 0.81 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2}{ct:Amid} | C7DLeu7-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 26.5 ± 4.45 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2}{ct:Amid} | C7Phe2DLeu7-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 8.34 ± 1.80 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R2}{ct:Amid} | C7Phe2DLeu7Phe8-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 64.2 ± 3.28 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R3}{ct:Amid} | C8-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 25.3 ± 4.15 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R4}{ct:Amid} | C10-Pat | Amidation | R4 = decanoyl | Linear | Mix | R4 = decanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 93.9 ± 7.57 % Hemolysis at 128 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R1 = hexanoyl}{ct:{nt:R4}{ct:Amid}} | C6-Pat | Amidation | R1 = hexanoyl | Linear | Mix | R1 = hexanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 0.08 ± 0.85 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 1.18 ± 0.68 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7DLeu7-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 4.86 ± 1.05 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7Phe2DLeu7-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 2.03 ± 0.44 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R2 = heptanoyl}{ct:Amid} | C7Phe2DLeu7Phe8-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 18.8 ± 2.44 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R3 = octanoyl}{ct:Amid} | C8-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 6.18 ± 2.48 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid} | C10-Pat | Amidation | R4 = decanoyl | Linear | Mix | R4 = decanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 73.4 ± 7.59 % Hemolysis at 64 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R1 = hexanoyl}{ct:Amid} | C6-Pat | Amidation | R1 = hexanoyl | Linear | Mix | R1 = hexanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 0.41 ± 0.58 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 0.78 ± 0.30 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7DLeu7-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 1.39 ± 0.55 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7Phe2DLeu7-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 0.39 ± 0.30 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R2 = heptanoyl}{ct:Amid} | C7Phe2DLeu7Phe8-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 5.10 ± 1.26 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R3 = octanoyl}{ct:Amid} | C8-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 1.91 ± 0.25 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid} | C10-Pat | Amidation | R4 = decanoyl | Linear | Mix | R4 = decanoyl, Dab = 2,4-diaminobutyric acid | 9 | broad Antibacterial activity | 37.2 ± 8.62 % Hemolysis at 32 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R1 = hexanoyl}{ct:Amid} | C6-Pat | Amidation | R1 = hexanoyl | Linear | Mix | R1 = hexanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 0.48 ± 0.64 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 0.18 ± 0.54 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7DLeu7-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 0.96 ± 0.59 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}LS{nt:R2 = heptanoyl}{ct:Amid} | C7Phe2DLeu7-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 0.14 ± 0.20 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}L{d}FS{nt:R2 = heptanoyl}{ct:Amid} | C7Phe2DLeu7Phe8-Pat | Amidation | R2 = heptanoyl | Linear | Mix | R2 = heptanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 0.99 ± 0.31 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R3 = octanoyl}{ct:Amid} | C8-Pat | Amidation | R3 = octanoyl | Linear | Mix | R3 = octanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 0.93 ± 0.45 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | Low hemolytic | ||
| 29136469 | 2017 | {nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid} | C10-Pat | Amidation | R4 = decanoyl | Linear | Mix | R4 = decanoyl, Dab = 2,4-diaminobutyric acid | 9 | Antibacterial | 14.3 ± 4.25 % Hemolysis at 16 μg/ml | Rabbit | Synthetic Paenipeptins Analogues | NA | NA | ||
| 28887200 | 2018 | FLFTVA-{nnr:Dhb}{ct:Acet} | ASP-1 | Acetylation | Free | Linear | L | Dhb = dehydrobutyrine | 7 | Antibacterial, Anti-MRSA, Antibiofilm | ~6 % Hemolysis at 128 μg/ml | Human | Bacillus Subtilis Urid 12.1 | β-Sheet | Low hemolytic | ||
| 32624860 | 2018 | KIIIPPLFH | barleycin | Free | Free | Linear | L | None | 9 | Antibacterial | 0 % Hemolysis at 64 μg/mL | Human | Highland Barley Or Tibetan Barley | α-Helix | Non-hemolytic | ||
| 32624860 | 2018 | KIIIPPLFH | barleycin | Free | Free | Linear | L | None | 9 | Antibacterial | 0 % Hemolysis at 128 μg/mL | Human | Highland Barley Or Tibetan Barley | α-Helix | Non-hemolytic | ||
| 32624860 | 2018 | KIIIPPLFH | barleycin | Free | Free | Linear | L | None | 9 | Antibacterial | 3.2 ± 1.7 % Hemolysis at 256 μg/mL | Human | Highland Barley Or Tibetan Barley | α-Helix | NA | ||
| 32624860 | 2018 | KIIIPPLFH | barleycin | Free | Free | Linear | L | None | 9 | Antibacterial | 19.5 ± 3.5 % Hemolysis at 512 μg/mL | Human | Highland Barley Or Tibetan Barley | α-Helix | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | Peptoid - 1 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 100 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | Peptoid - 2 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 9 | Antibacterial | 38.7 ± 5.4 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl){nt:H}{ct:Amid} | Peptoid - 3 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 100 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3){nt:H}{ct:Amid} | Peptoid - 4 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 100 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF){nt:H}{ct:Amid} | Peptoid - 5 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 100 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid} | Peptoid - 6 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 13 | Antibacterial | 48.1 ± 3 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid} | Peptoid - 7 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 10 | Antibacterial | 9.8 ± 0.8 % Hemolysis at 200 mM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | Peptoid - 1 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 10 % Hemolysis at 9.1 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | Peptoid - 2 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 9 | Antibacterial | 10 % Hemolysis at 119.5 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl){nt:H}{ct:Amid} | Peptoid - 3 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 10 % Hemolysis at <6.25 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3){nt:H}{ct:Amid} | Peptoid - 4 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 10 % Hemolysis at <6.25 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF){nt:H}{ct:Amid} | Peptoid - 5 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 10 % Hemolysis at <6.25 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid} | Peptoid - 6 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 13 | Antibacterial | 10 % Hemolysis at 19.5 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid} | Peptoid - 7 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 10 | Antibacterial | 10 % Hemolysis at >200 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | Peptoid - 1 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 50 % Hemolysis at 63.4 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}{nt:H}{ct:Amid} | Peptoid - 2 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 9 | Antibacterial | 50 % Hemolysis at 1>200 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl)-{nnr:Nlys}-{nnr:Nspe}(pCl)-{nnr:Nspe}(pCl){nt:H}{ct:Amid} | Peptoid - 3 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 50 % Hemolysis at 10.4 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3)-{nnr:Nlys}-{nnr:Nspe}(pCH3)-{nnr:Nspe}(pCH3){nt:H}{ct:Amid} | Peptoid - 4 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 50 % Hemolysis at 8.3 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF)-{nnr:Nlys}-{nnr:Nspe}(pF)-{nnr:Nspe}(pF){nt:H}{ct:Amid} | Peptoid - 5 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 12 | Antibacterial | 50 % Hemolysis at <6.25 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid} | Peptoid - 6 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 13 | Antibacterial | 50 % Hemolysis at >200 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29198866 | 2018 | {nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}-{nnr:Nspe}-{nnr:Nspe}-{nnr:Nlys}{nt:H}{ct:Amid} | Peptoid - 7 | Amidation | H | Linear | NA | Nlys = N-(4-aminobutyl)glycine, Nspe = N-(S)-(1-phenylethyl)glycine | 10 | Antibacterial | 50 % Hemolysis at >200 μM | Rat | Synthetic Peptoid | α-Helical | NA | ||
| 29310083 | 2018 | KWLKKWLKWLKK{ct:Amid} | A-12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 56 % Hemolysis at 250 μg/ml | Human | Analogues Of Α/Β Diastereomeric Peptide | α-Helical | NA | ||
| 29310083 | 2018 | KW{nnr:L}KKW{nnr:L}KW{nnr:L}KK{ct:Amid} | βA-12 | Amidation | Free | Linear | L | L = β-amino acid | 12 | Antibacterial | 0 % Hemolysis at 250 μg/ml | Human | Analogues Of Α/Β Diastereomeric Peptide | α-Helical | Non-hemolytic | ||
| 29310083 | 2018 | K{d}W{d}LK{d}K{d}W{d}LK{d}W{d}LK{d}K{d}{ct:Amid} | DA-12 | Amidation | Free | Linear | Mix | None | 12 | Antibacterial | 0 % Hemolysis at 250 μg/ml | Human | Analogues Of Α/Β Diastereomeric Peptide | α-Helical | Non-hemolytic | ||
| 29310083 | 2018 | K{d}W{d}{nnr:L}K{d}K{d}W{d}{nnr:L}K{d}W{d}{nnr:L}K{d}K{d}{ct:Amid} | UNA-12 | Amidation | Free | Linear | Mix | L = β-amino acid | 12 | Antibacterial | 0 % Hemolysis at 250 μg/ml | Human | Analogues Of Α/Β Diastereomeric Peptide | α-Helical | Non-hemolytic | ||
| 29310083 | 2018 | ILPWKWPWWPWRR{ct:Amid} | IL | Amidation | Free | Linear | L | None | 13 | Antibacterial | 70 % Hemolysis at 250 μg/ml | Human | Control Host Defense Peptide | NA | NA | ||
| 29277569 | 2018 | VYPFMWGGAYCFCKAKLV{ct:Amid} | VT18-KKLV | Amidation | Free | Linear | L | None | 18 | Antibacterial | 3 % Hemolysis at 100 µg/ml | Human | Chikungunya Virus Fusion Domain Vt18-Derived Peptides | Double Strand β-Sheet | Low hemolytic | ||
| 29277569 | 2018 | VYPFCWGGAYAFCKAKLV{ct:Amid} | VT18-CAKKLV | Amidation | Free | Linear | L | None | 18 | Antibacterial | 3.8 % Hemolysis at 100 µg/ml | Human | Chikungunya Virus Fusion Domain Vt18-Derived Peptides | Double Strand β-Sheet | Low hemolytic | ||
| 29277569 | 2018 | VYPFCWGGAYAFCKAKLV{cyc:N-C}{ct:Amid} | cVT18-CAKKLV | Amidation | Free | Cyclic | L | None | 18 | Antibacterial | 1.8 % Hemolysis at 100 µg/ml | Human | Vt18-Cakklv Cyclized Between Cys88 And Cys96 | Double Strand β-Sheet | Low hemolytic | ||
| 29551999 | 2018 | RRWQWR | Monomer LfcinB (20–25) | Free | Free | Linear | L | None | 6 | Antibacterial | 7.1 % Hemolysis at 25 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | RWQWRWQWR | Palindromic (PLS) | Free | Free | Linear | L | None | 9 | Antibacterial | 24.8 % Hemolysis at 100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | FKCRRWQWRMKKLGA | Reference Peptide (LfcinB (17–31)) | Free | Free | Linear | L | None | 15 | Antibacterial | 6.6 % Hemolysis at 25 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | RRWQWRRRWQWRK{nnr:Ahx} | Dimeric (LfcinB (20–25)2) | Free | Free | Branched | L | Ahx = hydrophobic spacer that prevents steric hindrance | 15 | Antibacterial | 5.6 % Hemolysis at 100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | RRWQWRRRWQWRRRWQWRRRWQWRKK{nnr:Ahx}{nnr:Ahx}CC | Tetrameric (LfcinB (20–25)4) | Free | Free | Branched | L | Ahx = hydrophobic spacer that prevents steric hindrance | 30 | Antibacterial | 49.1 % Hemolysis at 100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | RRWQWR | Monomer LfcinB (20–25) | Free | Free | Linear | L | None | 6 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | RWQWRWQWR | Palindromic (PLS) | Free | Free | Linear | L | None | 9 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | FKCRRWQWRMKKLGA | Reference Peptide (LfcinB (17–31)) | Free | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | RRWQWRRRWQWRK{nnr:Ahx} | Dimeric (LfcinB (20–25)2) | Free | Free | Branched | L | Ahx = hydrophobic spacer that prevents steric hindrance | 15 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | RRWQWRRRWQWRRRWQWRRRWQWRKK{nnr:Ahx}{nnr:Ahx}CC | Tetrameric (LfcinB (20–25)4) | Free | Free | Branched | L | Ahx = hydrophobic spacer that prevents steric hindrance | 30 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29275987 | 2018 | KKKKKK-AAF{nnr:X}AWA{nnr:X}FAA{nt:6 Lys}{ct:Amid} | S-6K-F17 | Amidation | 6 Lys | Stapled | L | X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined | 17 | Antibacterial | 2 % Hemolysis at 4 µM | Human | 6K-F17 Hydrocarbon Staple | Random coil | NA | ||
| 29275987 | 2018 | KKKKKK-AGF{nnr:X}AWA{nnr:X}FGA{nt:6 Lys}{ct:Amid} | S-6K-F17-2G | Amidation | 6 Lys | Stapled | L | X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined | 17 | Antibacterial | MHC at 15[5.8] µM | Human | 6K-F17 Hydrocarbon Staple | NA | NA | ||
| 29275987 | 2018 | KKKKKK-AGF{nnr:X}AWG{nnr:X}FGA{nt:6 Lys}{ct:Amid} | S-6K-F17-3G | Amidation | 6 Lys | Stapled | L | X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined | 17 | Antibacterial | MHC at 128[43.8] µM | Human | 6K-F17 Hydrocarbon Staple | Random coil | NA | ||
| 29275987 | 2018 | KKKKKK-NGF{nnr:X}AWG{nnr:X}FGA{nt:6 Lys}{ct:Amid} | S-6K-F17-3GN | Amidation | 6 Lys | Stapled | L | X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined | 17 | Antibacterial | MHC at 587[130.6] µM | Human | 6K-F17 Hydrocarbon Staple | Helical | NA | ||
| 29264738 | 2018 | K{nt:C16}{ct:Amid} | 1 | Amidation | C16 | Linear | L | C16 | 1 | Antibacterial | 10 % Hemolysis at 512 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KK{nt:C16}{ct:Amid} | 2 | Amidation | C16 | Linear | L | C16 | 2 | Antibacterial | 10 % Hemolysis at 256 µg/mL | Human | Synthetic Lipopeptides | NA | NA | ||
| 29264738 | 2018 | KKK{nt:C16}{ct:Amid} | 3 | Amidation | C16 | Linear | L | C16 | 3 | Antibacterial | 10 % Hemolysis at 32 µg/mL | Human | Synthetic Lipopeptides | NA | NA | ||
| 29264738 | 2018 | KKKK{nt:C16}{ct:Amid} | 4 | Amidation | C16 | Linear | L | C16 | 4 | Antibacterial | 10 % Hemolysis at 16 µg/mL | Human | Synthetic Lipopeptides | NA | NA | ||
| 29264738 | 2018 | KG{nt:C16}{ct:Amid} | 5 | Amidation | C16 | Linear | L | C16 | 2 | Antibacterial | 10 % Hemolysis at 256 µg/mL | Human | Synthetic Lipopeptides | NA | NA | ||
| 29264738 | 2018 | KGK{nt:C16}{ct:Amid} | 6 | Amidation | C16 | Linear | L | C16 | 3 | Antibacterial | 10 % Hemolysis at 64 µg/mL | Human | Synthetic Lipopeptides | NA | NA | ||
| 29264738 | 2018 | KGKG{nt:C16}{ct:Amid} | 7 | Amidation | C16 | Linear | L | C16 | 4 | Antibacterial | 10 % Hemolysis at 64 µg/mL | Human | Synthetic Lipopeptides | NA | NA | ||
| 29264738 | 2018 | K{nt:C14}{ct:Amid} | 8 | Amidation | C14 | Linear | L | C14 | 1 | Antibacterial | 10 % Hemolysis at 512 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KK{nt:C14}{ct:Amid} | 9 | Amidation | C14 | Linear | L | C14 | 2 | Antibacterial | 10 % Hemolysis at 128 µg/mL | Human | Synthetic Lipopeptides | NA | NA | ||
| 29264738 | 2018 | KKK{nt:C14}{ct:Amid} | 10 | Amidation | C14 | Linear | L | C14 | 3 | Antibacterial | 10 % Hemolysis at 256 µg/mL | Human | Synthetic Lipopeptides | NA | NA | ||
| 29264738 | 2018 | KKKK{nt:C14}{ct:Amid} | 11 | Amidation | C14 | Linear | L | C14 | 4 | Antibacterial | 10 % Hemolysis at 256 µg/mL | Human | Synthetic Lipopeptides | NA | NA | ||
| 29264738 | 2018 | KG{nt:C14}{ct:Amid} | 12 | Amidation | C14 | Linear | L | C14 | 2 | Antibacterial | 10 % Hemolysis at >1000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KGK{nt:C14}{ct:Amid} | 13 | Amidation | C14 | Linear | L | C14 | 3 | Antibacterial | 10 % Hemolysis at 128 µg/mL | Human | Synthetic Lipopeptides | NA | NA | ||
| 29264738 | 2018 | KGKG{nt:C14}{ct:Amid} | 14 | Amidation | C14 | Linear | L | C14 | 4 | Antibacterial | 10 % Hemolysis at 512 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | K{nt:C12}{ct:Amid} | 15 | Amidation | C12 | Linear | L | C12 | 1 | Antibacterial | 10 % Hemolysis at >1000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KK{nt:C12}{ct:Amid} | 16 | Amidation | C12 | Linear | L | C12 | 2 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KKK{nt:C12}{ct:Amid} | 17 | Amidation | C12 | Linear | L | C12 | 3 | Antibacterial | 10 % Hemolysis at 512 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KKKK{nt:C12}{ct:Amid} | 18 | Amidation | C12 | Linear | L | C12 | 4 | Antibacterial | 10 % Hemolysis at >1000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KG{nt:C12}{ct:Amid} | 19 | Amidation | C12 | Linear | L | C12 | 2 | Antibacterial | 10 % Hemolysis at >1000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KGK{nt:C12}{ct:Amid} | 20 | Amidation | C12 | Linear | L | C12 | 3 | Antibacterial | 10 % Hemolysis at >1000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KGKG{nt:C12}{ct:Amid} | 21 | Amidation | C12 | Linear | L | C12 | 4 | Antibacterial | 10 % Hemolysis at 256 µg/mL | Human | Synthetic Lipopeptides | NA | NA | ||
| 29264738 | 2018 | K{nt:C10}{ct:Amid} | 22 | Amidation | C10 | Linear | L | C10 | 1 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KK{nt:C10}{ct:Amid} | 23 | Amidation | C10 | Linear | L | C10 | 2 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KKK{nt:C10}{ct:Amid} | 24 | Amidation | C10 | Linear | L | C10 | 3 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KKKK{nt:C10}{ct:Amid} | 25 | Amidation | C10 | Linear | L | C10 | 4 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KG{nt:C10}{ct:Amid} | 26 | Amidation | C10 | Linear | L | C10 | 2 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KGK{nt:C10}{ct:Amid} | 27 | Amidation | C10 | Linear | L | C10 | 3 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KGKG{nt:C10}{ct:Amid} | 28 | Amidation | C10 | Linear | L | C10 | 4 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | K{nt:C8}{ct:Amid} | 29 | Amidation | C8 | Linear | L | C8 | 1 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KK{nt:C8}{ct:Amid} | 30 | Amidation | C8 | Linear | L | C8 | 2 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KKK{nt:C8}{ct:Amid} | 31 | Amidation | C8 | Linear | L | C8 | 3 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KKKK{nt:C8}{ct:Amid} | 32 | Amidation | C8 | Linear | L | C8 | 4 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KG{nt:C8}{ct:Amid} | 33 | Amidation | C8 | Linear | L | C8 | 2 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KGK{nt:C8}{ct:Amid} | 34 | Amidation | C8 | Linear | L | C8 | 3 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29264738 | 2018 | KGKG{nt:C8}{ct:Amid} | 35 | Amidation | C8 | Linear | L | C8 | 4 | Antibacterial | 10 % Hemolysis at >4000 µg/mL | Human | Synthetic Lipopeptides | NA | Low hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:NHCH2CH2OH} | 1 | NHCH2CH2OH | Cbz | Linear | L | Cbz = carboxybenzyl, AzPro = azaproline | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Hexadecameric Analogous Peptides | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Acet}{ct:NHCH2CH2OH} | 2 | NHCH2CH2OH | Acetylation | Linear | L | AzPro = azaproline, Ac = N-acetyl | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Hexadecameric Analogous Peptides | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Formyl}{ct:NHCH2CH2OH} | 3 | NHCH2CH2OH | Formyl | Linear | L | AzPro = azaproline, Formyl = Formyl | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Hexadecameric Analogous Peptides | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Formyl}{ct:NHCH2CH2OH} | 5 | NHCH2CH2OH | Formyl | Linear | L | AzPro = azaproline, Formyl = Formyl | 14 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Formyl}{ct:NHCH2CH2OH} | 6 | NHCH2CH2OH | Formyl | Linear | L | AzPro = azaproline, Formyl = Formyl | 12 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Formyl}{ct:NHCH2CH2OH} | 7 | NHCH2CH2OH | Formyl | Linear | L | AzPro = azaproline, Formyl = Formyl | 10 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:OtBu} | 8 | OtBu | Cbz | Linear | L | AzPro = azaproline, OtBu = ortho-tert-butyl, Cbz = carboxybenzyl | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Hexadecameric Analogous Peptides | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}{nt:Boc}{ct:Cbz} | 10 | Cbz | Boc | Linear | L | AzPro = azaproline, Boc = tert-butyloxycarbonyl, Cbz = carboxybenzyl | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Hexadecameric Analogous Peptides | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:OtBu} | 11 | OtBu | Cbz | Linear | L | AzPro = azaproline, OtBu = ortho-tert-butyl, Cbz = carboxybenzyl | 32 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Hexadecameric Analogous Peptides | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:OH} | 14 | OH | Cbz | Linear | L | AzPro = azaproline, Cbz = carboxybenzyl, OH = Hydroxyl | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:HCl.H}{ct:OtBu} | 15 | OtBu | HCl.H | Linear | L | AzPro = azaproline, HCl = hydrochloric acid, OtBu = ortho-tert-butyl | 16 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:OtBu} | 18 | OtBu | Cbz | Linear | L | AzPro = azaproline, OtBu = ortho-tert-butyl, Cbz = carboxybenzyl | 8 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:Cbz}{ct:OH} | 19 | OH | Cbz | Linear | L | AzPro = azaproline, Cbz = carboxybenzyl, OH = Hydroxyl | 8 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | {nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P{nt:H}{ct:OtBu} | 20 | OtBu | H | Linear | L | AzPro = azaproline, OtBu = ortho-tert-butyl, H = Hydrogen | 8 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}{nt:Boc}{ct:Cbz} | 21 | Cbz | Boc | Linear | L | AzPro = azaproline, Cbz = carboxybenzyl, Boc = tert-butyloxycarbonyl | 8 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}{nt:Boc}{ct:H} | 22 | H | Boc | Linear | L | AzPro = azaproline, Boc = tert-butyloxycarbonyl, H = Hydrogen | 8 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}-P-{nnr:AzPro}{nt:HCl.H}{ct:Cbz} | 23 | Cbz | HCl.H | Linear | L | AzPro = azaproline, Cbz = carboxybenzyl, HCl = hydrochloric acid | 8 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Gas Shorter Peptide Analogs | β 6.3-Helical | Non-hemolytic | ||
| 29501941 | 2018 | VGAL{d}AV{d}VV{d}WL{d}WL{d}WL{d}W{nt:Formyl}{ct:NHCH2CH2OH}{nt:Formyl}{ct:NHCH2CH2OH} | 24(Gramicidin A) | NHCH2CH2OH | Formyl | Linear | Mix | N-Terminal = Formyl | 15 | Antibacterial | 50 % Hemolysis at 5 µM | Human | Gramicidin A Amp | β 6.3-Helical | NA | ||
| 29553266 | 2018 | KIAKGALKALKIAKGALKAL{ct:Amid} | kiadin-3 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 100± 5 µM | Human | Modification Of Kiadin-1 Natural Amp (Pgla-H) | α-Helical | NA | ||
| 29553266 | 2018 | KIAGKAGKIAKIAGKAGKIA{ct:Amid} | kiadin-5 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 0 µM | Human | Ab Initio Designed | α-Helical | Non-hemolytic | ||
| 29688003 | 2018 | GIGKFLHSAKKFGKAFVGEIMNSC | Magainin 2 | Free | Free | Linear | L | None | 24 | Antibacterial | 7 % Hemolysis | Human | Synthetic Peptide | NA | NA | ||
| 29648811 | 2018 | RRIRIIIRIRR{ct:Amid} | 13 - I6 | Amidation | Free | Linear | L | None | 11 | Antifungal, Antibacterial | 10 % Hemolysis at >128 µM | Human | Synthetic Peptide - Developed Based On The Imperfectly Amphipathic Palindromic Structure Rn(Xrxxxrx)Rn (N = 1, 2; X Represents L, I, F, Or W) | α-Helical | Low hemolytic | ||
| 29738954 | 2018 | FGRKKRRQRRR{nt:Acet}{ct:Amid} | ctrlTat peptide | Amidation | Acetylation | Linear | L | None | 11 | Antibacterial | 12 % Hemolysis at 1 µM | Human | Human Immunodeficiency Virus 1 (Hiv-1) Tat Protein | at water Random coil structure, at TFE α-Helical | NA | ||
| 29738954 | 2018 | FG{nnr:r}KKR{nnr:r}Q{nnr:r}R{nnr:r}-{nnr:βA}{nt:Acet}{ct:Amid} | γTatM4 | Amidation | Acetylation | Linear | Mix | r = (2S,4S)-4-amino-N-(3-guanidinopropyl)-proline, βA = βAla(β-Alanine){nnr:Bala} – β-Alanine | 11 | Antibacterial and Anti-TB | 10 % Hemolysis at 1 µM | Human | Tat Peptide Analogues | NA | NA | ||
| 29738954 | 2018 | FGRKKRRQRRR{nt:Acet}{ct:Amid} | ctrlTat peptide | Amidation | Acetylation | Linear | L | None | 11 | Antibacterial | 14 % Hemolysis at 40 µM | Human | Human Immunodeficiency Virus 1 (Hiv-1) Tat Protein | at water Random coil structure, at TFE α-Helical | NA | ||
| 29738954 | 2018 | FG{nnr:r}KKR{nnr:r}Q{nnr:r}R{nnr:r}-{nnr:βA}{nt:Acet}{ct:Amid} | γTatM4 | Amidation | Acetylation | Linear | Mix | r = (2S,4S)-4-amino-N-(3-guanidinopropyl)-proline, βA = βAla(β-Alanine){nnr:Bala} – β-Alanine | 11 | Antibacterial and Anti-TB | 12 % Hemolysis at 40 µM | Human | Tat Peptide Analogues | NA | NA | ||
| 28659061 | 2018 | NLLNKALGTVNGLLGRS | Dc1.1 | Free | Free | Linear | L | None | 17 | Antibacterial | 50 % Hemolysis at >256 µM | Human | Dc1 Analogue | water = unordered structures , TFE = α-Helix | Non-hemolytic | ||
| 28659061 | 2018 | NLLKSALKTVNKLLAAS{ct:Amid} | Dc1.2 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 50 % Hemolysis at >256 µM | Human | Dc1 Analogue | water = unordered structures , TFE = α-Helix | Non-hemolytic | ||
| 29621496 | 2018 | {nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{cyc:N-C} | C1 | Free | Free | Cyclic | Mix | Nap = N-(3-aminopropyl)glycine, Npm = N-(1-phenylmethyl)glycine | 6 | Antibacterial | 10 % Hemolysis at 250 μg/mL | Human | Synthetic Peptoids Mimic Antimicrobial Peptides | NA | NA | ||
| 29621496 | 2018 | {nnr:Nap}{nnr:Ndmb}{nnr:Nap}{nnr:Ndmb}{nnr:Nap}{nnr:Ndmb}{cyc:N-C} | C2 | Free | Free | Cyclic | Mix | Nap = N-(3-aminopropyl)glycine, Ndmb = N-(3,5-dimethylbenzyl)glycine | 6 | Antibacterial | 10 % Hemolysis at 125 μg/mL | Human | Synthetic Peptoids Mimic Antimicrobial Peptides | NA | NA | ||
| 29621496 | 2018 | {nnr:Nap}{nnr:Nsne}{nnr:Nap}{nnr:Nsne}{nnr:Nap}{nnr:Nsne}{cyc:N-C} | C3 | Free | Free | Cyclic | Mix | Nap = N-(3-aminopropyl)glycine, Nsne = (S)-N-(1-naphthylethyl)glycine | 6 | Antibacterial | 10 % Hemolysis | Human | Synthetic Peptoids Mimic Antimicrobial Peptides | NA | NA | ||
| 29621496 | 2018 | {nnr:Nap}{nnr:Ndp}{nnr:Nap}{nnr:Ndp}{nnr:Nap}{nnr:Ndp}{cyc:N-C} | C4 | Free | Free | Cyclic | Mix | Nap = N-(3-aminopropyl)glycine, Ndp = N-(2,2-diphenylethyl)glycine | 6 | Antibacterial | 10 % Hemolysis at 31.3 μg/mL | Human | Synthetic Peptoids Mimic Antimicrobial Peptides | NA | NA | ||
| 29621496 | 2018 | {nnr:Nap}{nnr:Nbtfmb}{nnr:Nap}{nnr:Nbtfmb}{nnr:Nap}{nnr:Nbtfmb}{cyc:N-C} | C5 | Free | Free | Cyclic | Mix | Nap = N-(3-aminopropyl)glycine, Nbtfmb = N-(3,5-bis-trifluoromethylbenzyl)glycine | 6 | Antibacterial | 10 % Hemolysis at 31.3 μg/mL | Human | Synthetic Peptoids Mimic Antimicrobial Peptides | NA | NA | ||
| 29621496 | 2018 | {nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{cyc:N-C} | C1dec | Free | Free | Cyclic | Mix | Nap = N-(3-aminopropyl)glycine, Npm = N-(1-phenylmethyl)glycine | 10 | Antibacterial | 10 % Hemolysis at 250 μg/mL | Human | Synthetic Peptoids Mimic Antimicrobial Peptides | NA | NA | ||
| 29621496 | 2018 | V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C} | CGS (gramicidin S) | Free | Free | Cyclic | Mix | O = L-Ornithine, f = D-phenylalanine | 10 | Antibacterial | 10 % Hemolysis at >15.6 μg/mL | Human | Gram-Positive Bacterium Brevibacillus Brevis | NA | NA | ||
| 29984236 | 2018 | RRWQWR | Motif | Free | Free | Linear | L | None | 6 | Antibacterial | 7.1 % Hemolysis at 25 μM | Human | Bovine Lactoferricin | branched conformation | NA | ||
| 29984236 | 2018 | RWQWR WQWR | Palindromic | Free | Free | Linear | L | None | 9 | Antibacterial | 24.8 % Hemolysis at 100 μM | Human | Synthesised From Motif | NA | NA | ||
| 29984236 | 2018 | FKC R RWQWRM KKLGA | LfcinB reference | Free | Free | Linear | L | None | 15 | Antibacterial | 7.9 % Hemolysis at 12.5 μM | Human | Bovine Lactoferricin B | NA | NA | ||
| 29984236 | 2018 | RRWQWRRRWQWR-K-{nnr:Ahx} | Dimeric | Free | Free | Linear | L | Ahx = Aminohexanoic acid | 13 | Antibacterial | <5 % Hemolysis at 100 μM | Human | Synthesised And Modified From Motif | NA | Low hemolytic | ||
| 29984236 | 2018 | RRWQWRRRWQWRK-{nnr:Ahx}-CRRWQWRRRWQWRK-{nnr:Ahx}-C | Tetrameric | Free | Free | Linear | L | Ahx = Aminohexanoic acid | 28 | Antibacterial | 49.1 % Hemolysis at 100 μM | Human | Synthesised And Modified From Motif | NA | NA | ||
| 29925795 | 2018 | KWKLFKKIFKRIVQRIKDFLRN | Synthesized C–L | Free | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 219 ± 2.98 µg/mL | Sheep | Combination Of Cecropin A (C) And Ll-37 (L) Sequences | NA | NA | ||
| 29799150 | 2018 | AAGK{d}W{d}K{d}L{d}F{d}K{d}K{d}L{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid} | AAG‐P18 | Amidation | Free | Linear | Mix | None | 18 | Antibacterial | 75 % Hemolysis at 250 μM | Human | Cecropin/Magainin Hybrid | NA | NA | ||
| 29799150 | 2018 | AAGW{d}G{d}L{d}R{d}R{d}L{d}L{d}K{d}Y{d}G{d}K{d}R{d}S{d}{ct:Amid} | AAG‐WMR | Amidation | Free | Linear | Mix | None | 13 | Antibacterial | 5 % Hemolysis at 10 μM | Human | Myxinidin Analogue From Hagfish | NA | NA | ||
| 29197569 | 2018 | KWKLFKKYGRKKRRQRRR | CA-TAT | Free | Free | Linear | L | None | 18 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Attaching Cecropin A (1-7)+ Tat(47-57) | NA | Low hemolytic | ||
| 29197569 | 2018 | YGRKKRRQRRR | TAT(47-57) | Free | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Human Immunodeficiency Virus Type 1 (Hiv–1) Transactivation Of Transcription (Tat) Protein | NA | Low hemolytic | ||
| 29197569 | 2018 | KWKLFKK | cecropin A(1-7) | Free | Free | Linear | L | None | 7 | Antibacterial | 5 % Hemolysis at >64 μM | Human | Hemolymph Of Giant Silk | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 43 ± 1.4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | C5H11CO-KKLFKKILKYL{nt:hexanoyl}{ct:Amid} | BP367 | Amidation | hexanoyl | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 83 ± 6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC5H11})KLFKKILKYL{nt:Acet}{ct:Amid} | BP368 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 96 ± 0.9 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC5H11})LFKKILKYL{nt:Acet}{ct:Amid} | BP369 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 84 ± 8 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC5H11})KKILKYL{nt:Acet}{ct:Amid} | BP371 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 75 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC5H11})KILKYL{nt:Acet}{ct:Amid} | BP372 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 97 ± 2 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC5H11})ILKYL{nt:Acet}{ct:Amid} | BP373 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 92 ± 1 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC5H11})LKYL{nt:Acet}{ct:Amid} | BP374 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 19 ± 3 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC5H11})KYL{nt:Acet}{ct:Amid} | BP375 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 70 ± 6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC5H11})YL{nt:Acet}{ct:Amid} | BP376 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 90 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC5H11})L{nt:Acet}{ct:Amid} | BP377 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 92 ± 5 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | C3H7CO-KKLFKKILKYL{nt:butanoyl}{ct:Amid} | BP379 | Amidation | butanoyl | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 93 ± 0.8 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC3H7})KLFKKILKYL{nt:Acet}{ct:Amid} | BP380 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 93 ± 6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC3H7})FKKILKYL{nt:Acet}{ct:Amid} | BP382 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 0.9 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC3H7})KKILKYL{nt:Acet}{ct:Amid} | BP383 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 22 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC3H7})KILKYL{nt:Acet}{ct:Amid} | BP384 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC3H7})ILKYL{nt:Acet}{ct:Amid} | BP385 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 3 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC3H7})YL{nt:Acet}{ct:Amid} | BP388 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 38 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC3H7}){nt:Acet}{ct:Amid} | BP390 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 5 ± 0.3 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | Low hemolytic | ||
| 30052685 | 2018 | C11H23CO-KKLFKKILKYL{nt:lauroyl}{ct:Amid} | BP391 | Amidation | lauroyl | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 0.9 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC11H23})KLFKKILKYL{nt:Acet}{ct:Amid} | BP392 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 0.9 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC11H23})LFKKILKYL{nt:Acet}{ct:Amid} | BP393 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 97 ± 0.6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC11H23})FKKILKYL{nt:Acet}{ct:Amid} | BP394 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 1 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC11H23})KKILKYL{nt:Acet}{ct:Amid} | BP395 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC11H23})KILKYL{nt:Acet}{ct:Amid} | BP396 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC11H23})ILKYL{nt:Acet}{ct:Amid} | BP397 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC11H23})LKYL{nt:Acet}{ct:Amid} | BP398 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 3 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC11H23})KYL{nt:Acet}{ct:Amid} | BP399 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 5 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC11H23})YL{nt:Acet}{ct:Amid} | BP400 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 99 ± 0.4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC11H23})L{nt:Acet}{ct:Amid} | BP401 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 1 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC11H23}){nt:Acet}{ct:Amid} | BP402 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 57 ± 4.6 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | C5H11CO-KKLFKKILKYL{nt:hexanoyl}{ct:Amid} | BP367 | Amidation | hexanoyl | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 95 ± 13 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC5H11})KLFKKILKYL{nt:Acet}{ct:Amid} | BP368 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 97 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC5H11})LFKKILKYL{nt:Acet}{ct:Amid} | BP369 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 86 ± 8 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC5H11})KKILKYL{nt:Acet}{ct:Amid} | BP371 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 95 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC5H11})KILKYL{nt:Acet}{ct:Amid} | BP372 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 100 ± 0.9 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC5H11})ILKYL{nt:Acet}{ct:Amid} | BP373 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 95 ± 6 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC5H11})LKYL{nt:Acet}{ct:Amid} | BP374 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 28 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC5H11})KYL{nt:Acet}{ct:Amid} | BP375 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 86 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC5H11})YL{nt:Acet}{ct:Amid} | BP376 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 89 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC5H11})L{nt:Acet}{ct:Amid} | BP377 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 89 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | C3H7CO-KKLFKKILKYL{nt:butanoyl}{ct:Amid} | BP379 | Amidation | butanoyl | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 96 ± 1 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC3H7})KLFKKILKYL{nt:Acet}{ct:Amid} | BP380 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 97 ± 5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC3H7})FKKILKYL{nt:Acet}{ct:Amid} | BP382 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC3H7})KKILKYL{nt:Acet}{ct:Amid} | BP383 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 40 ± 4 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC3H7})KILKYL{nt:Acet}{ct:Amid} | BP384 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC3H7})ILKYL{nt:Acet}{ct:Amid} | BP385 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC3H7})YL{nt:Acet}{ct:Amid} | BP388 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 89 ± 10 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC3H7}){nt:Acet}{ct:Amid} | BP390 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 7 ± 0.9 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | Low hemolytic | ||
| 30052685 | 2018 | C11H23CO-KKLFKKILKYL{nt:lauroyl}{ct:Amid} | BP391 | Amidation | lauroyl | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 0.5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC11H23})KLFKKILKYL{nt:Acet}{ct:Amid} | BP392 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC11H23})LFKKILKYL{nt:Acet}{ct:Amid} | BP393 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 99 ± 0.5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC11H23})FKKILKYL{nt:Acet}{ct:Amid} | BP394 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC11H23})KKILKYL{nt:Acet}{ct:Amid} | BP395 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC11H23})KILKYL{nt:Acet}{ct:Amid} | BP396 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 7 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC11H23})ILKYL{nt:Acet}{ct:Amid} | BP397 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC11H23})LKYL{nt:Acet}{ct:Amid} | BP398 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC11H23})KYL{nt:Acet}{ct:Amid} | BP399 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 6 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC11H23})YL{nt:Acet}{ct:Amid} | BP400 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 14 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC11H23})L{nt:Acet}{ct:Amid} | BP401 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC11H23}){nt:Acet}{ct:Amid} | BP402 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 0.5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 28072492 | 2018 | FFPGIIKVASAILPTAICAITKRC | Brevinin1 HYba1 B1/1 COOH | Free | Free | Linear | L | None | 24 | Antimicrobial, Antibacterial | >40 % Hemolysis at 100 μM | Human | Frog Crude Skin Secretion Of Hydrophylax Bahuvistara | membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation | NA | ||
| 28072492 | 2018 | FFPGIIKVASAILPTAICAITKRC{ct:Amid} | Brevinin1 HYba1 B1/1 CONH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial, Antibacterial | >80 % Hemolysis at 100 μM | Human | Frog Crude Skin Secretion Of Hydrophylax Bahuvistara | membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation | NA | ||
| 28072492 | 2018 | FFPGIIKVAGAILPTAICAITKRC | Brevinin1 HYba2 B1/2 COOH | Free | Free | Linear | L | None | 24 | Antimicrobial, Antibacterial | >50 % Hemolysis at 100 μM | Human | Frog Crude Skin Secretion Of Hydrophylax Bahuvistara | membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation | NA | ||
| 28072492 | 2018 | FFPGIIKVAGAILPTAICAITKRC{ct:Amid} | Brevinin1 HYba2 B1/2 CONH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial, Antibacterial | >90 % Hemolysis at 100 μM | Human | Frog Crude Skin Secretion Of Hydrophylax Bahuvistara | membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation | NA | ||
| 29682907 | 2018 | ACPIFTKIQGTYRGKAKCK{ct:myristoylated} | MPhd1 | myristoylated | Free | Linear | L | Myr = Myristic acid | 19 | Antibacterial | >70 % Hemolysis at 10 μM | Rat | Human-Β-Defensins | buffer = β-conformation | NA | ||
| 29682907 | 2018 | FCPRRYKQIGTGLPGTKCK{ct:myristoylated} | MPhd2 | myristoylated | Free | Linear | L | Myr = Myristic acid | 19 | Antibacterial | >20 % Hemolysis at 10 μM | Rat | Human-Β-Defensins | buffer = unordered conformation | NA | ||
| 29682907 | 2018 | SCLPKEEQIGKSTRGRKCRRKK{ct:myristoylated} | MPhd3 | myristoylated | Free | Linear | L | Myr = Myristic acid | 22 | Antimicrobial, Antibacterial | >40 % Hemolysis at 10 μM | Rat | Human-Β-Defensins | buffer = unordered conformation | NA | ||
| 29770868 | 2018 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | melittin monomer | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anticancer | 100 % Hemolysis at 10 μM | mouse | Bee Venom | α-Helix | NA | ||
| 29770868 | 2018 | GIGAVLKVLTTGLPALISWIKRKRQQ-({nnr:Dab}-NH2)-GIGAVLKVLTTGLPALISWIKRKRQQ | melittin dimer | Free | Free | Branched | L | Dab = 3,3ʹ-diaminobenzidine | 52 | Antibacterial | 100 % Hemolysis at 10 μM | mouse | Synthetic Dimer Of Melittin | NA | NA | ||
| 29842923 | 2018 | FLPIVGRLISGIL | Temporin-CPb | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >100 μM | Human | Gopher Frog Lithobates Capito | NA | NA | ||
| 29842923 | 2018 | SILPTIVSFLSKVF | Temporin-1Ga | Free | Free | Linear | L | None | 14 | Antibacterial, Antifungal, Anticancer | 50 % Hemolysis at 12.5 μM | Human | Frog Rana Grylio | NA | NA | ||
| 29842923 | 2018 | FLPFLKSILGKIL | Temporin-1OLa | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Anticancer | 50 % Hemolysis at 50 μM | Human | Frog Rana Okaloosae | α-Helical | NA | ||
| 29842923 | 2018 | FLSAITSILGKFF | Temporin-1SPa | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 37.5 μM | Human | Frog Rana Septentrionalis | NA | NA | ||
| 29842923 | 2018 | FLPLLASLFSRLF | Temporin-1Oc | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at <12.5 μM | Human | Frog Rana Ornativentris | NA | NA | ||
| 29842923 | 2018 | IPPFIKKVLTTVF | Temporin-CPa | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >100 μM | Human | Gopher Frog Lithobates Capito | NA | NA | ||
| 29900628 | 2018 | RVRWRlF{d}-{nnr:2-Abz}-A{d}RWRVR | Peptide 2 | Free | Free | Linear | Mix | 2-Abz = 2-aminobenzoic acid, f = D-Phenylalanine | 13 | Antibacterial, Antifungal | <3 % Hemolysis at 200 μM | Mouse | Synthetic Amphipathic Antimicrobial Peptide | aqueous = β‐Hairpin | Low hemolytic | ||
| 29900628 | 2018 | RIKWRlF{d}-{nnr:2-Abz}-A{d}RWKIR | Peptide 3 | Free | Free | Linear | Mix | 2-Abz = 2-aminobenzoic acid, f = D-Phenylalanine | 13 | Antibacterial | <3 % Hemolysis at 600 μM | Mouse | Synthetic Amphipathic Antimicrobial Peptide | aqueous = β‐Hairpin | Non-hemolytic | ||
| 30110916 | 2018 | KLLKHKLLVTLA | HJH-1 | Free | Free | Linear | L | None | 12 | Antibacterial | 20 % Hemolysis at 400 µg/mL | Rabbit | Hemoglobin Α-Subunit Of Bovine Erythrocytes P3 | NA | Low hemolytic | ||
| 30021422 | 2018 | VKEWIKYLKSLF | LPcin-YK3 | Free | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 1 μg/ml | Mouse | Bovine Lactophoricin-Derived Peptide | aqueous = Random coils, DPC solution = α-Helical | Non-hemolytic | ||
| 30021422 | 2018 | VKEWIKYLKSLF | LPcin-YK3 | Free | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 10 μg/ml | Mouse | Bovine Lactophoricin-Derived Peptide | aqueous = Random coils, DPC solution = α-Helical | Non-hemolytic | ||
| 30021422 | 2018 | VKEWIKYLKSLF | LPcin-YK3 | Free | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 40 μg/ml | Mouse | Bovine Lactophoricin-Derived Peptide | aqueous = Random coils, DPC solution = α-Helical | Non-hemolytic | ||
| 29760411 | 2018 | L/I-A-L/I-L/I-L/I-R-L/I -L/I-V-K-L/I-(K-K-S-L/I-T-L/I-K-V-L/I-L/I-R-I/L){cyc:N-C} | Paenialvin-A | Free | Free | Bicyclic | Mix | None | 23 | Antibacterial,Antitumor | 3.61 % Hemolysis at 50 μg/ml | Rabbit | Bacteria Paenibacillus Alvei Dsm 29 | NA | Non-hemolytic | ||
| 29760411 | 2018 | L/I-A-L/I-L/I-I/L-R-L/I -L/I-V-K-L/I-(K-K-A-L/I-T-L/I-K-V-L/I-L/I-R-I/L){cyc:N-C} | Paenialvin-B | Free | Free | Bicyclic | Mix | None | 23 | Antibacterial | 1.93 % Hemolysis at 50 μg/ml | Rabbit | Bacteria Paenibacillus Alvei Dsm 29 | NA | Non-hemolytic | ||
| 29760411 | 2018 | L-A-L-L-V-R-L-L-V-K-L-(K-K-S-L/I-T-L/I-K-V-L/I-L/I-R-V){cyc:N-C} | Paenialvin-C | Free | Free | Bicyclic | D | None | 23 | Antibacterial | 0 % Hemolysis at 50 μg/ml | Rabbit | Bacteria Paenibacillus Alvei Dsm 29 | NA | Non-hemolytic | ||
| 29760411 | 2018 | FVPAILCSILKTC | Paenialvin-D | Free | Free | Linear | Mix | None | 16 | Antibacterial | 0.64 % Hemolysis at 50 μg/ml | Rabbit | Bacteria Paenibacillus Alvei Dsm 29 | NA | Non-hemolytic | ||
| 29890152 | 2018 | MNFNKFFVLFALIMVAVVGQSEAGWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKG | Lucilin | Free | Free | Linear | L | None | 63 | Antibacterial | 0 % Hemolysis at 250 μg/ml | Human | Australian Sheep Blowfly (Lucilia Cuprina) | α-Helix | Non-hemolytic | ||
| 30468326 | 2018 | MKFFTLLAALMALFAICNNFSMVSASRDSRPVQPRVQPPPPPPKQKPSIYDTPIRRPGGQKTMYA | MDAP-2 | Free | Free | Linear | L | None | 65 | Antibacterial | 3.4 % Hemolysis at 800 μg/ml | Rabbit | House Fly (Musca Domestica) | water = α-Helical and β-fold, 50% of TFA and SDS = α-Helical | Low hemolytic | ||
| 30177656 | 2018 | MDSQYPKRIFHIIKIWLMIALIALILGLLIGFALGEGNPLKLFLPSTWVHFFKFLR | LGH2 | Free | Free | Linear | L | None | 56 | Antibacterial, Antifungal | >5 % Hemolysis at 8 μM | Sheep | Lactobacillus Casei Hz1 | water = 4.35% α-Helix, 30 mM SDS, 25% TFE, and 50% TFE = α-Helix | NA | ||
| 30177656 | 2018 | MDSQYPKRIFHIIKIWLMIALIALILGLLIGFALGEGNPLKLFLPSTWVHFFKFLR | LGH2 | Free | Free | Linear | L | None | 56 | Antibacterial, Antifungal | 100 % Hemolysis at 64 μM | Sheep | Lactobacillus Casei Hz1 | water = 4.35% α-Helix, 30 mM SDS, 25% TFE, and 50% TFE = α-Helix | NA | ||
| 30192822 | 2018 | KIFGAIWPLALGALKNLIK | K0-W6-Hy-a1 | Free | Free | Linear | L | None | 19 | Antibacterial | 1 % Hemolysis at 25 mM | Human | Analogue Of Hylin-A1 | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | IETFLKQLRSAANKIVGL | Citrus-amp1 | Free | Free | Linear | L | None | 18 | Antibacterial | 1 % Hemolysis at 25 mM | Human | Citrus Sinensis | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | KIFGAIWPLALGALKNLIK | K0-W6-Hy-a1 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 50 mM | Human | Analogue Of Hylin-A1 | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | IETFLKQLRSAANKIVGL | Citrus-amp1 | Free | Free | Linear | L | None | 18 | Antibacterial | 3 % Hemolysis at 50 mM | Human | Citrus Sinensis | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | KIFGAIWPLALGALKNLIK | K0-W6-Hy-a1 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 75 mM | Human | Analogue Of Hylin-A1 | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | IETFLKQLRSAANKIVGL | Citrus-amp1 | Free | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 75 mM | Human | Citrus Sinensis | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | KIFGAIWPLALGALKNLIK | K0-W6-Hy-a1 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 100 mM | Human | Analogue Of Hylin-A1 | amphipathic α-Helix | Low hemolytic | ||
| 30192822 | 2018 | IETFLKQLRSAANKIVGL | Citrus-amp1 | Free | Free | Linear | L | None | 18 | Antibacterial | 28 % Hemolysis at 100 mM | Human | Citrus Sinensis | amphipathic α-Helix | Low hemolytic | ||
| 29859288 | 2018 | LGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFH | L31-P113 | Free | Free | Linear | L | None | 42 | Antibacterial, Antifungal | 12.0±0.7 % Hemolysis at 500 μg/ml | Human | Hybrid Peptide Of Ll-37 And Hst-5 | α-Helical | NA | ||
| 29859288 | 2018 | ALGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFHLEY | AL32-P113 a | Free | Free | Linear | L | None | 46 | Antibacterial, Antifungal | 10.4±2.2 % Hemolysis at 500 μg/ml | Human | Recombinant Hybrid Peptide Of Ll-37 And Hst-5 | α-Helical | NA | ||
| 30095906 | 2018 | GFAWNVCVYRNGVRVCHRRAN | 2 | Free | Free | Linear | L | None | 21 | Antibacterial | 2.06 % Hemolysis at 100 μM | Human | Cathepsin-Cleavable Linker | NA | Non-hemolytic | ||
| 30216370 | 2018 | RRWVRRVRRVWRRVVRVVRRWVRR | WLBU2 | Free | Free | Linear | L | None | 24 | Antibacterial | 20 % Hemolysis at 100 μM | Human | Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1) | Helical amphipathic structure | NA | ||
| 30262770 | 2018 | KWRRWQWRRWK{ct:Amid} | KW-WK | Amidation | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derived From Lfcinb18–28 | 10 mM PBS = unordered conformations, 50% TFE = α-Helix (negative bands at 208 nm, 222 nm), 30 mM SDS = α-Helix | Non-hemolytic | ||
| 30262770 | 2018 | FPRRWQWRRPF{ct:Amid} | FP-PF | Amidation | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derived From Lfcinb18–28 | 10 mM PBS = unordered conformations, 50% TFE = Disordered structure, 30 mM SDS = Disordered structure | Non-hemolytic | ||
| 30262770 | 2018 | FWRRWQWRRRWF{ct:Amid} | FW-WF | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 8 μM | Human | Derived From Lfcinb18–28 | 10 mM PBS = unordered conformations, 50% TFE = α-Helix (negative bands at 208 nm, 222 nm), 30 mM SDS = α-Helix | NA | ||
| 30262770 | 2018 | FWRRWQWRRRWF{ct:Amid} | FW-WF | Amidation | Free | Linear | L | None | 12 | Antibacterial | 52.91 % Hemolysis at 128 μM | Human | Derived From Lfcinb18–28 | 10 mM PBS = unordered conformations, 50% TFE = α-Helix (negative bands at 208 nm, 222 nm), 30 mM SDS = α-Helix | NA | ||
| 30262770 | 2018 | KKRRWQWRRKK{ct:Amid} | KK-KK | Amidation | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derived From Lfcinb18–28 | 10 mM PBS = unordered conformations, 50% TFE = α-Helix (negative bands at 208 nm, 222 nm), 30 mM SDS = Disordered structure | Non-hemolytic | ||
| 30262770 | 2018 | KCRRWQWRMKK{ct:Amid} | LFcinB18–28 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Truncated Peptide Of Lfcinb | 10 mM PBS = unordered conformations, 50% TFE = β-Sheet (positive peak 195-198 nm, negative peak 217-218 nm), 30 mM SDS = Disordered structure | Non-hemolytic | ||
| 29626331 | 2018 | AILRKATRRLVKLIV{ct:Amid} | P3-B | Amidation | Free | Linear | L | None | 15 | Antibacterial | 4.4 % Hemolysis at 50 μM | Human | Synthetic Amps | α-Helix | Low hemolytic | ||
| 29626331 | 2018 | AIWRKATRRLVKLIV{ct:Amid} | P3-C | Amidation | Free | Linear | L | None | 15 | Antibacterial | 68.7 % Hemolysis at 50 μM | Human | Synthetic Amps | α-Helix Loop | NA | ||
| 30112781 | 2018 | K{nnr:β}{nnr:cf}KK{cyc:N-C} | 5a | Free | Free | Cyclic | Mix | β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 ) | 4 | Antibacterial | 50 % Hemolysis at >500 μg/mL | Human | Synthetic Cyclic Amps | NA | NA | ||
| 30112781 | 2018 | K{nnr:β}{nnr:cf}GK{cyc:N-C} | 5b | Free | Free | Cyclic | Mix | β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 ) | 4 | Antibacterial | 50 % Hemolysis at >500 μg/mL | Human | Synthetic Cyclic Amps | NA | NA | ||
| 30112781 | 2018 | K{nnr:β}{nnr:cf}AK{cyc:N-C} | 5c | Free | Free | Cyclic | Mix | β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 ) | 4 | Antibacterial | 50 % Hemolysis at >500 μg/mL | Human | Synthetic Cyclic Amps | NA | NA | ||
| 30112781 | 2018 | K{nnr:β}{nnr:cf}FK{cyc:N-C} | 5d | Free | Free | Cyclic | Mix | β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 ) | 4 | Antibacterial | 50 % Hemolysis at 88 μg/mL | Human | Synthetic Cyclic Amps | NA | NA | ||
| 30112781 | 2018 | K{nnr:β}{nnr:dicf}KK{cyc:N-C} | 6a | Free | Free | Cyclic | Mix | β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups) | 4 | Antibacterial | 50 % Hemolysis at 216 μg/mL | Human | Synthetic Cyclic Amps | NA | NA | ||
| 30112781 | 2018 | K{nnr:β}{nnr:dicf}GK{cyc:N-C} | 6b | Free | Free | Cyclic | Mix | β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups) | 4 | Antibacterial | 50 % Hemolysis at 100 μg/mL | Human | Synthetic Cyclic Amps | NA | NA | ||
| 30112781 | 2018 | K{nnr:β}{nnr:dicf}AK{cyc:N-C} | 6c | Free | Free | Cyclic | Mix | β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups) | 4 | Antibacterial | 50 % Hemolysis at 67 μg/mL | Human | Synthetic Cyclic Amps | NA | NA | ||
| 30112781 | 2018 | K{nnr:β}{nnr:dicf}FK{cyc:N-C} | 6d | Free | Free | Cyclic | Mix | β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups) | 4 | Antibacterial | 50 % Hemolysis at 84 μg/mL | Human | Synthetic Cyclic Amps | NA | NA | ||
| 30215282 | 2018 | SMWSGMWRRKLKKLRNALKKKLKGE | Ltc 1 | Free | Free | Linear | L | None | 25 | Antibacterial | 20 % Hemolysis at 80 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | GLFGKLIKKFGRKAISYAVKKARGKH | Ltc 2a | Free | Free | Linear | L | None | 26 | Antibacterial | 20 % Hemolysis at 6 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | SWKSMAKKLKEYMEKLKQRA{ct:Amid} | Ltc 3a | Amidation | Free | Linear | L | None | 20 | Antibacterial | 20 % Hemolysis at >120 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | SWASMAKKLKEYMEKLKQRA{ct:Amid} | Ltc 3b | Amidation | Free | Linear | L | None | 20 | Antibacterial | 20 % Hemolysis at >120 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | GLKDKFKSMGEKLKQYIQTWKAKF{ct:Amid} | Ltc 4a | Amidation | Free | Linear | L | None | 24 | Antibacterial | 20 % Hemolysis at >120 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | SLKDKVKSMGEKLKQYIQTWKAKF{ct:Amid} | Ltc 4b | Amidation | Free | Linear | L | None | 24 | Antibacterial | 20 % Hemolysis at >120 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | GFFGKMKEYFKKFGASFKRRFANLKKRL{ct:Amid} | Ltc 5 | Amidation | Free | Linear | L | None | 28 | Antibacterial | 20 % Hemolysis at 40 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | QAFQTFKPDWNKIRYDAMKMQTSLGQMKKRFNL | Ltc 6a | Free | Free | Linear | L | None | 33 | Antibacterial | 20 % Hemolysis at >120 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | GETFDKLKEKLKTFYQKLVEKAEDLKGDLKAKLS | Ltc 7 | Free | Free | Linear | L | None | 34 | Antibacterial | 20 % Hemolysis at >120 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | GIRCPKSWKCKAFKQRVLKRLLAMLRQHAF | Oxt 4a | Free | Free | Linear | L | None | 30 | Antibacterial | 50 % Hemolysis at 7 μM | Human | Lynx Spider Peptide | aqueous = Disordered, SDS= α-Helical | NA | ||
| 30215282 | 2018 | KAFKQRVLKRKKAMKRQKAF | P1 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Mutation Oxki4A(11-30)4K | aqueous = Random coil, SDS= α-Helical | Non-hemolytic | ||
| 30215282 | 2018 | GIRAPKSWKAKAFKQRVLKR | P2 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Mutation Oxt 4A(1-20)(C→A) | aqueous = Random coil, SDS= α-Helical | Non-hemolytic | ||
| 30215282 | 2018 | KSWKAKAFKQRVLKRLLAML | P3 | Free | Free | Linear | L | None | 20 | Antibacterial | 40 % Hemolysis at 100 μM | Human | Mutation Oxt 4A(6-25) (C→A) | aqueous = Random coil, SDS= α-Helical | NA | ||
| 30215282 | 2018 | FAHQRLMALLRKLVRQKFAK | P4 | Free | Free | Linear | L | None | 20 | Antibacterial | 40 % Hemolysis at 100 μM | Human | Mutation Oxt 4A(10-30)Inversion | aqueous = Random coil, SDS= α-Helical | NA | ||
| 30215282 | 2018 | SMWSGMWRKRLKAMLRQHAF | P5 | Free | Free | Linear | L | None | 20 | Antibacterial | >5 % Hemolysis at 100 μM | Human | Mutation Ltc1(1-8)Oxt 4A(19-30)(L22→K) | aqueous = Random coil, SDS= α-Helical | Low hemolytic | ||
| 30279591 | 2018 | GFKLKGMARISCLPNGQWSNFPPKCIRECAMVSS | Sushi 1 Wild Type | Free | Free | Linear | L | None | 34 | Antibacterial | 100 % Hemolysis at 50 μM | Human | Horseshoe Crabs | aqueous = Random coil + Extended Strand, PBS = Random coil | NA | ||
| 30279591 | 2018 | GFGLGGLARILCLGNRQWSNFFKKLNRKCAMVKK | SRP-1 | Free | Free | Linear | L | None | 34 | Antibacterial | 0 % Hemolysis at 50 μM | Human | Designed From Horseshoe Crab Peptide | aqueous = α-Helix | Non-hemolytic | ||
| 30279591 | 2018 | GFALAGLARILCLWFREFSGFFRRLNRRFAMRRR | SRP-2 | Free | Free | Linear | L | None | 34 | Antibacterial | 0 % Hemolysis at 50 μM | Human | Designed From Horseshoe Crab Peptide | aqueous = α-Helix, 50% TFE = α-Helix | Non-hemolytic | ||
| 30279591 | 2018 | GAALAGLAKILCLWAKEFTGAFKKLNKKFAMKKK | SRP-3 | Free | Free | Linear | L | None | 34 | Antibacterial | 100 % Hemolysis at 50 μM | Human | Designed From Horseshoe Crab Peptide | aqueous = α-Helix | NA | ||
| 30301180 | 2018 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 0 % Hemolysis at 64 µM | Mouse | African Clawed Fogs Xenopus Laevis | 50% TFE and 30mM SDS = α-Helical, 10 mM sodium phosphate buffer = Random coil | Non-hemolytic | ||
| 30322120 | 2018 | FLGAVLKVAGKLVPAAICKISKKC | Brevinin-1GHa | Free | Free | Linear | L | None | 24 | Antibiofilm, Antibacterial, Antifungal | 20 % Hemolysis at 16 µM | Horse | Frog Hylarana Guentheri | α-Helix | NA | ||
| 30322120 | 2018 | FLGAVLKVAGKLVPAAI | Brevinin-1GHb | Free | Free | Linear | L | None | 17 | Antibacterial | 20 % Hemolysis at 512 µM | Horse | Analogue Of Brevinin-1Gha | α-Helix | Low hemolytic | ||
| 30322120 | 2018 | FLGAVLKVCKISKKCAGKLVPAAI | Brevinin-1GHc | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal | 20 % Hemolysis at 128 µM | Horse | Analogue Of Brevinin-1Gha | α-Helix | NA | ||
| 30360541 | 2018 | GFWSSVWDGAKNVGTAIIKNAKVCVYAVCVSHK | Nicomicin-1 | Free | Free | Linear | L | None | 33 | Antibacterial | 50 % Hemolysis at 64 µM | Human | Polychaeta Tubeworm Nicomache Minor | aqueous = Disordered, Membrane-Mimicking Environment = α-Helix | NA | ||
| 30360541 | 2018 | GFWSSVWDGAKNVGTAI | Nico(1-17) | Free | Free | Linear | L | None | 17 | Antibacterial | 1 % Hemolysis at 128 µM | Human | Fragment Of Nicomicin-1 | aqueous = α-Helix, Membrane-Mimicking Environment = α-Helix | Non-hemolytic | ||
| 30360541 | 2018 | IKNAKVCVYAVCVSHK | Nico(18-33) | Free | Free | Linear | L | None | 16 | Antibacterial | 50 % Hemolysis at 128 µM | Human | Fragment Of Nicomicin-1 | aqueous = Random coil, Membrane-Mimicking Environment = Disordered | NA | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Carboxyl (COO-)} | DMS-DA6-OH | Carboxyl (COO-) | H3N = amine | Linear | L | None | 26 | Antibacterial | 0.9 ± 1.5 % Hemolysis at 10 µM | Human | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | Non-hemolytic | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Amid} | DMS-DA6-NH2 | Amidation | H3N = amine | Linear | L | None | 26 | Antibacterial | 1.2 ± 1.8 % Hemolysis at 10 µM | Human | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | Non-hemolytic | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Carboxyl (COO-)} | DMS-DA6-OH | Carboxyl (COO-) | H3N = amine | Linear | L | None | 26 | Antibacterial | 7.4 ± 5.5 % Hemolysis at 50 µM | Human | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | NA | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Amid} | DMS-DA6-NH2 | Amidation | H3N = amine | Linear | L | None | 26 | Antibacterial | 3.7 ± 3.3 % Hemolysis at 50 µM | Human | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | Low hemolytic | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Carboxyl (COO-)} | DMS-DA6-OH | Carboxyl (COO-) | H3N = amine | Linear | L | None | 26 | Antibacterial | 0 ± 2.8 % Hemolysis at 10 µM | Mouse | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | Non-hemolytic | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Amid} | DMS-DA6-NH2 | Amidation | H3N = amine | Linear | L | None | 26 | Antibacterial | 0 ± 1.1 % Hemolysis at 10 µM | Mouse | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | Non-hemolytic | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Carboxyl (COO-)} | DMS-DA6-OH | Carboxyl (COO-) | H3N = amine | Linear | L | None | 26 | Antibacterial | 5.4 ± 3.5 % Hemolysis at 50 µM | Mouse | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | NA | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Amid} | DMS-DA6-NH2 | Amidation | H3N = amine | Linear | L | None | 26 | Antibacterial | 4.7 ± 5.6 % Hemolysis at 50 µM | Mouse | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | NA | ||
| 30365554 | 2018 | FLRSLLRGAKAIYRGARAGWRG | dicentracin-like | Free | Free | Linear | L | None | 22 | Antibacterial | 50 % Hemolysis at 2.34 μg/ml | Human | Fish Barramundi (Lates Calcarifer) | α-Helix | NA | ||
| 30365554 | 2018 | FLRSLLRGAKAIYRGARAGWRG | dicentracin-like | Free | Free | Linear | L | None | 22 | Antibacterial | <100 % Hemolysis at 75 μg/ml | Human | Fish Barramundi (Lates Calcarifer) | α-Helix | NA | ||
| 30365554 | 2018 | FFHHIFRGIVHVGKTIHRLVTG | moronecidin | Free | Free | Linear | L | None | 22 | Antibacterial | 50 % Hemolysis at 57 μg/ml | Human | Fish Striped Bass (Morone Saxatilis) | α-Helix | NA | ||
| 30121851 | 2018 | FIKIFHHIFKGNPKFSIIK | FK19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | Non-hemolytic | ||
| 30121851 | 2018 | KIRFTRTVSRLLKAALAST | KT19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | Non-hemolytic | ||
| 30121851 | 2018 | VILTRFRFLNRIVEPLLKKA | VA20 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | Non-hemolytic | ||
| 30121851 | 2018 | GSTSFHLIYNKWFAVKRRRKR | GR21 | Free | Free | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | Non-hemolytic | ||
| 30121851 | 2018 | FFHHIFDPQIKSGLLVSMYD | FD20 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIKIFHHIFKGNPKFSIIK | FK19 | Free | Free | Linear | L | None | 19 | Antibacterial | 44.03 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | KIRFTRTVSRLLKAALAST | KT19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | Non-hemolytic | ||
| 30121851 | 2018 | VILTRFRFLNRIVEPLLKKA | VA20 | Free | Free | Linear | L | None | 20 | Antibacterial | 10.79 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | NA | ||
| 30121851 | 2018 | GSTSFHLIYNKWFAVKRRRKR | GR21 | Free | Free | Linear | L | None | 21 | Antibacterial | 3.76 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | FFHHIFDPQIKSGLLVSMYD | FD20 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIKIFHHIFKGNPKFSIIK | FK19 | Free | Free | Linear | L | None | 19 | Antibacterial | 63.35 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | KIRFTRTVSRLLKAALAST | KT19 | Free | Free | Linear | L | None | 19 | Antibacterial | 7.78 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | VILTRFRFLNRIVEPLLKKA | VA20 | Free | Free | Linear | L | None | 20 | Antibacterial | 25.34 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | NA | ||
| 30121851 | 2018 | GSTSFHLIYNKWFAVKRRRKR | GR21 | Free | Free | Linear | L | None | 21 | Antibacterial | 7.15 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | FFHHIFDPQIKSGLLVSMYD | FD20 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | NA | Non-hemolytic | ||
| 30121851 | 2018 | FIKIFHHIFKGNPKFSIIK | FK19 | Free | Free | Linear | L | None | 19 | Antibacterial | 66.49 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | KIRFTRTVSRLLKAALAST | KT19 | Free | Free | Linear | L | None | 19 | Antibacterial | 21.58 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | VILTRFRFLNRIVEPLLKKA | VA20 | Free | Free | Linear | L | None | 20 | Antibacterial | 42 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | ɑ-Helix | NA | ||
| 30121851 | 2018 | GSTSFHLIYNKWFAVKRRRKR | GR21 | Free | Free | Linear | L | None | 21 | Antibacterial | 8.5 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | FFHHIFDPQIKSGLLVSMYD | FD20 | Free | Free | Linear | L | None | 20 | Antibacterial | 9.2 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | NA | NA | ||
| 30325566 | 2018 | TELLVDLL{nt:Amid}{ct:Amid} | SP1 | Amidation | Amidation | Linear | L | None | 8 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30325566 | 2018 | SELLVDLL{nt:Amid}{ct:Amid} | SP2 | Amidation | Amidation | Linear | L | None | 8 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30325566 | 2018 | EELLVDLL{nt:Amid}{ct:Amid} | SP3 | Amidation | Amidation | Linear | L | None | 8 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30325566 | 2018 | TCELLVDLLC{nt:Amid}{ct:Amid} | SP4 | Amidation | Amidation | Linear | L | None | 8 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30325566 | 2018 | DDDELLVDLL{nt:CH3-(CH2)16-(CO)-NH = fatty acid chain}{ct:Amid} | LP5 | Amidation | CH3-(CH2)16-(CO)-NH = fatty acid chain | Linear | L | CH3-(CH2)16-(CO)-NH = N-Terminal fatty acid chain | 10 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Lipopeptide | NA | Non-hemolytic | ||
| 30325566 | 2018 | HHHELLVDLL{nt:CH3-(CH2)16-(CO)-NH = fatty acid chain}{ct:Amid} | LP6 | Amidation | CH3-(CH2)16-(CO)-NH = fatty acid chain | Linear | L | CH3-(CH2)16-(CO)-NH = N-Terminal fatty acid chain | 10 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Lipopeptide | NA | Non-hemolytic | ||
| 30325566 | 2018 | RRRELLVDLL{nt:CH3-(CH2)16-(CO)-NH = fatty acid chain}{ct:Amid} | LP7 | Amidation | CH3-(CH2)16-(CO)-NH = fatty acid chain | Linear | L | CH3-(CH2)16-(CO)-NH = N-Terminal fatty acid chain | 10 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Lipopeptide | NA | Non-hemolytic | ||
| 30325566 | 2018 | YYYELLVDLL{nt:CH3-(CH2)16-(CO)-NH = fatty acid chain}{ct:Amid} | LP8 | Amidation | CH3-(CH2)16-(CO)-NH = fatty acid chain | Linear | L | CH3-(CH2)16-(CO)-NH = N-Terminal fatty acid chain | 10 | Antibacterial | high % Hemolysis at 100 µM | Human | Synthetic Lipopeptide | NA | NA | ||
| 30361948 | 2018 | K{nnr:*}WK{nnr:Nle}{nnr:*}K{ct:Amid} | KKK | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | 3 % Hemolysis at 50 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | Low hemolytic | ||
| 30361948 | 2018 | R{nnr:*}WK{nnr:Nle}{nnr:*}K{ct:Amid} | RKK | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | 4.3 % Hemolysis at 50 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | NA | ||
| 30361948 | 2018 | K{nnr:*}WR{nnr:Nle}{nnr:*}K{ct:Amid} | KRK | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | 2 % Hemolysis at 50 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | Low hemolytic | ||
| 30361948 | 2018 | K{nnr:*}WK{nnr:Nle}{nnr:*}R{ct:Amid} | KKR | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | 5.4 % Hemolysis at 50 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | NA | ||
| 30361948 | 2018 | R{nnr:*}WR{nnr:Nle}{nnr:*}K{ct:Amid} | RRK | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | <1 % Hemolysis at 50 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | Non-hemolytic | ||
| 30361948 | 2018 | R{nnr:*}WK{nnr:Nle}{nnr:*}R{ct:Amid} | RKR | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | 17 % Hemolysis at 50 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | NA | ||
| 30361948 | 2018 | K{nnr:*}WR{nnr:Nle}{nnr:*}R{ct:Amid} | KRR | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | 5.6 % Hemolysis at 50 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | NA | ||
| 30361948 | 2018 | R{nnr:*}WR{nnr:Nle}{nnr:*}R{ct:Amid} | RRR | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | 3.2 % Hemolysis at 50 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | NA | ||
| 30361948 | 2018 | K{nnr:*}WK{nnr:Nle}{nnr:*}K{ct:Amid} | KKK | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | 1.5 % Hemolysis at 25 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | Low hemolytic | ||
| 30361948 | 2018 | R{nnr:*}WK{nnr:Nle}{nnr:*}K{ct:Amid} | RKK | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | 1.5 % Hemolysis at 25 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | Low hemolytic | ||
| 30361948 | 2018 | K{nnr:*}WR{nnr:Nle}{nnr:*}K{ct:Amid} | KRK | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | < 1 % Hemolysis at 25 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | Non-hemolytic | ||
| 30361948 | 2018 | K{nnr:*}WK{nnr:Nle}{nnr:*}R{ct:Amid} | KKR | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | 1.4 % Hemolysis at 25 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | Low hemolytic | ||
| 30361948 | 2018 | R{nnr:*}WR{nnr:Nle}{nnr:*}K{ct:Amid} | RRK | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | < 1 % Hemolysis at 25 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | Non-hemolytic | ||
| 30361948 | 2018 | R{nnr:*}WK{nnr:Nle}{nnr:*}R{ct:Amid} | RKR | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | 8.2 % Hemolysis at 25 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | NA | ||
| 30361948 | 2018 | K{nnr:*}WR{nnr:Nle}{nnr:*}R{ct:Amid} | KRR | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | 1.8 % Hemolysis at 25 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | Low hemolytic | ||
| 30361948 | 2018 | R{nnr:*}WR{nnr:Nle}{nnr:*}R{ct:Amid} | RRR | Amidation | Free | Linear | Mix | Nle = Norleucine, oct4-enyl = hydrocarbon staple, * = shows the staple site | 7 | Antibacterial | < 1 % Hemolysis at 25 µM | Human | Synthetic Stapled Heptapeptides | ɑ-Helix | Non-hemolytic | ||
| 30409520 | 2018 | RRRR{nt:C16 - palmitic acid}{ct:Amid} | C16-4R | Amidation | C16 - palmitic acid | Linear | L | C16 = palmitic acid | 4 | Antifungal, Antibacterial | 6.3 % Hemolysis at 32 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30409520 | 2018 | RRRR{nt:C16 - palmitic acid}{ct:Amid} | C16-4R | Amidation | C16 - palmitic acid | Linear | L | C16 = palmitic acid | 4 | Antifungal, Antibacterial | 36.1 % Hemolysis at 64 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30409520 | 2018 | RRRR{nt:C16 - palmitic acid}{ct:Amid} | C16-4R | Amidation | C16 - palmitic acid | Linear | L | C16 = palmitic acid | 4 | Antifungal, Antibacterial | 82.8 % Hemolysis at 128 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30409520 | 2018 | RRRR{nt:C16 - palmitic acid}{ct:Amid} | C16-4R | Amidation | C16 - palmitic acid | Linear | L | C16 = palmitic acid | 4 | Antifungal, Antibacterial | 96.4 % Hemolysis at 256 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30409520 | 2018 | RRRR{nt:C16 - palmitic acid}{ct:Amid} | C16-4R | Amidation | C16 - palmitic acid | Linear | L | C16 = palmitic acid | 4 | Antifungal, Antibacterial | 100 % Hemolysis at 512 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30409520 | 2018 | RRRR{nt:C14 - myristic acid}{ct:Amid} | C14-4R | Amidation | C14 - myristic acid | Linear | L | C14 = myristic acid | 4 | Antifungal, Antibacterial | 0 % Hemolysis at 32 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | Non-hemolytic | ||
| 30409520 | 2018 | RRRR{nt:C14 - myristic acid}{ct:Amid} | C14-4R | Amidation | C14 - myristic acid | Linear | L | C14 = myristic acid | 4 | Antifungal, Antibacterial | 0 % Hemolysis at 64 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | Non-hemolytic | ||
| 30409520 | 2018 | RRRR{nt:C14 - myristic acid}{ct:Amid} | C14-4R | Amidation | C14 - myristic acid | Linear | L | C14 = myristic acid | 4 | Antifungal, Antibacterial | 3.6 % Hemolysis at 128 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30409520 | 2018 | RRRR{nt:C14 - myristic acid}{ct:Amid} | C14-4R | Amidation | C14 - myristic acid | Linear | L | C14 = myristic acid | 4 | Antifungal, Antibacterial | 18.6 % Hemolysis at 256 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30409520 | 2018 | RRRR{nt:C14 - myristic acid}{ct:Amid} | C14-4R | Amidation | C14 - myristic acid | Linear | L | C14 = myristic acid | 4 | Antifungal, Antibacterial | 63.7 % Hemolysis at 512 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30409520 | 2018 | RRRR{nt:C12 - lauric acid}{ct:Amid} | C12-4R | Amidation | C12 - lauric acid | Linear | L | C12 = lauric acid | 4 | Antifungal, Antibacterial | 0 % Hemolysis at 32 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | Non-hemolytic | ||
| 30409520 | 2018 | RRRR{nt:C12 - lauric acid}{ct:Amid} | C12-4R | Amidation | C12 - lauric acid | Linear | L | C12 = lauric acid | 4 | Antifungal, Antibacterial | 0 % Hemolysis at 64 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | Non-hemolytic | ||
| 30409520 | 2018 | RRRR{nt:C12 - lauric acid}{ct:Amid} | C12-4R | Amidation | C12 - lauric acid | Linear | L | C12 = lauric acid | 4 | Antifungal, Antibacterial | 0 % Hemolysis at 128 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | Non-hemolytic | ||
| 30409520 | 2018 | RRRR{nt:C12 - lauric acid}{ct:Amid} | C12-4R | Amidation | C12 - lauric acid | Linear | L | C12 = lauric acid | 4 | Antifungal, Antibacterial | 0 % Hemolysis at 256 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | Non-hemolytic | ||
| 30409520 | 2018 | RRRR{nt:C12 - lauric acid}{ct:Amid} | C12-4R | Amidation | C12 - lauric acid | Linear | L | C12 = lauric acid | 4 | Antifungal, Antibacterial | 0 % Hemolysis at 512 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | Non-hemolytic | ||
| 30409520 | 2018 | PRRR{nt:C16 - palmitic acid}{ct:Amid} | C16-P3R | Amidation | C16 - palmitic acid | Linear | L | C16 = palmitic acid | 4 | Antifungal, Antibacterial | 0 % Hemolysis at 14 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | Non-hemolytic | ||
| 30409520 | 2018 | PRRR{nt:C16 - palmitic acid}{ct:Amid} | C16-P3R | Amidation | C16 - palmitic acid | Linear | L | C16 = palmitic acid | 4 | Antifungal, Antibacterial | 12.6 % Hemolysis at 30 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30409520 | 2018 | PRRR{nt:C16 - palmitic acid}{ct:Amid} | C16-P3R | Amidation | C16 - palmitic acid | Linear | L | C16 = palmitic acid | 4 | Antifungal, Antibacterial | 57.6 % Hemolysis at 60 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30409520 | 2018 | PRRR{nt:C16 - palmitic acid}{ct:Amid} | C16-P3R | Amidation | C16 - palmitic acid | Linear | L | C16 = palmitic acid | 4 | Antifungal, Antibacterial | 91 % Hemolysis at 128 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30409520 | 2018 | PRRR{nt:C16 - palmitic acid}{ct:Amid} | C16-P3R | Amidation | C16 - palmitic acid | Linear | L | C16 = palmitic acid | 4 | Antifungal, Antibacterial | 97.1 % Hemolysis at 256 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30409520 | 2018 | PRRR{nt:C16 - palmitic acid}{ct:Amid} | C16-P3R | Amidation | C16 - palmitic acid | Linear | L | C16 = palmitic acid | 4 | Antifungal, Antibacterial | 100 % Hemolysis at 512 μg/mL | Human | Synthetic Arginine-Rich Lipopeptides | NA | NA | ||
| 30423858 | 2018 | DEMKLDGFNMHLE{ct:Amid} | P1-Ll-1577 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 12 % Hemolysis at 320 µM | Human | Frog Leptodactylus Latrans | Random coil | NA | ||
| 30423858 | 2018 | AAGKGLVSNLLEK{ct:Amid} | P2-Ll-1298 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 320 µM | Human | Frog Leptodactylus Latrans | TFE = ɑ-Helix | NA | ||
| 30423858 | 2018 | GLLDFLKAAGKGLVSNLLEK{ct:Amid} | P3-Ll-2085 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 100 % Hemolysis at 40 µM | Human | Frog Leptodactylus Latrans | TFE = ɑ-Helix | NA | ||
| 30462698 | 2018 | HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK | PACAP38 | Free | Free | Linear | L | None | 38 | Antibacterial | 0 % Hemolysis at 45 μg/mL | Human | Human | α-Helix | Non-hemolytic | ||
| 30462698 | 2018 | SYSRYRKQMAVKKYLAAVLGKRYKQRVKNK | PACAP(9–38) | Free | Free | Linear | L | None | 30 | Antibacterial | 0 % Hemolysis at 45 μg/mL | Human | Human | α-Helix | Non-hemolytic | ||
| 30538681 | 2018 | IHKFWRCRRRFCRWFKHI{ct:Amid} | PQ | Amidation | Free | Linear | L | None | 18 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Designs Amps | 10 mM PBS = unordered, 30 mM SDS and 50% TFE = α-Helix | Low hemolytic | ||
| 30538681 | 2018 | IHKFWRPGRWFKHI{ct:Amid} | PP | Amidation | Free | Linear | L | None | 14 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Designs Amps | 10 mM PBS = unordered, 30 mM SDS and 50% TFE = α-Helix | Low hemolytic | ||
| 30538681 | 2018 | IHKFWRGGRWFKHI{ct:Amid} | GG | Amidation | Free | Linear | L | None | 14 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Designs Amps | 10 mM PBS = unordered, 30 mM SDS and 50% TFE = α-Helix | Low hemolytic | ||
| 30538681 | 2018 | IHKFWRRWFKHI{ct:Amid} | Qa | Amidation | Free | Linear | L | None | 12 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Designs Amps | α-Helix | Low hemolytic | ||
| 30538681 | 2018 | IHFKWRRWKFHI{ct:Amid} | Qna | Amidation | Free | Linear | L | None | 12 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Designs Amps | unordered | Low hemolytic | ||
| 30538681 | 2018 | RGGRLCYCRRRFCVCVGR{ct:Amid} | PG-1 | Amidation | Free | Linear | L | None | 18 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Designs Amps | β-Hairpin | Low hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 2 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 1 % Hemolysis at 4 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 18.72 % Hemolysis at 16 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 32 % Hemolysis at 32 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 43 % Hemolysis at 64 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 67 % Hemolysis at 128 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 76 % Hemolysis at 256 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 85 % Hemolysis at 512 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 2 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 4 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 16 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 32 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 1 % Hemolysis at 64 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 4 % Hemolysis at 128 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 11 % Hemolysis at 256 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 35 % Hemolysis at 512 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555984 | 2018 | YYHFWHRGVTKR | YR12 | Free | Free | Linear | L | None | 12 | Antibacterial | ~5 % Hemolysis at 100 µM | Human | Human Prodomain Of Human Furin | NA | Low hemolytic | ||
| 30555984 | 2018 | YYHFWHRGVTKRSLSPHRPR | YR20 | Free | Free | Linear | L | None | 20 | Antibacterial | ~5 % Hemolysis at 100 µM | Human | Human Prodomain Of Human Furin | NA | Low hemolytic | ||
| 30555984 | 2018 | YYHFWHRGVTKRSLSPHRPRHSR | YR23 | Free | Free | Linear | L | None | 23 | Antibacterial | ~5 % Hemolysis at 100 µM | Human | Human Prodomain Of Human Furin | NA | Low hemolytic | ||
| 30555984 | 2018 | YYHFWHRGVTKRSLSPHRPRHSRLQR | YR26 | Free | Free | Linear | L | None | 26 | Antibacterial | ~8 % Hemolysis at 100 µM | Human | Human Prodomain Of Human Furin | SDS micelle = Helix-Turn-Helix | NA | ||
| 30555984 | 2018 | RKHGFLNLQGIFGDYYHFWHRGV | RV23 | Free | Free | Linear | L | None | 23 | Antibacterial | 48 % Hemolysis at 100 µM | Human | Human Prodomain Of Human Furin | NA | NA | ||
| 30570384 | 2018 | RKYVRFLHRWVKYFRAYL | Adevonin | Free | Free | Linear | L | None | 18 | Antibacterial | 0 % Hemolysis at 87.5 µM | Human | Plant Adenanthera Pavonina Designed From Apti | SDS = α-Helix | Non-hemolytic | ||
| 30570384 | 2018 | RKYVRFLHRWVKYFRAYL | Adevonin | Free | Free | Linear | L | None | 18 | Antibacterial | >70 % Hemolysis at 175 µM | Human | Plant Adenanthera Pavonina Designed From Apti | SDS = α-Helix | NA | ||
| 30563217 | 2018 | VGTDFSGNDDISDVQK | Lg-AMP1 | Free | Free | Linear | L | None | 16 | Antibacterial | 0.1 % Hemolysis at 68.5 µM | Human | Spider Venom (Loxosceles Gaucho) | α-Helix | Non-hemolytic | ||
| 30563217 | 2018 | VGTDFSGNDDISDVQK | Lg-AMP1 | Free | Free | Linear | L | None | 16 | Antibacterial | 0.15 % Hemolysis at 137 µM | Human | Spider Venom (Loxosceles Gaucho) | α-Helix | Non-hemolytic | ||
| 35559296 | 2018 | WFGHLYRGITKVVKHVHGLLKG | KS-Cnd | Free | Free | Linear | L | None | 22 | Antibacterial | 10 % Hemolysis at 8 µM | Human | Fish Derived From Chionodracine(Chionodraco Hamatus) | aqueous = Random coil, POPC = α-Helix | NA | ||
| 35559296 | 2018 | WFGKLYRGITSVVKKVKGLLSG | KH-Cnd | Free | Free | Linear | L | None | 22 | Antibacterial | 10 % Hemolysis at 9 µM | Human | Fish Derived From Chionodracine(Chionodraco Hamatus) | aqueous = Random coil, POPC = α-Helix | NA | ||
| 35559296 | 2018 | WFGKLYRGITKVVKKVKGLLKG | KHS_Cnd | Free | Free | Linear | L | None | 22 | Antibacterial | 10 % Hemolysis at 13 µM | Human | Fish Derived From Chionodracine(Chionodraco Hamatus) | aqueous = Random coil, POPC = α-Helix | NA | ||
| 29523276 | 2018 | QVKGAKLWLSLMKWGGI | GIBIM-P1 | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | GFLGKGLFSVVKGVLKG | GIBIM-P2 | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | GFLGKGLFSVVKGVLKI | GIBIM-P2G17I | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | GFLGKGLFSVVKGVLKL | GIBIM-P2G17L | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | GFLGKGLFSVVKNVLKG | GIBIM-P2G13N | Free | Free | Linear | L | None | 17 | Antibacterial | 10 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | NVAATARGWLKKLGKRI | GIBIM-P3 | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | NVGATARGWLKKLGKRI | GIBIM-P3A3G | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | NVAASARGWLKKLGKRI | GIBIM-P3T5S | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | NVAATKRGWLKKLGKRI | GIBIM-P3A6K | Free | Free | Linear | L | None | 17 | Antibacterial | ~15 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | ANVAATARGWLKKIGKK | GIBIM-P4 | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | INVAATARGWLKKIGKK | GIBIM-P4A1I | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | VNVAATARGWLKKIGKK | GIBIM-P4A1V | Free | Free | Linear | L | None | 17 | Antibacterial | 11 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | AFVAATARGWLKKIGKK | GIBIM-P4N2F | Free | Free | Linear | L | None | 17 | Antibacterial | 31 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | ATKKCGLFSILKGVGKI | GIBIM-P5 | Free | Free | Linear | L | None | 17 | Antibacterial | 25 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | AKKKCGLFSILKGVGKI | GIBIM-P5T2K | Free | Free | Linear | L | None | 17 | Antibacterial | ~20 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 29523276 | 2018 | ATKKCGLFKILKGVGKI | GIBIM-P5S9K | Free | Free | Linear | L | None | 17 | Antibacterial | 30 % Hemolysis at 50 µM | Sheep | Synthetic Peptide | 30% TFE = α-Helix | NA | ||
| 30176540 | 2019 | AKRHHGYKRKFH{nt:Acet}{ct:Amid} | P-113 | Amidation | Acetylation | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μg/ml | Human | Human Fragment Of The Saliva Protein Histatin 5 | NA | Non-hemolytic | ||
| 30393205 | 2019 | LLWIALRKK{ct:Amid} | CopW | Amidation | Free | Linear | L | None | 9 | Antibacterial | 0.08 ± 0.04 % Hemolysis at 100 µM | Human | Derived From Coprisin Dung Beetle Copris Tripartitus | NA | Non-hemolytic | ||
| 30393205 | 2019 | LLWIALRKK{conj:C10:0}{ct:Amid} | CopW3 | Amidation | Free | Linear | L | C10 = decanoic acid | 9 | Antibacterial | 11.84 ± 0.46 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | NA | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid} | dCopW | Amidation | Free | Linear | D | None | 9 | Antibacterial | 2.32 ± 0.78 % Hemolysis at 100 µM | Human | Synthetic Copw With D-Amino | NA | Non-hemolytic | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C6:0}{ct:Amid} | dCopW1 | Amidation | Free | Linear | D | C6 = hexanoic acid | 9 | Antibacterial | 0.39 ± 0.66 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | Non-hemolytic | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C8:0}{ct:Amid} | dCopW2 | Amidation | Free | Linear | D | C8 = Octanoic Acid | 9 | Antibacterial | 0.68 ± 0.47 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | Non-hemolytic | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C10:0}{ct:Amid} | dCopW3 | Amidation | Free | Linear | D | C10 = decanoic acid | 9 | Antibacterial | 3.66 ± 0.39 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | Non-hemolytic | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C12:0}{ct:Amid} | dCopW4 | Amidation | Free | Linear | D | C12 = Dodecanoic Acid | 9 | Antibacterial | 7.10 ± 0.32 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | NA | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C14:0}{ct:Amid} | dCopW5 | Amidation | Free | Linear | D | C14 = Tetradecanoic Acid | 9 | Antibacterial | 8.36 ± 0.26 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | NA | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C16:0}{ct:Amid} | dCopW6 | Amidation | Free | Linear | D | C16 = hexadecanoic acid | 9 | Antibacterial | 11.67 ± 0.55 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | NA | ||
| 30393205 | 2019 | K{d}{conj:C10:0}K{d}R{d}L{d}A{d}I{d}W{d}L{d}L{d}{ct:Amid} | Retro-dCopW3 | Amidation | Free | Linear | D | C10 = decanoic acid | 9 | Antibacterial | 20.88 ± 1.15 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | NA | ||
| 34377965 | 2019 | K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}LA{d}K{d}A{d}A{d}K{d}L{d}LT{d}L{d}L{d}LA{d}L{d}S{d}L{nt:Acet}{ct:Amid} | D84 (Lys1-6 Lys-1) | Amidation | Acetylation | Linear | Mix | None | 26 | Antibacterial | 50 % Hemolysis at 54.3 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}{nnr:Dab}{nt:Acet}{ct:Amid} | D86 (Lys1-6 Dab-1) | Amidation | Acetylation | Linear | Mix | L-Dab = (2,4-diaminobutyric acid) | 26 | Antibacterial | 50 % Hemolysis at >742 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}{nnr:Dap}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dap}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap}{nt:Acet}{ct:Amid} | D105 (Lys1-6 Dap-1) | Amidation | Acetylation | Linear | Mix | L-Dap = (2,3-diaminopropionic acid) | 26 | Antibacterial | 50 % Hemolysis at >1148 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}LA{d}K{d}A{d}A{d}K{d}L{d}LT{d}L{d}L{d}LA{d}L{d}S{d}S{nt:Acet}{ct:Amid} | D101 (Lys1Ser26-5 Lys-1) | Amidation | Acetylation | Linear | Mix | None | 26 | Antibacterial | 50 % Hemolysis at 103.9 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}S{nt:Acet}{ct:Amid} | D102 (Lys1Ser26-5 Dab-1) | Amidation | Acetylation | Linear | Mix | L-Dab = (2,4-diaminobutyric acid) | 26 | Antibacterial | 50 % Hemolysis at >708 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}A{d}A{d}K{d}LLK{d}L{d}A{d}T{d}L{d}L{d}LA{d}L{d}S{d}L{nt:Acet}{ct:Amid} | D88 (Lys1-6 Lys-2) | Amidation | Acetylation | Linear | Mix | None | 26 | Antibacterial | 50 % Hemolysis at 80.6 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | AKR{nnr:bip}{nnr:bip}GYKRKF{nnr:bip}{nt:Acet}{ct:Amid} | D89 (Lys1-6 Dab-2) | Amidation | Acetylation | Linear | Mix | L-Dab = (2,4-diaminobutyric acid) | 26 | Antibacterial | 50 % Hemolysis at >1112 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}A{d}A{d}K{d}{nnr:Dap}{nnr:Dap}K{d}L{d}A{d}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap}{nt:Acet}{ct:Amid} | D106 (Lys1-6 Dap-2) | Amidation | Acetylation | Linear | Mix | L-Dap = (2,3-diaminopropionic acid) | 26 | Antibacterial | 50 % Hemolysis at 340.2 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}A{d}A{d}K{d}LLK{d}L{d}A{d}T{d}L{d}L{d}LA{d}L{d}S{d}S{nt:Acet}{ct:Amid} | D103 (Lys1Ser26-5 Lys-2) | Amidation | Acetylation | Linear | Mix | None | 26 | Antibacterial | 50 % Hemolysis at 134.9 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}A{d}A{d}K{d}{nnr:Dab}{nnr:Dab}K{d}L{d}A{d}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}S{nt:Acet}{ct:Amid} | D104 (Lys1Ser26-5 Dab-2) | Amidation | Acetylation | Linear | Mix | L-Dab = (2,4-diaminobutyric acid) | 26 | Antibacterial | 50 % Hemolysis at >1490 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 30658410 | 2019 | IWGALLGTLIPAITSAIQ{ct:Amid} | PLP5 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 94.8 % Hemolysis at 50 µM | Human | Ant Odontomachus Monticola | α-Helix | NA | ||
| 30658410 | 2019 | IWGALLGTLIPAITSAIQ{ct:Amid} | PLP5 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 6.9 % Hemolysis at 10 µM | Human | Ant Odontomachus Monticola | α-Helix | NA | ||
| 30701481 | 2019 | GLPLLISWIKRKRQQGSKKPVPIIYCNRRTGKCQRM | Hybrid Peptide | Free | Free | Linear | L | None | 36 | Antibacterial, Anticancer | 0 % Hemolysis at 45 μmol/L | Sheep | Mutant Fragments Of Melittin And Thanatin | x | Non-hemolytic | ||
| 30389515 | 2019 | CPAIQRCC | Mo-CBP3-PepI | Free | Free | Linear | L | None | 8 | Antibacterial, Anticandidal | 0 % Hemolysis at 70 µM | Human | Plant Moringa Oleifera Seeds | 75% α-Helix and 25% β-Turns | Non-hemolytic | ||
| 30389515 | 2019 | NIQPPCRCC | Mo-CBP3-PepII | Free | Free | Linear | L | None | 9 | Antibacterial, Anticandidal | 0 % Hemolysis at 70 µM | Human | Plant Moringa Oleifera Seeds | 60% α-Helix and 40% β-Turns | Non-hemolytic | ||
| 30389515 | 2019 | AIQRCC | Mo-CBP3-PepIII | Free | Free | Linear | L | None | 6 | Antibacterial, Anticandidal | 0 % Hemolysis at 70 µM | Human | Plant Moringa Oleifera Seeds | 75% α-Helix and 25% β-Turns | Non-hemolytic | ||
| 30389515 | 2019 | CPAIQRCC | Mo-CBP3-PepI | Free | Free | Linear | L | None | 8 | Antibacterial, Anticandidal | 0 % Hemolysis at 280 µM | Human | Plant Moringa Oleifera Seeds | 75% α-Helix and 25% β-Turns | Non-hemolytic | ||
| 30389515 | 2019 | NIQPPCRCC | Mo-CBP3-PepII | Free | Free | Linear | L | None | 9 | Antibacterial, Anticandidal | 0 % Hemolysis at 280 µM | Human | Plant Moringa Oleifera Seeds | 60% α-Helix and 40% β-Turns | Non-hemolytic | ||
| 30389515 | 2019 | AIQRCC | Mo-CBP3-PepIII | Free | Free | Linear | L | None | 6 | Antibacterial, Anticandidal | 0 % Hemolysis at 280 µM | Human | Plant Moringa Oleifera Seeds | 75% α-Helix and 25% β-Turns | Non-hemolytic | ||
| 30508627 | 2019 | GWGSFFKKAAHVGKHVGKAALTHYL | Pleurocidin | Free | Free | Linear | L | None | 25 | Antibiofilm, Antibacterial | 10 % Hemolysis at 32 µM | Mouse | Fish Winter Flounder (Pseudopleuronectes Americanus) | 10 mM sodium phosphate buffer = Random coil, SDS and TFE = α-Helix | NA | ||
| 30607494 | 2019 | KWKLFKKIHKVGQNIRKGIIKAGPAVAVVGQAAQIAK | PEW300 | Free | Free | Linear | L | None | 37 | Antibacterial | 0 % Hemolysis at 224 μg/ml | Sheep | Synthetic Cecropin A-Derived | α-Helix | Non-hemolytic | ||
| 30384016 | 2019 | SISLL | BRCA1(782–786) | Free | Free | Linear | L | None | 5 | Antibacterial | 5 % Hemolysis at >250 μg/ml | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30384016 | 2019 | YGRKKRRQRRR | TAT(47–57) | Free | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at >62.5 μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 30384016 | 2019 | YGRKKRRQRRRSISLL | TAT–SISLL | Free | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >250 μg/ml | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30384016 | 2019 | SISLLYGRKKRRQRRR | SISLL–TAT | Free | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >250 μg/ml | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30702120 | 2019 | RRWVRRVRRWVRRVVRVVRRWVRR | WLBU2 | Free | Free | Linear | L | None | 24 | Antibacterial | 14 ± 1 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | NA | ||
| 30702120 | 2019 | RRWV{d}RRV{d}RRWV{d}RRV{d}V{d}RV{d}V{d}RRWV{d}RR | D8 | Free | Free | Linear | Mix | None | 24 | Antibacterial | 0 ± 1 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30789942 | 2019 | RIWR{nt:Lau}{ct:Amid} | Lp-I | Amidation | Lau | Linear | L | l = Lau(lauric acid (C12)) | 4 | Antibacterial, Antifungal | ≤10 % Hemolysis at 25 μg/mL | Human | Synthetic Argrich Ultra-Short Cationic Lipopeptides | NA | NA | ||
| 30789942 | 2019 | RRIWRR{nt:Lau}{ct:Amid} | Lp-IRR | Amidation | Lau | Linear | L | l = Lau(lauric acid (C12)) | 6 | Antibacterial, Antifungal | ≤10 % Hemolysis at 25 μg/mL | Human | Synthetic Argrich Ultra-Short Cationic Lipopeptides | NA | NA | ||
| 30789942 | 2019 | RIWR{nt:Lau}{ct:Amid} | Lp-I | Amidation | Lau | Linear | L | l = Lau(lauric acid (C12)) | 4 | Antibacterial, Antifungal | ≤60 % Hemolysis at 50 μg/mL | Human | Synthetic Argrich Ultra-Short Cationic Lipopeptides | NA | NA | ||
| 30789942 | 2019 | RRIWRR{nt:Lau}{ct:Amid} | Lp-IRR | Amidation | Lau | Linear | L | l = Lau(lauric acid (C12)) | 6 | Antibacterial, Antifungal | ≤10 % Hemolysis at 50 μg/mL | Human | Synthetic Argrich Ultra-Short Cationic Lipopeptides | NA | NA | ||
| 30789942 | 2019 | RIWR{nt:Lau}{ct:Amid} | Lp-I | Amidation | Lau | Linear | L | l = Lau(lauric acid (C12)) | 4 | Antibacterial, Antifungal | 100 % Hemolysis at 100 μg/mL | Human | Synthetic Argrich Ultra-Short Cationic Lipopeptides | NA | NA | ||
| 30789942 | 2019 | RRIWRR{nt:Lau}{ct:Amid} | Lp-IRR | Amidation | Lau | Linear | L | l = Lau(lauric acid (C12)) | 6 | Antibacterial, Antifungal | ≤60 % Hemolysis at 100 μg/mL | Human | Synthetic Argrich Ultra-Short Cationic Lipopeptides | NA | NA | ||
| 32254776 | 2019 | KLAKLAKKLAKLAK | KLA | Free | Free | Linear | L | None | 7 | Antibacterial | 0.025 % Hemolysis at 50 μM | mouse | Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 32254776 | 2019 | {conj:PpIX}-{conj:PEG8}-KLAKLAKKLAKLAK-{conj:PEG8}-KLAKLAKKLAKLAK | PPK | Free | Free | Linear | L | conjugating a photosensitizer PpIX = photosensitizer protoporphyrin IX conjugating, PEG = Polyethylene glycol linker | 7 | Antibacterial | 0.025 % Hemolysis at 50 μM | mouse | Chimeric Synthetic Peptide | α-Helix | Non-hemolytic | ||
| 30811391 | 2019 | KLKNFAKGVAQSLLNKASCKLSGQC | Brevinin 2R | Free | Free | Linear | L | None | 25 | Antibacterial, Anti-leishmanial | 0 % Hemolysis at 500 μg/mL | Human | Frog Skin (Rana Brevipoda) | NA | Non-hemolytic | ||
| 30811391 | 2019 | KLKNFAKGVAQSLLNKASCKLSGQC{nt:lauric acid} | L- Brevinin 2R | Free | lauric acid | Linear | L | l = Lau(lauric acid) | 25 | Antibacterial, Anti-leishmanial | 50 % Hemolysis at 250 μg/mL | Human | Modified Brevinin 2R | NA | NA | ||
| 30811391 | 2019 | LPKPPKPVSKMRMATPLLMQALPM | CLIP | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-leishmanial | 0 % Hemolysis at 500 μg/mL | Human | Derived From The Mhc Class Ii Associated Invariant Chain | NA | Non-hemolytic | ||
| 30811391 | 2019 | LPKPPKPVSKMRMATPLLMQALPM{nt:lauric acid} | L-CLIP | Free | lauric acid | Linear | L | l = Lau(lauric acid) | 24 | Antibacterial, Anti-leishmanial | 30 % Hemolysis at 500 μg/mL | Human | Modified Clip | NA | NA | ||
| 30392097 | 2019 | KKKK{nt:Dilipid C7 acylation}{ct:Amid} | 1 | Amidation | Dilipid C7 acylation | Linear | L | None | 4 | Antibacterial | 1.03 % Hemolysis at 50 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | Non-hemolytic | ||
| 30392097 | 2019 | KKKK{nt:Dilipid C9 acylation}{ct:Amid} | 2 | Amidation | Dilipid C9 acylation | Linear | L | None | 4 | Antibacterial | 1.53 % Hemolysis at 50 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | Non-hemolytic | ||
| 30392097 | 2019 | KKKK{nt:Dilipid C11 acylation}{ct:Amid} | 3 | Amidation | Dilipid C11 acylation | Linear | L | None | 4 | Antibacterial | 2.32 % Hemolysis at 50 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | Non-hemolytic | ||
| 30392097 | 2019 | KKKK{nt:Dilipid C14 acylation}{ct:Amid} | 4 | Amidation | Dilipid C14 acylation | Linear | L | None | 4 | Antibacterial | 1 % Hemolysis at 50 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | Non-hemolytic | ||
| 30392097 | 2019 | KKGK{nt:Dilipid C7 acylation}{ct:Amid} | 5 | Amidation | Dilipid C7 acylation | Linear | L | None | 4 | Antibacterial | 1 % Hemolysis at 50 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | Non-hemolytic | ||
| 30392097 | 2019 | KKGK{nt:Dilipid C9 acylation}{ct:Amid} | 6 | Amidation | Dilipid C9 acylation | Linear | L | None | 4 | Antibacterial | 1.21 % Hemolysis at 50 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | Non-hemolytic | ||
| 30392097 | 2019 | KKGK{nt:Dilipid C11 acylation}{ct:Amid} | 7 | Amidation | Dilipid C11 acylation | Linear | L | None | 4 | Antibacterial | 13.66 % Hemolysis at 50 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30392097 | 2019 | KKGK{nt:Dilipid C14 acylation}{ct:Amid} | 8 | Amidation | Dilipid C14 acylation | Linear | L | None | 4 | Antibacterial | 22.23 % Hemolysis at 50 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30392097 | 2019 | KKKK{nt:Dilipid C7 acylation}{ct:Amid} | 1 | Amidation | Dilipid C7 acylation | Linear | L | None | 4 | Antibacterial | 0.75 % Hemolysis at 100 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | Non-hemolytic | ||
| 30392097 | 2019 | KKKK{nt:Dilipid C9 acylation}{ct:Amid} | 2 | Amidation | Dilipid C9 acylation | Linear | L | None | 4 | Antibacterial | 2.07 % Hemolysis at 100 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | Non-hemolytic | ||
| 30392097 | 2019 | KKKK{nt:Dilipid C11 acylation}{ct:Amid} | 3 | Amidation | Dilipid C11 acylation | Linear | L | None | 4 | Antibacterial | 23.72 % Hemolysis at 100 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30392097 | 2019 | KKKK{nt:Dilipid C14 acylation}{ct:Amid} | 4 | Amidation | Dilipid C14 acylation | Linear | L | None | 4 | Antibacterial | 42.1 % Hemolysis at 100 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30392097 | 2019 | KKGK{nt:Dilipid C7 acylation}{ct:Amid} | 5 | Amidation | Dilipid C7 acylation | Linear | L | None | 4 | Antibacterial | 1.1 % Hemolysis at 100 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | Non-hemolytic | ||
| 30392097 | 2019 | KKGK{nt:Dilipid C9 acylation}{ct:Amid} | 6 | Amidation | Dilipid C9 acylation | Linear | L | None | 4 | Antibacterial | 3.78 % Hemolysis at 100 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30392097 | 2019 | KKGK{nt:Dilipid C11 acylation}{ct:Amid} | 7 | Amidation | Dilipid C11 acylation | Linear | L | None | 4 | Antibacterial | 19.73 % Hemolysis at 100 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30392097 | 2019 | KKGK{nt:Dilipid C14 acylation}{ct:Amid} | 8 | Amidation | Dilipid C14 acylation | Linear | L | None | 4 | Antibacterial | 30.5 % Hemolysis at 100 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30392097 | 2019 | KKKK{nt:Dilipid C7 acylation}{ct:Amid} | 1 | Amidation | Dilipid C7 acylation | Linear | L | None | 4 | Antibacterial | 1.03 % Hemolysis at 500 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | Non-hemolytic | ||
| 30392097 | 2019 | KKKK{nt:Dilipid C9 acylation}{ct:Amid} | 2 | Amidation | Dilipid C9 acylation | Linear | L | None | 4 | Antibacterial | 22.44 % Hemolysis at 500 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30392097 | 2019 | KKKK{nt:Dilipid C11 acylation}{ct:Amid} | 3 | Amidation | Dilipid C11 acylation | Linear | L | None | 4 | Antibacterial | 96.4 % Hemolysis at 500 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30392097 | 2019 | KKKK{nt:Dilipid C14 acylation}{ct:Amid} | 4 | Amidation | Dilipid C14 acylation | Linear | L | None | 4 | Antibacterial | 97.97 % Hemolysis at 500 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30392097 | 2019 | KKGK{nt:Dilipid C7 acylation}{ct:Amid} | 5 | Amidation | Dilipid C7 acylation | Linear | L | None | 4 | Antibacterial | 2.21 % Hemolysis at 500 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | Non-hemolytic | ||
| 30392097 | 2019 | KKGK{nt:Dilipid C9 acylation}{ct:Amid} | 6 | Amidation | Dilipid C9 acylation | Linear | L | None | 4 | Antibacterial | 74.28 % Hemolysis at 500 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30392097 | 2019 | KKGK{nt:Dilipid C11 acylation}{ct:Amid} | 7 | Amidation | Dilipid C11 acylation | Linear | L | None | 4 | Antibacterial | 36.78 % Hemolysis at 500 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30392097 | 2019 | KKGK{nt:Dilipid C14 acylation}{ct:Amid} | 8 | Amidation | Dilipid C14 acylation | Linear | L | None | 4 | Antibacterial | 77 % Hemolysis at 500 μg/mL | Pig | Synthetic Dilipid Ultrashort Cationic Lipopeptides | NA | NA | ||
| 30414293 | 2019 | RNCTWLFSTKLKLPA | RN15 | Free | Free | Linear | L | None | 15 | Antibacterial | <10 % Hemolysis at 200 μg/mL | Human | Siamese Crocodile Crocodylus Siamensis | α-Helix | Low hemolytic | ||
| 30824786 | 2019 | AGYLLGKINLKALAALAKKIL{nt:Van-NH-PEG3-Tra(1,4)-C(O)}{ct:Amid} | Van-PEG3-TP10 | Amidation | Van-NH-PEG3-Tra(1,4)-C(O) | Linear | L | Van = vancomycin, PEG3 = 3,6,9-trioxaundecane linker, Tra = 1,2,3-triazole ring | 21 | Antibacterial | 15 % Hemolysis at 12.5 µM | Sheep | Synthetic Conjugate Transportan 10 (Tp10) Peptide | α-Helix | NA | ||
| 30824786 | 2019 | AGYLLGKINLKALAALAKKIL{nt:Van-C(O)-PEG4-Tra(1,4)-C(O)}{ct:Amid} | Van-PEG4-TP10 | Amidation | Van-C(O)-PEG4-Tra(1,4)-C(O) | Linear | L | Van = vancomycin, PEG4 = 4,7,10,13-tetraoxapentadecane linker, Tra = 1,2,3-triazole ring | 21 | Antibacterial | 5 % Hemolysis at 12.5 µM | Sheep | Synthetic Conjugate Transportan 10 (Tp10) Peptide | α-Helix | NA | ||
| 30824786 | 2019 | AGYLLGKINLKALAALAKKIL{nt:Van-NH-PEG3-Tra(1,4)-C(O)}{ct:Amid} | Van-PEG3-TP10 | Amidation | Van-NH-PEG3-Tra(1,4)-C(O) | Linear | L | Van = vancomycin, PEG3 = 3,6,9-trioxaundecane linker, Tra = 1,2,3-triazole ring | 21 | Antibacterial | 93 % Hemolysis at 100 µM | Sheep | Synthetic Conjugate Transportan 10 (Tp10) Peptide | α-Helix | NA | ||
| 30824786 | 2019 | AGYLLGKINLKALAALAKKIL{nt:Van-C(O)-PEG4-Tra(1,4)-C(O)}{ct:Amid} | Van-PEG4-TP10 | Amidation | Van-C(O)-PEG4-Tra(1,4)-C(O) | Linear | L | Van = vancomycin, PEG4 = 4,7,10,13-tetraoxapentadecane linker, Tra = 1,2,3-triazole ring | 21 | Antibacterial | 77 % Hemolysis at 100 µM | Sheep | Synthetic Conjugate Transportan 10 (Tp10) Peptide | α-Helix | NA | ||
| 30842436 | 2019 | K-K-{nnr:(NBu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(NPhe)Gly}-{nnr:(N1-Nal)Gly} | 2 | Free | Free | Linear | L | (NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (NPhe)Gly = N-Phenylalanine glycine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | K-K-K-{nnr:(NBu)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(NPhe)Gly}-{nnr:(N1-Nal)Gly} | 3 | Free | Free | Linear | L | (NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (NPhe)Gly = N-Phenylalanine glycine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | {nnr:(N1-Nal)Gly}-{nnr:(NPhe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(NBu)Gly}-K-K-K | 4 | Free | Free | Linear | L | (NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (NPhe)Gly = N-Phenylalanine glycine | 7 | Antibacterial | 24 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | {nnr:(N1-Nal)Gly}-{nnr:(NPhe)Gly}-{nnr:(N1-Nal)Gly}-K-{nnr:(NBu)Gly}-K-K | 5 | Free | Free | Linear | L | (NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (NPhe)Gly = N-Phenylalanine glycine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 6 | Free | Free | Linear | L | (1-Nal)Ala = 1-Naphthylalanine | 7 | Antibacterial | 96 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 7 | Free | Free | Linear | L | (1-Nal)Ala = 1-Naphthylalanine | 7 | Antibacterial | 55 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 8 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine | 7 | Antibacterial | 34 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 9 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine | 7 | Antibacterial | 39 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-K-L-K-K | 10 | Free | Free | Linear | L | (1-Nal)Ala = 1-Naphthylalanine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | {nnr:(2-Nal)Ala}-F -{nnr:(2-Nal)Ala}-K-L-K-K | 11 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-L-K-K-K | 12 | Free | Free | Linear | L | (1-Nal)Ala = 1-Naphthylalanine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | {nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-L-K-K-K | 13 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine | 7 | Antibacterial | 15 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-L-K-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala} | 14 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | 58 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L{d}-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala} | 15 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | 88 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L{d}-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala} | 16 | Free | Free | Linear | Mix | (2-Nal)ala = D-2-Naphthylalanine | 7 | Antibacterial | 60 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-L{d}-K-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala} | 17 | Free | Free | Linear | Mix | (2-Nal)ala = D-2-Naphthylalanine | 7 | Antibacterial | 40 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | {nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala}-K-L{d}-K-K | 18 | Free | Free | Linear | Mix | (2-Nal)ala = D-2-Naphthylalanine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | {nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala}-L{d}-K-K-K | 19 | Free | Free | Linear | Mix | (2-Nal)ala = D-2-Naphthylalanine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | {nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala}-K-L{d}-K-K | 20 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | {nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala}-L{d}-K-K-K | 21 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 22 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine | 7 | Antibacterial | 14 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 24 | Free | Free | Linear | L | (1-Nal)Ala = 1-Naphthylalanine, Nle= norleucine | 7 | Antibacterial | 60 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L{d}-{nnr:(1-Nal)ala}-Y{d}-{nnr:(1-Nal)ala} | 25 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | 53 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 27 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine, Nle= norleucine | 7 | Antibacterial | 54 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L{d}-(2-Nal)ala-Y{d}-(2-Nal)ala | 28 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | 64 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | {nnr:NLys}-{nnr:NLys}-{nnr:NLys}-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 29 | Free | Free | Linear | L | (2-Nal)Ala = D-2-Naphthylalanine, NLys | 7 | Antibacterial | 46 % Hemolysis at 150 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | {nnr:(N1-Nal)Gly}-{nnr:(NPhe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(NBu)Gly}-K-K-K | 4 | Free | Free | Linear | L | (NBu)Gly = N-(4-aminobutyl)glycine, (N1-Nal)Gly = N-(1-naphthyl)glycine, (NPhe)Gly = N-Phenylalanine glycine | 7 | Antibacterial | 10 % Hemolysis at 54 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 6 | Free | Free | Linear | L | (1-Nal)Ala = 1-Naphthylalanine | 7 | Antibacterial | 10 % Hemolysis at 5 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | K-K-K-L-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 7 | Free | Free | Linear | L | (1-Nal)Ala = 1-Naphthylalanine | 7 | Antibacterial | 10 % Hemolysis at 8 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 8 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine | 7 | Antibacterial | 10 % Hemolysis at 56 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 9 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine | 7 | Antibacterial | 10 % Hemolysis at 46 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | {nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-L-K-K-K | 13 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine | 7 | Antibacterial | 10 % Hemolysis at 110 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-L-K-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala} | 14 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | 10 % Hemolysis at 28 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L{d}-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala} | 15 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | 10 % Hemolysis at 8 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L{d}-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala} | 16 | Free | Free | Linear | Mix | (2-Nal)ala = D-2-Naphthylalanine | 7 | Antibacterial | 10 % Hemolysis at 18 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-L{d}-K-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala} | 17 | Free | Free | Linear | Mix | (2-Nal)ala = D-2-Naphthylalanine | 7 | Antibacterial | 10 % Hemolysis at 8 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 22 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine | 7 | Antibacterial | 10 % Hemolysis at 117 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 24 | Free | Free | Linear | L | (1-Nal)Ala = 1-Naphthylalanine, Nle= norleucine | 7 | Antibacterial | 10 % Hemolysis at 3 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | K-K-K-L{d}-{nnr:(1-Nal)ala}-Y{d}-{nnr:(1-Nal)ala} | 25 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | 10 % Hemolysis at 38 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 27 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine, Nle= norleucine | 7 | Antibacterial | 10 % Hemolysis at 3 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | Low hemolytic | ||
| 30842436 | 2019 | K-K-K-L{d}-{nnr:(2-Nal)ala}-Y{d}-{nnr:(2-Nal)ala} | 28 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | 10 % Hemolysis at 6 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | NLys-NLys-NLys-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 29 | Free | Free | Linear | L | (2-Nal)Ala = D-2-Naphthylalanine, NLys | 7 | Antibacterial | 10 % Hemolysis at 9 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 6 | Free | Free | Linear | L | (1-Nal)Ala = 1-Naphthylalanine | 7 | Antibacterial | 50 % Hemolysis at 58 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 7 | Free | Free | Linear | L | (1-Nal)Ala = 1-Naphthylalanine | 7 | Antibacterial | 50 % Hemolysis at 140 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-L-K-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala} | 14 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | 50 % Hemolysis at 128 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L{d}-{nnr:(1-Nal)ala}-F{d}-{nnr:(1-Nal)ala} | 15 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | 50 % Hemolysis at 40 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L{d}-{nnr:(2-Nal)ala}-F{d}-{nnr:(2-Nal)ala} | 16 | Free | Free | Linear | Mix | (2-Nal)ala = D-2-Naphthylalanine | 7 | Antibacterial | 50 % Hemolysis at 118 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 24 | Free | Free | Linear | L | (1-Nal)Ala = 1-Naphthylalanine, Nle= norleucine | 7 | Antibacterial | 50 % Hemolysis at 41 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L{d}-{nnr:(1-Nal)ala}-Y{d}-{nnr:(1-Nal)ala} | 25 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | 50 % Hemolysis at 138 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 27 | Free | Free | Linear | L | (2-Nal)Ala = 2-Naphthylalanine, Nle= norleucine | 7 | Antibacterial | 50 % Hemolysis at 56 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30842436 | 2019 | K-K-K-L{d}-{nnr:(2-Nal)ala}-Y{d}-{nnr:(2-Nal)ala} | 28 | Free | Free | Linear | Mix | (1-Nal)ala = D-1-Naphthylalanine | 7 | Antibacterial | 50 % Hemolysis at 50 µM | Human | Synthetic Peptide-Peptoid Hybrid | Random coil | NA | ||
| 30872680 | 2019 | FLPKLFAKITKKNMAHIR | Andersonin-Y1 (AY1) | Free | Free | Linear | L | None | 18 | Antibacterial | 5 % Hemolysis at 100 µM | Human | Frog Odorrana Andersonii | membrane bound structure = Helical Hairpin (Helix-Loop-Helix) structure, Aqueous = unstructured | Low hemolytic | ||
| 30886247 | 2019 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antibacterial | 30 % Hemolysis at 40 µM | Porcine | Human | α-Helix | NA | ||
| 30886247 | 2019 | RFGRFLRKIRRFRPKVTITIQGSARF{ct:Amid} | CATH-2 | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antifungal | <10 % Hemolysis at 40 µM | Porcine | Chicken | α-Helix and α-Helix | NA | ||
| 30886247 | 2019 | GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG{nt:Acet} | PMAP-36 | Free | Acetylation | Linear | L | None | 36 | Antibacterial | <10 % Hemolysis at 40 µM | Porcine | Porcine Cathelicidin | α-Helix | NA | ||
| 30967458 | 2019 | ILKPGGGTSGGLLGGLLGKVTSVIPGLNNI | α4 | Free | Free | Linear | L | None | 30 | Antibacterial, Antiiofilm | 0 % Hemolysis at 64 µM | Human | Derived From The Human Respiratory Host Defense Protein Splunc1 | α-Helix | Non-hemolytic | ||
| 30967458 | 2019 | LKKWW K TS K GLLGGLLGKVTSVIK | α4-short | Free | Free | Linear | L | None | 24 | Antibacterial, Antiiofilm | 0 % Hemolysis at 64 µM | Human | Modified Α4 | NA | Non-hemolytic | ||
| 31118709 | 2019 | KFKKLFKKLSPVFKRIVQRIKDFLR{nt:Amid} | B1 | Free | Amidation | Linear | L | None | 25 | Antibiofilm, Antibacterial | 37 % Hemolysis at 150 µM | Human | Hybrid Peptide From Ll-37 And Bmap-27 | α-Helix = 88% and Random coils = 12% | NA | ||
| 31016971 | 2019 | LLGDFFRKSKEKIGKEFKRI | Fragment LL-20 | Free | Free | Linear | L | None | 20 | Antibacterial | 0 % Hemolysis at 10 µM | Human | Fragment Of Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 30127331 | 2019 | FLPFFAACAITRKC{ct:Amid} | Amurin-9KY | Amidation | Free | Linear | L | C8-C14 = heptapeptide ring | 14 | Antibacterial | 2 % Hemolysis at 100 μg/mL | Human | Frog Rana Kunyuensis China | water = Random coil, 50% TFE-water = α-Helix | Non-hemolytic | ||
| 30127331 | 2019 | FLPFFAACAITRKC{ct:Amid} | Amurin-9KY1 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 15.4 % Hemolysis at 100 μg/mL | Human | Derived From Amurin-9Ky | NA | NA | ||
| 30919848 | 2019 | GKKLGLWLGLKKG{ct:Amid} | F1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | KKLLGWGLLKK{ct:Amid} | F2 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = unordered conformations | Non-hemolytic | ||
| 30919848 | 2019 | KKLGWGLKK{ct:Amid} | F3 | Amidation | Free | Linear | L | None | 9 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = unordered conformations | Non-hemolytic | ||
| 30919848 | 2019 | KKLGLWLGLKK{ct:Amid} | F4 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | GKKLLWLLKKG{ct:Amid} | F5 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | LKGKLWLKGKL{ct:Amid} | F6 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | KLLGKWKGLLK{ct:Amid} | F7 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30919848 | 2019 | KKLLKGLLKGW{ct:Amid} | F8 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30919848 | 2019 | KKIGIWIGIKK{ct:Amid} | F9 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | RRLGLWLGLRR{ct:Amid} | F10 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | KKLTLWLTLKK{ct:Amid} | F11 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | 30 mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 30919848 | 2019 | KKLGLCLGLKK{ct:Amid} | F12 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30951211 | 2019 | {nnr:Nlys}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Nile}{nt:H}{ct:Amid} | GN-2 | Amidation | H | Linear | L | Nlys = Nlys, Ntrp = Ntrp, Nile = Nile | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Peptoids Of Gn-2 | NA | Low hemolytic | ||
| 30951211 | 2019 | {nnr:Nlys}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Nile}{nt:H}{ct:Amid} | GN-2-Nlys1-4Ntrp5-8 | Amidation | H | Linear | L | Nlys = Nlys, Ntrp = Ntrp, Nile = Nile | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Peptoids Of Gn-2 | NA | Low hemolytic | ||
| 30951211 | 2019 | {nnr:Nlys}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Npm}{nt:H}{ct:Amid} | GN-2-Npm9 | Amidation | H | Linear | L | Nlys = Nlys, Ntrp = Ntrp, Npm = Npm | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Peptoids Of Gn-2 | NA | NA | ||
| 30951211 | 2019 | RWKRWWRWI{ct:Amid} | GN-2 | Amidation | Free | Linear | L | None | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Peptide | water = α-Helix, TFE = α-Helix | NA | ||
| 30951211 | 2019 | RWRRWWRWI{ct:Amid} | GN-2-Arg1,3,4,7 | Amidation | Free | Linear | L | None | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Analogue Peptide | water = Random coil, TFE = Random coil | Low hemolytic | ||
| 30951211 | 2019 | KWKKWWKWI{ct:Amid} | GN-2-Lys1,3,4,7 | Amidation | Free | Linear | L | None | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Analogue Peptide | water = Random coil, TFE = Random coil | Low hemolytic | ||
| 30951211 | 2019 | KKKKWWWWI{ct:Amid} | GN-2-Lys1-4Trp5-8 | Amidation | Free | Linear | L | None | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Analogue Peptide | NA | Low hemolytic | ||
| 30951211 | 2019 | KWKKWWKWF{ct:Amid} | GN-2-Lys1,3,4,7Phe9 | Amidation | Free | Linear | L | None | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Analogue Peptide | water = Random coil, TFE = Random coil | NA | ||
| 31303986 | 2019 | KKKKKKKKKGGGLLALLALLA{nt:H}{ct:Amid} | Block | Amidation | H | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at 25 μM | Human | Synthetic Peptide | 20 mM phosphate buffer solution with 1% SDS solution = α-Helix | NA | ||
| 31303986 | 2019 | KLLKKAGKLLKKAGKLLKKAG{nt:H}{ct:Amid} | Stripe | Amidation | H | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at >100 μM | Human | Synthetic Peptide | 20 mM phosphate buffer solution with 1% SDS solution = α-Helix | Non-hemolytic | ||
| 31303986 | 2019 | KKKLAKLKLGAKLKLKGKLGA{nt:H}{ct:Amid} | Random | Amidation | H | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at 100 μM | Human | Synthetic Peptide | 20 mM phosphate buffer solution with 1% SDS solution = α-Helix | Low hemolytic | ||
| 31199859 | 2019 | FIGAIARLLSKI | BmKn-21 | Free | Free | Linear | L | None | 12 | Antibiofilm, Antibacterial | 100 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | NA | ||
| 31199859 | 2019 | FIGAIARLLSK | BmKn-22 | Free | Free | Linear | L | None | 11 | Antibiofilm, Antibacterial | 10 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | Low hemolytic | ||
| 31199859 | 2019 | FIGAIARLLS | BmKn-23 | Free | Free | Linear | L | None | 10 | Antibiofilm, Antibacterial | 5 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | Non-hemolytic | ||
| 31199859 | 2019 | FIGAIARLL | BmKn-24 | Free | Free | Linear | L | None | 9 | Antibiofilm, Antibacterial | 0 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | Non-hemolytic | ||
| 31199859 | 2019 | FIGAIARL | BmKn-25 | Free | Free | Linear | L | None | 8 | Antibiofilm, Antibacterial | 10 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | Low hemolytic | ||
| 31199859 | 2019 | FIGAIAR | BmKn-26 | Free | Free | Linear | L | None | 7 | Antibiofilm, Antibacterial | 0 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | Non-hemolytic | ||
| 31216348 | 2019 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR | bNK2A-C10C20 | Free | Free | Linear | L | None | 30 | Antibacterial | <2 % Hemolysis at 5 μM | Cattle | Nk-Lysin-Derived Peptides | TFE = α-Helix, NaPB = Random coil | Non-hemolytic | ||
| 31216348 | 2019 | TVIEVASKMSSKMRLLKGLSKSITKRFLRR | bNK2A-S10S20 | Free | Free | Linear | L | None | 30 | Antibacterial | <2 % Hemolysis at 5 μM | Cattle | Nk-Lysin-Derived Peptides | TFE = α-Helix, NaPB = Random coil | Non-hemolytic | ||
| 31216348 | 2019 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR | bNK2A-C10C20 | Free | Free | Linear | L | None | 30 | Antibacterial | <2 % Hemolysis at 20 μM | Cattle | Nk-Lysin-Derived Peptides | TFE = α-Helix, NaPB = Random coil | Non-hemolytic | ||
| 31216348 | 2019 | TVIEVASKMSSKMRLLKGLSKSITKRFLRR | bNK2A-S10S20 | Free | Free | Linear | L | None | 30 | Antibacterial | <2 % Hemolysis at 20 μM | Cattle | Nk-Lysin-Derived Peptides | TFE = α-Helix, NaPB = Random coil | Non-hemolytic | ||
| 30790604 | 2019 | WFGKLYRGKTKVVKKVKGLLKG{nt:Amid} | Cnd-m3a | Free | Amidation | Linear | L | None | 22 | Antibacterial | 5 % Hemolysis at 3 μM | Human | Mutant Of Cnd(Icefish Chionodraco Hamatus) | α-Helix | NA | ||
| 30790604 | 2019 | WFGKLYRGKTKVVKKVKGLLKG{nt:Amid} | Cnd-m3a | Free | Amidation | Linear | L | None | 22 | Antibacterial | 30 % Hemolysis at 50 μM | Human | Mutant Of Cnd(Icefish Chionodraco Hamatus) | α-Helix | NA | ||
| 32641937 | 2019 | CGAGHVPC-YY{d}({nnr:GABA})F{d}YG{cyc:1-8} | MccJ25-derived peptide | Free | Free | Cyclic | Mix | GABA = gamma amino butyric acid | 14 | Antibacterial | 0.26 ± 0.01 % Hemolysis at 200 μM | Human | Bacteria Enterobacteriacea Mccj25- Derived Peptide | β-Sheet | Non-hemolytic | ||
| 31016969 | 2019 | KKLRLKIAFK | PaDBS1R6F10 | Free | Free | Linear | L | None | 10 | Antibiofilm, Antibacterial, Anti-infective | 50 % Hemolysis at >100 μM | Human | Derived From A Pyrobaculum Aerophilum Ribosomal Protein | NA | Low hemolytic | ||
| 31145591 | 2019 | RWKRHISEQLRRRDRLQR | K17 | Free | Free | Linear | L | None | 18 | Antibacterial | >1 % Hemolysis at 500 μM | Mouse | Synthetic Amp | NA | Non-hemolytic | ||
| 31145591 | 2019 | RWKRHISEQLRRRDRLQRQAF | K18 | Free | Free | Linear | L | None | 21 | Antibacterial | >1 % Hemolysis at 500 μM | Mouse | Synthetic Amp | NA | Non-hemolytic | ||
| 31145591 | 2019 | RWKRHISEQLRRRDRLQRQA{nnr:J} | K22 | Free | Free | Linear | L | J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | >1 % Hemolysis at 500 μM | Mouse | Analogue Of K18 | NA | Non-hemolytic | ||
| 31145591 | 2019 | RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid} | K22.2 | Amidation | Free | Linear | L | J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | >1 % Hemolysis at 500 μM | Mouse | Synthetic Amp | NA | Non-hemolytic | ||
| 31145591 | 2019 | {conj:R1}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid} | K30 | Amidation | R1 | Linear | L | R1 = 4-methylhexanoyl, J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | >1 % Hemolysis at 500 μM | Mouse | Fatty Acid Conjugated With K22.2 | D8PG at 206nm = Random coil, D8PG at 220nm = α-Helix | Non-hemolytic | ||
| 31145591 | 2019 | {conj:R2}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid} | K31 | Amidation | R2 | Linear | L | R2 = myristoyl, J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | >80 % Hemolysis at 500 μM | Mouse | Fatty Acid Conjugated With K22.2 | NA | NA | ||
| 31145591 | 2019 | {conj:R3}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid} | K33 | Amidation | R3 | Linear | L | R3 = palmitoyl, J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | 100 % Hemolysis at 500 μM | Mouse | Fatty Acid Conjugated With K22.2 | NA | NA | ||
| 31145591 | 2019 | {conj:R5}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid} | K36 | Amidation | R5 | Linear | L | R5 = Fmoc, J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | >20 % Hemolysis at 500 μM | Mouse | Fatty Acid Conjugated With K22.2 | NA | NA | ||
| 31145591 | 2019 | {conj:R4}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid} | K46 | Amidation | R4 | Linear | L | R4 = capryl, J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | >10 % Hemolysis at 500 μM | Mouse | Fatty Acid Conjugated With K22.2 | NA | NA | ||
| 31363941 | 2019 | KWKKLLKKPLLKKLLKKL{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilms | 14 % Hemolysis at 100 μM | mouse | Cecropin A-Magainin 2 Hybrid Analog Peptide | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | NA | ||
| 31363941 | 2019 | KWKKLLKKPLLKKLLK{ct:Amid} | P5-CT1 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | Non-hemolytic | ||
| 31363941 | 2019 | KWKKLLKKPLLKKL{ct:Amid} | P5-CT2 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = Random coil, LTA and LPS = Random coil | Non-hemolytic | ||
| 31363941 | 2019 | KWKKLLKKPLLK{ct:Amid} | P5-CT3 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = Random coil, LTA and LPS = Random coil | Non-hemolytic | ||
| 31363941 | 2019 | KKLLKKPLLKKLLKKL{ct:Amid} | P5-NT1 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | Non-hemolytic | ||
| 31363941 | 2019 | LLKKPLLKKLLKKL{ct:Amid} | P5-NT2 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | Non-hemolytic | ||
| 31363941 | 2019 | KKPLLKKLLKKL{ct:Amid} | P5-NT3 | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | Non-hemolytic | ||
| 31241636 | 2019 | YNHNF | F3-3-a | Free | Free | Linear | L | None | 5 | Antibacterial | 3.89±0.18 % Hemolysis at 300 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | WPTSFT | F3-3-b | Free | Free | Linear | L | None | 6 | Antibacterial | 4.73±0.23 % Hemolysis at 300 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | AVDRAV | F3-3-c | Free | Free | Linear | L | None | 6 | Antibacterial | 4.71±0.21 % Hemolysis at 300 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | YNHNF | F3-3-a | Free | Free | Linear | L | None | 5 | Antibacterial | 2.86±0.11 % Hemolysis at 150 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | WPTSFT | F3-3-b | Free | Free | Linear | L | None | 6 | Antibacterial | 3.60±0.20 % Hemolysis at 150 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | AVDRAV | F3-3-c | Free | Free | Linear | L | None | 6 | Antibacterial | 2.07±0.07 % Hemolysis at 150 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | YNHNF | F3-3-a | Free | Free | Linear | L | None | 5 | Antibacterial | 2.02±0.03 % Hemolysis at 10 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | WPTSFT | F3-3-b | Free | Free | Linear | L | None | 6 | Antibacterial | 2.53±0.11 % Hemolysis at 10 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | AVDRAV | F3-3-c | Free | Free | Linear | L | None | 6 | Antibacterial | 1.32±0.03 % Hemolysis at 10 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Non-hemolytic | ||
| 31241636 | 2019 | YNHNF | F3-3-a | Free | Free | Linear | L | None | 5 | Antibacterial | 3.91 ± 0.21 % Hemolysis at 250 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | WPTSFT | F3-3-b | Free | Free | Linear | L | None | 6 | Antibacterial | 4.24 ± 0.13 % Hemolysis at 250 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | AVDRAV | F3-3-c | Free | Free | Linear | L | None | 6 | Antibacterial | 3.82 ± 0.09 % Hemolysis at 250 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | YNHNF | F3-3-a | Free | Free | Linear | L | None | 5 | Antibacterial | 3.56 ± 0.09 % Hemolysis at 200 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | WPTSFT | F3-3-b | Free | Free | Linear | L | None | 6 | Antibacterial | 3.63 ± 0.09 % Hemolysis at 200 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | AVDRAV | F3-3-c | Free | Free | Linear | L | None | 6 | Antibacterial | 2.31 ± 0.03 % Hemolysis at 200 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | YNHNF | F3-3-a | Free | Free | Linear | L | None | 5 | Antibacterial | 2.24 ± 0.03 % Hemolysis at 100 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | WPTSFT | F3-3-b | Free | Free | Linear | L | None | 6 | Antibacterial | 3.19 ± 0.18 % Hemolysis at 100 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | AVDRAV | F3-3-c | Free | Free | Linear | L | None | 6 | Antibacterial | 1.41± 0.12 % Hemolysis at 100 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | YNHNF | F3-3-a | Free | Free | Linear | L | None | 5 | Antibacterial | 2.15 ± 0.05 % Hemolysis at 50 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | WPTSFT | F3-3-b | Free | Free | Linear | L | None | 6 | Antibacterial | 2.97 ± 0.14 % Hemolysis at 50 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Low hemolytic | ||
| 31241636 | 2019 | AVDRAV | F3-3-c | Free | Free | Linear | L | None | 6 | Antibacterial | 1.41 ± 0.08 % Hemolysis at 50 μM | Mouse | Laba Garlic (Allium Sativum L.) | PBS = Random coil, PBS+50%TFE = α-Helix, PBS+50%TFE+methanol = β-Sheet | Non-hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 4.30 ± 0.15 % Hemolysis at 31.25 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 4.82 ± 0.33 % Hemolysis at 62.5 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 6.58 ± 0.25 % Hemolysis at 125 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | NA | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 10.01 ± 0.52 % Hemolysis at 250 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | NA | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 14.46 ± 1.82 % Hemolysis at 500 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | NA | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 1.26 ± 0.38 % Hemolysis at 31.25 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 3.12 ± 0.38 % Hemolysis at 62.5 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 2.32 ± 0.43 % Hemolysis at 125 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 4.82 ± 0.74 % Hemolysis at 250 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 9.27 ± 0.27 % Hemolysis at 500 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | NA | ||
| 31359624 | 2019 | GIIAGIIIKIKK{ct:Amid} | zp3 | Amidation | Free | Linear | L | None | 12 | Antibacterial | <5 % Hemolysis at 256 μM | Rat | Derived From Phenol-Soluble Modulins (Psms) Virulent Staphylococcus Aureus Strains | water = Random coil, SDS = α-Helix | Low hemolytic | ||
| 31291603 | 2019 | RIVELTLPRVSVRL{ct:Amid} | CF-14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <5 % Hemolysis at 500 µg/ml | Sheep | Catfish Skin Mucus Of Pelteobagrus Fulvidraco | PBS buffer = Random coil, membrane-mimetic 2.5% SDS micelle = α-Helix | Non-hemolytic | ||
| 31448597 | 2019 | KWKLFKKIGAVLKVL{ct:Amid} | CM15 | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 40 ± 5 % Hemolysis at 2 μM | mouse | Derived From Citropin1.1 | α-Helix | NA | ||
| 31448597 | 2019 | GGHKWKLFKKIGAVLKVL{ct:Amid} | GGH-CM15 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 29 ± 2 % Hemolysis at 2 μM | mouse | Variant Of Cm15 | α-Helix | NA | ||
| 31448597 | 2019 | VIHKWKLFKKIGAVLKVL{ct:Amid} | VIH-CM15 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 29 ± 3 % Hemolysis at 1 μM | mouse | Variant Of Cm15 | α-Helix | NA | ||
| 31448597 | 2019 | GLFDVIKKVASVIGGL{ct:Amid} | citropin1.1 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antibiofilm | 16.5 ± 3 % Hemolysis at 10 μM | mouse | Tree Frog Of The Litora Genus | α-Helix | NA | ||
| 31448597 | 2019 | GGHGLFDVIKKVASVIGGL{ct:Amid} | GGH-citropin1.1 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm | 0.2 ± 0.05 % Hemolysis at 34 μM | mouse | Modified Citropin1.1 | α-Helix | Non-hemolytic | ||
| 31448597 | 2019 | VIHGLFDVIKKVASVIGGL{ct:Amid} | VIH-citropin1.1 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm | 0.9 ± 0.1 % Hemolysis at >33 μM | mouse | Modified Citropin1.1 | α-Helix | Non-hemolytic | ||
| 31207076 | 2019 | LRWWLWKLLRRMR{ct:Amid} | LR-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm, | 0 % Hemolysis at 3.3 μM(PBS) | Rabbit | Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,) | NA | Non-hemolytic | ||
| 31207076 | 2019 | LRWWLWKLLRRMR{ct:Amid} | LR-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm, | 0 % Hemolysis at 3.3 μM(IGF) | Rabbit | Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,) | NA | Non-hemolytic | ||
| 31207076 | 2019 | LRWWLWKLLRRMR{ct:Amid} | LR-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm, | >80 % Hemolysis at 52.3 μM(PBS) | Rabbit | Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,) | NA | NA | ||
| 31207076 | 2019 | LRWWLWKLLRRMR{ct:Amid} | LR-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm, | 100 % Hemolysis at 52.3 μM(IGF) | Rabbit | Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,) | NA | NA | ||
| 31513374 | 2019 | CFQWKRAMRKVR{ct:Amid} | HLopt2-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 µg/ml | Human | Antimicrobial Analogue | NA | Non-hemolytic | ||
| 31513374 | 2019 | {conj:CIP-CH2CO}CFQWKRAMRKVR{ct:Amid} | CIP-CH2CO-HLopt2-NH2 | Amidation | CIP-CH2CO | Linear | L | Cip = ciprofloxacin | 12 | Antibacterial | 0 % Hemolysis at 200 µg/ml | Human | Hlopt2 With Conjugate | NA | Non-hemolytic | ||
| 31513374 | 2019 | {conj:CIP-Cys-S-S}CFQWKRAMRKVR{ct:Amid} | CIP-Cys-S-S-HLopt2-NH2 | Amidation | CIP-Cys-S-S | Linear | L | Cip = ciprofloxacin | 13 | Antibacterial | 0 % Hemolysis at 200 µg/ml | Human | Hlopt2 With Conjugate | NA | Non-hemolytic | ||
| 31513374 | 2019 | {conj:LVX}CFQWKRAMRKVR{ct:Amid} | LVX-HLopt2-NH2 | Amidation | LVX | Linear | L | Lvx = levofloxacin | 12 | Antibacterial | 0 % Hemolysis at 200 µg/ml | Human | Hlopt2 With Conjugate | NA | Non-hemolytic | ||
| 31749789 | 2019 | RLCRIVVIRVCR{ct:Amid} | L2C3V10C11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 64 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Low hemolytic | ||
| 31749789 | 2019 | RRFRIVVIRWLR{ct:Amid} | R2F3W10L11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 128 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Low hemolytic | ||
| 31749789 | 2019 | RRWRIVVIRWRR{ct:Amid} | R2W3W10R11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 128 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Low hemolytic | ||
| 31749789 | 2019 | RKWRIVVIRVRR{ct:Amid} | K2W3V10R11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Non-hemolytic | ||
| 31749789 | 2019 | RWRRIVVIRVRR{ct:Amid} | W2R3V10R11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Non-hemolytic | ||
| 31749789 | 2019 | RWKRIVVIRKRR{ct:Amid} | W2K3K10R11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Non-hemolytic | ||
| 31749789 | 2019 | RKRRIVVIRRKR{ct:Amid} | K2R3R10K11 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Derivatives Of Bactenecin | microbial membrane mimetic environments α-Helix | Non-hemolytic | ||
| 31710627 | 2019 | FPFLLSLIPSAISAIKRL{ct:Amid} | Uy234 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 26.18 % Hemolysis at 380 μM | Human | Scorpion Urodacus Yaschenkoi | α-Helix | Low hemolytic | ||
| 31710627 | 2019 | ILSAIWSGIKGLL{ct:Amid} | Uy17 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 25 % Hemolysis at >380 μM | Human | Scorpion Urodacus Yaschenkoi | α-Helix | Low hemolytic | ||
| 31710627 | 2019 | FLSTIWNGIKGLL{ct:Amid} | Uy192 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 25 % Hemolysis at >380 μM | Human | Scorpion Urodacus Yaschenkoi | α-Helix | Low hemolytic | ||
| 31710627 | 2019 | FFSLIPSLISGLI{ct:Amid} | QnCs-BUAP | Amidation | Free | Linear | L | None | 13 | Antibacterial | 25 % Hemolysis at >380 μM | Human | Synthetic Peptide From Conserved Region | α-Helix | Low hemolytic | ||
| 31667994 | 2019 | GIGKFLHSAKKFGKAFVGEIMNS{nt:H}{ct:Amid} | Mag 2 | Amidation | H | Linear | L | None | 23 | Antibacterial | Hemolysis at >100 µM | Human | Frogs | 1%SDS = α-Helix | NA | ||
| 31667994 | 2019 | GIGKFLHSAKKFGKAFV{nt:H}{ct:Amid} | peptide-7 | Amidation | H | Linear | L | None | 17 | Antibacterial | Hemolysis at >100 µM | Human | Truncated Peptide | 1%SDS = Random coil | NA | ||
| 31667994 | 2019 | GIKKFLKSAKKFVKAFK{nt:H}{ct:Amid} | peptide-8 | Amidation | H | Linear | L | None | 17 | Antibacterial | Hemolysis at 50 µM | Human | Truncated Peptide | 1%SDS = α-Helix | NA | ||
| 31667994 | 2019 | GIGKFLHS{nnr:U}KKFGK{nnr:U}FV{nt:H}{ct:Amid} | peptide-9 | Amidation | H | Linear | L | U = Aib(2-aminoisobutyric acid) | 17 | Antibacterial | Hemolysis at >100 µM | Human | Truncated Peptide | 1%SDS = α-Helix | NA | ||
| 31667994 | 2019 | GIGKFLHS{nnr:Z}KKFGK{nnr:Z}FV{nt:H}{ct:Amid} | peptide-10 | Amidation | H | Linear | L | Z = Ac6c(1-aminocyclohexylcarboxylic acid) | 17 | Antibacterial | Hemolysis at 3 µM | Human | Truncated Peptide | NA | NA | ||
| 31667994 | 2019 | GIKKFLKS{nnr:U}KKFVK{nnr:U}FK{nt:H}{ct:Amid} | peptide-11 | Amidation | H | Linear | L | U = Aib(2-aminoisobutyric acid) | 17 | Antibacterial | Hemolysis at 50 µM | Human | Truncated Peptide | 1%SDS = Helical | NA | ||
| 31667994 | 2019 | GIKKFLKS{nnr:Z}KKFVK{nnr:Z}FK{nt:H}{ct:Amid} | peptide-12 | Amidation | H | Linear | L | Z = Ac6c(1-aminocyclohexylcarboxylic acid) | 17 | Antibacterial | Hemolysis at 3 µM | Human | Truncated Peptide | 1%SDS = Helical | NA | ||
| 31775224 | 2019 | IRPIRP{cyc:N-C} | OIR1 | Free | Free | Cyclic | L | None | 6 | Antibacterial | ≥5 % Hemolysis at >128 µM | Human | Synthetic Cyclic Amps | aqueous = unordered, β-Hairpin | Low hemolytic | ||
| 31775224 | 2019 | IRIRPIRIRP{cyc:N-C} | OIR2 | Free | Free | Cyclic | L | None | 10 | Antibacterial | ≥5 % Hemolysis at >128 µM | Human | Synthetic Cyclic Amps | aqueous = unordered, β-Hairpin | Low hemolytic | ||
| 31775224 | 2019 | IRIRIRPIRIRIRP{cyc:N-C} | OIR3 | Free | Free | Cyclic | L | None | 14 | Antibacterial, Anti-Inflammatory | ≥5 % Hemolysis at >128 µM | Human | Synthetic Cyclic Amps | aqueous = unordered, β-Hairpin | Low hemolytic | ||
| 31775224 | 2019 | IRPIRP | IR1 | Free | Free | Linear | L | None | 6 | Antibacterial | ≥5 % Hemolysis at >128 µM | Human | Synthetic Linear Amps | aqueous = unordered, 30 mM anionic = unordered | Low hemolytic | ||
| 31775224 | 2019 | IRIRPIRIRP | IR2 | Free | Free | Linear | L | None | 10 | Antibacterial | ≥5 % Hemolysis at >128 µM | Human | Synthetic Linear Amps | aqueous = unordered, 30 mM anionic = unordered | Low hemolytic | ||
| 31775224 | 2019 | IRIRIRPIRIRIRP | IR3 | Free | Free | Linear | L | None | 14 | Antibacterial, Anti-Inflammatory | ≥5 % Hemolysis at >128 µM | Human | Synthetic Linear Amps | aqueous = unordered, 30 mM anionic = unordered | Low hemolytic | ||
| 31775224 | 2019 | IRP{d}IRP{d} | DIR1 | Free | Free | Linear | Mix | p = D-Proline | 6 | Antibacterial | ≥5 % Hemolysis at >128 µM | Human | Synthetic D-Proline Amps | 50% TFE = β-Sheet | Low hemolytic | ||
| 31775224 | 2019 | IRIRP{d}IRIRP{d} | DIR2 | Free | Free | Linear | Mix | p = D-Proline | 10 | Antibacterial | ≥5 % Hemolysis at >128 µM | Human | Synthetic D-Proline Amps | aqueous = unordered, 50% TFE = β-Sheet | Low hemolytic | ||
| 31775224 | 2019 | IRIRIRP{d}IRIRIRP{d} | DIR3 | Free | Free | Linear | Mix | p = D-Proline | 14 | Antibacterial, Anti-Inflammatory | ≥5 % Hemolysis at >128 µM | Human | Synthetic D-Proline Amps | aqueous = unordered, 50% TFE = β-Hairpin | Low hemolytic | ||
| 31442359 | 2019 | WLKAAAKAAAKLW{ct:Amid} | WL | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at 256 µM | Human | Synthetic Peptide | 30 mM SDS or 50% TFE = α‐Helix | Low hemolytic | ||
| 31442359 | 2019 | LWKAAAKAAAKWL{ct:Amid} | LW | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | 30 mM SDS or 50% TFE = α‐Helix | Low hemolytic | ||
| 31442359 | 2019 | LWKAAAKAAAKLL{ct:Amid} | LW-1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at 256 µM | Human | Synthetic Peptide | 30 mM SDS or 50% TFE = α‐Helix | Low hemolytic | ||
| 31442359 | 2019 | LWKAAAKAAAKLW{ct:Amid} | LW-2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at 256 µM | Human | Synthetic Peptide | 30 mM SDS or 50% TFE = α‐Helix | Low hemolytic | ||
| 31442359 | 2019 | AAKAWLKLWAKAA{ct:Amid} | LW-3 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 5 % Hemolysis at >256 µM | Human | Synthetic Peptide | 30 mM SDS or 50% TFE = α‐Helix | Low hemolytic | ||
| 31520928 | 2019 | YEIKINRHFKTLKKNLKK{ct:Amid} | H5 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | Bighead Carp Aristicluthys Nobilia Ifn-I | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKINRHFKTLKKNLKK{ct:Amid} | P1 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKTLNKNLKK{ct:Amid} | P2 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLNKNLKK{ct:Amid} | P3 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YFRTIRRFFKKLFKTLKK{ct:Amid} | P4 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 640 µg/ml | Murine | H5-Derived Peptides | MME = α‐Helical | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLKKILKK{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 10 % Hemolysis at 640 µg/ml | Murine | H5-Derived Peptides | Helical | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKRFKFRKK{ct:Amid} | P6 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | WVRKVRRWWKKVKKVVKK{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 80.04 ± 7.2 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | NA | ||
| 31520928 | 2019 | SYEIKINRHFKTLKKNLKKK{ct:Amid} | P8 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | SYERKINRHFKTLKKNLKKK{ct:Amid} | P9 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | WYERLINRKFKWLKGRLSKK{ct:Amid} | P10 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 178.82 ± 12.6 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | NA | ||
| 31520928 | 2019 | LYKRYILRKFKFLKKKLKKK{ct:Amid} | P11 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | VWKRWVVRKWKWVKKKVKKK{ct:Amid} | P12 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 57.24 ± 5.2 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | NA | ||
| 31520928 | 2019 | YEIKINRHFKTLKKNLKK{ct:Amid} | H5 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | Bighead Carp Aristicluthys Nobilia Ifn-I | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKINRHFKTLKKNLKK{ct:Amid} | P1 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKTLNKNLKK{ct:Amid} | P2 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLNKNLKK{ct:Amid} | P3 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YFRTIRRFFKKLFKTLKK{ct:Amid} | P4 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | MME = α‐Helical | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLKKILKK{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | Helical | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKRFKFRKK{ct:Amid} | P6 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | WVRKVRRWWKKVKKVVKK{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | Low hemolytic | ||
| 31520928 | 2019 | SYEIKINRHFKTLKKNLKKK{ct:Amid} | P8 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | SYERKINRHFKTLKKNLKKK{ct:Amid} | P9 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | WYERLINRKFKWLKGRLSKK{ct:Amid} | P10 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | Low hemolytic | ||
| 31520928 | 2019 | LYKRYILRKFKFLKKKLKKK{ct:Amid} | P11 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | VWKRWVVRKWKWVKKKVKKK{ct:Amid} | P12 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | Low hemolytic | ||
| 31713951 | 2019 | KGIRGYKGGYCKGAFKQTCKCY | Os | Free | Free | Linear | L | None | 22 | Antibacterial | 0 % Hemolysis at 25 µM | Human | Soft Tick Ornithodoros Savignyi | NA | Non-hemolytic | ||
| 31713951 | 2019 | IRGYKGGYCK{ct:Amid} | Os(3‐12)NH2 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 0 % Hemolysis at 25 µM | Human | Synthetic Peptide Analogues Of Os | water = unstructured, SDS = unstructured | Non-hemolytic | ||
| 31713951 | 2019 | CKGAFKQTCKCY{ct:Amid} | Os(11‐22)NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 µM | Human | Synthetic Peptide Analogues Of Os | water = Random coil, SDS = Random coil | Non-hemolytic | ||
| 31713951 | 2019 | KGIRGYKGGYCKGAFKQTCKCY | Os | Free | Free | Linear | L | None | 22 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Soft Tick Ornithodoros Savignyi | NA | Non-hemolytic | ||
| 31713951 | 2019 | IRGYKGGYCK{ct:Amid} | Os(3‐12)NH2 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Peptide Analogues Of Os | water = unstructured, SDS = unstructured | Non-hemolytic | ||
| 31713951 | 2019 | CKGAFKQTCKCY{ct:Amid} | Os(11‐22)NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Synthetic Peptide Analogues Of Os | water = Random coil, SDS = Random coil | Non-hemolytic | ||
| 31827113 | 2019 | G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-IEI-{nnr:aIle}-S | M1 (or M) | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid | 13 | Antibacterial | 10 % Hemolysis at 128 µg/ml | Rabbit | Tridecaptin M A Mud Bacterium, Paenibacillus Sp. M-152 | NA | Low hemolytic | ||
| 31827113 | 2019 | G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-IEVV{d}S | M2 | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), Dab = 2,4-diaminobutyric acid | 13 | Antibacterial | 2 % Hemolysis at 128 µg/ml | Rabbit | Variants Of Tridecaptin M | NA | Non-hemolytic | ||
| 31827113 | 2019 | G-{nnr:dab}-GS{d}DFS-{nnr:Dab}-{nnr:dab}-IEIV{d}S | M5 | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), Dab = 2,4-diaminobutyric acid | 13 | Antibacterial | 0 % Hemolysis at 128 µg/ml | Rabbit | Variants Of Tridecaptin M | NA | Non-hemolytic | ||
| 31827113 | 2019 | G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-IEIV{d}S | M6 | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), Dab = 2,4-diaminobutyric acid | 13 | Antibacterial | >15 % Hemolysis at 128 µg/ml | Rabbit | Variants Of Tridecaptin M | NA | NA | ||
| 31827113 | 2019 | G-{nnr:dab}-GS{d}W{d}S-{nnr:Dab}-{nnr:dab}-VEI-{nnr:aIle}-S | M7 | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid | 13 | Antibacterial | 1 % Hemolysis at 128 µg/ml | Rabbit | Variants Of Tridecaptin M | NA | Non-hemolytic | ||
| 31827113 | 2019 | G-{nnr:dab}-GS{d}DFS-{nnr:Dab}-{nnr:dab}-IEI-{nnr:aIle}-S | M8 | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid | 13 | Antibacterial | >9 % Hemolysis at 128 µg/ml | Rabbit | Variants Of Tridecaptin M | NA | Low hemolytic | ||
| 31827113 | 2019 | {nnr:dab}-FEI-{nnr:aIle}-S | M11 | Free | Free | Linear | Mix | dab = D-2,4-diaminobutyric acid (D-Dab), aile = D-aIle, Dab = 2,4-diaminobutyric acid | 6 | Antibacterial | 50 % Hemolysis at 128 µg/ml | Rabbit | Variants Of Tridecaptin M | NA | NA | ||
| 31676352 | 2019 | GLLK{d}{conj:C4}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C4 | Amidation | Free | Linear | Mix | C4 = C4 | 10 | Antibacterial, | 10 % Hemolysis at >256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}{conj:C6}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C6 | Amidation | Free | Linear | Mix | C6 = C6 | 10 | Antibacterial | 10 % Hemolysis at >256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}{conj:C8}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C8 | Amidation | Free | Linear | Mix | C8 = C8 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}{conj:C10}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C10 | Amidation | Free | Linear | Mix | C10 = C10 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}{conj:C12}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C12 | Amidation | Free | Linear | Mix | C12 = C12 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 32 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLK{d}{conj:C14}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C14 | Amidation | Free | Linear | Mix | C14 = C14 | 10 | Antibacterial | 10 % Hemolysis at 32 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLK{d}{conj:C16}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C16 | Amidation | Free | Linear | Mix | C16 = C16 | 10 | Antibacterial | 10 % Hemolysis at 16 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C4}TLL{ct:Amid} | Ano-D4,7-7C4 | Amidation | Free | Linear | Mix | C4 = C4 | 10 | Antibacterial | 10 % Hemolysis at >256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C6}TLL{ct:Amid} | Ano-D4,7-7C6 | Amidation | Free | Linear | Mix | C6 = C6 | 10 | Antibacterial | 10 % Hemolysis at >256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C8}TLL{ct:Amid} | Ano-D4,7-7C8 | Amidation | Free | Linear | Mix | C8 = C8 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C10}TLL{ct:Amid} | Ano-D4,7-7C10 | Amidation | Free | Linear | Mix | C10 = C10 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 128 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C12}TLL{ct:Amid} | Ano-D4,7-7C12 | Amidation | Free | Linear | Mix | C12 = C12 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 32 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C14}TLL{ct:Amid} | Ano-D4,7-7C14 | Amidation | Free | Linear | Mix | C14 = C14 | 10 | Antibacterial | 10 % Hemolysis at 16 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C16}TLL{ct:Amid} | Ano-D4,7-7C16 | Amidation | Free | Linear | Mix | C16 = C16 | 10 | Antibacterial | 10 % Hemolysis at 16 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 µM | mouse | Venom Sac Of Solitary Spider Wasps | α-Helical | Low hemolytic | ||
| 31676352 | 2019 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 75 % Hemolysis at 2 µM | mouse | Honey Bee Apis Mellifera | α-Helical | NA | ||
| 31938070 | 2020 | GIGKFLKKAKKFGK | MSI-78 | Free | Free | Linear | L | None | 14 | Antibacterial | 50 % Hemolysis at >400 µM | Sheep | Derived From The Magainin 2 Peptide | α-Helix | Low hemolytic | ||
| 31938070 | 2020 | GIWKFLKKAKKFWK | MSI-1 | Free | Free | Linear | L | None | 14 | Antibacterial | 50 % Hemolysis at >400 µM | Sheep | Msi-78 Analogs | SDS = α-Helix | Low hemolytic | ||
| 31938070 | 2020 | GIWKFLKKAKKFW | MSI-3 | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >400 µM | Sheep | Msi-78 Analogs | Helical | Low hemolytic | ||
| 31938070 | 2020 | WIRKFLKRVKKFG | MSI-4 | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at >400 µM | Sheep | Msi-78 Analogs | Helical | Low hemolytic | ||
| 31887002 | 2020 | LKKLCARLKKLCAR{ct:Amid} | CAR2 | Amidation | Free | Linear | L | None | 14 | Antifungal, Antibacterial | 10 % Hemolysis at >128 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | Low hemolytic | ||
| 31887002 | 2020 | LKKLCARLKKLCARLKKLCAR{ct:Amid} | CAR3 | Amidation | Free | Linear | L | None | 21 | Antifungal, Antibacterial | 10 % Hemolysis at >128 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | Low hemolytic | ||
| 31887002 | 2020 | LKKLCARLKKLCARLKKLCARLKKLCAR{ct:Amid} | CAR4 | Amidation | Free | Linear | L | None | 28 | Antifungal, Antibacterial | 10 % Hemolysis at 8 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, SDS/TFE = α-Helical | NA | ||
| 31887002 | 2020 | LKKLACRLKKLACR{ct:Amid} | ACR2 | Amidation | Free | Linear | L | None | 14 | Antifungal, Antibacterial | 10 % Hemolysis at >128 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | Low hemolytic | ||
| 31887002 | 2020 | LKKLACRLKKLACRLKKLACR{ct:Amid} | ACR3 | Amidation | Free | Linear | L | None | 21 | Antibiofilm, Antifungal, Antibacterial | 10 % Hemolysis at >128 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | Low hemolytic | ||
| 31887002 | 2020 | LKKLACRLKKLACRLKKLACRLKKLACR{ct:Amid} | ACR4 | Amidation | Free | Linear | L | None | 28 | Antifungal, Antibacterial | 10 % Hemolysis at 32 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | NA | ||
| 31887002 | 2020 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin (MLT) | Amidation | Free | Linear | L | None | 26 | Antifungal, Antibacterial | 10 % Hemolysis at 1 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | NA | ||
| 31483516 | 2020 | VGGTICGPACAVAGAHYLPI | 1 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | low helicity, Random coil | Low hemolytic | ||
| 31483516 | 2020 | GWFKTYKDWPVIISNVPGVI | 2 | Free | Free | Linear | L | None | 20 | Antibacterial | increased % Hemolysis at 128 μM | Sheep | Synthetic Peptide | low helicity, Random coil | NA | ||
| 31483516 | 2020 | IKKIGKKAAKKVIVKAIQAI | 3 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 31483516 | 2020 | KKIGKKAAKKVIVKAIQAIV | 4 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 31483516 | 2020 | FLGEWLFVTRKAKRKHKHAA | 5 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | VKFAIKKIGKKAAKKVIVKA | 6 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | SFLGEWLFVTRKAKRKHKHA | 7 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | QAAKKMSNKEKAAKRWIAMR | 8 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | AKAIVRTIEQAPKTAKAKKS | 9 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | EVVPKVKKHFKDKENKKKLF | 10 | Free | Free | Linear | L | None | 20 | Antibacterial | increased % Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | NA | ||
| 31483516 | 2020 | KKIAIITKNLKNFFIMLNII | 11 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | β-Sheet | Low hemolytic | ||
| 31483516 | 2020 | KKSINSLHLAMLKKQRLNRD | 12 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | LLLGIKYKKIGANNFREVKK | 13 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | FMKKIVKIGKIARYSHKAKK | 14 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | LFRKKRHHWFVRTKNSLSKN | 15 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | Helical | Low hemolytic | ||
| 31483516 | 2020 | VNHGYRKVTLTKTVRIKKFM | 16 | Free | Free | Linear | L | None | 20 | Antibacterial | Low Hemolysis at 128 μM | Sheep | Synthetic Peptide | low helicity, Random coil | Low hemolytic | ||
| 31778756 | 2020 | RIVQRIKKWLLKWKKLGY | peptide 5 | Free | Free | Linear | L | None | 18 | Antibiofilm, Antibacterial | <10 % Hemolysis at 1024 μg/ml | mouse | Synthetic Peptide | SDS = α-Helix | Low hemolytic | ||
| 31778756 | 2020 | GLLRKWGKKWKEFLRRVWK | peptide 6.2 | Free | Free | Linear | L | None | 19 | Antibiofilm, Antibacterial | <5 % Hemolysis at 128 μg/ml | mouse | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 31778756 | 2020 | GLLRKWGKKWKEFLRRVWK | peptide 6.2 | Free | Free | Linear | L | None | 19 | Antibiofilm, Antibacterial | 30 % Hemolysis at 1024 μg/ml | mouse | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 31802582 | 2020 | GWWRRTVDKVRNAGRK{ct:-OH} | P2-HC(1‐16) | -OH | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVRNAGRK{ct:Amid} | P3-HC(1‐16)A8 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Low hemolytic | ||
| 31802582 | 2020 | AWWRRTVAKVRK{ct:Amid} | P8-G1A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 1.6 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Low hemolytic | ||
| 31802582 | 2020 | GAWRRTVAKVRK{ct:Amid} | P9-W2A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWARRTVAKVRK{ct:Amid} | P10-W3A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWARTVAKVRK{ct:Amid} | P11-R4A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 3.6 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Low hemolytic | ||
| 31802582 | 2020 | GWWRATVAKVRK{ct:Amid} | P12-R5A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRAVAKVRK{ct:Amid} | P13-T6A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 4.1 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Low hemolytic | ||
| 31802582 | 2020 | GWWRRTAAKVRK{ct:Amid} | P14-V7A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVRK{ct:Amid} | P6-HC(1‐12)A8K12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 25.1 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | α‐‐Helical | NA | ||
| 31802582 | 2020 | GWWRRTVAAVRK{ct:Amid} | P15-K9A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5.1 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Low hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKARK{ct:Amid} | P16-V10A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 1 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVAK{ct:Amid} | P17-R11A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVRA{ct:Amid} | P18-K12A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 200 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVDKVRNAGRK{ct:-OH} | P2-HC(1‐16) | -OH | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVRNAGRK{ct:Amid} | P3-HC(1‐16)A8 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | AWWRRTVAKVRK{ct:Amid} | P8-G1A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GAWRRTVAKVRK{ct:Amid} | P9-W2A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWARRTVAKVRK{ct:Amid} | P10-W3A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWARTVAKVRK{ct:Amid} | P11-R4A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRATVAKVRK{ct:Amid} | P12-R5A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRAVAKVRK{ct:Amid} | P13-T6A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0.9 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Low hemolytic | ||
| 31802582 | 2020 | GWWRRTAAKVRK{ct:Amid} | P14-V7A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVRK{ct:Amid} | P6-HC(1‐12)A8K12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 2.4 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | α‐‐Helical | NA | ||
| 31802582 | 2020 | GWWRRTVAAVRK{ct:Amid} | P15-K9A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKARK{ct:Amid} | P16-V10A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVAK{ct:Amid} | P17-R11A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31802582 | 2020 | GWWRRTVAKVRA{ct:Amid} | P18-K12A | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolysis at 25 μM | Human | Truncated P1 Pepetide | NA | Non-hemolytic | ||
| 31862270 | 2020 | PFKISIHL | Jellein | Free | Free | Linear | L | None | 8 | Antibacterial, Anti-leishmanial activity, inhibition of Leishmania major promastigotes | 8 % Hemolysis at 500 μg/ml | Human | Royal Jelly Of Honeybee | NA | Low hemolytic | ||
| 31862270 | 2020 | {conj:Lauric acid}LPKPPKPVSKMRMATPLLMQALPM | Lauric acid-LIP (L-CLIP) | Free | Lauric acid | Linear | L | None | 24 | Antibacterial | 58 % Hemolysis at 319 μg/ml | Human | Lauric Acid Conjugated Clip | NA | NA | ||
| 32153547 | 2020 | RNGCIVDPRCPYQQCRRPLYCRRR | NCR247 | Free | Free | Linear | L | None | 24 | Antibacterial | 1.75 % Hemolysis at 100 μM | Human | Plant Medicago Truncatula Nodule-Specific Cysteine-Rich (Ncr) Peptides | NA | Low hemolytic | ||
| 32153547 | 2020 | QQCRRPLYCRRR | NCR247C | Free | Free | Linear | L | None | 12 | Antibacterial | 0.88 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | QQCRRPLYCRRRWSHPQFEK | NCR247C-StrepII | Free | Free | Linear | L | None | 20 | Antibacterial | 1.75 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | RPLNFKMLRFWGQQQCRRPLYCRRR | X1-NCR247C | Free | Free | Linear | L | None | 25 | Antibacterial | 3.51 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | RPLNFKMLRFWGQQQCRRPLYCRRRWSHPQFEK | X1-NCR247C-StrepII | Free | Free | Linear | L | None | 33 | Antibacterial | 3.51 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | QQCRRPLYCRRRKALAALAKKIL | NCR247C-X2 | Free | Free | Linear | L | None | 23 | Antibacterial | 7.02 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | NA | ||
| 32153547 | 2020 | QQCRRPLYCRRRKALAALAKKILWSHPQFEK | NCR247C-X2-StrepII | Free | Free | Linear | L | None | 31 | Antibacterial | 11.4 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | NA | ||
| 32153547 | 2020 | KALAALAKKILQQCRRPLYCRRR | X2-NCR247C | Free | Free | Linear | L | None | 23 | Antibacterial | 6.14 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | NA | ||
| 32153547 | 2020 | KALAALAKKIL | X2 | Free | Free | Linear | L | None | 11 | Antibacterial | 1.75 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | GWTLNSAGYLLGKINLKALAALAKKIL | Transportan | Free | Free | Linear | L | None | 27 | Antibacterial | 95.61 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | NA | ||
| 32153547 | 2020 | RNGCIVDPRCPYQQCRRPLYCRRR | NCR247 | Free | Free | Linear | L | None | 24 | Antibacterial | 0.88 % Hemolysis at 25 μM | Human | Plant Medicago Truncatula Nodule-Specific Cysteine-Rich (Ncr) Peptides | NA | Low hemolytic | ||
| 32153547 | 2020 | QQCRRPLYCRRR | NCR247C | Free | Free | Linear | L | None | 12 | Antibacterial | 0.88 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | QQCRRPLYCRRRWSHPQFEK | NCR247C-StrepII | Free | Free | Linear | L | None | 20 | Antibacterial | 1.75 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | RPLNFKMLRFWGQQQCRRPLYCRRR | X1-NCR247C | Free | Free | Linear | L | None | 25 | Antibacterial | 1.75 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | RPLNFKMLRFWGQQQCRRPLYCRRRWSHPQFEK | X1-NCR247C-StrepII | Free | Free | Linear | L | None | 33 | Antibacterial | 1.75 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | QQCRRPLYCRRRKALAALAKKIL | NCR247C-X2 | Free | Free | Linear | L | None | 23 | Antibacterial | 1.75 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | QQCRRPLYCRRRKALAALAKKILWSHPQFEK | NCR247C-X2-StrepII | Free | Free | Linear | L | None | 31 | Antibacterial | 6.14 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | NA | ||
| 32153547 | 2020 | KALAALAKKILQQCRRPLYCRRR | X2-NCR247C | Free | Free | Linear | L | None | 23 | Antibacterial | 1.75 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | KALAALAKKIL | X2 | Free | Free | Linear | L | None | 11 | Antibacterial | 0.88 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | GWTLNSAGYLLGKINLKALAALAKKIL | Transportan | Free | Free | Linear | L | None | 27 | Antibacterial | 38.6 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | NA | ||
| 32258871 | 2020 | ACPIFTKIQGTYRGKAKCK | Phd1 | Free | Free | Linear | L | None | 19 | Antibacterial | >12.5 % Hemolysis at 5 μM | Rat | Human-Β-Defensins Hbd1 Analogues | NA | NA | ||
| 32258871 | 2020 | SCLPKEEQIGKSTRGRKCRRKK | Phd3 | Free | Free | Linear | L | None | 22 | Antibacterial | >12.5 % Hemolysis at 12 μM | Rat | Human-Β-Defensins Hbd3 Analogues | NA | NA | ||
| 32258871 | 2020 | ACPIFTKIQGTYRGKAKCK{nt:Myr = myristoylated} | MPhd1 | Free | Myr = myristoylated | Linear | L | None | 19 | Antibacterial | >80 % Hemolysis at 5 μM | Rat | Myristoylated Mphd1 | NA | NA | ||
| 32258871 | 2020 | SCLPKEEQIGKSTRGRKCRRKK{nt:Myr = myristoylated} | MPhd3 | Free | Myr = myristoylated | Linear | L | None | 22 | Antibacterial | >50 % Hemolysis at 12 μM | Rat | Myristoylated Mphd3 | NA | NA | ||
| 32003561 | 2020 | K{d}W{d}C{d}F{d}R{d}V{d}C{d}Y{d}R{d}G{d}L{d}C{d}Y{d}R{d}R{d}C{d}R{d}X{d} | TPAD | Free | Free | Linear | D | None | 18 | Antibacterial | 10 % Hemolysis at 16 μg/mL | Human | D-Amino Acid Analogue Of Tpi | β-Hairpin | NA | ||
| 32242658 | 2020 | RRRRRRRRRRRR | R12 | Free | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >4000 μg/mL | Rat | Arginine-Based Four-Armed Copolypeptides | NA | Non-hemolytic | ||
| 32242658 | 2020 | RRRRRRRRRRRRKKK{ct:Amid} | 4R3 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at >4000 μg/mL | Rat | Arginine-Based Four-Armed Copolypeptides | NA | Non-hemolytic | ||
| 32242658 | 2020 | RRRRRRRRRRRRRRRRRRRRRRRRKKK{ct:Amid} | 4R6 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 5 % Hemolysis at >4000 μg/mL | Rat | Arginine-Based Four-Armed Copolypeptides | NA | Non-hemolytic | ||
| 32242658 | 2020 | RGRGRGRGRGRGRGRGRGRGRGRGKKK{ct:Amid} | 4R3G3 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 5 % Hemolysis at >4000 μg/mL | Rat | Arginine-Based Four-Armed Copolypeptides | NA | Non-hemolytic | ||
| 32242658 | 2020 | RGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGRGKKK{ct:Amid} | 4R6G6 | Amidation | Free | Linear | L | None | 51 | Antibacterial | 5 % Hemolysis at >4000 μg/mL | Rat | Arginine-Based Four-Armed Copolypeptides | NA | Non-hemolytic | ||
| 32134261 | 2020 | FIIWPLRYRK{ct:Amid} | somuncurin-1 | Amidation | Free | Linear | L | None | 10 | Antibacterial | <5 % Hemolysis at 180 μM | Human | Frog Pleurodema Somuncurence | water = Random coil, TFE = α-Helical | Low hemolytic | ||
| 32134261 | 2020 | FILKRSYPQYY{ct:Amid} | somuncurin-2 | Amidation | Free | Linear | L | None | 11 | Antibacterial | <5 % Hemolysis at 180 μM | Human | Frog Pleurodema Somuncurence | water = Random coil, TFE = Random coil | Low hemolytic | ||
| 32134261 | 2020 | NLVGSLLGGILKK{ct:Amid} | thaulin-3 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 180 μM | Human | Frog Pleurodema Somuncurence | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 32342079 | 2020 | RLKKIGKVLKWI{ct:Amid} | RI12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36) | 10 mM PBS = Random coil + <30% α-Helical, TFE = α-Helical | Low hemolytic | ||
| 32342079 | 2020 | RWKKIGKVWKWI{ct:Amid} | RI12[L2W,L9W] | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36) | 10 mM PBS & TFE = TrpZip Hairpin | Low hemolytic | ||
| 32342079 | 2020 | RWKKIGWVWKWI{ct:Amid} | RI12[L2W,K7W,L9W] | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 128 μM | Human | Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36) | 10 mM PBS & TFE = TrpZip Hairpin | Low hemolytic | ||
| 32342079 | 2020 | RLKKIGWVLKWI{ct:Amid} | RI12[K7W] | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 128 μM | Human | Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36) | 10 mM PBS = Random coil + <30% α-Helical, TFE = α-Helical | Low hemolytic | ||
| 32342079 | 2020 | RLWKIGKVLKWI{ct:Amid} | RI12[K3W] | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36) | 10 mM PBS = Random coil + <30% α-Helical, TFE = α-Helical | Low hemolytic | ||
| 32342079 | 2020 | RLWKIGWVLKWI{ct:Amid} | RI12[K3W,K7W] | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 32 μM | Human | Dodecapeptide From Pig (Porcine Myeloid Antimicrobial Peptide-36 (Pmap-36) | 10 mM PBS = Random coil + <30% α-Helical, TFE = α-Helical | NA | ||
| 32367434 | 2020 | PFKISIHL{ct:Amid} | JI (Jelleine-I) | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antifungal | 50 % Hemolysis at 500 µmol /L | Human | Buffer = Random Coil, Anionic Environments = Β-Strands | octapeptide royal jelly honey bee | Low hemolytic | ||
| 32367434 | 2020 | PWKISIHL{ct:Amid} | JIF2W | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antifungal | 50 % Hemolysis at 500 µmol /L | Human | Buffer = Random Coil, Anionic Environments = Β-Strands | analogs of Jelleine-I | Low hemolytic | ||
| 32367434 | 2020 | PWRISIRL{ct:Amid} | JIF2WR | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antifungal | 50 % Hemolysis at 91 µmol /L | Human | Buffer = Random Coil, Anionic Environments = Β-Strands | analogs of Jelleine-I | NA | ||
| 33937618 | 2020 | LLKELWTKMKGAGKAVLGKIKGLL | L1 | Free | Free | Linear | L | None | 24 | Antibacterial | 1 % Hemolysis at 15 μM | Human | Ponerine Ant Neoponera Goeldii | water = Random/dosordered structure, lipid vesicles = α-Helix | Low hemolytic | ||
| 33937618 | 2020 | LLKQLWTKMKGAGKAVLGKIKGLL | L1-Q | Free | Free | Linear | L | None | 24 | Antibacterial | 1 % Hemolysis at 15 μM | Human | L1 Variants | water = Random/dosordered structure, lipid vesicles = α-Helix | Low hemolytic | ||
| 33937618 | 2020 | LLKKLWTKMKGAGKAVLGKIKGLL | L1-K | Free | Free | Linear | L | None | 24 | Antibacterial | 1 % Hemolysis at 15 μM | Human | L1 Variants | water = Random/dosordered structure, lipid vesicles = α-Helix | Low hemolytic | ||
| 33937618 | 2020 | LLRELWTRMRGAGRAVLGRIRGLL | L1-R | Free | Free | Linear | L | None | 24 | Antibacterial | <5 % Hemolysis at 15 μM | Human | L1 Variants | water = Random/dosordered structure, lipid vesicles = α-Helix | Low hemolytic | ||
| 33937618 | 2020 | LL{nnr:O}ELWT{nnr:O}M{nnr:O}GAG{nnr:O}AVLG{nnr:O}I{nnr:O}GLL | L1-O | Free | Free | Linear | L | O = L-Ornithine | 24 | Antibacterial | 1 % Hemolysis at 15 μM | Human | L1 Variants | water = Helical, lipid vesicles = α-Helix | Low hemolytic | ||
| 33937618 | 2020 | LL{nnr:X}ELWT{nnr:X}M{nnr:X}GAG{nnr:X}AVLG{nnr:X}I{nnr:X}GLL | L1-X | Free | Free | Linear | L | X = L-di-amino-propionic acid | 24 | Antibacterial | 1 % Hemolysis at 15 μM | Human | L1 Variants | water = Random/dosordered structure, lipid vesicles = α-Helix | Low hemolytic | ||
| 32443921 | 2020 | FLGAILKIGHALAKTVLPMVTNAFKPKQ | Figainin 2 | Free | Free | Linear | L | None | 28 | Antibacterial, Anticancer, Anti-Epimastigote, Antiviral, Antitrypanosomal, exhibits immunomodulatory effects in human neutrophils | 50 % Hemolysis at 48.9 μM | Human | Skin Chaco Tree Frog, Boana Raniceps | α-Helix, Milli-Q water and 10% (v/v) TFE = Random coil, 30% and 50% (v/v) TFE = α-Helix | NA | ||
| 32443921 | 2020 | FLGAILKIGHALAKTVLPMVTNAFKPKQ | Figainin 2 | Free | Free | Linear | L | None | 28 | Antibacterial, Anticancer, Anti-Epimastigote, Antiviral, Antitrypanosomal, exhibits immunomodulatory effects in human neutrophils | 23 % Hemolysis at 32 μM | Human | Skin Chaco Tree Frog, Boana Raniceps | α-Helix, Milli-Q water and 10% (v/v) TFE = Random coil, 30% and 50% (v/v) TFE = α-Helix | NA | ||
| 32443921 | 2020 | FLGAILKIGHALAKTVLPMVTNAFKPKQ | Figainin 2 | Free | Free | Linear | L | None | 28 | Antibacterial, Anticancer, Anti-Epimastigote, Antiviral, Antitrypanosomal, exhibits immunomodulatory effects in human neutrophils | 9 % Hemolysis at 16 μM | Human | Skin Chaco Tree Frog, Boana Raniceps | α-Helix, Milli-Q water and 10% (v/v) TFE = Random coil, 30% and 50% (v/v) TFE = α-Helix | NA | ||
| 32670215 | 2020 | KRFWQLVPLAIKIYRAWKRR{ct:Amid} | dCATH | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 4 μM | Human | Cath Amp From Duck | α-Helix | NA | ||
| 32670215 | 2020 | KRFAQLVPLAIKIYRAAKRR{ct:Amid} | dCATH-AA | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 256 μM | Human | Modified Verison Of Dcath | α-Helix | Low hemolytic | ||
| 32670215 | 2020 | KRFWQLVPLAIKIYRA{ct:Amid} | dCATH(1–16) | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at 256 μM | Human | Modified Verison Of Dcath | α-Helix | Low hemolytic | ||
| 32670215 | 2020 | KRFWQLVPLAIKIYRAW{ct:Amid} | dCATH(1–17) | Amidation | Free | Linear | L | None | 17 | Antibacterial | 10 % Hemolysis at 8 μM | Human | Modified Verison Of Dcath | α-Helix | NA | ||
| 32670215 | 2020 | KRFWQLVPLAIKIYRAWK{ct:Amid} | dCATH(1–18) | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 8 μM | Human | Modified Verison Of Dcath | α-Helix | NA | ||
| 32670215 | 2020 | QLVPLAIKIYRAWKRR{ct:Amid} | dCATH(5–20) | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at 128 μM | Human | Modified Verison Of Dcath | α-Helix | Low hemolytic | ||
| 32670215 | 2020 | WQLVPLAIKIYRAWKRR{ct:Amid} | dCATH(4–20) | Amidation | Free | Linear | L | None | 17 | Antibacterial | 10 % Hemolysis at 16 μM | Human | Modified Verison Of Dcath | α-Helix | NA | ||
| 32670215 | 2020 | FWQLVPLAIKIYRAWKRR{ct:Amid} | dCATH(3–20) | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 4 μM | Human | Modified Verison Of Dcath | α-Helix | NA | ||
| 32670215 | 2020 | QLVPLAIKIYRA{ct:Amid} | dCATH(5–16) | Amidation | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 256 μM | Human | Modified Verison Of Dcath | unordered conformation | Low hemolytic | ||
| 32670215 | 2020 | KRFAQLVPLAIKIYRA{ct:Amid} | dCATH(1–16)-4A | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at 256 μM | Human | Modified Verison Of Dcath | α-Helix | Low hemolytic | ||
| 32670215 | 2020 | QLVPLAIKIYRAAKRR{ct:Amid} | dCATH(5–20)-17A | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at 256 μM | Human | Modified Verison Of Dcath | α-Helix | Low hemolytic | ||
| 32499514 | 2020 | RKEKIKKRIGKIDRL{ct:Amid} | P0 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >250 µg/ml | Human | Designed From The Conserved Sequences Of Cathelicidin | α-Helical | Low hemolytic | ||
| 32499514 | 2020 | KIAKRIWKILRR{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 250 µg/ml | Human | Modification By Truncation Of P0 | NA | Low hemolytic | ||
| 32499514 | 2020 | GLFDIVKKVAG{ct:Amid} | A0 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 10 % Hemolysis at >250 µg/ml | Human | Designed From The Conserved Sequences Of Aurein | α-Helical | Low hemolytic | ||
| 32499514 | 2020 | RLFRRVKKVAG{ct:Amid} | A3 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 10 % Hemolysis at >250 µg/ml | Human | Modification By Truncation Of A0 | NA | Low hemolytic | ||
| 32499514 | 2020 | KIAKRIWKILRRRLFRRVKKVAG{ct:Amid} | P7A3 | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 3.91 µg/ml | Human | Hybrid Peptide Derivatives Of P7 & A3 | NA | NA | ||
| 32499514 | 2020 | KIAKRIWKILRRRLFRRV{ct:Amid} | PA-18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 3.91 µg/ml | Human | Truncated Derivatives Of The Hybrid Analogue (P7A3) | α-Helical | NA | ||
| 32499514 | 2020 | KIAKRIWKILRRRLFRR{ct:Amid} | PA-17 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 10 % Hemolysis at 3.91 µg/ml | Human | Truncated Derivatives Of The Hybrid Analogue (P7A3) | NA | NA | ||
| 32499514 | 2020 | KIAKRIWKILRRRLFR{ct:Amid} | PA-16 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 10 % Hemolysis at 3.91 µg/ml | Human | Truncated Derivatives Of The Hybrid Analogue (P7A3) | NA | NA | ||
| 32499514 | 2020 | KIAKRIWKILRRRLF{ct:Amid} | PA-15 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at 3.91 µg/ml | Human | Truncated Derivatives Of The Hybrid Analogue (P7A3) | NA | NA | ||
| 32499514 | 2020 | KIAKRIWKILRRRL{ct:Amid} | PA-14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 15.63 µg/ml | Human | Truncated Derivatives Of The Hybrid Analogue (P7A3) | NA | NA | ||
| 32499514 | 2020 | KIAKRIWKILRRR{ct:Amid} | PA-13 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at 125 µg/ml | Human | Truncated Derivatives Of The Hybrid Analogue (P7A3) | aqueous = Random coil, 30mM SDS, 50% TFE, and 0.05% LPS (MME) = α-Helical | NA | ||
| 32521823 | 2020 | RYRRKKKMKKALQYIKLLKE{ct:Amid} | 35409 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 1.56 μM | Human | Parasite Plasmodium Falciparum Rifin Protein-Derived Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | NA | ||
| 32521823 | 2020 | RKKKMKKALQYIKLLKE{ct:Amid} | 35409-1 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiotic Synergy | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = α-Helix (200 to 260nm) | Non-hemolytic | ||
| 32521823 | 2020 | KKKMKKALQYIKLLKE{ct:Amid} | 35409-2 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antibiotic Synergy | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = α-Helix (200 to 260nm) | Non-hemolytic | ||
| 32521823 | 2020 | KKMKKALQYIKLLKE{ct:Amid} | 35409-3 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = Helical | Non-hemolytic | ||
| 32521823 | 2020 | KMKKALQYIKLLKE{ct:Amid} | 35409-4 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiotic Synergy | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = α-Helix (200 to 260nm) | Non-hemolytic | ||
| 32521823 | 2020 | MKKALQYIKLLKE{ct:Amid} | 35409-5 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = Helical | Non-hemolytic | ||
| 32521823 | 2020 | ALQYIKLLKE{ct:Amid} | 35409-6 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | YIKLLKE{ct:Amid} | 35409-7 | Amidation | Free | Linear | L | None | 7 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Seven Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | RYRRKKKMKKALQYIKL{ct:Amid} | 35409-8 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Five Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | RYRRKKKMKKALQY{ct:Amid} | 35409-9 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Five Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | RYRRKKKMKKA{ct:Amid} | 35409-10 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Five Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | RYRRKKKMKK{ct:Amid} | 35409-11 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Five Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | RYRRKKK{ct:Amid} | 35409-12 | Amidation | Free | Linear | L | None | 7 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Five Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | KKMKKALQYIKLLK{ct:Amid} | 35409-13 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiotic Synergy | 10 % Hemolysis at >200 μM | Human | 35409 Four Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = α-Helix (200 to 260nm) | Non-hemolytic | ||
| 32521823 | 2020 | KKMKKALQYIKL{ct:Amid} | 35409-14 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 100 μM | Human | 35409 Four Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | NA | ||
| 32521823 | 2020 | RKKKMKKALQY{ct:Amid} | 35409-15 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 10 % Hemolysis at 200 μM | Human | 35409 Four Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32521823 | 2020 | KMKKALQY{ct:Amid} | 35409-16 | Amidation | Free | Linear | L | None | 8 | Antibacterial | 10 % Hemolysis at >200 μM | Human | 35409 Four Truncated Modification Sequence Peptide | 1X PBS = Disordered, PBS with 10 mM SDS = distorted trend (195 and 210nm) | Non-hemolytic | ||
| 32576824 | 2020 | GFCWYVCVYRNGVRVCYRRCN | Arenicin-3 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 204 µg/ml | Human | Marine Lugworm Arenicola Marina | (twisted β-Hairpin) anti-parallel β-Sheet and two stabilizing disulfide bonds | NA | ||
| 32576824 | 2020 | GFCWYVCARRNGARVCYRRCN | AA139 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576824 | 2020 | GFCWRVCASRNGLRVCYRRCN | NZ17125 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 181 µg/ml | Human | Arenicin-3 Analogs | NA | NA | ||
| 32576824 | 2020 | GFCWYACAKRNGLRVCYRRCN | NZ17126 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 232 µg/ml | Human | Arenicin-3 Analogs | NA | NA | ||
| 32576824 | 2020 | GFCWNVCVRRNGVRVCHRRCN | NZ17143 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576824 | 2020 | GFCWYVCVKRNGVRSCYRRCN | NZ17160 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576824 | 2020 | GFCWNVCVYRNGVRICHRRCN | NZ17211 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576824 | 2020 | GFCWHVCARRNGVRVCYRRCN | NZ17224 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576824 | 2020 | GFCWRACVYRNGVRACYRRCN | NZ17228 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576824 | 2020 | GFCWRACVYRNGVRVCYRRCN | NZ17230 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576874 | 2020 | GFLSILKKVLPKVMAHMK{ct:Amid} | Melectin | Amidation | Free | Linear | L | None | 18 | Antibacterial, Anti-inflammatory | 0 % Hemolysis at 32 μM | Sheep | Bee Venom Melecta Albifrons | LTA and LPS (208 and 222nm) = α-Helical | Non-hemolytic | ||
| 32334835 | 2020 | QAK{nt:Amid} | QAK | Free | Amidation | Linear | L | None | 3 | Antibacterial, Antibiofilm | 12 % Hemolysis at 30 µg/ml | Rabbit | Hemolymph Non-Mulberry Silkworm Antheraea Mylitta | NA | NA | ||
| 32334835 | 2020 | QAK{nt:Amid} | QAK | Free | Amidation | Linear | L | None | 3 | Antibacterial, Antibiofilm | 18 % Hemolysis at 60 µg/ml | Rabbit | Hemolymph Non-Mulberry Silkworm Antheraea Mylitta | NA | NA | ||
| 32334835 | 2020 | QAK{nt:Acet}{ct:Acet} | acetylated-QAK | Acetylation | Acetylation | Linear | L | None | 3 | Antibacterial, Antibiofilm | 1 % Hemolysis at 3.75 µg/ml | Rabbit | Synthesized-Qak | NA | Low hemolytic | ||
| 32334835 | 2020 | QAK{nt:Acet}{ct:Acet} | acetylated-QAK | Acetylation | Acetylation | Linear | L | None | 3 | Antibacterial, Antibiofilm | 2 % Hemolysis at 7.5 µg/ml | Rabbit | Synthesized-Qak | NA | Low hemolytic | ||
| 32334835 | 2020 | QAK{nt:Acet}{ct:Acet} | acetylated-QAK | Acetylation | Acetylation | Linear | L | None | 3 | Antibacterial, Antibiofilm | 19.55 % Hemolysis at 100 µg/ml | Rabbit | Synthesized-Qak | NA | Low hemolytic | ||
| 32334835 | 2020 | QAK{nt:Acet}{ct:Acet} | acetylated-QAK | Acetylation | Acetylation | Linear | L | None | 3 | Antibacterial, Antibiofilm | 38.28 % Hemolysis at 200 µg/ml | Rabbit | Synthesized-Qak | NA | NA | ||
| 32636607 | 2020 | RNFFKRIRRAGKRIRKAI{nt:Amid} | CAMP-CecD | Free | Amidation | Linear | L | None | 18 | Antibacterial | 0 % Hemolysis at 256 µg/mL | Human | Derived Δm2 Greater Wax Moth Galleria Mellonella | Helical | Non-hemolytic | ||
| 32439180 | 2020 | ARLDVASEFRKKWNKWALSR{ct:Amid} | PAMP | Amidation | Free | Linear | L | None | 20 | Antibacterial | >10 % Hemolysis at >256 μM | Sheep | Proadrenomedullin | NA | Non-hemolytic | ||
| 32439180 | 2020 | FRKKWNKWALSR{ct:Amid} | PAMP(9-20) | Amidation | Free | Linear | L | None | 12 | Antibacterial | >10 % Hemolysis at >256 μM | Sheep | Derived From Pamp | NA | Non-hemolytic | ||
| 32629881 | 2020 | K{nnr:Nal}KK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KN{cyc:N-C} | BSI-9 | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid | 9 | Antibacterial | 33 % Hemolysis at 150 μM | Human | Synthetic Cyclic Amp | NA | NA | ||
| 32629881 | 2020 | K{nnr:Nal}KK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}NK{cyc:N-C} | BSI-9 stage-1 (1) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid | 9 | Antibacterial | Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32629881 | 2020 | K{nnr:Nal}KN{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KK{cyc:N-C} | BSI-9 stage-1 (2) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid | 9 | Antibacterial | Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32629881 | 2020 | K{nnr:Nal}NK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KK{cyc:N-C} | BSI-9 stage-1 (3) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid | 9 | Antibacterial | Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32629881 | 2020 | N{nnr:Nal}KK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KK{cyc:N-C} | BSI-9 stage-1 (4) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid | 9 | Antibacterial | Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32629881 | 2020 | KFKK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KN{cyc:N-C} | BSI-9 stage-2 (5) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid | 9 | Antibacterial | 4 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | Non-hemolytic | ||
| 32629881 | 2020 | K{nnr:Nal}KKF-{nnr:O2Oc}-{nnr:Nal}KN{cyc:N-C} | BSI-9 stage-2 (6) | Free | Free | Cyclic | L | Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid | 9 | Antibacterial | 6 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | Non-hemolytic | ||
| 32629881 | 2020 | K{nnr:Nal}KK{nnr:Bip}-{nnr:O2Oc}-FKN{cyc:N-C} | BSI-9 stage-2 (7) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid | 9 | Antibacterial | 7 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | Non-hemolytic | ||
| 32629881 | 2020 | KFKKF-{nnr:O2Oc}-FKN{cyc:N-C} | BSI-9 stage-2 (8) | Free | Free | Cyclic | L | O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid | 9 | Antibacterial | 3 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | Non-hemolytic | ||
| 32629881 | 2020 | {nnr:Dab}{nnr:Nal}{nnr:Dab}{nnr:Dab}{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C} | BSI-9 stage-2 (9) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid | 9 | Antibacterial | 76 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32629881 | 2020 | R{nnr:Nal}{nnr:Dab}{nnr:Dab}{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C} | BSI-9 stage-3 (10) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid | 9 | Antibacterial | 66 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32629881 | 2020 | {nnr:Dab}{nnr:Nal}R{nnr:Dab}{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C} | BSI-9 stage-3 (11) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid | 9 | Antibacterial | 36 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32629881 | 2020 | {nnr:Dab}{nnr:Nal}{nnr:Dab}R{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C} | BSI-9 stage-3 (12) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid | 9 | Antibacterial | 98 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32629881 | 2020 | {nnr:Dab}{nnr:Nal}{nnr:Dab}{nnr:Dab}{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}RN{cyc:N-C} | BSI-9 stage-3 (13) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid | 9 | Antibacterial | 80 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32629881 | 2020 | R{nnr:Nal}RR{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}RN{cyc:N-C} | BSI-9 stage-3 (14) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid | 9 | Antibacterial | 68 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32629881 | 2020 | R{nnr:Nal}RDap{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C} | BSI-9 stage-4 (15) | Free | Free | Cyclic | L | Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid | 9 | Antibacterial | 100 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32629881 | 2020 | R{nnr:Nal}R{nnr:Dab}F-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C} | BSI-9 stage-4 (16) | Free | Free | Cyclic | L | Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid | 9 | Antibacterial | 16 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32629881 | 2020 | R{nnr:Nal}{nnr:Dab}{nnr:Dab}F-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C} | BSI-9 stage-4 (17) | Free | Free | Cyclic | L | Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid | 9 | Antibacterial | 3 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | Non-hemolytic | ||
| 32629881 | 2020 | {nnr:Dab}{nnr:Nal}R{nnr:Dab}F-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C} | BSI-9 stage-4 (18) | Free | Free | Cyclic | L | Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid | 9 | Antibacterial | 30 % Hemolysis at 150 μM | Human | Analogues Of Bsi-9 | NA | NA | ||
| 32151610 | 2020 | LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | analogs of 1 (12res) | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 12 | Antibacterial | −1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | {nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | analogs of 1 (13res) | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 13 | Antibacterial | −1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | L-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | analogs of 1 (14res) | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 0 ± 3 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | Non-hemolytic | ||
| 32151610 | 2020 | LL-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | analogs of 1 (15res) | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 15 | Antibacterial | 0 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | LLL-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | analogs of 1 (16res) | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 16 | Antibacterial | −1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | Non-hemolytic | ||
| 32151610 | 2020 | LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH} | 12-residue R4R11 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 12 | Antibacterial | −1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | β-Sheet, TFE = α-Helical | Non-hemolytic | ||
| 32151610 | 2020 | {nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH} | 13-residue R4R11 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 12 | Antibacterial | −1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | β-Sheet, TFE = α-Helical | Non-hemolytic | ||
| 32151610 | 2020 | LL-{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH} | 15-residue R4R11 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 15 | Antibacterial | 0 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | β-Sheet, TFE = α-Helical | Non-hemolytic | ||
| 32151610 | 2020 | LLL-{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH} | 16-residue R4R11 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 16 | Antibacterial | −1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | β-Sheet, TFE = α-Helical | NA | ||
| 32151610 | 2020 | LLR-{nnr:CE}-LL-{nnr:CE}-R-LL-{nnr:CE}-L{nt:H}{ct:OH} | 12-residue R5R10 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 12 | Antibacterial | 96 ± 6 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | {nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH} | 13-residue R5R10 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 13 | Antibacterial | 28 ± 7 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | LL-{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH} | 15-residue R5R10 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 15 | Antibacterial | 102 ± 10 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | LLL-{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH} | 16-residue R5R10 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 16 | Antibacterial | 104 ± 5 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | α-Helical | NA | ||
| 32151610 | 2020 | L-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | 15C5 1 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 0 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | NA | Non-hemolytic | ||
| 32151610 | 2020 | L-{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH} | 15C5 R4R11 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 1 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | NA | Non-hemolytic | ||
| 32151610 | 2020 | L-{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH} | 15C5 R5R10 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 13 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | NA | NA | ||
| 32151610 | 2020 | L-{nnr:CE}-LLL-{nnr:CE}-LL-{nnr:CE}-LLL-{nnr:CE}-L{nt:H}{ct:OH} | 18C6 1 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 2 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | NA | NA | ||
| 32151610 | 2020 | L-{nnr:CE}-LRL-{nnr:CE}-LL-{nnr:CE}-LRL-{nnr:CE}-L{nt:H}{ct:OH} | 18C6 R4R11 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 0 ± 1 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | NA | Non-hemolytic | ||
| 32151610 | 2020 | L-{nnr:CE}-LLR-{nnr:CE}-LL-{nnr:CE}-RLL-{nnr:CE}-L{nt:H}{ct:OH} | 18C6 R5R10 | OH | H | Linear | L | CE = 21-crown-7-modified phenylalanine | 14 | Antibacterial | 22 ± 2 % Hemolysis at 100 μM | Sheep | Synthetic Peptide | NA | NA | ||
| 32333997 | 2020 | MSLLERKLLMHFLRV | La-AMP1 | Free | Free | Linear | L | None | 15 | Antibacterial | 52 % Hemolysis at 128 µg/mL | Human | Plant Lippia Alba | α-Helix | NA | ||
| 32333997 | 2020 | GLMKLLRELLHMFSRVG | La-AMP1a | Free | Free | Linear | L | None | 17 | Antibacterial | 0.5 % Hemolysis at 128 µg/mL | Human | Derived From La-Amp1 Plant Lippia Alba | α-Helix | Non-hemolytic | ||
| 32333997 | 2020 | MRIGLRFVLM | Lr-AMP1 | Free | Free | Linear | L | None | 10 | Antibacterial | 71.5 % Hemolysis at 128 µg/mL | Human | Plant Lippia Rotundifolia | Random coil | NA | ||
| 32333997 | 2020 | SVAGRAMRIGLRFVLM | Lr-AMP1d | Free | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 128 µg/mL | Human | Derived From Lr-Amp1 Plant Lippia Rotundifolia | α-Helix | Non-hemolytic | ||
| 32333997 | 2020 | GIAGLLRSFVRMLAKIMGG | Lr-AMP1e | Free | Free | Linear | L | None | 19 | Antibacterial | 50 % Hemolysis at 128 µg/mL | Human | Derived From Lr-Amp1 Plant Lippia Rotundifolia | α-Helix | NA | ||
| 32333997 | 2020 | GSVLRAIMRMFAKLMG | Lr-AMP1f | Free | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 128 µg/mL | Human | Derived From Lr-Amp1 Plant Lippia Rotundifolia | α-Helix | Non-hemolytic | ||
| 32333997 | 2020 | GIHGVVRSFMRMLGHLG | Lr-AMP1g | Free | Free | Linear | L | None | 17 | Antibacterial | 0 % Hemolysis at 128 µg/mL | Human | Derived From Lr-Amp1 Plant Lippia Rotundifolia | α-Helix | Non-hemolytic | ||
| 32333997 | 2020 | GSVIRALMRMFARLVG | Lr-AMP1h | Free | Free | Linear | L | None | 16 | Antibacterial | 2.3 % Hemolysis at 128 µg/mL | Human | Derived From Lr-Amp1 Plant Lippia Rotundifolia | α-Helix | NA | ||
| 32567085 | 2020 | FKRIVQRIKDFLR{nt:NA}{ct:Amid} | 1 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | LKRIVQRIKDFLR{nt:NA}{ct:Amid} | 2 | Amidation | NA | Linear | L | None | 13 | Antibacterial, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | AKRIVQRIKDFLR{nt:NA}{ct:Amid} | 3 | Amidation | NA | Linear | L | None | 13 | Antibacterial, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | F{nnr:κ}RIVQRILDFLR{nt:Acet}{ct:Amid} | 4 | Amidation | Acetylation | Linear | L | κ = κ | 13 | Antibacterial, Anticancer | 50 % Hemolysis at 450 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FK({nnr:SA})RIVQRILDFLR{nt:Acet}{ct:Amid} | 5 | Amidation | Acetylation | Linear | L | SA = SA | 14 | Antibacterial, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRIVQRIRDFLR{nt:NA}{ct:Amid} | 6 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRIVQRIRDFLR{nt:Acet}{ct:Amid} | 7 | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRIVQ{nnr:κ}IKDFLR{nt:NA}{ct:Amid} | 8 | Amidation | NA | Linear | L | κ = κ | 13 | Antibacterial, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRIVQLIKDFLR{nt:NA}{ct:Amid} | 9 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 114 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FKRIVQLIKDFLR{nt:Acet}{ct:Amid} | 10 | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 227 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FKRIVQRIKDLLR{nt:NA}{ct:Amid} | 11 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRIVQRIKDLLR{nt:Acet}{ct:Amid} | 12 | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRIVQIIKKFLR{nt:NA}{ct:Amid} | 13 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 361 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FKRIVQIIKKFLR{nt:Acet}{ct:Amid} | 14 | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 292 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FKRIVQLLKKLLR{nt:NA}{ct:Amid} | 15 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 411 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FKRIVQLLKKLLR{nt:Acet}{ct:Amid} | 16 | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 185 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | NA | ||
| 32567085 | 2020 | FKRILQRIKDFLR{nt:NA}{ct:Amid} | 17 | Amidation | NA | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32567085 | 2020 | FKRILQRIKDFLR{nt:Acet}{ct:Amid} | 18 | Amidation | Acetylation | Linear | L | None | 13 | Antibacterial,Antifungal, Anticancer | 50 % Hemolysis at 0 µg/mL | Human | Derivedm From Cathelicidin Ll-37 | α-Helix | Non-hemolytic | ||
| 32654770 | 2020 | {nnr:Aβ}LLKRIKTLL{ct:Amid} | Ano-1β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | G{nnr:Aβ}LKRIKTLL{ct:Amid} | Ano-2β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GL{nnr:Aβ}KRIKTLL{ct:Amid} | Ano-3β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLL{nnr:Aβ}RIKTLL{ct:Amid} | Ano-4β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLK{nnr:Aβ}IKTLL{ct:Amid} | Ano-5β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKR{nnr:Aβ}KTLL{ct:Amid} | Ano-6β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRI{nnr:Aβ}TLL{ct:Amid} | Ano-7β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRIK{nnr:Aβ}LL{ct:Amid} | Ano-8β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRIKT{nnr:Aβ}L{ct:Amid} | Ano-9β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRIKTL{nnr:Aβ}{ct:Amid} | Ano-10β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | {nnr:Aβ}LLKRIK{nnr:Aβ}LL{ct:Amid} | Ano-1β8β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Venom Sac Of Solitary Spider Wasps | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32569466 | 2020 | WFQVKTRVRTKVQFW | WF-1 | Free | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at 64 μM | Human | Mutagenesis Modification Peptide Of Wi-6 | SDS = β-Sheet | NA | ||
| 32569466 | 2020 | FWRRYKKVKKYRRWF | FW-2 | Free | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at >256 μM | Human | Mutagenesis Modification Peptide Of Wi-6 | PBS (aqueous)= Disordered, TFE = α-Helical | Low hemolytic | ||
| 32569466 | 2020 | FWQVIKKVKKIVQWF | FW-3 | Free | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at 64 μM | Human | Mutagenesis Modification Peptide Of Wi-6 | PBS (aqueous)= Disordered, TFE = α-Helical | NA | ||
| 32569466 | 2020 | FKQFYRRVRRYFQKF | FK-4 | Free | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at 128 μM | Human | Mutagenesis Modification Peptide Of Wi-6 | PBS (aqueous)= Disordered, TFE = α-Helical | NA | ||
| 32569466 | 2020 | FRQWYRRVRRYWQRF | FR-5 | Free | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at 64 μM | Human | Mutagenesis Modification Peptide Of Wi-6 | PBS (aqueous)= Disordered, TFE = α-Helical | NA | ||
| 32569466 | 2020 | WIQPKTKVIPYVRYL | WI-6 | Free | Free | Linear | L | None | 15 | Antibacterial | 5 % Hemolysis at 256 μM | Human | Bovine Αs2-Casein F21 (193-207) | PBS (aqueous)= Disordered | Low hemolytic | ||
| 32704013 | 2020 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antibacterial | 0 % Hemolysis at 1 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet) | Non-hemolytic | ||
| 32704013 | 2020 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antibacterial | 1 % Hemolysis at 2 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet) | NA | ||
| 32704013 | 2020 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antibacterial | 1 % Hemolysis at 4 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet) | NA | ||
| 32704013 | 2020 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antibacterial | 3 % Hemolysis at 8 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet) | NA | ||
| 32704013 | 2020 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antibacterial | 2 % Hemolysis at 16 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet) | NA | ||
| 32704013 | 2020 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antibacterial | 2 % Hemolysis at 32 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet) | NA | ||
| 32704013 | 2020 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antibacterial | 4 % Hemolysis at 64 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet) | NA | ||
| 32704013 | 2020 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antibacterial | 6 % Hemolysis at 128 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet) | NA | ||
| 32704013 | 2020 | KLKLKL{ct:Amid} | KL6 | Amidation | Free | Linear | L | None | 6 | Antibacterial | 7 % Hemolysis at 256 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC (pH ≈ 6) = Random coil, DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = Mixture (Random coil + β-Sheet) | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 11 % Hemolysis at 1 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 12 % Hemolysis at 2 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 16 % Hemolysis at 4 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 20 % Hemolysis at 8 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 28 % Hemolysis at 16 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 40 % Hemolysis at 32 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 59 % Hemolysis at 64 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 81 % Hemolysis at 128 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKL{ct:Amid} | KL10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 94 % Hemolysis at 256 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10) = 54% β-Sheet (34% antiparallel, 20% parallel), rest Helical + others, 10 mM Phosphate Buffer (pH = 7.0) = β-Sheet (100%: 83% antiparallel, 17% parallel), DMPC/DMPG (4/1) (pH ≈ 6) = Mixture (Ran | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 47 % Hemolysis at 1 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 86 % Hemolysis at 2 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 96 % Hemolysis at 4 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 96 % Hemolysis at 8 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 95 % Hemolysis at 16 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 94 % Hemolysis at 32 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 94 % Hemolysis at 64 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 91 % Hemolysis at 128 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKL{ct:Amid} | KL14 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 89 % Hemolysis at 256 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 33 % Hemolysis at 1 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 80 % Hemolysis at 2 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 95 % Hemolysis at 4 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 95 % Hemolysis at 8 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 90 % Hemolysis at 16 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 82 % Hemolysis at 32 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 79 % Hemolysis at 64 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 78 % Hemolysis at 128 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32704013 | 2020 | KLKLKLKLKLKLKLKLKL{ct:Amid} | KL18 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 78 % Hemolysis at 256 µg/mL | Human | Kl Peptides | Water (pH ≈ 6), DMPC (pH ≈ 6) = Random coil, Water (pH ≈ 10), 10 mM Phosphate Buffer (pH = 7.0), DMPC/DMPG (4/1) (pH ≈ 6), POPC/POPG (1/1) (pH ≈ 6) = β-Sheet | NA | ||
| 32722535 | 2020 | GIFSKLAGKKLKNLLISG{ct:Amid} | Esc(1-18) | Amidation | Free | Linear | L | None | 18 | Antibacterial | ~10 % Hemolysis at 64 μM | Sheep | Frog Derived Esculentin Peptide | NA | NA | ||
| 32722535 | 2020 | GIFSKLAGKKIKNLLISGLKG{ct:Amid} | Esc(1-21) | Amidation | Free | Linear | L | None | 21 | Antibacterial | ~10 % Hemolysis at 64 μM | Sheep | Frog Derived Esculentin Peptide | NA | NA | ||
| 32229648 | 2020 | LVGALVSTLLSLVPSLMK{ct:Amid} | Dq-1840 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 7.8 % Hemolysis at 10 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | NA | ||
| 32229648 | 2020 | FWGTLAKWALKAIPAAMGMKQNK | Dq-2562 | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal, histamine-releasing | 5.1 % Hemolysis at 10 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | NA | ||
| 32229648 | 2020 | GLKDWWNKHKDKIVKVVKEMGKAGINAA{ct:Amid} | Dq-3162 | Amidation | Free | Linear | L | None | 28 | Antibacterial, Antifungal, histamine-releasing | 0 % Hemolysis at 10 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | Non-hemolytic | ||
| 32229648 | 2020 | LVGALVSTLLSLVPSLMK{ct:Amid} | Dq-1840 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 35.3 % Hemolysis at 50 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | NA | ||
| 32229648 | 2020 | FWGTLAKWALKAIPAAMGMKQNK | Dq-2562 | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal, histamine-releasing | 82.9 % Hemolysis at 50 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | NA | ||
| 32229648 | 2020 | GLKDWWNKHKDKIVKVVKEMGKAGINAA{ct:Amid} | Dq-3162 | Amidation | Free | Linear | L | None | 28 | Antibacterial, Antifungal, histamine-releasing | 5.6 % Hemolysis at 50 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | NA | ||
| 32130974 | 2020 | RIRIRWIIR{nt:Amid}{ct:Amid} | A1 | Amidation | Amidation | Linear | L | None | 9 | Antibacterial | 50 % Hemolysis at >250 µg/mL | Human | Synthetic Amp | NA | Low hemolytic | ||
| 32130974 | 2020 | RIRIRWIIR{nt:(β-Ala)(β-Ala)(Lys)}{ct:Amid} | A2 | Amidation | (β-Ala)(β-Ala)(Lys) | Linear | L | Ala spacers and Lys | 9 | Antibacterial | 50 % Hemolysis at >250 µg/mL | Human | Modification Of A1 With Ala Spacers And Lys | NA | Low hemolytic | ||
| 32130974 | 2020 | RIRIRWIIR{nt:Caprylic acid (C8)}{ct:Amid} | A3 | Amidation | Caprylic acid (C8) | Linear | L | C8 = Caprylic acid | 9 | Antibacterial | 50 % Hemolysis at 132 µg/mL | Human | Modification Of A1 With Caprylic Acid (C8) | NA | NA | ||
| 32130974 | 2020 | RIRIRWIIR{nt:Capric acid (C10)}{ct:Amid} | A4 | Amidation | Capric acid (C10) | Linear | L | C10 = Capric acid | 9 | Antibacterial | 50 % Hemolysis at 73 µg/mL | Human | Modification Of A1 With Capric Acid (C10) | NA | NA | ||
| 32130974 | 2020 | RIRIRWIIR{nt:Lauric acid (C12)}{ct:Amid} | A5 | Amidation | Lauric acid (C12) | Linear | L | C12 = Lauric acid | 9 | Antibacterial | 50 % Hemolysis at 35 µg/mL | Human | Modification Of A1 With Lauric Acid (C12) | NA | NA | ||
| 32130974 | 2020 | RIRIRWIIR{nt:Myristic acid (C14)}{ct:Amid} | A6 | Amidation | Myristic acid (C14) | Linear | L | C14 = Myristic acid | 9 | Antibacterial | 50 % Hemolysis at 28 µg/mL | Human | Modification Of A1 With Myristic Acid (C14) | NA | NA | ||
| 32130974 | 2020 | RIRIRWIIR{nt:Ser-Glucose}{ct:Amid} | A7 | Amidation | Ser-Glucose | Linear | L | Glucose = Glucose | 9 | Antibacterial | 50 % Hemolysis at >250 µg/mL | Human | Modification Of A1 With Glucose | NA | Low hemolytic | ||
| 32130974 | 2020 | RIRIRWIIR{nt:Ser-N-Acetylglucosamine (GlcNac)}{ct:Amid} | A8 | Amidation | Ser-N-Acetylglucosamine (GlcNac) | Linear | L | GlcNAc = GlcNAc | 9 | Antibacterial | 50 % Hemolysis at >250 µg/mL | Human | Modification Of A1 With Glcnac | NA | Low hemolytic | ||
| 32130974 | 2020 | RIRIRWIIR{nt:Ser-Galactose}{ct:Amid} | A9 | Amidation | Ser-Galactose | Linear | L | Galactose = Galactose | 9 | Antibacterial | 50 % Hemolysis at >250 µg/mL | Human | Modification Of A1 With Galactose | NA | Low hemolytic | ||
| 32130974 | 2020 | RIRIRWIIR{nt:Ser-Mannose}{ct:Amid} | A10 | Amidation | Ser-Mannose | Linear | L | Mannose = Mannose | 9 | Antibacterial | 50 % Hemolysis at >250 µg/mL | Human | Modification Of A1 With Mannose | NA | Low hemolytic | ||
| 32130974 | 2020 | RIRIRWIIR{nt:Ser-Lactose}{ct:Amid} | A11 | Amidation | Ser-Lactose | Linear | L | Lactose = Lactose | 9 | Antibacterial | 50 % Hemolysis at >250 µg/mL | Human | Modification Of A1 With Lactose | NA | Low hemolytic | ||
| 32130974 | 2020 | RIRIRWIIR{nt:Meo-PEG}{ct:Amid} | A12 | Amidation | Meo-PEG | Linear | L | PEG = PEG | 9 | Antibacterial | 50 % Hemolysis at >250 µg/mL | Human | Modification Of A1 With Peg | NA | Low hemolytic | ||
| 32130974 | 2020 | KRRVRWIIW{nt:Amid}{ct:Amid} | B1 | Amidation | Amidation | Linear | L | None | 9 | Antibacterial | 50 % Hemolysis at >250 µg/mL | Human | Synthetic Amp | NA | Low hemolytic | ||
| 32130974 | 2020 | KRRVRWIIW{nt:(β-Ala)(β-Ala)(Lys)}{ct:Amid} | B2 | Amidation | (β-Ala)(β-Ala)(Lys) | Linear | L | Ala spacers and Lys | 9 | Antibacterial | 50 % Hemolysis at >250 µg/mL | Human | Modification Of B1 With Ala Spacers And Lys | NA | Low hemolytic | ||
| 32130974 | 2020 | KRRVRWIIW{nt:Caprylic acid (C8)}{ct:Amid} | B3 | Amidation | Caprylic acid (C8) | Linear | L | C8 = Caprylic acid | 9 | Antibacterial | 50 % Hemolysis at >250 µg/mL | Human | Modification Of B1 With Caprylic Acid (C8) | NA | Low hemolytic | ||
| 32130974 | 2020 | KRRVRWIIW{nt:Capric acid (C10)}{ct:Amid} | B4 | Amidation | Capric acid (C10) | Linear | L | C10 = Capric acid | 9 | Antibacterial | 50 % Hemolysis at 50 µg/mL | Human | Modification Of B1 With Capric Acid (C10) | NA | NA | ||
| 32130974 | 2020 | KRRVRWIIW{nt:Lauric acid (C12)}{ct:Amid} | B5 | Amidation | Lauric acid (C12) | Linear | L | C12 = Lauric acid | 9 | Antibacterial | 50 % Hemolysis at 38 µg/mL | Human | Modification Of B1 With Lauric Acid (C12) | NA | NA | ||
| 32130974 | 2020 | KRRVRWIIW{nt:Myristic acid (C14)}{ct:Amid} | B6 | Amidation | Myristic acid (C14) | Linear | L | C14 = Myristic acid | 9 | Antibacterial | 50 % Hemolysis at 25 µg/mL | Human | Modification Of B1 With Myristic Acid (C14) | NA | NA | ||
| 32171739 | 2020 | GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK | hBD-3 | Free | Free | Linear | L | None | 45 | Antibacterial | >15 % Hemolysis at 250 µg/mL | Human | Human Beta Defensin-3 | LPS aggregates = α-Helical | Low hemolytic | ||
| 32171739 | 2020 | GIINTLQKYYCRVRGGRSAVLSSLPKEEQIGKSSTRGRKCSRRKK{cyc:N-C} | hBD-3-c | Free | Free | Cyclic | L | None | 45 | Antibacterial | >15 % Hemolysis at 250 µg/mL | Human | Hbd-3 Cyclic Variant With One Disulfide Bond | LPS aggregates = α-Helical | Low hemolytic | ||
| 32171739 | 2020 | GIINTLQKYYSRVRGGRSAVLSSLPKEEQIGKSSTRGRKSSRRKK | hBD-3-l | Free | Free | Linear | L | None | 45 | Antibacterial | >15 % Hemolysis at 250 µg/mL | Human | Hbd-3 Linear Variant Without Disulfide Bond | LPS aggregates = α-Helical | Low hemolytic | ||
| 32406577 | 2020 | ALWKTLLKKVLKAAAKAALNAVLVGANA | K4S4 | Free | Free | Linear | L | None | 28 | Antibacterial | 50 % Hemolysis at 27.92 ± 8.1 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32406577 | 2020 | TLLKKVLKAAAKAALNAVLVGANA | S4(5–28) | Free | Free | Linear | L | None | 24 | Antibacterial | 50 % Hemolysis at >100 ± 0.0 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32406577 | 2020 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | S4(5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial | 50 % Hemolysis at >100 ± 0.0 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32406577 | 2020 | TLLKKVLKAAAKAALKAVLVGANA | K20S4(5–28) | Free | Free | Linear | L | None | 24 | Antibacterial | 50 % Hemolysis at >100 ± 0.0 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32406577 | 2020 | ALWKTLLKKVLKAAAK{ct:Amid} | K4S4(1–16)a | Amidation | Free | Linear | L | None | 16 | Antibacterial | 50 % Hemolysis at 88.21 ± 5.1 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32406577 | 2020 | ALWKTLLKKVLKAAA{ct:Amid} | K4S4(1–15)a | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 83.25 ± 7.0 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32406577 | 2020 | ALWKTLLKKVLKAAAK | K4S4(1–15) | Free | Free | Linear | L | None | 16 | Antibacterial | 50 % Hemolysis at >100 ± 0.0 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32738898 | 2020 | MNFSRVLVFVFACLVAMCA-VSAAPEPRWKVFKKIEKMGRNIRDGIIKAGPAVAVLGDAKALGK | Armyworm cecropin 1, AC-1 | Free | Free | Linear | L | None | 63 | Antibacterial | 14.47 ± 1.03 % Hemolysis at 500 µg/mL | Chicken | Armyworm Mythimna Separata | 20 mM PBS, pH 7.4 = anti-parallel (44.5%), β-Turn (22.6%), and Random coil (32.6%) | Low hemolytic | ||
| 32764602 | 2020 | K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal-)Ala} | 1 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Bu)Gly}-K-K-K | 2 | Free | Free | Linear | L | (N-Phe)Gly = N-benzylglycine, (N1-Nal)Gly = N-1-naphthylmethylglycine, (N-Bu)Gly = N-butylglycine | 7 | Antibacterial, Anticancer | 78.1 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K | 3 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K | 4 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-L-K-K-K | 5 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial, Anticancer | 36 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 6 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 42.7 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L-{nnr:(1-Nal)Ala}-F{nnr:(1-Nal)Ala} | 7 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 83.8 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K | 8 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 34.3 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K | 9 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 30.8 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala} | 10 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala} | 11 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial, Anticancer | 33.3 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala} | 12 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 43.5 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-K-L-K-K | 13 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 55.3 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-{nnr:(N-Bu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly} | 14 | Free | Free | Linear | L | (N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine | 7 | Antibacterial | 66.4 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:(N-Bu)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly} | 15 | Free | Free | Linear | L | (N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine | 7 | Antibacterial, Anticancer | 94.2 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-K-L-K-K | 16 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 55.5 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 17 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 78.1 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 18 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine, Nle= norleucine | 7 | Antibacterial | 58.8 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-Leu{nnr:(1-Nal)Ala}-Y-{nnr:(1-Nal)Ala} | 19 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 82.7 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 20 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine, Nle= norleucine | 7 | Antibacterial | 27.5 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala} | 21 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, y = D-Tyr | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 22 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine, Nle= norleucine | 7 | Antibacterial | 23.7 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:N-Lys}-{nnr:N-Lys}-{nnr:N-Lys}-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 23 | Free | Free | Linear | L | N-Lys = N-(4-aminobutyl)glycine, (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 35.9 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala} | 24 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu | 7 | Antibacterial | 23.4 % Hemolysis at 150 µM | Human | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal-)Ala} | 1 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial, Anticancer | 19.7 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Bu)Gly}-K-K-K | 2 | Free | Free | Linear | L | (N-Phe)Gly = N-benzylglycine, (N1-Nal)Gly = N-1-naphthylmethylglycine, (N-Bu)Gly = N-butylglycine | 7 | Antibacterial, Anticancer | 100.1 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K | 3 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 10.5 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K | 4 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-L-K-K-K | 5 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial, Anticancer | 22.5 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 6 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 101.2 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L-{nnr:(1-Nal)Ala}-F{nnr:(1-Nal)Ala} | 7 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 102.1 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K | 8 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 25.8 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K | 9 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 25.5 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala} | 10 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 36.3 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala} | 11 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial, Anticancer | 40.7 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala} | 12 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 50.2 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-K-L-K-K | 13 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 27.4 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-{nnr:(N-Bu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly} | 14 | Free | Free | Linear | L | (N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine | 7 | Antibacterial | 28.1 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:(N-Bu)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly} | 15 | Free | Free | Linear | L | (N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine | 7 | Antibacterial, Anticancer | 87.1 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-K-L-K-K | 16 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 27.7 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 17 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 100 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 18 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine, Nle= norleucine | 7 | Antibacterial | 100.7 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-Leu{nnr:(1-Nal)Ala}-Y-{nnr:(1-Nal)Ala} | 19 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 100.8 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 20 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine, Nle= norleucine | 7 | Antibacterial | 36 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala} | 21 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, y = D-Tyr | 7 | Antibacterial | 19.9 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 22 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine, Nle= norleucine | 7 | Antibacterial | 83 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:N-Lys}-{nnr:N-Lys}-{nnr:N-Lys}-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 23 | Free | Free | Linear | L | N-Lys = N-(4-aminobutyl)glycine, (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 35.1 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala} | 24 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu | 7 | Antibacterial | 38.5 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal-)Ala} | 1 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Bu)Gly}-K-K-K | 2 | Free | Free | Linear | L | (N-Phe)Gly = N-benzylglycine, (N1-Nal)Gly = N-1-naphthylmethylglycine, (N-Bu)Gly = N-butylglycine | 7 | Antibacterial, Anticancer | 100 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K | 3 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K | 4 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-L-K-K-K | 5 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial, Anticancer | 10.2 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 6 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 18.2 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L-{nnr:(1-Nal)Ala}-F{nnr:(1-Nal)Ala} | 7 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 54.3 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K | 8 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K | 9 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala} | 10 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala} | 11 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial, Anticancer | 11.3 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala} | 12 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 17.9 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-K-L-K-K | 13 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-{nnr:(N-Bu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly} | 14 | Free | Free | Linear | L | (N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine | 7 | Antibacterial | 31.6 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:(N-Bu)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly} | 15 | Free | Free | Linear | L | (N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine | 7 | Antibacterial, Anticancer | 99.5 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-K-L-K-K | 16 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 11 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 17 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 100.1 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 18 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine, Nle= norleucine | 7 | Antibacterial | 98.6 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-Leu{nnr:(1-Nal)Ala}-Y-{nnr:(1-Nal)Ala} | 19 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 100.6 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 20 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine, Nle= norleucine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala} | 21 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, y = D-Tyr | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 22 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine, Nle= norleucine | 7 | Antibacterial | 24.2 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:N-Lys}-{nnr:N-Lys}-{nnr:N-Lys}-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 23 | Free | Free | Linear | L | N-Lys = N-(4-aminobutyl)glycine, (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala} | 24 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Rat | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal-)Ala} | 1 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial, Anticancer | 32.5 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Bu)Gly}-K-K-K | 2 | Free | Free | Linear | L | (N-Phe)Gly = N-benzylglycine, (N1-Nal)Gly = N-1-naphthylmethylglycine, (N-Bu)Gly = N-butylglycine | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K | 3 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K | 4 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-L-K-K-K | 5 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 6 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 39.9 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L-{nnr:(1-Nal)Ala}-F{nnr:(1-Nal)Ala} | 7 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 16 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K | 8 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K | 9 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala} | 10 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala} | 11 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial, Anticancer | 17.4 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala} | 12 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-K-L-K-K | 13 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 17.6 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-{nnr:(N-Bu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly} | 14 | Free | Free | Linear | L | (N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine | 7 | Antibacterial | 13.9 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:(N-Bu)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly} | 15 | Free | Free | Linear | L | (N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-K-L-K-K | 16 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 30.6 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 17 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 19.9 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 18 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine, Nle= norleucine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-K-Leu{nnr:(1-Nal)Ala}-Y-{nnr:(1-Nal)Ala} | 19 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 20 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine, Nle= norleucine | 7 | Antibacterial | 20.1 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala} | 21 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, y = D-Tyr | 7 | Antibacterial | 16 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 22 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine, Nle= norleucine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:N-Lys}-{nnr:N-Lys}-{nnr:N-Lys}-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 23 | Free | Free | Linear | L | N-Lys = N-(4-aminobutyl)glycine, (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 11.1 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala} | 24 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu | 7 | Antibacterial | 29.8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32781587 | 2020 | FLPLIAGLAAKFLPKIFCAITKKC | B1A | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal | 10 % Hemolysis at 1.576 µM | Horse | Modified From Brevinin-1 (Lithobates Palustris (Rana Palustris)) Frog | aqueous, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | FLPLIAGLAAKCAITKKC | B1A1 | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >512 µM | Horse | Truncated Analogue Of B1A | aqueous = Random coil, 1% SDS micelle solution = α-Helix | Low hemolytic | ||
| 32781587 | 2020 | FLPKIFCAITKKC | B1A2 | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 10 % Hemolysis at >512 µM | Horse | Truncated Analogue Of B1A | aqueous = Random coil, 1% SDS micelle solution = α-Helix | Low hemolytic | ||
| 32781587 | 2020 | KFLPKIFCAITKKC | KB2 | Free | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 10 % Hemolysis at 154 µM | Horse | Derived From B1A2 | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KKFLPKIFCAITKKC | KKB2 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 10 % Hemolysis at 207 µM | Horse | Modification Of Kb2 | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KFLPWKIFCAITKKC | KWB2 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 10 % Hemolysis at 99.81 µM | Horse | Modified From Kb2 | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KKFLPWKIFCAITKKC | KKWB2 | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 10 % Hemolysis at 140.04 µM | Horse | Modification Of Kwb | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KFWPWKIFCAITKKC | KW3,5B2 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 10 % Hemolysis at 32.07 µM | Horse | B1A Analogues | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KFLPWKWFCAITKKC | KW5,7B2 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 10 % Hemolysis at 58.42 µM | Horse | B1A Analogues | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32770019 | 2020 | QNLCNIYYIQHADHCLAVINS | AtR100 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0.49 % Hemolysis at 125 µg/ml | Porcine | Plant Aegilops Tauschii Cosson | α-Helix β-Strand | Non-hemolytic | ||
| 32770019 | 2020 | QNLCNIYYIQHADHCLAVINS | AtR100 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0.98 % Hemolysis at 250 µg/ml | Porcine | Plant Aegilops Tauschii Cosson | α-Helix β-Strand | Non-hemolytic | ||
| 32770019 | 2020 | QNLCNIYYIQHADHCLAVINS | AtR100 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 1.35 % Hemolysis at 500 µg/ml | Porcine | Plant Aegilops Tauschii Cosson | α-Helix β-Strand | Non-hemolytic | ||
| 32770019 | 2020 | QNLCNIYYIQHADHCLAVINS | AtR100 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 2.09 % Hemolysis at 1000 µg/ml | Porcine | Plant Aegilops Tauschii Cosson | α-Helix β-Strand | Non-hemolytic | ||
| 32770019 | 2020 | LCVSYSVRPSCKFVGRSNWKRNTCLEWCDQLFLFCFLIGGEMANS | AtR472 | Free | Free | Linear | L | None | 45 | Antibacterial, Antifungal | 0.73 % Hemolysis at 125 µg/ml | Porcine | Plant Aegilops Tauschii Cosson | α-Helix β-Strand | Non-hemolytic | ||
| 32770019 | 2020 | LCVSYSVRPSCKFVGRSNWKRNTCLEWCDQLFLFCFLIGGEMANS | AtR472 | Free | Free | Linear | L | None | 45 | Antibacterial, Antifungal | 1.11 % Hemolysis at 250 µg/ml | Porcine | Plant Aegilops Tauschii Cosson | α-Helix β-Strand | Non-hemolytic | ||
| 32770019 | 2020 | LCVSYSVRPSCKFVGRSNWKRNTCLEWCDQLFLFCFLIGGEMANS | AtR472 | Free | Free | Linear | L | None | 45 | Antibacterial, Antifungal | 1.35 % Hemolysis at 500 µg/ml | Porcine | Plant Aegilops Tauschii Cosson | α-Helix β-Strand | Non-hemolytic | ||
| 32770019 | 2020 | LCVSYSVRPSCKFVGRSNWKRNTCLEWCDQLFLFCFLIGGEMANS | AtR472 | Free | Free | Linear | L | None | 45 | Antibacterial, Antifungal | 1.97 % Hemolysis at 1000 µg/ml | Porcine | Plant Aegilops Tauschii Cosson | α-Helix β-Strand | Non-hemolytic | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C} | S3(B) | Free | Free | Cyclic | L | Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 77 % Hemolysis at 150 μM | Human | Cyclic Antimicrobial Peptide S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab(C10)}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C} | (C10)1 | Free | Free | Cyclic | L | Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 100 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Dab(C10)}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C} | (C10)2 | Free | Free | Cyclic | L | Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 100 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Dab(C12)}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C} | (C12)2 | Free | Free | Cyclic | L | Dab(C12) = Dab(C12), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 100 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Dab(C14)}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C} | (C14)2 | Free | Free | Cyclic | L | Dab(C14) = Dab(C14), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 100 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab(C10)}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C} | (C10)4 | Free | Free | Cyclic | L | Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 100 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C4)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C} | (C4)5 | Free | Free | Cyclic | L | Dab(C4) = Dab(C4), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 5 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | Low hemolytic | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C6)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C} | (C6)5 | Free | Free | Cyclic | L | Dab(C6) = Dab(C6), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 13 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C8)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C} | (C8)5 | Free | Free | Cyclic | L | Dab(C8) = Dab(C8), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 42 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C10)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C} | (C10)5 | Free | Free | Cyclic | L | Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 100 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C12)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C} | (C12)5 | Free | Free | Cyclic | L | Dab(C12) = Dab(C12), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 100 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C14)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C} | (C14)5 | Free | Free | Cyclic | L | Dab(C14) = Dab(C14), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 100 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C4)}-{nnr:Dab}-N{cyc:N-C} | (C4)7 | Free | Free | Cyclic | L | Dab(C4) = Dab(C4), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 4 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | Low hemolytic | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C6)}-{nnr:Dab}-N{cyc:N-C} | (C6)7 | Free | Free | Cyclic | L | Dab(C6) = Dab(C6), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 8 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C8)}-{nnr:Dab}-N{cyc:N-C} | (C8)7 | Free | Free | Cyclic | L | Dab(C8) = Dab(C8), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 56 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C10)}-{nnr:Dab}-N{cyc:N-C} | (C10)7 | Free | Free | Cyclic | L | Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 100 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C12)}-{nnr:Dab}-N{cyc:N-C} | (C12)7 | Free | Free | Cyclic | L | Dab(C12) = Dab(C12), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 96 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C14)}-{nnr:Dab}-N{cyc:N-C} | (C14)7 | Free | Free | Cyclic | L | Dab(C14) = Dab(C14), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 98 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32823798 | 2020 | {nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab(C10)}-N{cyc:N-C} | (C10)8 | Free | Free | Cyclic | L | Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid | 9 | Antibacterial | 100 % Hemolysis at 150 μM | Human | Lipidated Analogues Of S3(B) | NA | NA | ||
| 32847054 | 2020 | ASSFLTPRLSSLGKRSWAV | AV19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 5 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | GFCNFMHLKPISRELRRELYGRTRRRRK | GK28 | Free | Free | Linear | L | None | 28 | Antibacterial | 0 % Hemolysis at 5 μM | Human | Cuttlefish (Sepia Officinalis) | NA | Non-hemolytic | ||
| 32847054 | 2020 | NYWLLVLRRLLITKKVMWF | NF19 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 5 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | ASSFLTPRLSSLGKRSWAV | AV19 | Free | Free | Linear | L | None | 19 | Antibacterial | 33 % Hemolysis at 100 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | NA | ||
| 32847054 | 2020 | GFCNFMHLKPISRELRRELYGRTRRRRK | GK28 | Free | Free | Linear | L | None | 28 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Cuttlefish (Sepia Officinalis) | NA | Non-hemolytic | ||
| 32847054 | 2020 | NYWLLVLRRLLITKKVMWF | NF19 | Free | Free | Linear | L | None | 19 | Antibacterial | 50 % Hemolysis at 100 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | GFCNFMHLKPISRELRRELYGRTRRRRK | GK28 | Free | Free | Linear | L | None | 28 | Antibacterial | 0 % Hemolysis at 20 μM | Human | Cuttlefish (Sepia Officinalis) | NA | Non-hemolytic | ||
| 32847054 | 2020 | GFCNFMHLKPISRELRRELYGRTRRRRK | GK28 | Free | Free | Linear | L | None | 28 | Antibacterial | 0 % Hemolysis at 50 μM | Human | Cuttlefish (Sepia Officinalis) | NA | Non-hemolytic | ||
| 32847054 | 2020 | NYWLLVLRRLLITKKVMWF | NF19 | Free | Free | Linear | L | None | 19 | Antibacterial | 35 % Hemolysis at 50 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32350599 | 2020 | RFRRLRWKTRWRLKKIRFGRFLRKIRRFRPK{ct:Amid} | PR-FO | Amidation | Free | Linear | L | None | 31 | Antibacterial | 10 % Hemolysis at 128 μM | Human | Hybrid Peptide Of Prw4 And Fowlicidin-2 | α-Helix | Low hemolytic | ||
| 32590058 | 2020 | G{d}F{d}G{d}S{d}L{d}L{d}G{d}K{d}A{d}L{d}R{d}L{d}G{d}A{d}N{d}V{d}L{d}{ct:Amid} | DCPF-C1 | Amidation | Free | Linear | D | None | 17 | Antibacterial | ≥10 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = α-Helical (reverse Helical) | NA | ||
| 32590058 | 2020 | K{d}FW{d}SLLK{d}KALRLW{d}ANVL{ct:Amid} | CPF-2 | Amidation | Free | Linear | Mix | None | 17 | Antibiofilm, Antibacterial | 100 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = Random coil | NA | ||
| 32590058 | 2020 | K{d}F{d}W{d}S{d}L{d}L{d}K{d}K{d}A{d}L{d}R{d}L{d}W{d}A{d}N{d}V{d}L{d}{ct:Amid} | DCPF-2 | Amidation | Free | Linear | Mix | None | 17 | Antibacterial | 100 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = α-Helical (reverse Helical) | NA | ||
| 32590058 | 2020 | K{d}FW{d}SLLK{d}KAL{d}R{d}LW{d}KK{d}VL{ct:Amid} | CPF-2-1 | Amidation | Free | Linear | Mix | None | 17 | Antibacterial | 0 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = Random coil | Non-hemolytic | ||
| 32590058 | 2020 | K{d}FW{d}SLLK{d}KAL{d}R{d}LW{d}AK{d}VL{ct:Amid} | CPF-2-2 | Amidation | Free | Linear | Mix | None | 17 | Antibacterial | 0 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = Random coil | Non-hemolytic | ||
| 32590058 | 2020 | GFGSLLGKALRLWKKVL{ct:Amid} | CPF-13 | Amidation | Free | Linear | D | None | 17 | Antibacterial | ≥75 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = α-Helical | NA | ||
| 32590058 | 2020 | GFGSLLGKALRLW{d}KK{d}VL{ct:Amid} | CPF-14 | Amidation | Free | Linear | Mix | None | 17 | Antibacterial | ≥10 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = α-Helical | NA | ||
| 32590058 | 2020 | GFGSLLGKAL{d}R{d}LW{d}KK{d}VL{ct:Amid} | CPF-15 | Amidation | Free | Linear | Mix | None | 17 | Antibacterial | ≥75 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = Random coil | NA | ||
| 32841003 | 2020 | GITDLRGMLKRLKKMK | Sm-A1 | Free | Free | Linear | L | None | 16 | Antibacterial, Antibiofilm | 10 % Hemolysis at 80 μM | Human | Derived From Turbot Viscera Hydrolysate | α-Helix | Low hemolytic | ||
| 32841003 | 2020 | ATLTAKDLTFLQDYKKTKKRVK | Sm-A2 | Free | Free | Linear | L | None | 22 | Antibacterial | 10 % Hemolysis at 20 μM | Human | Derived From Turbot Viscera Hydrolysate | α-Helix | NA | ||
| 32841003 | 2020 | HTMWRCVRLSACLFSVRRR | Sm-A3 | Free | Free | Linear | L | None | 19 | Antibacterial | 10 % Hemolysis at 10 μM | Human | Derived From Turbot Viscera Hydrolysate | α-Helix | NA | ||
| 32967114 | 2020 | FIGTLIPLALGALTKLFK{ct:Amid} | Figainin 1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Anticancer, Anti-infective, Antitrypanosomal | 50 % Hemolysis at 10 μM | Human | Frog Boana Raniceps | water and 10% (v/v) TFE = Disordered, 30% (v/v) and 50% (v/v) TFE = α-Helical | NA | ||
| 32967333 | 2020 | ALWKKLLKK-{nnr:Cha}{ct:Amid} | DMPC-10A | Amidation | Free | Linear | L | Cha = Cyclohexanylalanine | 10 | Antibacterial, Antibiofilm | ≥20 % Hemolysis at 128 μM | Horse | Derived From A Dermaseptin (Phyllomedusa Frogs) | amphipathic environment = α-Helix | NA | ||
| 32967333 | 2020 | AL{d}WK{d}K{d}L{d}L{d}K{d}K{d}-{nnr:Cha}{ct:Amid} | DMPC-10B | Amidation | Free | Linear | Mix | Cha = Cyclohexanylalanine | 10 | Antibacterial, Antibiofilm | 0 % Hemolysis at 128 μM | Horse | Modificaiton Of Dmpc-10A | TFE = α-Helix | Non-hemolytic | ||
| 32959824 | 2020 | LKLLKKLLKLLKKL | LK Free | Free | Free | Linear | L | None | 14 | Antibacterial | ~100 % Hemolysis at 50 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 32710881 | 2020 | FQRYFHRYARFLAKIWKG | Adepamycin | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | < 10 % Hemolysis at 1.3 μM | Human | Synthetic Peptide | aqueous = Disordered, TFE = α-Helix | NA | ||
| 32710881 | 2020 | FQRYFHRYARFLAKIWKG | Adepamycin | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | < 10 % Hemolysis at 10.4 μM | Human | Synthetic Peptide | aqueous = Disordered, TFE = α-Helix | NA | ||
| 32710881 | 2020 | FQRYFHRYARFLAKIWKG | Adepamycin | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 60 % Hemolysis at 335 μM | Human | Synthetic Peptide | aqueous = Disordered, TFE = α-Helix | NA | ||
| 32591801 | 2020 | AFRPIPTHSC | P1 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 32591801 | 2020 | YNYSYIITRS | P2 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 32591801 | 2020 | PTTVHIIYRI | P3 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | NA | ||
| 32591801 | 2020 | ASVTWLLYAM | P4 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 32591801 | 2020 | LRCLMLKFPI | P5 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | NA | ||
| 32591801 | 2020 | CLRPSIISRA | P6 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 32591801 | 2020 | WRYQWTILFI | P7 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 32591801 | 2020 | FCIRLATYVI | P8 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 32591801 | 2020 | PGHRVSCWLS | P9 | Free | Free | Linear | L | None | 10 | Antibacterial | <20 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | NA | ||
| 32715598 | 2020 | RKIKVYLPRMK | TK9.1 | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 0 % Hemolysis at 42 μg/ml | Mouse | Ovalbumin Peptide Fragment | α-Helix | Non-hemolytic | ||
| 32715598 | 2020 | RKIKRYLRRMI | TK9.1.3 | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 0 % Hemolysis at 42 μg/ml | Mouse | Ovalbumin Peptide Fragment | α-Helix | Non-hemolytic | ||
| 32715598 | 2020 | RKIKVYLPRMK | TK9.1 | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 10 % Hemolysis at 1660 μg/ml | Mouse | Ovalbumin Peptide Fragment | α-Helix | Non-hemolytic | ||
| 32715598 | 2020 | RKIKRYLRRMI | TK9.1.3 | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 10 % Hemolysis at 1660 μg/ml | Mouse | Ovalbumin Peptide Fragment | α-Helix | Non-hemolytic | ||
| 33063186 | 2020 | FTILKKLKSFIK | Coco1 | Free | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 100 μM | Human | Derived From The Green Algae Coccomyxa Subellipsoidea | NA | NA | ||
| 33063186 | 2020 | KLVKKLLKKYITF | Coco2 | Free | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at 100 μM | Human | Derived From The Green Algae Coccomyxa Subellipsoidea | NA | NA | ||
| 33063186 | 2020 | LARFVLRILKYGFK | Coco3 | Free | Free | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 9.38 μM | Human | Derived From The Green Algae Coccomyxa Subellipsoidea. | α‐Helix | NA | ||
| 33063186 | 2020 | IPLLRKGKKIIWW | Opero1 | Free | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at 100 μM | Human | Derived From The Invertebrate Operophtera Brumata | NA | NA | ||
| 33063186 | 2020 | GLKKVIKLLRPLL | Opero2 | Free | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at 100 μM | Human | Derived From The Invertebrate Operophtera Brumata | NA | NA | ||
| 33063186 | 2020 | IVIKSLGKFLKNVGGFAG | Pyro1 | Free | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 100 μM | Human | Derived From The Thermophilic Bacteria Pyrococcus | NA | NA | ||
| 33063186 | 2020 | ITKWLLNAIKKGFKL | Thermo1 | Free | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at 21.9 μM | Human | Derived From The Thermophilic Bacteria Thermococcus Onnurineus. | NA | NA | ||
| 33063186 | 2020 | IHKLVKLWLNLGKKF | Thermo2 | Free | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at 39.3 μM | Human | Derived From The Thermophilic Bacteria Thermococcus Onnurineus. | NA | NA | ||
| 33063186 | 2020 | LFSIIWKLNRKLIKA | Thermo3 | Free | Free | Linear | L | None | 15 | Antibacterial | 10 % Hemolysis at 37.3 μM | Human | Derived From The Thermophilic Bacteria Thermococcus Onnurineus. | NA | NA | ||
| 33074344 | 2020 | EKKRLLKWWR{nt:H}{ct:Amid} | AMP-2 | Amidation | H | Linear | L | None | 10 | Antibacterial | <1 % Hemolysis at 0.2 mg/ml | Sheep | Synthetic Peptide | Helix | Non-hemolytic | ||
| 33074344 | 2020 | KWWKLLRKKR{nt:H}{ct:Amid} | AMP-3 | Amidation | H | Linear | L | None | 10 | Antibacterial | <1 % Hemolysis at 0.2 mg/ml | Sheep | Synthetic Peptide | Helix | Non-hemolytic | ||
| 32909733 | 2020 | KIKKIIKKIIKI{ct:Amid} | KI | Amidation | Free | Linear | L | None | 12 | Antibacterial | 10 % Hemolysis at 4000 μM | Human | Synthetic Peptide | Random coil | Non-hemolytic | ||
| 32909733 | 2020 | GIIKKIIKKIIKKI{ct:Amid} | G3 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 50 % Hemolysis at 800 μM | Human | Synthetic Peptide | Random coil | Low hemolytic | ||
| 32909733 | 2020 | GILKKILKKILKKL{ct:Amid} | G7 | Amidation | Free | Linear | L | None | 14 | Antibacterial | 50 % Hemolysis at 80 μM | Human | Synthetic Peptide | aqueous = α-Helical | NA | ||
| 33194795 | 2020 | RFRLPFRRPPIRIHPPPFYPPFRRFL | ChBac3.4-COOH | Free | Free | Linear | L | None | 26 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRLPFRRIHPPPFVRIHPPPFYRRFL{ct:Amid} | ChBac3.4-1-NH2 | Amidation | Free | Linear | L | None | 27 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRLPFRRIHPPPFVRIHPPPFYRRFL | ChBac3.4-1-COOH | Free | Free | Linear | L | None | 27 | Antitumor, Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRRFRLPFRRIHPPPFVRIHPPPFYRRFL{ct:Amid} | RFR-ChBac3.4-1-NH2 | Amidation | Free | Linear | L | None | 30 | Antibacterial, Antibiofilm | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRLPFRRPWPIRIHPPPFYPWPFRRFL | ChBac3.4-2-COOH | Free | Free | Linear | L | None | 28 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRLPFRRPPIRIPPPFYPPFRRFL{ct:Amid} | ChBac3.4(Н-) | Amidation | Free | Linear | L | None | 25 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RIHPPPFYPPFRRFL{ct:Amid} | ChBac3.4 (12-26) | Amidation | Free | Linear | L | None | 15 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Truncated Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRLPFRRPPIRIHPPPFY{ct:Amid} | ChBac3.4(1-19)-NH2 | Amidation | Free | Linear | L | None | 19 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Truncated Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRLPFRRPPIRIH{ct:Amid} | ChBac3.4(1-14)-NH2 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Truncated Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRRFRLPFRRPPIRIH{ct:Amid} | RFR-ChBac3.4(1-14)-NH2 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Truncated Variants | NA | Low hemolytic | ||
| 33092132 | 2020 | GLLDLLKGAGKGLLTHLASQI{ct:Amid} | Ocellatin-1I | Amidation | Free | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at > 250 μg/ml | Mouse | Ocellatins Frog Leptodactylus Insularum | α-Helical at 2–9, 13–19 | Low hemolytic | ||
| 33092132 | 2020 | GLLDFFKGAGKELLTHLASQI{ct:Amid} | Ocellatin-2I | Amidation | Free | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at > 250 μg/ml | Mouse | Ocellatins Frog Leptodactylus Insularum | α-Helical at 11–19 | Low hemolytic | ||
| 33092132 | 2020 | GAVVDILKGAGKNLLSLALNKLSEKVA{ct:Amid} | Ocellatin-1N | Amidation | Free | Linear | L | None | 26 | Antibacterial | 50 % Hemolysis at >500 μg/ml | Mouse | Ocellatins Frog Leptodactylus Nesiotus | α-Helical at 3–10, 12–24 | Non-hemolytic | ||
| 33092132 | 2020 | GIFDVLKNLAKGVITSLAS{ct:Amid} | Ocellatin-3N | Amidation | Free | Linear | L | None | 19 | Antibacterial | 50 % Hemolysis at 210 μg/ml | Mouse | Ocellatins Frog Leptodactylus Nesiotus | α-Helical at 4–11, 13–18 | NA | ||
| 33084564 | 2020 | RRWRRFFQKAKRLLRRFG | DRGN-6 | Free | Free | Linear | L | None | 18 | Antibacterial | ~10 % Hemolysis at 10 μg/ml | Sheep | Synthetic Peptides Komodo Dragon Cathelicidin-Inspired Antimicrobial Peptides | Helical | NA | ||
| 33084564 | 2020 | RRWRRFFQKAKRLLRRFG | DRGN-7 | Free | Free | Linear | L | None | 18 | Antibacterial | ~10 % Hemolysis at 10 μg/ml | Sheep | Synthetic Peptides Komodo Dragon Cathelicidin-Inspired Antimicrobial Peptides | Helical | NA | ||
| 33084564 | 2020 | RRWRRFFRKAKRLLRRFG{ct:Amid} | DRGN-8 | Amidation | Free | Linear | L | None | 18 | Antibacterial | ~10 % Hemolysis at 10 μg/ml | Sheep | Synthetic Peptides Komodo Dragon Cathelicidin-Inspired Antimicrobial Peptides | Helical | NA | ||
| 33084564 | 2020 | KRFKKFFKKLKNSVKKRAKKFFKKPKVIGVTFPF | NACATH | Free | Free | Linear | L | None | 34 | Antibacterial | <10 % Hemolysis at 100 μg/ml | Sheep | Cathelicidin Peptide From The Chinese Cobra | Helical | Non-hemolytic | ||
| 33138816 | 2020 | GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSEFFQS | PMAP-37 | Free | Free | Linear | L | None | 37 | Antibacterial | <5 % Hemolysis at 1280 μg/ml | Mouse | Porcine Myeloma Cells | α-Helix | Non-hemolytic | ||
| 33138816 | 2020 | GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS | PMAP-37(F34-R) | Free | Free | Linear | L | None | 37 | Antibacterial | <5 % Hemolysis at 1280 μg/ml | Mouse | Modified Pmap-37 | NA | Non-hemolytic | ||
| 33138816 | 2020 | GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS{nt:Chol} | Chol-37(F34-R) | Free | Chol | Linear | L | Chol = cholesterol | 37 | Antibacterial, Wound healing and abscess reduction | <5 % Hemolysis at 1280 μg/ml | Mouse | Addition Of Cholesterol | NA | Non-hemolytic | ||
| 33085895 | 2020 | F{d}{nnr:X}{nnr:X}L{nt:C16} | C16-fXXL | Free | C16 | Linear | Mix | X = L-2,4-diaminobutyric acid, f = D-phenylalanine | 4 | Antibacterial | ~10 % Hemolysis at 5 μg/mL | Horse | Synthetic Lipopeptide | NA | NA | ||
| 33085895 | 2020 | F{d}{nnr:X}{nnr:X}L{nt:C14} | C14-fXXL | Free | C14 | Linear | Mix | X = L-2,4-diaminobutyric acid, f = D-phenylalanine | 4 | Antibacterial | ~10 % Hemolysis at 5 μg/mL | Horse | Synthetic Lipopeptide | NA | NA | ||
| 33085895 | 2020 | F{d}{nnr:X}{nnr:X}{nnr:L}{nt:C12} | C12-fXXL | Free | C12 | Linear | Mix | X = L-2,4-diaminobutyric acid, f = D-phenylalanine, L = L-leucine | 4 | Antibacterial | <5 % Hemolysis at 5 μg/mL | Horse | Synthetic Lipopeptide | NA | NA | ||
| 33085895 | 2020 | F{d}{nnr:X}{nnr:X}L{nt:C16} | C16-fXXL | Free | C16 | Linear | Mix | X = L-2,4-diaminobutyric acid, f = D-phenylalanine | 4 | Antibacterial | <5 % Hemolysis at 5 μg/mL | Sheep | Synthetic Lipopeptide | NA | NA | ||
| 33085895 | 2020 | F{d}{nnr:X}{nnr:X}L{nt:C14} | C14-fXXL | Free | C14 | Linear | Mix | X = L-2,4-diaminobutyric acid, f = D-phenylalanine | 4 | Antibacterial | ~10 % Hemolysis at 5 μg/mL | Sheep | Synthetic Lipopeptide | NA | NA | ||
| 33085895 | 2020 | F{d}{nnr:X}{nnr:X}{nnr:L}{nt:C12} | C12-fXXL | Free | C12 | Linear | Mix | X = L-2,4-diaminobutyric acid, f = D-phenylalanine, L = L-leucine | 4 | Antibacterial | 0 % Hemolysis at 5 μg/mL | Sheep | Synthetic Lipopeptide | NA | Non-hemolytic | ||
| 33224970 | 2020 | MKLLLLALPMLVLLPQVIPAYSGEKKCWNRSGHCRKQCKDGEAVKDTCKNLRACCIPSNEDHRRVPATSPTPLSDSTPGIIDDILTVRFTTDYFEVSSKKDMVEESEAGRGTETSLPNVHHSS | β-Defensin 118 (DEFB118) | Free | Free | Linear | L | None | 123 | Antibacterial, Anti-inflammatory | <2 % Hemolysis at 256 μg/mL | Pig | Human Host Defense Peptide (Hdp) | Betα-ring conformation | Non-hemolytic | ||
| 33175275 | 2020 | AFALIAGALYRIFHRR | LHH1 | Free | Free | Linear | L | None | 16 | Antibacterial | 50 % Hemolysis at 187.2 μM | Goat | Lactobacillus Casei Hz1 | water = Random coil, 50% TFE and 30 mM SDS = α-Helical | Low hemolytic | ||
| 33218175 | 2020 | LVDIYTHVYNCTSSEKHTHCYEIRKSIS | OrR214 | Free | Free | Linear | L | None | 28 | Antibacterial | 0.142 % Hemolysis at 150 μM | Goat | Plant Oryza Rufipogon Griff | α-Helix Random coil | Non-hemolytic | ||
| 33218175 | 2020 | LGVPVSSTLRLNNTTMNPCLPS | OrR935 | Free | Free | Linear | L | None | 22 | Antibacterial | 0.306 % Hemolysis at 150 μM | Goat | Plant Oryza Rufipogon Griff | Random coil | Non-hemolytic | ||
| 33233541 | 2020 | FFGSLLSLGSKLLPSVFKLFQRKKE{ct:Amid} | Css54 | Amidation | Free | Linear | L | None | 25 | Antibacterial, Antibiofilm | 40 % Hemolysis at 16 μM | Sheep | Scorpion Venom Of Centruroides Suffusus | aqueous(10mM sodium phosphate) = Random coil, TFE and SDS = α-Helix | NA | ||
| 32445120 | 2020 | DFFRKSKEKIGKEFKRIVQRIKDFLR | Human CAP18 | Free | Free | Linear | L | None | 26 | Antibacterial | ≥20 % Hemolysis at 1000 μg/mL | Human | Human Cap18 Peptide | NA | Low hemolytic | ||
| 32445120 | 2020 | RKRLRKFRNKKKIGQKIQ | Rabbit CAP18 | Free | Free | Linear | L | None | 18 | Antibacterial | ≥50 % Hemolysis at 1000 μg/mL | Human | Rabbit Cap18 Peptides | NA | Low hemolytic | ||
| 32445120 | 2020 | WKFFRKLLKKIRKKFKR | hCap18 | Free | Free | Linear | L | None | 17 | Antibacterial | 95 % Hemolysis at 1000 μg/mL | Human | Truncated Human Cap18 Peptides | Random coil | Low hemolytic | ||
| 32445120 | 2020 | WRKRLRKFRLKKKILQ | rCap18 | Free | Free | Linear | L | None | 16 | Antibacterial | ≥5 % Hemolysis at 1000 μg/mL | Human | Truncated Rabbit Cap18 Peptides | Random coil | Non-hemolytic | ||
| 32569448 | 2020 | GGLRRLGRKILRAVKKYG | CP | Free | Free | Linear | L | None | 18 | Antibacterial | 0.2 ± 0.2 % Hemolysis at 100 μM | Human | Modified Bmap28(1-18) Synthetic Peptide | NA | Non-hemolytic | ||
| 32569448 | 2020 | GGLRSLGLKILLAWKKYG | DP | Free | Free | Linear | L | None | 18 | Antibacterial | 14.9 ± 2.5 % Hemolysis at 100 μM | Human | Modified Bmap28(1-18) Synthetic Peptide | NA | NA | ||
| 32569448 | 2020 | RGLRRLGRKIKKGLKKYG | Mapcon | Free | Free | Linear | L | None | 18 | Antibacterial | 0 ± 0.02 % Hemolysis at 100 μM | Human | Map Family Consensus Peptide | NA | Non-hemolytic | ||
| 32569448 | 2020 | GGLRSLGRKILRAWKKYG | BMAP28(1-18) | Free | Free | Linear | L | None | 18 | Antibacterial | 4.6 ± 1.2 % Hemolysis at 100 μM | Human | Map Family Peptide | NA | NA | ||
| 32569448 | 2020 | GGLRSLGLKILLAWKKYG | DP | Free | Free | Linear | L | None | 18 | Antibacterial | 0.27 ± 0.44 % Hemolysis at 6.25 μM | Human | Modified Bmap28(1-18) Synthetic Peptide | NA | NA | ||
| 32569448 | 2020 | GGLRSLGRKILRAWKKYG | BMAP28(1-18) | Free | Free | Linear | L | None | 18 | Antibacterial | 1.11 ± 1.24 % Hemolysis at 25 μM | Human | Map Family Peptide | NA | NA | ||
| 33316868 | 2020 | RRWYRRWYRRWY{ct:Amid} | RY12WY | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 1437.1 μM | Fish | Synthetic Short Amps | right-handed α-Helical | Non-hemolytic | ||
| 33316868 | 2020 | RRWYRRWYRRWY{ct:Amid} | RY12WY | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antifungal | 0 % Hemolysis at 125 μM | Fish | Synthetic Short Amps | right-handed α-Helical | Non-hemolytic | ||
| 33316868 | 2020 | RRWYRRWYRRWY{ct:Amid} | RY12WY | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antifungal | 10 % Hemolysis at 250 μM | Fish | Synthetic Short Amps | right-handed α-Helical | Non-hemolytic | ||
| 33369262 | 2020 | KLLKKAGKLLKKAGKLLKKAG | Stripe | Free | Free | Linear | L | None | 21 | Antibacterial | No Hemolysis at >100 μM | Human | Synthetic Rationally Designed Amphipathic Amp | 20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical | Non-hemolytic | ||
| 33369262 | 2020 | KLLKKGGKLLKKGGKLLKKGG | 1 | Free | Free | Linear | L | None | 21 | Antibacterial | No Hemolysis at >100 μM | Human | Stripe Side-Chain Stapling Analogue Peptide | 20mM PBS (PH7.5) with 1%SDS at 202-222nm = Helical | Non-hemolytic | ||
| 33369262 | 2020 | KLLKK{nnr:X}GKLLKK{nnr:X}GKLLKK{nnr:X}G | 2 | Free | Free | Linear | L | X = Aib (2-aminoisobutyric acid) | 21 | Antibacterial | No Hemolysis at >100 μM | Human | Stripe Side-Chain Stapling Analogue Peptide | 20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical | Non-hemolytic | ||
| 33369262 | 2020 | KLLKK{nnr:Z}GKLLKK{nnr:Z}GKLLKK{nnr:Z}G | 3 | Free | Free | Linear | L | Z = Ac6c(1-aminocyclohexanecarboxylic acid) | 21 | Antibacterial | Hemolysis at 1.56 μM | Human | Stripe Side-Chain Stapling Analogue Peptide | 20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical | NA | ||
| 33369262 | 2020 | KLLKKAGKLLKK{nnr:R}GKLLKK{nnr:S}G | 4 | Free | Free | Linear | L | R8 = (R)-(7-octenyl)alanine, S5 = (S)-(4-pentenyl)alanine, R8 and S5 in peptides 4 and 5 denote side-stapling produced by (R)-(7-octenyl)alanine and (S)-(4-pentenyl)alanine. | 21 | Antibacterial | Hemolysis at 0.78 μM | Human | Stripe Side-Chain Stapling Analogue Peptide | 20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical | NA | ||
| 33369262 | 2020 | KLLKK{nnr:R}GKLLKK{nnr:S}GKLLKKAG | 5 | Free | Free | Linear | L | R8 = (R)-(7-octenyl)alanine, S5 = (S)-(4-pentenyl)alanine, R8 and S5 in peptides 4 and 5 denote side-stapling produced by (R)-(7-octenyl)alanine and (S)-(4-pentenyl)alanine. | 21 | Antibacterial | Hemolysis at 1.56 μM | Human | Stripe Side-Chain Stapling Analogue Peptide | 20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGALGRLF | GHaR | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 10 % Hemolysis at 13.6 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 10 % Hemolysis at 156 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 10 % Hemolysis at 11.6 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 10 % Hemolysis at 22.3 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGARGRLF | GHaR9R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 10 % Hemolysis at >200 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | NA | Low hemolytic | ||
| 33291521 | 2020 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 10 % Hemolysis at 32.8 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGALGRLF | GHaR | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 46.4 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 50 % Hemolysis at >200 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | Low hemolytic | ||
| 33291521 | 2020 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 50 % Hemolysis at 10.9 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 50 % Hemolysis at 167.6 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGARGRLF | GHaR9R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | NA | Low hemolytic | ||
| 33291521 | 2020 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 50 % Hemolysis at 86.3 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291782 | 2020 | SPRVCIRVCRNGVCYRRCWG | Capitellacin | Free | Free | Linear | L | None | 20 | Antibacterial, Anti-infective | 0 % Hemolysis at 64 μM | Human | Marine Polychaeta Capitella Teleta | membrane mimicking media = β-Hairpin | Non-hemolytic | ||
| 33291782 | 2020 | SPRVCIRVCRNGVCYRRCWG | Capitellacin | Free | Free | Linear | L | None | 20 | Antibacterial, Anti-infective | ≥2 % Hemolysis at 128 μM | Human | Marine Polychaeta Capitella Teleta | membrane mimicking media = β-Hairpin | Non-hemolytic | ||
| 33291782 | 2020 | KWCFRVCYRGICYRRCR | Tachyplesin-1 | Free | Free | Linear | L | None | 17 | Antibacterial, Anti-infective | 50 % Hemolysis at 128 μM | Human | Horseshoe Crab Tachypleus Tridentatus | membrane mimicking media = β-Hairpin right-handed twist | NA | ||
| 33236874 | 2020 | FKRLKKLISWIKRKRQQC{ct:Amid} | HnMc | Amidation | Free | Linear | L | None | 18 | Antibacterial | ≥10 % Hemolysis at 1 mg/mL | Rat | Analogue Helicobacter Pylori Ribosomal Protein L1 (Hpa3Nt3) | NA | Low hemolytic | ||
| 33205989 | 2020 | LKKLLKLLKKLLKL{nt:Acet}{ct:Amid} | LK | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 5 μM | Human | Proline Hinged Amphipathic Α‑Helical Peptide | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | LKKLLPLLKKLLKL{nt:Acet}{ct:Amid} | LK-K6P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 1.25 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | LKKLLKLLPKLLKL{nt:Acet}{ct:Amid} | LK-K9P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 5 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | LKKLLKLLKPLLKL{nt:Acet}{ct:Amid} | LK-K10P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 5 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | LKKPLKLGKKLLKL{nt:Acet}{ct:Amid} | LK-L4P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 160 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | Low hemolytic | ||
| 33205989 | 2020 | LKKLPKLSKKLLKL{nt:Acet}{ct:Amid} | LK-L5P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 80 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | LKKLLKPLKKLLKL{nt:Acet}{ct:Amid} | LK-L7P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 160 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | Low hemolytic | ||
| 33205989 | 2020 | LKKLLKLLKKLPKL{nt:Acet}{ct:Amid} | LK-L12P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 40 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | LKKLLKLPKKLLKL{nt:Acet}{ct:Amid} | LK-L8P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 640 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | Non-hemolytic | ||
| 33205989 | 2020 | LKKLLKLLKKPLKL{nt:Acet}{ct:Amid} | LK-L11P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 320 μM | Human | Lk Pro-Scanning Peptides | PPB + TFE = α-Helical | Non-hemolytic | ||
| 33205989 | 2020 | KLLKLLKKLLKLLK{nt:Acet}{ct:Amid} | KL | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 0.625 μM | Human | Proline Hinged Amphipathic Α‑Helical Peptide | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KPLKLLKKLLKLLK{nt:Acet}{ct:Amid} | KL-L2P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 5 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLPKLLKKLLKLLK{nt:Acet}{ct:Amid} | KL-L3P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 10 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKLLPKLLKLLK{nt:Acet}{ct:Amid} | KL-K7P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 5 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKLLKPLLKLLK{nt:Acet}{ct:Amid} | KL-K8P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 2.5 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKPLKKLLKLLK{nt:Acet}{ct:Amid} | KL-L5P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 80 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKLLKKLPKLLK{nt:Acet}{ct:Amid} | KL-L10P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 80 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKLLKKLLKPLK{nt:Acet}{ct:Amid} | KL-L12P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 40 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKLLKKLLKLPK{nt:Acet}{ct:Amid} | KL-L13P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 40 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | NA | ||
| 33205989 | 2020 | KLLKLPKKLLKLLK{nt:Acet}{ct:Amid} | KL-L6P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at 640 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | Non-hemolytic | ||
| 33205989 | 2020 | KLLKLLKKPLKLLK{nt:Acet}{ct:Amid} | KL-L9P | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial | 10 % Hemolysis at >1280 μM | Human | Kl Pro-Scanning Peptides | PPB + TFE = α-Helical | Non-hemolytic | ||
| 33321960 | 2020 | RWCVYAYVRVRGVLVRYRRCW | Ar-1 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 2.9 ± 1.2 μM | Human | Sea Polychaete Arenicola Marina | Aqueous = right-twisted and kinked β-Hairpin, SDS = β-Sheet | NA | ||
| 33321960 | 2020 | RWCVYAYVRIRGVLVRYRRCW | Ar-2 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 1.8 ± 0.9 μM | Human | Sea Polychaete Arenicola Marina | Aqueous = right-twisted and kinked β-Hairpin, SDS = β-Sheet | NA | ||
| 33321960 | 2020 | RWAVYAYVRVRGVLVRYRRAW | Ar-1-(C/A) | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 11.1 ± 2.3 μM | Human | Synthetic Derivative Of Ar-1 | Aqueous = right-twisted antiparallel β-Sheet, SDS = relaxed antiparallel and parallel β-Sheets | NA | ||
| 33348729 | 2020 | GFAWNVCVYRNGVRVCHRRAN{ct:Amid} | N6NH2 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 0.19 % Hemolysis at 256 μg/mL | Mouse | Marine Peptide-N6 | ddH2O = coil and antiparallel Strand or β-Turn, SDS solution = α-Helix and antiparallel Strand, 50% TFE = β-Turn, coil and antiparallel Sheet | Non-hemolytic | ||
| 33348729 | 2020 | GFAWNVCVYRNGVRVCHRRAN | N6 | Free | Free | Linear | L | None | 21 | Antibacterial | 1.9 % Hemolysis at 256 μg/mL | Mouse | N6 Anaog Amidated | ddH2O = coil and antiparallel Strand or β-Turn, SDS solution = α-Helix and antiparallel Strand, 50% TFE = β-Turn, coil and antiparallel Sheet | Non-hemolytic | ||
| 33374458 | 2020 | GSKKPVPIIYCNRRSGKCQRM | TS | Free | Free | Linear | L | None | 21 | Antibacterial | <10 % Hemolysis at 160 μM | Human | Modified From Thanatin (Hemipteran Insect Podisus Maculiventris) | β-Helix | Non-hemolytic | ||
| 32798369 | 2021 | AIPWIWIWRLLRKG | WWW | Free | Free | Linear | L | None | 14 | Antibacterial | 100 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | NA | ||
| 32798369 | 2021 | AIPYIWIYRLLRKG | YWY | Free | Free | Linear | L | None | 14 | Antibacterial | ~2 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | Low hemolytic | ||
| 32798369 | 2021 | AIPFIWIFRLLRKG | FWF | Free | Free | Linear | L | None | 14 | Antibacterial | ~80 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | NA | ||
| 32798369 | 2021 | AIPYIYIYRLLRKG | YYY | Free | Free | Linear | L | None | 14 | Antibacterial | ~2 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | Low hemolytic | ||
| 32798369 | 2021 | AIPFIFIFRLLRKG | FFF | Free | Free | Linear | L | None | 14 | Antibacterial | ~2 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | Low hemolytic | ||
| 32798369 | 2021 | AIPYIYIWRLLRKG | YYW | Free | Free | Linear | L | None | 14 | Antibacterial | ~5 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | NA | ||
| 32798369 | 2021 | AIPFIFIWRLLRKG | FFW | Free | Free | Linear | L | None | 14 | Antibacterial | ~40 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | NA | ||
| 32798369 | 2021 | AIPWIYIYRLLRKG | WYY | Free | Free | Linear | L | None | 14 | Antibacterial | ~40 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | NA | ||
| 32798369 | 2021 | AIPWIFIFRLLRKG | WFF | Free | Free | Linear | L | None | 14 | Antibacterial | ~60 % Hemolysis at 15 μM | Human | Short Length Bucathl4B Peptide (Water Buffalo (Bubalus Bubalis)) | NA | NA | ||
| 33398076 | 2021 | R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid} | D-11 | Amidation | Free | Linear | D | None | 11 | Antibacterial | 10 % Hemolysis at 1200 μM | Human | Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ) | NA | Non-hemolytic | ||
| 33398076 | 2021 | R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid} | D-11 | Amidation | Free | Linear | D | None | 11 | Antibacterial | 0 % Hemolysis at 500 μM | Human | Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ) | NA | Non-hemolytic | ||
| 33398076 | 2021 | R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid} | D-11 | Amidation | Free | Linear | D | None | 11 | Antibacterial | 0 % Hemolysis at 600 μM | Human | Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ) | NA | Non-hemolytic | ||
| 33296183 | 2021 | FLKILKKLL{ct:Amid} | Feleucin-K46 | Amidation | Free | Linear | L | None | 9 | Antibacterial | <10 % Hemolysis at 128 μg/mL | Mouse | Feleucin-K3 Analogues (Frog Bombina Orientalis) | 50% TFE = α-Helix | Low hemolytic | ||
| 33296183 | 2021 | FLKFLKKLL{ct:Amid} | Feleucin-K48 | Amidation | Free | Linear | L | None | 9 | Antibacterial | ≥20 % Hemolysis at 128 μg/mL | Mouse | Feleucin-K3 Analogues (Frog Bombina Orientalis) | TFE = α-Helix | NA | ||
| 33296183 | 2021 | FLKWLKKLL{ct:Amid} | Feleucin-K52 | Amidation | Free | Linear | L | None | 9 | Antibacterial | ≥60 % Hemolysis at 128 μg/mL | Mouse | Feleucin-K3 Analogues (Frog Bombina Orientalis) | TFE = α-Helix | NA | ||
| 33296183 | 2021 | FLKYLKKLL{ct:Amid} | Feleucin-K53 | Amidation | Free | Linear | L | None | 9 | Antibacterial | ≥10 % Hemolysis at 128 μg/mL | Mouse | Feleucin-K3 Analogues (Frog Bombina Orientalis) | TFE = α-Helix | Low hemolytic | ||
| 33296183 | 2021 | FLK{nnr:L-2-Nal}LKKLL{ct:Amid} | Feleucin-K55 | Amidation | Free | Linear | L | L-2-NAL = L-2-NAL | 9 | Antibacterial | ≥80 % Hemolysis at 128 μg/mL | Mouse | Feleucin-K3 Analogues (Frog Bombina Orientalis) | TFE = α-Helix | NA | ||
| 33296183 | 2021 | FLK{nnr:D-2-NaI}LKKLL{ct:Amid} | Feleucin-K56 | Amidation | Free | Linear | Mix | D-2-nal = D-2-nal | 9 | Antibacterial | ≥10 % Hemolysis at 128 μg/mL | Mouse | Feleucin-K3 Analogues (Frog Bombina Orientalis) | TFE = α-Helix | Low hemolytic | ||
| 33296183 | 2021 | FLK{nnr:α-(4-pentenyl)-Ala}LKKLL{ct:Amid} | Feleucin-K59 | Amidation | Free | Linear | L | α-(4-pentenyl)-Ala | 9 | Antibacterial, Antibiofilm | ≥60 % Hemolysis at 128 μg/mL | Mouse | Feleucin-K3 Analogues (Frog Bombina Orientalis) | TFE = α-Helix | NA | ||
| 33495505 | 2021 | VRNSQSCRRNKGICVPIRCPGSMRQIGTCLGAQVKCCRRK | cystine dense peptide CDP-B11 | Free | Free | Linear | L | None | 40 | Antibacterial | 0 % Hemolysis at 200 μg/mL | Sheep | Bubalus Bubalis (Domestic Water Buffalo) | NA | Non-hemolytic | ||
| 33532575 | 2021 | KYKKALKKLAKLL | L-SB1 | Free | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm | MHC at >2000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | K{d}Y{d}K{d}K{d}A{d}L{d}K{d}K{d}L{d}A{d}K{d}L{d}L{d} | D-SB1 | Free | Free | Linear | D | None | 13 | Antibacterial. Antibiofilm | MHC at >2000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | VQWRAIRVRVIR | L-DJK5 | Free | Free | Linear | L | None | 12 | Antibacterial. Antibiofilm | MHC at >2000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | V{d}Q{d}W{d}R{d}A{d}I{d}R{d}V{d}R{d}V{d}I{d}R{d} | D-DJK5 | Free | Free | Linear | D | None | 12 | Antibacterial. Antibiofilm | MHC at 1000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | ILPWKWPWWPWRR | L-Indo | Free | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm | MHC at 125 μg/mL | Human | Derived From Bovin | PB and 20%TFE = α-Helical | NA | ||
| 33532575 | 2021 | I{d}L{d}P{d}W{d}K{d}W{d}P{d}W{d}W{d}P{d}W{d}R{d}R{d} | D-Indo | Free | Free | Linear | D | None | 13 | Antibacterial. Antibiofilm | MHC at 125 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | NA | ||
| 33532575 | 2021 | KLKLKLKLKLKLKLKLKKLKKLKKLKKLKKLKKLKKL | L-G3KL | Free | Free | Branched | L | None | 37 | Antibacterial. Antibiofilm | MHC at 1000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d} | D-G3KL | Free | Free | Branched | D | None | 37 | Antibacterial. Antibiofilm | MHC at 1000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | OFOFOFOFKBLKBLKKLK{ct:C10} | L-TNS18 | Free | Free | Branched | L | None | 18 | Antibacterial. Antibiofilm | MHC at 1000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | O{d}F{d}O{d}F{d}O{d}F{d}O{d}F{d}K{d}B{d}L{d}K{d}B{d}L{d}K{d}K{d}L{d}K{d}{ct:C10} | D-TNS18 | Free | Free | Branched | D | None | 18 | Antibacterial. Antibiofilm | MHC at 500 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Low hemolytic | ||
| 33532575 | 2021 | KLKLKLKLKLKLKLKLKKLKKLKKLKKLKLLKLLKKLL | L-T25 | Free | Free | Branched | L | None | 38 | Antibacterial. Antibiofilm | MHC at 62.5 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | NA | ||
| 33532575 | 2021 | K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}L{d}L{d}K{d}L{d}L{d}K{d}K{d}L{d}L{d} | D-T25 | Free | Free | Branched | D | None | 38 | Antibacterial. Antibiofilm | MHC at 125 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 32666297 | 2021 | RIIDLLWRVRRPQKPKFVTVWVR | PMAP-23 | Free | Free | Linear | L | None | 23 | Antibacterial | <4 % Hemolysis at 1000 μg/mL | Mouse | Synthetic Peptide | two α-Helix regions | Non-hemolytic | ||
| 32666297 | 2021 | RIIDRLWRVRRPQKPKFVTVWVR | PMAP-23R | Free | Free | Linear | L | None | 23 | Antibacterial | <4 % Hemolysis at 1000 μg/mL | Mouse | Pmap-23 Analogs | NA | Non-hemolytic | ||
| 32666297 | 2021 | RIIDLLWRVRRPQKPKFVIVWVR | PMAP-23I | Free | Free | Linear | L | None | 23 | Antibacterial | <4 % Hemolysis at 1000 μg/mL | Mouse | Pmap-23 Analogs | NA | Non-hemolytic | ||
| 32666297 | 2021 | RIIDRLWRVRRPQKPKFVIVWVR | PMAP-23RI | Free | Free | Linear | L | None | 23 | Antibacterial | <4 % Hemolysis at 1000 μg/mL | Mouse | Pmap-23 Analogs | NA | Non-hemolytic | ||
| 32812694 | 2021 | FALGAVTKVLPKLFCLITRKC | Brevinin-1H | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm, Antifungal | >20 % Hemolysis at 32 µM | Horse | Frog Amolops Hainanensis | Helix | NA | ||
| 32812694 | 2021 | FALGAVTKVLPKLFCLITRKC | Brevinin-1H | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm, Antifungal | 50 % Hemolysis at 53.12 µM | Horse | Frog Amolops Hainanensis | Helix | NA | ||
| 32812694 | 2021 | FALGAVTKVLPKLFCLITRKC | Brevinin-1H | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm, Antifungal | 9.49 % Hemolysis at 4 µM | Horse | Frog Amolops Hainanensis | Helix | NA | ||
| 32812694 | 2021 | FALGAVTCLIRTKCKVLPKLF | Brevinin-1Ha | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 22.1 % Hemolysis at 128 µM | Horse | Brevinin-1H Analogues | NA | NA | ||
| 32812694 | 2021 | FALGAVTKVLYKLFCLITRKC | Brevinin-1HY | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 28.48 % Hemolysis at 4 µM | Horse | Brevinin-1H Analogues | Helix | NA | ||
| 33141035 | 2021 | RIIDLLWRVRRPQKPKFVTVWVR | PMAP-23 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | ≤4 % Hemolysis at 1280 μg/mL | Mouse | Porcine Myeloid | two α-Helical | Non-hemolytic | ||
| 33141035 | 2021 | RIIDRLWRVRRPQKPKFVIVWVR | PMAP-23R | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | ≤4 % Hemolysis at 1280 μg/mL | Mouse | Pmap-23 Analogs | NA | Non-hemolytic | ||
| 33141035 | 2021 | RIIDRLWRVRRPQKPKFVIVWVR-K-{nnr:Dec}{ct:Dec} | PMAP-23RI-Dec | Dec | Free | Linear | L | Dec = Decanoic acid | 24 | Antibacterial, Antibiofilm | ≤4 % Hemolysis at 1280 μg/mL | Mouse | Pmap-23 Analogs With Decanoic Acid | NA | Non-hemolytic | ||
| 33175610 | 2021 | IWLTALKFLGKNLGKHLAKQQLAKL{nt:H}{ct:Amid} | LyeTx I | Amidation | H | Linear | L | None | 25 | Antibacterial, Antifungal | 50 % Hemolysis at 32.35 µM | Rabbit | Spider Lycosa Erythrognatha | water = Random coil, TFE = α-Helix | NA | ||
| 33175610 | 2021 | IWLTALKFLGKNLGK{nt:H}{ct:Amid} | LyeTx I mn | Amidation | H | Linear | L | None | 15 | Antibacterial, Antifungal | 50 % Hemolysis at 381.4 µM | Rabbit | Lyetx I Analogs | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 33175610 | 2021 | IWLTKALKFLGKNLGK{nt:H}{ct:Amid} | LyeTx I mnΔK | Amidation | H | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 506.5 µM | Rabbit | Lyetx I Analogs | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 33175610 | 2021 | IWLTKALKFLGKNLGK{nt:Acet}{ct:Amid} | LyeTx I mnΔKAc | Amidation | Acetylation | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 207.5 µM | Rabbit | Lyetx I Analogs | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 33175610 | 2021 | IWLTALKFLGKNLGKHLAKQQLAKL{nt:H}{ct:Amid} | LyeTx I | Amidation | H | Linear | L | None | 25 | Antibacterial, Antifungal | 1 % Hemolysis at 5.06 µM | Rabbit | Spider Lycosa Erythrognatha | water = Random coil, TFE = α-Helix | NA | ||
| 33175610 | 2021 | IWLTALKFLGKNLGK{nt:H}{ct:Amid} | LyeTx I mn | Amidation | H | Linear | L | None | 15 | Antibacterial, Antifungal | 1 % Hemolysis at 48.06 µM | Rabbit | Lyetx I Analogs | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 33175610 | 2021 | IWLTKALKFLGKNLGK{nt:H}{ct:Amid} | LyeTx I mnΔK | Amidation | H | Linear | L | None | 16 | Antibacterial, Antifungal | 1 % Hemolysis at 44.67 µM | Rabbit | Lyetx I Analogs | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 33175610 | 2021 | IWLTKALKFLGKNLGK{nt:Acet}{ct:Amid} | LyeTx I mnΔKAc | Amidation | Acetylation | Linear | L | None | 16 | Antibacterial, Antifungal | 1 % Hemolysis at 27.44 µM | Rabbit | Lyetx I Analogs | water = Random coil, TFE = α-Helix | Low hemolytic | ||
| 33271197 | 2021 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 50 μg/mL | Human | Southern Bell Frog Litoria Aurea And Litoria Raniformis | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFDIIKKIWESF{ct:Amid} | Aurein M1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 25 μg/mL | Human | Aurein 1.2 Analogs | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFKIIKKIAKSF{ct:Amid} | Aurein M2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 100 μg/mL | Human | Aurein 1.2 Analogs | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFKIIKKIWKSF{ct:Amid} | Aurein M3 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 25 μg/mL | Human | Aurein 1.2 Analogs | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFDIIKKIAESF{ct:Amid} | Aurein 1.2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 39.96 % Hemolysis at 200 μg/mL | Human | Southern Bell Frog Litoria Aurea And Litoria Raniformis | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFDIIKKIWESF{ct:Amid} | Aurein M1 | Amidation | Free | Linear | L | None | 13 | Antibacterial | ~50 % Hemolysis at 200 μg/mL | Human | Aurein 1.2 Analogs | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFKIIKKIAKSF{ct:Amid} | Aurein M2 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 15.48 % Hemolysis at 200 μg/mL | Human | Aurein 1.2 Analogs | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33271197 | 2021 | GLFKIIKKIWKSF{ct:Amid} | Aurein M3 | Amidation | Free | Linear | L | None | 13 | Antibacterial | 43.86 % Hemolysis at 200 μg/mL | Human | Aurein 1.2 Analogs | 20 mM phosphate buffer with 10mM SDS = α-Helix | NA | ||
| 33242568 | 2021 | KKCNFFCKLKKKVKSVGSRNLIGSATHHHRIYRV | PN-CATH1 | Free | Free | Linear | L | None | 34 | Antibacterial, Antifungal, Antibiofilm, Anti-inflammatory, anitoxidant | 5.9 % Hemolysis at 200 μg/mL | Mouse | Black-Spotted Frog, Pelophylax Nigromaculata | SDS = α-Helical | Low hemolytic | ||
| 33242568 | 2021 | EGCNILCLLKRKVKAVKNVVKNVVKSVVG | PN-CATH2 | Free | Free | Linear | L | None | 29 | Antibacterial, Antifungal, Antibiofilm, Anti-inflammatory, anitoxidant | 7.5 % Hemolysis at 200 μg/mL | Mouse | Black-Spotted Frog, Pelophylax Nigromaculata | SDS = α-Helical | Low hemolytic | ||
| 33807972 | 2021 | LARLRRLCFLWAAAWPWPWR | ZM-804 | Free | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 256 µM | Mouse | Plant Maize Zea Mays B73 | α-Helix | Low hemolytic | ||
| 33809374 | 2021 | AIPWIWIWRLLRKG | WWW | Free | Free | Linear | L | None | 14 | Antibacterial | ~34 % Hemolysis at 15 µM | Sheep | Bucathl4B Peptides | phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical | NA | ||
| 33809374 | 2021 | AIPWIWIWRLLRKG | WWW | Free | Free | Linear | L | None | 14 | Antibacterial | ~15 % Hemolysis at 7.5 µM | Sheep | Variants Of Bucathl-4B | phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical | NA | ||
| 33809374 | 2021 | AIPZIWIWRLLRKG | Z4 | Free | Free | Linear | L | AzAla = Azulenyl-Alanine | 14 | Antibacterial | ~9 % Hemolysis at 15 µM | Sheep | Variants Of Bucathl-4B | phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical | NA | ||
| 33809374 | 2021 | AIPWIZIWRLLRKG | Z6 | Free | Free | Linear | L | AzAla = Azulenyl-Alanine | 14 | Antibacterial | ~14 % Hemolysis at 15 µM | Sheep | Variants Of Bucathl-4B | phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical | NA | ||
| 33809374 | 2021 | AIPWIWIZRLLRKG | Z8 | Free | Free | Linear | L | AzAla = Azulenyl-Alanine | 14 | Antibacterial | ~9 % Hemolysis at 15 µM | Sheep | Variants Of Bucathl-4B | phospholipid POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) = α-Helical | NA | ||
| 32889698 | 2021 | A({nnr:Nle})WKK({nnr:Nle})({nnr:Nle})KK({nnr:Nle})({nnr:Nle})KSAKK({nnr:Nle})G | C18G-Nle | Free | Free | Linear | L | Nle = Norleucine | 18 | Antibacterial | 24 % Hemolysis at 10 µM | Human | Variants Of C18G (Human Platelet Factor Iv Protein) | PBS = Disordered, TFE = α-Helix | NA | ||
| 32889698 | 2021 | A({nnr:Nva})WKK({nnr:Nva})({nnr:Nva})KK({nnr:Nva})({nnr:Nva})KSAKK({nnr:Nva})G | C18G-Nva | Free | Free | Linear | L | Nva = Norvaline | 18 | Antibacterial | <5 % Hemolysis at 10 µM | Human | Variants Of C18G (Human Platelet Factor Iv Protein) | PBS = Disordered, TFE = α-Helix | NA | ||
| 32889698 | 2021 | A({nnr:Cha})WKK({nnr:Cha})({nnr:Cha})KK({nnr:Cha})({nnr:Cha})KSAKK({nnr:Cha})G | C18G-Cha | Free | Free | Linear | L | Cha = Cyclohexylalanine | 18 | Antibacterial | 65 % Hemolysis at 10 µM | Human | Variants Of C18G (Human Platelet Factor Iv Protein) | PBS = Disordered, TFE = α-Helix | NA | ||
| 32889698 | 2021 | A({nnr:Abu})WKK({nnr:Abu})({nnr:Abu})KK({nnr:Abu})({nnr:Abu})KSAKK({nnr:Abu})G | C18G-Abu | Free | Free | Linear | L | Abu = Aminobutyric | 18 | Antibacterial | <5 % Hemolysis at 10 µM | Human | Variants Of C18G (Human Platelet Factor Iv Protein) | PBS = Disordered, TFE = α-Helix | NA | ||
| 32889698 | 2021 | AAWKKAAKKAAKSAKKAG | C18G-Ala | Free | Free | Linear | L | None | 18 | Antibacterial | <5 % Hemolysis at 10 µM | Human | Variants Of C18G (Human Platelet Factor Iv Protein) | PBS = Disordered, TFE = α-Helix | NA | ||
| 33206284 | 2021 | MASKRDCNLMKATCAGQAVTYAIHSLLNRLGGDSSDPAGC NDIVRKYCK | C13T | Free | Free | Linear | L | None | 49 | Antibacterial | 15-20 % Hemolysis at 600 µM | Human | Variant Of Ent96 | NA | Low hemolytic | ||
| 33206284 | 2021 | MASKYYGNGVKRDCNLMKACCAGQAVTYAIHSLLNRLGGDSSDPAGCNDIVRKYCK | Ent96-K4_K5insYYGNGV# | Free | Free | Linear | L | diglycosylated | 56 | Antibacterial | 15-20 % Hemolysis at 600 µM | Human | Variant Of Ent96 | NA | Low hemolytic | ||
| 33206284 | 2021 | MASKRDCNLMKACCAGQAVTYAIHSLLNRLGGDCSDPAGCNDIVRKYCK | S34C | Free | Free | Linear | L | None | 49 | Antibacterial | 15-20 % Hemolysis at 600 µM | Human | Variant Of Ent96 | NA | Low hemolytic | ||
| 33206284 | 2021 | MASKACCAGQAVTYAIHSLLNRLGGDSSDPAGCNDIVRKYCK | Ent96-R5_K11del# | Free | Free | Linear | L | diglycosylated | 42 | Antibacterial | 15-20 % Hemolysis at 600 µM | Human | Variant Of Ent96 | NA | Low hemolytic | ||
| 33206284 | 2021 | MASKRDCNLMKACCAGQAVTYAIHSLLNRLGGDSSGPAGC NDIVRKYCK | D36G | Free | Free | Linear | L | None | 49 | Antibacterial | 15-20 % Hemolysis at 600 µM | Human | Variant Of Ent96 | NA | Low hemolytic | ||
| 33206284 | 2021 | MASKRDCNLMKACCAEQAVTYAIQSLLNRLGGDSSDPAGCNDIVRKYCK | G16E-H24Q | Free | Free | Linear | L | None | 49 | Antibacterial | 15-20 % Hemolysis at 600 µM | Human | Variant Of Ent96 | NA | Low hemolytic | ||
| 33506605 | 2021 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Solitary Wasp Anoplius Samariensis | PBS = Random Coil, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLLKIIKKLL{ct:Amid} | Ano 1-F | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLLKIIKKLL{nt:C8 = octanoic acid}{ct:Amid} | Ano 1-C8 | Amidation | C8 = octanoic acid | Linear | L | C8 = Octanoic Acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Anoplin Analogs | PBS = Helical, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLLKIIKKLL{nt:C10 = decanoic acid}{ct:Amid} | Ano 1-C10 | Amidation | C10 = decanoic acid | Linear | L | C10 = decanoic acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at 44.6 μg/ml | Human | Anoplin Analogs | PBS = Helical, SDS = α-Helix | NA | ||
| 33506605 | 2021 | #ERROR! | Ano 2-F | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLKKIIKKLL{nt:C8 = octanoic acid}{ct:Amid} | Ano 2-C8 | Amidation | C8 = octanoic acid | Linear | L | C8 = Octanoic Acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at 80.8 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | NA | ||
| 33506605 | 2021 | GLKKIIKKLL{nt:C10 = decanoic acid}{ct:Amid} | Ano 2-C10 | Amidation | C10 = decanoic acid | Linear | L | C10 = decanoic acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at 75.5 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | NA | ||
| 33506605 | 2021 | GLLKFIKRLL{ct:Amid} | Ano 3-F | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLLKFIKRLL{nt:C10 = decanoic acid}{ct:Amid} | Ano 3-C10 | Amidation | C10 = decanoic acid | Linear | L | C10 = decanoic acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at 175.2 μg/ml | Human | Anoplin Analogs | PBS = Helical, SDS = α-Helix | NA | ||
| 33506605 | 2021 | GLLKKIKRLL{ct:Amid} | Ano 4-F | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLLKKIKRLL{nt:C10 = decanoic acid}{ct:Amid} | Ano 4-C10 | Amidation | C10 = decanoic acid | Linear | L | C10 = decanoic acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at 44.2 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | NA | ||
| 33506605 | 2021 | GLLKIIKRLL{ct:Amid} | Ano 5-F | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Anoplin Analogs | PBS = Helical, SDS = α-Helix | Low hemolytic | ||
| 33506605 | 2021 | GLLKIIKRLL{nt:C10 = decanoic acid}{ct:Amid} | Ano 5-C10 | Amidation | C10 = decanoic acid | Linear | L | C10 = decanoic acid | 10 | Antibacterial, Antifungal | 50 % Hemolysis at 68.1 μg/ml | Human | Anoplin Analogs | PBS = Random Coil, SDS = α-Helix | NA | ||
| 33917850 | 2021 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 50 % Hemolysis at 163 µM | Human | Combines The Sequence Of Melittin And Cecropin A | α-Helical | NA | ||
| 33917850 | 2021 | {conj:Naphthalimide}AAKKLFKKILKYL{ct:Amid} | NAPHT-BP100 | Amidation | Naphthalimide | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 23 µM | Human | Naphthalimide-Conjugated Bp10 Peptide | aqueous = Random/flexible structure, POPG = α-Helix | NA | ||
| 33920239 | 2021 | GANAAKKFATIAKKFINYLW | GW-Q4 | Free | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 128 μg/ml | NA | Synthetic Peptide | NA | NA | ||
| 33920239 | 2021 | GANAAKKFATIAKKFINYLW{ct:Amid} | GW-Q4a | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 32 μg/ml | NA | Analogs Gw-Q4 | NA | NA | ||
| 33920239 | 2021 | KKFATIAKKFINYLW | Q4-15 | Free | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 128 μg/ml | NA | Derived From Truncation Of Gw-Q4 | NA | NA | ||
| 33920239 | 2021 | KKFATIAKKFINYLW{ct:Amid} | Q4-15a | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 16 μg/ml | NA | C-Terminal Amide Derivative Of Q4-15 | NA | NA | ||
| 33920239 | 2021 | KKFATIAKKFINKLW | Q4-15-1 | Free | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 256 μg/ml | NA | Derived From Q4-15 With A Substitution | NA | Low hemolytic | ||
| 33920239 | 2021 | KKFATIAKKFINKLW{ct:Amid} | Q4-15a-1 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 256 μg/ml | NA | C-Terminal Amide Derivative Of Q4-15-1 | NA | Low hemolytic | ||
| 33920239 | 2021 | KKFATIAKKFINWLW | Q4-15-2 | Free | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 32 μg/ml | NA | Derived From Q4-15 With A Substitution | NA | NA | ||
| 33920239 | 2021 | KKFATIAKKFINWLW{ct:Amid} | Q4-15a-2 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 16 μg/ml | NA | C-Terminal Amide Derivative Of Q4-15-2 | NA | NA | ||
| 33676184 | 2021 | KWKLFKKIKFLHSAKKF | CE-MA | Free | Free | Linear | L | None | 17 | Antibacterial, Antiviral, Antiparasitic, Antifungal, Anticancer | >20 % Hemolysis at 500 μg/ml | Human | Synthetic Peptide Consisting Of Cecropin A And Magenin B | α-Helix | NA | ||
| 33981626 | 2021 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 10 % Hemolysis at 45 μM | Human | Synthetic Peptide | micelles and lipid bilayers = α-Helix | NA | ||
| 33981626 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS | MAG2 | Free | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at >100 μM | Human | Frog Xenopus Laevis | NA | Low hemolytic | ||
| 33981626 | 2021 | GMASKAGAIAGKIAKVALKAL{ct:Amid} | PGLa | Amidation | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 16 μM | Human | Frog Xenopus Laevis | NA | NA | ||
| 33981626 | 2021 | KIAGKIAKIAGKIAKIAGKIA{ct:Amid} | MSI-103 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 9 μM | Human | Pgla Analog | α-Helix | NA | ||
| 33981626 | 2021 | KLALKLALKALKAALKLA{ct:Amid} | MAP | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 2 μM | Human | Synthetic Peptide | Helical | NA | ||
| 33981626 | 2021 | GRKKRRQRRRPPQ | TAT | Free | Free | Linear | L | None | 13 | Antibacterial | 10 % Hemolysis at >>100 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 34093476 | 2021 | FKFLARTGKFL | PN5 | Free | Free | Linear | L | None | 11 | Antibacterial | 5 % Hemolysis at 200 μg/ml | Mouse | Pinus Densiflora | α-Helical | Low hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 49.2 % Hemolysis at 50 µM | Mouse | Scorpion Heterometrus Petersii | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | NA | ||
| 34073939 | 2021 | GILGKLWEGVKSIA{ct:Amid} | Hp1404-A | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIK{ct:Amid} | Hp1404-K | Amidation | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIV{ct:Amid} | Hp1404-V | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIL{ct:Amid} | Hp1404-L | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 45.8 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | NA | ||
| 34073939 | 2021 | GILGKLWEGVKSIL{ct:Amid} | Hp1404-L | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 21.3 % Hemolysis at 25 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | NA | ||
| 34073939 | 2021 | GILGKLWEGVKSII{ct:Amid} | Hp1404-I | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 25 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIW{ct:Amid} | Hp1404-W | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 15.9 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | NA | ||
| 34073939 | 2021 | GILGKLWEGVKSIW{ct:Amid} | Hp1404-W | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 1.7 % Hemolysis at 25 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Low hemolytic | ||
| 34070683 | 2021 | {nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}-{nnr:hArg}-{nnr:βNPhe}{nt:Acet}{ct:Amid} | Subclass I-1 | Amidation | Acetylation | Linear | NA | hArg = homoarginine, βNPhe = N-benzyl-β-alanine | 16 | Antibacterial | 6.1 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Low hemolytic | ||
| 34070683 | 2021 | {nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}-{nnr:hArg}-{nnr:βNsce}{nt:Acet}{ct:Amid} | Subclass I-2 | Amidation | Acetylation | Linear | NA | hArg = homoarginine, βNsce = N-(S)-1-cyclohexylethyl-β-alanine | 12 | Antibacterial | 98.4 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | NA | ||
| 34070683 | 2021 | {nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}{nt:SpermineAc = H2N(CH2)3NH(CH2)4NH(CH2)3NHCH2(C=O)-}{ct:Amid} | Subclass II-3 | Amidation | SpermineAc = H2N(CH2)3NH(CH2)4NH(CH2)3NHCH2(C=O)- | Linear | L | hArg = homoarginine, βNspe = N-(S)-1-phenylethyl-β-alanine | 13 | Antibacterial | 0.6 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Non-hemolytic | ||
| 34070683 | 2021 | {nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}{nt:H}{ct:Amid} | Subclass II-4 | Amidation | H | Linear | L | hArg = homoarginine, βNspe = N-(S)-1-phenylethyl-β-alanine | 16 | Antibacterial | 2.6 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Non-hemolytic | ||
| 34070683 | 2021 | {nnr:hArg}-{nnr:βNsce}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNsce}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNsce}-K-{nnr:βNspe}{nt:Acet}{ct:Amid} | Subclass II-5 | Amidation | Acetylation | Linear | L | hArg = homoarginine, βNspe = N-(S)-1-phenylethyl-β-alanine, βNsce = N-(S)-1-cyclohexylethyl-β-alanine | 12 | Antibacterial | 9.4 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Low hemolytic | ||
| 34070683 | 2021 | {nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}-{nnr:hArg}-{nnr:βNspe}-K-{nnr:βNspe}{nt:Cinn = cinnamoyl}{ct:Amid} | Subclass II-6 | Amidation | Cinn = cinnamoyl | Linear | L | hArg = homoarginine, βNspe = N-(S)-1-phenylethyl-β-alanine | 13 | Antibacterial | 15.7 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Low hemolytic | ||
| 34070683 | 2021 | K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}-K-{nnr:βNPhe(F)}{nt:H}{ct:Amid} | Subclass III-7 | Amidation | H | Linear | L | βNPhe(F) = N-(4-fluorobenzyl)-β-alanine | 16 | Antibacterial | 1.5 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Non-hemolytic | ||
| 34070683 | 2021 | K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}-K-{nnr:βNPhe(F3)}{nt:H}{ct:Amid} | Subclass III-8 | Amidation | H | Linear | L | βNPhe(F3) = N-(3,4,5-trifluorobenzyl)-β-alanine | 12 | Antibacterial | 28.8 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Low hemolytic | ||
| 34070683 | 2021 | K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}-K-{nnr:βNCha}{nt:H}{ct:Amid} | Subclass III-9 | Amidation | H | Linear | L | βNCha = N-cyclohexylmethyl-β-alanine | 16 | Antibacterial | 23 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Low hemolytic | ||
| 34070683 | 2021 | K-{nnr:βNspe}-K-{nnr:βNspe}-K-{nnr:βNspe}-K-{nnr:βNspe}-K-{nnr:βNspe}-K-{nnr:βNspe}{nt:Oct = octanoyl}{ct:Amid} | Subclass III-10 | Amidation | Oct = octanoyl | Linear | L | βNspe = N-(S)-1-phenylethyl-β-alanine | 13 | Antibacterial | 6.9 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | Low hemolytic | ||
| 34070683 | 2021 | K-{nnr:βNPhe}-K-{nnr:βNPhe}-K-{nnr:βNPhe}-K-{nnr:βNPhe}-K-{nnr:βNPhe}-K-{nnr:βNPhe}{nt:Lau = lauroyl}{ct:Amid} | Subclass III-11 | Amidation | Lau = lauroyl | Linear | L | βNPhe = N-benzyl-β-alanine | 13 | Antibacterial | 95.6 % Hemolysis at 400 µg/mL | Human | Synthetic Peptide/Β-Peptoid Hybrids | NA | NA | ||
| 34158805 | 2021 | PSAWQITKCAGSIAWALGSGIF | CBP22 | Free | Free | Linear | L | None | 22 | Antibacterial | <10 % Hemolysis at 256 μg/ml | Human | Bacteriocin Clostridium Butyricum Zju-F1 | NA | Low hemolytic | ||
| 34198776 | 2021 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 3 ± 3.5 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34198776 | 2021 | RINSAKDDAAGLQIA{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antibacterial | 0 ± 0 % Hemolysis at 375 μM | Horse | Bacterial Flagellin | NA | Non-hemolytic | ||
| 34198776 | 2021 | RINSAKDDAAGLQIA-KKLFKKILKKL{ct:Amid} | BP358 (flg15-BP16) | Amidation | Free | Linear | L | None | 26 | Antibacterial | 5 ± 0.2 % Hemolysis at 375 μM | Horse | Combination Of Flg15 And Bp16 | NA | Low hemolytic | ||
| 34198776 | 2021 | KKLFKKILKKL-RINSAKDDAAGLQIA{ct:OH} | BP359 (BP16-flg15) | OH | Free | Linear | L | None | 26 | Antibacterial | 0.8 ± 0.5 % Hemolysis at 375 μM | Horse | Combination Of Bp16 And Flg15 | NA | Non-hemolytic | ||
| 33890759 | 2021 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES{ct:Amid} | LL-37 | Amidation | Free | Linear | L | None | 37 | Antibacterial | 50 % Hemolysis at 170 μM | Human | Human Cathelicidin Ll-37 | Helical | NA | ||
| 33890759 | 2021 | KRIWQRIKDFLR{ct:Amid} | KR12 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 50 % Hemolysis at >340 μM | Human | Fragement Of Ll-37 | NA | Low hemolytic | ||
| 33890759 | 2021 | KRIWQRIKDF{nt:C14}{ct:Amid} | C14-KR10 | Amidation | C14 | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIK{nt:C14}{ct:Amid} | C14-KR8 | Amidation | C14 | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQR{nt:C14}{ct:Amid} | C14-KR6 | Amidation | C14 | Linear | L | None | 6 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIW{nt:C14}{ct:Amid} | C14-KR4 | Amidation | C14 | Linear | L | None | 4 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDFLR{nt:C12}{ct:Amid} | C12-KR12 | Amidation | C12 | Linear | L | None | 12 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDF{nt:C12}{ct:Amid} | C12-KR10 | Amidation | C12 | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIK{nt:C12}{ct:Amid} | C12-KR8 | Amidation | C12 | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at 35 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQR{nt:C12}{ct:Amid} | C12-KR6 | Amidation | C12 | Linear | L | None | 6 | Antibacterial | 50 % Hemolysis at 75 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIW{nt:C12}{ct:Amid} | C12-KR4 | Amidation | C12 | Linear | L | None | 4 | Antibacterial | 50 % Hemolysis at 30 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDFLR{nt:C10}{ct:Amid} | C10-KR12 | Amidation | C10 | Linear | L | None | 12 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDF{nt:C10}{ct:Amid} | C10-KR10 | Amidation | C10 | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIK{nt:C10}{ct:Amid} | C10-KR8 | Amidation | C10 | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at 300 μM | Human | Synthetic Peptide | Helical | Low hemolytic | ||
| 33890759 | 2021 | K{d}R{d}I{d}W{d}Q{d}R{d}I{d}K{d}{nt:C10}{ct:Amid} | C10-KR8d | Amidation | C10 | Linear | D | None | 8 | Antibacterial | 50 % Hemolysis at 300 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 33890759 | 2021 | KRIWQR{nt:C10}{ct:Amid} | C10-KR6 | Amidation | C10 | Linear | L | None | 6 | Antibacterial | 50 % Hemolysis at >340 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 33890759 | 2021 | KRIW{nt:C10}{ct:Amid} | C10-KR4 | Amidation | C10 | Linear | L | None | 4 | Antibacterial | 50 % Hemolysis at 150 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDFLR{nt:C8}{ct:Amid} | C8-KR12 | Amidation | C8 | Linear | L | None | 12 | Antibacterial | 50 % Hemolysis at <25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDF{nt:C8}{ct:Amid} | C8-KR10 | Amidation | C8 | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at 250 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 33890759 | 2021 | K{d}R{d}I{d}W{d}Q{d}R{d}I{d}K{d}D{d}F{d}{nt:C8}{ct:Amid} | C8-KR10d | Amidation | C8 | Linear | D | None | 10 | Antibacterial | 50 % Hemolysis at 150 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIK{nt:C8}{ct:Amid} | C8-KR8 | Amidation | C8 | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at >200 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 33890759 | 2021 | KRIWQR{nt:C8}{ct:Amid} | C8-KR6 | Amidation | C8 | Linear | L | None | 6 | Antibacterial | 50 % Hemolysis at >200 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 33890759 | 2021 | KRIW{nt:C8}{ct:Amid} | C8-KR4 | Amidation | C8 | Linear | L | None | 4 | Antibacterial | 50 % Hemolysis at >200 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 33890759 | 2021 | KRIWQRIKDFLR{nt:C6}{ct:Amid} | C6-KR12 | Amidation | C6 | Linear | L | None | 12 | Antibacterial | 50 % Hemolysis at 25 μM | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | KRIWQRIKDF{nt:C6}{ct:Amid} | C6-KR10 | Amidation | C6 | Linear | L | None | 10 | Antibacterial | 50 % Hemolysis at >200 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 33890759 | 2021 | KRIWQRIK{nt:C6}{ct:Amid} | C6-KR8 | Amidation | C6 | Linear | L | None | 8 | Antibacterial | 50 % Hemolysis at >200 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 33890759 | 2021 | KRIWQR{nt:C6}{ct:Amid} | C6-KR6 | Amidation | C6 | Linear | L | None | 6 | Antibacterial | 50 % Hemolysis at >200 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 33890759 | 2021 | KRIW{nt:C6}{ct:Amid} | C6-KR4 | Amidation | C6 | Linear | L | None | 4 | Antibacterial | 50 % Hemolysis at >200 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | WKKLKKLLKKLKKL{nt:Acet}{ct:Amid} | pepD2 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 9.6 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | WKKLKKLLKKL{nt:Acet}{ct:Amid} | pepD3 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 3.15 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | PE/PG liposomes = α-Helical | Low hemolytic | ||
| 34220763 | 2021 | WKKVKKVVKKVKKV{nt:Acet}{ct:Amid} | pepV2 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0.31 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Non-hemolytic | ||
| 34220763 | 2021 | WKKIKKIIKKIKKI{nt:Acet}{ct:Amid} | pepI2 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0.27 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Non-hemolytic | ||
| 34220763 | 2021 | WRRLRRLLRRLRRL{nt:Acet}{ct:Amid} | pepR2 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 105.65 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | W{nnr:O}{nnr:O}L{nnr:O}{nnr:O}LL{nnr:O}{nnr:O}L{nnr:O}{nnr:O}L{nt:Acet}{ct:Amid} | pepO2 | Amidation | Acetylation | Linear | L | O = L-Ornithine | 14 | Antibacterial, Antibiofilm | 0.23 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Non-hemolytic | ||
| 34220763 | 2021 | WK{d}K{d}L{d}K{d}K{d}L{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}{nt:Acet}{ct:Amid} | pepdD2 | Amidation | Acetylation | Linear | Mix | None | 14 | Antibacterial, Antibiofilm | 2.9 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | MY{d}R{d}-WKKLKKLLKKLKKL{nt:Myr = myristyl}{ct:Amid} | pepD2M | Amidation | Myr = myristyl | Linear | L | None | 14 | Antibacterial, Antibiofilm | 93.63 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | PA{d}L{d}-WKKLKKLLKKLKKL{nt:Pal = palmitoyl}{ct:Amid} | pepD2P | Amidation | Pal = palmitoyl | Linear | L | None | 14 | Antibacterial, Antibiofilm | 83.45 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | ST{d}E{d}-WKKLKKLLKKLKKL{nt:Ste = stearyl}{ct:Amid} | pepD2S | Amidation | Ste = stearyl | Linear | L | None | 14 | Antibacterial, Antibiofilm | 60.7 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | OC{d}T{d}-WKKLKKLLKKL{nt:Oct = octanoyl}{ct:Amid} | pepD3O | Amidation | Oct = octanoyl | Linear | L | None | 11 | Antibacterial, Antibiofilm | 86.03 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | HE{d}X{d}-WKKLKKLLKKL{nt:Hex = hexanoyl}{ct:Amid} | pepD3H | Amidation | Hex = hexanoyl | Linear | L | None | 11 | Antibacterial, Antibiofilm | 54.07 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | BU{d}T{d}-WKKLKKLLKKL{nt:But = butanoyl}{ct:Amid} | pepD3B | Amidation | But = butanoyl | Linear | L | None | 11 | Antibacterial, Antibiofilm | 7.89 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34205705 | 2021 | KKLF{d}KKILKYL{nt:C5H11CO}{ct:Amid} | BP472 | Amidation | C5H11CO | Linear | Mix | None | 11 | Antifungal, Antibacterial | 78 ± 5 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KK({nnr:COC3H7})IL{d}KYL{d}{nt:Acet}{ct:Amid} | BP473 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 84 ± 11 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKIK({nnr:COC3H7})KYL{d}{nt:Acet}{ct:Amid} | BP474 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 0 ± 0 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}KK({nnr:COC3H7})L{d}{nt:Acet}{ct:Amid} | BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 0 ± 0 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | α-Helical | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}KYK({nnr:COC11H23}){nt:Acet}{ct:Amid} | BP476 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 94 ± 10 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}k({nnr:COC5H11})KKIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP484 | Amidation | Acetylation | Linear | Mix | COC5H11 = hexanoyl | 11 | Antifungal, Antibacterial | 10 ± 2 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}{d}KKIL{d}KYL{d}{nt:C3H7CO}{ct:Amid} | BP485 | Amidation | C3H7CO | Linear | Mix | None | 11 | Antifungal, Antibacterial | 24 ± 9 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KK({nnr:COC3H7})L{d}F{d}KKIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP486 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 14 ± 5 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}k({nnr:COC11H23})KKIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP488 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 86 ± 14 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKK({nnr:COC11H23})L{d}KYL{d}{nt:Acet}{ct:Amid} | BP489 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 100 ± 6 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKIK({nnr:COC11H23})KYL{d}{nt:Acet}{ct:Amid} | BP490 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 100 ± 6 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKK({nnr:COC5H11})L{d}KYL{d}{nt:Acet}{ct:Amid} | BP494 | Amidation | Acetylation | Linear | Mix | COC5H11 = hexanoyl | 11 | Antifungal, Antibacterial | 0.2 ± 0.2 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}KYK({nnr:COC5H11}){nt:Acet}{ct:Amid} | BP495 | Amidation | Acetylation | Linear | Mix | COC5H11 = hexanoyl | 11 | Antifungal, Antibacterial | 0.6 ± 1 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}KYK({nnr:COC3H7}){nt:Acet}{ct:Amid} | BP496 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 1 ± 1 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}K({nnr:COC11H23})YL{d}{nt:Acet}{ct:Amid} | BP497 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 100 ± 2 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}K({nnr:COC3H7})KIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP498 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 21 ± 3 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}K({nnr:COC3H7})YL{d}{nt:Acet}{ct:Amid} | BP499 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 11 ± 1 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKK({nnr:COC11H23})F{d}KKIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP500 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 71 ± 8 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 33862164 | 2021 | FWSTLLSIGKSLL{ct:Amid} | VpCT1 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 10.5±0.4 μM | Human | Scorpion Mesomexovis Variegatu | 60 % aqueous TFE = α-Helix | NA | ||
| 33862164 | 2021 | FWSTIWNAAKSLI{ct:Amid} | VpCT2 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 10.8±0.4 μM | Human | Scorpion Mesomexovis Variegatu | 60 % aqueous TFE = α-Helix | NA | ||
| 33862164 | 2021 | FLQGIIDTVGKWL{ct:Amid} | VpCT3 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 83.7±1.8 μM | Human | Scorpion Mesomexovis Variegatu | 60 % aqueous TFE = α-Helix | NA | ||
| 33862164 | 2021 | FLQGIWDTVGKWL{ct:Amid} | VpCT3W | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 37.9±0.4 μM | Human | Scorpion Mesomexovis Variegatu | 60 % aqueous TFE = α-Helix | NA | ||
| 33862164 | 2021 | FLSKIWDGVKSLL{ct:Amid} | VpCTConsensus | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 50 % Hemolysis at 4.8±0.7 μM | Human | Scorpion Mesomexovis Variegatu | 60 % aqueous TFE = α-Helix | NA | ||
| 33862164 | 2021 | LWGALLGLGSTLLSKL{ct:Amid} | VpCT4 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 39.9±0.4 μM | Human | Scorpion Mesomexovis Variegatu | 60 % aqueous TFE = α-Helix | NA | ||
| 33972716 | 2021 | IWLTALKFLGKNLGKHLAKQQLAKL{nt:H}{ct:Amid} | LyeTx I | Amidation | H | Linear | L | None | 25 | Antibacterial, Antifungal | 50 % Hemolysis at 32.35 μM | Human | Lycosa Erythrognatha Spider Venom | NA | NA | ||
| 33972716 | 2021 | IWLTKALKFLGKNLGK{nt:H}{ct:Amid} | LyeTx I mnΔK | Amidation | H | Linear | L | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 55.31 ± 5 μM | Human | Lycosa Erythrognatha Spider Venom | NA | NA | ||
| 34335511 | 2021 | FIGAIARLLSKIF | BmKn2 | Free | Free | Linear | L | None | 13 | Antibacterial | 91.8 % Hemolysis at 25 μg/mL | Human | Scorpion Mesobuthus Martensii Karsch | α-Helical | NA | ||
| 34335511 | 2021 | FIKAIARLLSKIF | Kn2(G3K) | Free | Free | Linear | L | None | 13 | Antibacterial | 69 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | NA | NA | ||
| 34335511 | 2021 | FIGRIARLLSKIF | Kn2(A4R) | Free | Free | Linear | L | None | 13 | Antibacterial | 100 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | NA | NA | ||
| 34335511 | 2021 | FIGAIARLLRKIF | Kn2(S10R) | Free | Free | Linear | L | None | 13 | Antibacterial | 50.9 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | NA | NA | ||
| 34335511 | 2021 | FIKRIARLLSKIF | Kn2(G3K_A4R) | Free | Free | Linear | L | None | 13 | Antibacterial | 8.3 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | NA | NA | ||
| 34335511 | 2021 | FIKAIARLLRKIF | Kn2(G3K_S10R) | Free | Free | Linear | L | None | 13 | Antibacterial | 77.5 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | NA | NA | ||
| 34335511 | 2021 | FIGRIARLLRKIF | Kn2(A4R_S10R) | Free | Free | Linear | L | None | 13 | Antibacterial | 18 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | NA | NA | ||
| 34335511 | 2021 | FIKRIARLLRKIF | BmKn2-7 | Free | Free | Linear | L | None | 13 | Antibacterial | 6.9 % Hemolysis at 25 μg/mL | Human | Mutant Of Bmkn2-7 | aqueous = Random coil, 30% or 70% TFE solutions = α-Helical | NA | ||
| 34301247 | 2021 | FKRIVQRIKRFLRFKRIVQRIKRFLR | (FR)2 | Free | Free | Linear | L | None | 26 | Antibacterial | 20 % Hemolysis at 16 μM | Human | Synthetic Peptide | NA | NA | ||
| 34301247 | 2021 | FKRIVQRIKRFLRGGGGSFKRIVQRIKRFLR | LG | Free | Free | Linear | L | None | 31 | Antibacterial | 20 % Hemolysis at 64 μM | Human | Synthetic Peptide | NA | NA | ||
| 34301247 | 2021 | FKRIVQRIKRFLRAEAAAKAFKRIVQRIKRFLR | LA | Free | Free | Linear | L | None | 33 | Antibacterial | 20 % Hemolysis at 32 μM | Human | Synthetic Peptide | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 (1–28) dermaseptin S4 (DS4) | Free | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 54.2±5.43 % Hemolysis at 8 μg/mL | Human | Frog Skin Of Phyllomedusa Sauvagii | lipid bilayers = amphipathic α-Helical | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 (1–28) dermaseptin S4 (DS4) | Free | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 60±3.94 % Hemolysis at 16 μg/mL | Human | Frog Skin Of Phyllomedusa Sauvagii | lipid bilayers = amphipathic α-Helical | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 (1–28) dermaseptin S4 (DS4) | Free | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 65.7±4.57 % Hemolysis at 32 μg/mL | Human | Frog Skin Of Phyllomedusa Sauvagii | lipid bilayers = amphipathic α-Helical | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 (1–28) dermaseptin S4 (DS4) | Free | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 85.7±7.6 % Hemolysis at 64 μg/mL | Human | Frog Skin Of Phyllomedusa Sauvagii | lipid bilayers = amphipathic α-Helical | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 (1–28) dermaseptin S4 (DS4) | Free | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 85.7±9.28 % Hemolysis at 128 μg/mL | Human | Frog Skin Of Phyllomedusa Sauvagii | lipid bilayers = amphipathic α-Helical | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 (1–28) dermaseptin S4 (DS4) | Free | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 80±3.32 % Hemolysis at 256 μg/mL | Human | Frog Skin Of Phyllomedusa Sauvagii | lipid bilayers = amphipathic α-Helical | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (1–28)a | Amidation | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 0 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | Non-hemolytic | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (1–28)a | Amidation | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 2.8±0.86 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (1–28)a | Amidation | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 22.8±4.88 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (1–28)a | Amidation | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 31.4±4.28 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (1–28)a | Amidation | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 51.4±6.05 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (1–28)a | Amidation | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 68.5±10.83 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid} | DS4 (1–26)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 28.5±5.01 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid} | DS4 (1–26)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 31.4±5.98 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid} | DS4 (1–26)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 54.2±6.91 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid} | DS4 (1–26)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 65.7±7.01 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid} | DS4 (1–26)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 68.5±5.1 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid} | DS4 (1–26)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 74.2±5.82 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid} | DS4 (1–24)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 2.8±1.03 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid} | DS4 (1–24)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 11.4±2.8 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid} | DS4 (1–24)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 31.4±3.83 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid} | DS4 (1–24)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 40±3.5 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid} | DS4 (1–24)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 51.4±8.1 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid} | DS4 (1–24)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 57.1±6.34 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAV{ct:Amid} | DS4 (1–22)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 5.7±1.21 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAV{ct:Amid} | DS4 (1–22)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 31.4±3.8 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAV{ct:Amid} | DS4 (1–22)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 40±5.06 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAV{ct:Amid} | DS4 (1–22)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 54.2±4.41 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAV{ct:Amid} | DS4 (1–22)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 68.5±7.85 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAV{ct:Amid} | DS4 (1–22)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 80±1.12 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (3–28)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 0 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | Non-hemolytic | ||
| 33774792 | 2021 | WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (3–28)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 25.7±5.81 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (3–28)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 40±5.25 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (3–28)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 48.5±9.3 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (3–28)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 57.1±7.45 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (3–28)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 68.5±7.58 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 0 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | Non-hemolytic | ||
| 33774792 | 2021 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 5.7±3.14 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 8.5±2.79 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 34.2±4.43 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 54.2±6.9 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 57.1±7.64 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | LKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (7–28)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 0 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | Non-hemolytic | ||
| 33774792 | 2021 | LKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (7–28)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 0 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | Non-hemolytic | ||
| 33774792 | 2021 | LKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (7–28)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 3.2±0.62 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | LKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (7–28)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 6.4±1.74 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | LKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (7–28)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 6.4±2.88 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | LKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (7–28)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 35.4±6.28 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 34129853 | 2021 | INWKGIAAMAKRLL | Vp1b | Free | Free | Linear | L | None | 14 | Antioxidant, Antibacterial | 4.08 % Hemolysis at 120 μM | mouse | Asian Hornet Vespa Velutina | NA | Non-hemolytic | ||
| 34129853 | 2021 | FFPIIAKLLGGFLGKK | Vp2a | Free | Free | Linear | L | None | 16 | Antioxidant, Antibacterial | 3.46 % Hemolysis at 120 μM | mouse | Asian Hornet Vespa Velutina | NA | Non-hemolytic | ||
| 34282000 | 2021 | RLELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS | K9CATH | Free | Free | Linear | L | None | 37 | Antibacterial, Anti-inflammatory | >40 % Hemolysis at 80 μM | Human | Cathelicidin In Canines (Dogs) | 0.1% SDS or 50 μM LPS = α-Helical | NA | ||
| 34282000 | 2021 | ({nnr:Cit})LKELITTGGQKIGEKI({nnr:Cit})({nnr:Cit})IGQ({nnr:Cit})IKDFFKNLQP({nnr:Cit})EEKS | K9CATHCit5 | Free | Free | Linear | L | Cit = citrulline | 38 | Antibacterial | 0 % Hemolysis at 80 μM | Human | Cathelicidins Modified K9Cath | 0.1% SDS or 50 μM LPS = α-Helical | Non-hemolytic | ||
| 34282000 | 2021 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antibacterial | >25 % Hemolysis at 80 μM | Human | Human Cathelicidin Hcap18 | α-Helical | NA | ||
| 34180670 | 2021 | GLLKRIKTLL | anoplin | Free | Free | Linear | L | None | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at ≥512 μM | Human | Venom Of Wasps (Anoplius Samariensis) | α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GAAKRAKTAA | A-1 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GAAKRAKTAL | A-2 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GALKRAKTAL | A-3 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GLAKRAKTLL | A-4 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GLLKRLKTLA | A-5 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GLLKRFKTLL | A-6 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GWFKRIKTFW | A-7 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 384 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Low hemolytic | ||
| 34180670 | 2021 | GWWKRWKTWW | A-8 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 40.79 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34180670 | 2021 | GFLKRFKTLF | A-9 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 384 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Low hemolytic | ||
| 34180670 | 2021 | GLLKRWKTLL | A-10 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GFFKRWKTFF | A-11 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GWLKRWKTLW | A-12 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 320 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Low hemolytic | ||
| 34180670 | 2021 | GWWKRIKTWW | A-13 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 102.54 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34180670 | 2021 | GIRWKFWKFT | A-14 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | KWFKRIKTFW | A-15 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GLWKRWKKFW | A-16 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 83.63 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34180670 | 2021 | KWWKRWKKWW | A-17 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 77.65 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34180670 | 2021 | GFFRRIKTFF | A-18 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GFFKRIRTFF | A-19 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | GFFRRIRTFF | A-20 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at ≥512 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | KWWKKWKKWW | A-21 | Free | Free | Linear | L | None | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 134.38 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34180670 | 2021 | RWWRRWRRWW | A-22 | Free | Free | Linear | L | None | 10 | Antibacterial | 10 % Hemolysis at 43.67 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34342438 | 2021 | {nnr:O}PFT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O} | Orn analog | Free | Free | Linear | L | O = L-Ornithine | 30 | Antibacterial | 10 ± 2 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | NA | ||
| 34342438 | 2021 | {nnr:X}PFT{nnr:X}AQWFAIQHISP{nnr:X}TIAM{nnr:X}AINNY{nnr:X}W{nnr:X} | Dab analog | Free | Free | Linear | L | X = L-2,4-diaminobutyric acid | 30 | Antibacterial | 14 ± 6 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | NA | NA | ||
| 34342438 | 2021 | {nnr:Z}PFT{nnr:Z}AQWFAIQHISP{nnr:Z}TIAM{nnr:Z}AINNY{nnr:Z}W{nnr:Z} | Har analog | Free | Free | Linear | L | Z = L-homoarginine | 30 | Antibacterial | 43 ± 1 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | NA | NA | ||
| 34342438 | 2021 | FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O} | Des[Orn1-Pro2] analog | Free | Free | Linear | L | O = L-Ornithine | 28 | Antibacterial | 11 ± 4 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | NA | NA | ||
| 34342438 | 2021 | {nnr:O}P{d}FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O} | [Orn,1D-Pro2] analog | Free | Free | Linear | Mix | O = L-Ornithine, p = D-Proline | 30 | Antibacterial | 1.1 ± 0.9 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | Low hemolytic | ||
| 34342438 | 2021 | {nnr:o}P{d}FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O} | [D-Orn,1D-Pro2] analog | Free | Free | Linear | Mix | o = D-Ornithine, p = D-Proline | 30 | Antibacterial | 3.6 ± 0.7 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-F-{nnr:NLys}-F-{nnr:NLys}-F-{nnr:NLys}-F-{nnr:NLys}-F-{nnr:NLys}-F{nt:H}{ct:Amid} | CEP-124 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine | 12 | Antibacterial | 2.7 % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-L-{nnr:NLys}-L-{nnr:NLys}-L-{nnr:NLys}-L-{nnr:NLys}-L-{nnr:NLys}-L{nt:H}{ct:Amid} | CEP-126 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine | 12 | Antibacterial | 1.5 % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-Y-{nnr:NLys}-Y-{nnr:NLys}-Y-{nnr:NLys}-Y-{nnr:NLys}-Y-{nnr:NLys}-Y{nt:H}{ct:Amid} | CEP-129 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine | 12 | Antibacterial | 1.6 % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}-{nnr:NLys}-{nnr:Tyr(Me)}{nt:H}{ct:Amid} | CEP-130 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine, Tyr(Me) = Tyr(Me) | 12 | Antibacterial | 3 % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}-{nnr:NLys}-{nnr:tBuAla}{nt:H}{ct:Amid} | CEP-136 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine, tBuAla = tBuAla | 12 | Antibacterial | 3.9 (±2.0) % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}-{nnr:NLys}-{nnr:Phe(4)}{nt:H}{ct:Amid} | CEP-140 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine, Phe(4-NH2) = Phe(4-NH2) | 12 | Antibacterial | 0.1 % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Non-hemolytic | ||
| 34227804 | 2021 | {nnr:NOrn}-F-{nnr:NOrn}-F-{nnr:NOrn}-F-{nnr:NOrn}-F-{nnr:NOrn}-F-{nnr:NOrn}-F{nt:H}{ct:Amid} | CEP-144 | Amidation | H | Linear | L | NOrn = NOrn | 12 | Antibacterial | 5.5 (±2.5) % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-W-{nnr:NLys}-W-{nnr:NLys}-W-{nnr:NLys}-W{nt:H}{ct:Amid} | CEP-246 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine | 8 | Antibacterial | 4.6 (±3) % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | Low hemolytic | ||
| 34227804 | 2021 | {nnr:NLys}-{nnr:Cha}-{nnr:NLys}-{nnr:Cha}-{nnr:NLys}-{nnr:Cha}{nt:H}{ct:Amid} | CEP-391 | Amidation | H | Linear | L | NLys = N-(4-aminobutyl)glycine, Cha = Cha | 6 | Antibacterial | 22.6 (±2) % Hemolysis at 400 μg/mL | Human | Synthetic Peptidomimetics | NA | NA | ||
| 34577539 | 2021 | CRRRGSPHC | mCA4-4 | Free | Free | Linear | L | None | 9 | Antibacterial | <6 % Hemolysis at 100 µM | Chicken | Chicken Angiogenin 4 (Chang4) | NA | Low hemolytic | ||
| 34577539 | 2021 | CRFKFRIVIC | mCA4-5 | Free | Free | Linear | L | None | 10 | Antibacterial | <6 % Hemolysis at 100 µM | Chicken | Chicken Angiogenin 4 (Chang4) | NA | Low hemolytic | ||
| 34564152 | 2021 | FFKRLKNAFKSARQAWRDYK | β-Pte20 | Free | Free | Linear | L | None | 20 | Antibacterial | <5 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | Low hemolytic | ||
| 34564152 | 2021 | FFKRLKNAFKSARQAWR | β-Pte17 | Free | Free | Linear | L | None | 17 | Antibacterial | <5 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | Low hemolytic | ||
| 34564152 | 2021 | FFKRLKNAFKSAR | β-Pte13 | Free | Free | Linear | L | None | 13 | Antibacterial | <5 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | Low hemolytic | ||
| 34564152 | 2021 | FFKRLKNAFK | β-Pte10 | Free | Free | Linear | L | None | 10 | Antibacterial | <5 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | NA | Low hemolytic | ||
| 34564152 | 2021 | FFRHLKSLWKGAKAAFRGAR | γ-Pte20 | Free | Free | Linear | L | None | 20 | Antibacterial | <10 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | Low hemolytic | ||
| 34564152 | 2021 | FFRHLKSLWKGAKAAFR | γ-Pte17 | Free | Free | Linear | L | None | 17 | Antibacterial | <10 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | Low hemolytic | ||
| 34564152 | 2021 | FFRHLKSLWKGAK | γ-Pte13 | Free | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | Low hemolytic | ||
| 34564152 | 2021 | FFRHLKSLWK | γ-Pte10 | Free | Free | Linear | L | None | 10 | Antibacterial | <10 % Hemolysis at 50 µM | Human | Lionfish (Pterois Volitans) | NA | Low hemolytic | ||
| 34564152 | 2021 | FFRHLKSLWKGAKAAFRGAR | γ-Pte20 | Free | Free | Linear | L | None | 20 | Antibacterial | 19 % Hemolysis at 200 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | NA | ||
| 34564152 | 2021 | FFRHLKSLWKGAKAAFR | γ-Pte17 | Free | Free | Linear | L | None | 17 | Antibacterial | 43 % Hemolysis at 200 µM | Human | Lionfish (Pterois Volitans) | 75% trifluoroethanol (TFE) = α-Helix | NA | ||
| 34423969 | 2021 | WLGSALKIGAKLLPSVVGLFKKKKQ{nt:NH3}{ct:Amid} | Ponericin W1 | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 80 % Hemolysis at 50 µM | Human | Ants Pachycondyla Goeldii | negatively charged liposomes = α-Helix | NA | ||
| 34423969 | 2021 | WLKKALKIGAKLLPSVVKLFKGSGQ{nt:NH3}{ct:Amid} | PonAmp | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 70 % Hemolysis at 100 µM | Human | Ponericin W1 Analogues | NA | NA | ||
| 34423969 | 2021 | KKKKKKWLGSALIGALLPSVVGLFQ{nt:NH3}{ct:Amid} | PonN | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 20 % Hemolysis at 100 µM | Human | Ponericin W1 Analogues | NA | NA | ||
| 34423969 | 2021 | WLGSALIGALLPSVVGLFQKKKKKK{nt:NH3}{ct:Amid} | PonC | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 90 % Hemolysis at 100 µM | Human | Ponericin W1 Analogues | Helical and unstructured | NA | ||
| 34423969 | 2021 | WAKKAAKIGAKLLPSVVKLFKGSGQ{nt:NH3}{ct:Amid} | PonAmp 2A | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Ponericin W1 Analogues | NA | Non-hemolytic | ||
| 34423969 | 2021 | KKKKKKWAGSAAIGALLPSVVGLFQ{nt:NH3}{ct:Amid} | PonN 2A | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Ponericin W1 Analogues | NA | Non-hemolytic | ||
| 34423969 | 2021 | WAGSAAIGALLPSVVGLFQKKKKKK{nt:NH3}{ct:Amid} | PonC 2A | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Ponericin W1 Analogues | NA | Non-hemolytic | ||
| 34159664 | 2021 | RGGRLCYCRRRFCVCVGR{nt:H}{ct:Amid} | PG-1 | Amidation | H | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at 6.3±1.6 µM | Human | Wild Boar Porcine Leukocytes (Sus Scrofa) | antiparallel β-Sheet | NA | ||
| 34159664 | 2021 | GGVCPKILQRCRRDSDCPGACICRGNGYCGSGSGGRLCYCRRRFCVCVGRR{cyc:N-C} | MCo-PG2 | Free | Free | Cyclic | L | None | 51 | Antibacterial | 50 % Hemolysis at 88± 5 µM | Human | Cyclotide Mcoti-I Modified From Pg-1 | NA | NA | ||
| 34526600 | 2021 | KRIVQRIKDWLRKLCKKW | CaD23 | Free | Free | Linear | L | None | 18 | Antibacterial | 7.1 % Hemolysis at 200 μg/ml | Human | 2Nd Generation Hyhdps (Human-Derived Hybrid Host Defense Peptides) | NA | Low hemolytic | ||
| 34576320 | 2021 | SMWSGMWRRKLKKLRNALKKKLKGE | Ltc1 | Free | Free | Linear | L | None | 25 | Antibacterial | 100 % Hemolysis at 256 μg/ml | Human | Spider Lachesana Tarabaevi | vesicles composed of DMPC/DMPG (7/3) = α-Helix | NA | ||
| 34576320 | 2021 | GLFGKLIKKFGRKAISYAVKKARGKH | Ltc2a | Free | Free | Linear | L | None | 26 | Antibacterial | 36 % Hemolysis at 256 μg/ml | Human | Spider Lachesana Tarabaevi | vesicles composed of DMPC/DMPG (7/3) = α-Helix | NA | ||
| 34576320 | 2021 | SWKSMAKKLKEYMEKLKQRA{ct:Amid} | Ltc3a | Amidation | Free | Linear | L | None | 20 | Antibacterial | 16 % Hemolysis at 256 μg/ml | Human | Spider Lachesana Tarabaevi | vesicles composed of DMPC/DMPG (7/3) = α-Helix | Low hemolytic | ||
| 34576320 | 2021 | GLKDKFKSMGEKLKQYIQTWKAKF{ct:Amid} | Ltc4a | Amidation | Free | Linear | L | None | 24 | Antibacterial | 12 % Hemolysis at 256 μg/ml | Human | Spider Lachesana Tarabaevi | vesicles composed of DMPC/DMPG (7/3) = α-Helix | Low hemolytic | ||
| 34576320 | 2021 | GFFGKMKEYFKKFGASFKRRFANLKKRL{ct:Amid} | Ltc5 | Amidation | Free | Linear | L | None | 28 | Antibacterial | 27 % Hemolysis at 256 μg/ml | Human | Spider Lachesana Tarabaevi | vesicles composed of DMPC/DMPG (7/3) = α-Helix | Low hemolytic | ||
| 34576320 | 2021 | QAFQTFKPDWNKIRYDAMKMQTSLGQMKKRFNL | Ltc6a | Free | Free | Linear | L | None | 33 | Antibacterial | 3 % Hemolysis at 256 μg/ml | Human | Spider Lachesana Tarabaevi | vesicles composed of DMPC/DMPG (7/3) = α-Helix | Low hemolytic | ||
| 34576320 | 2021 | GETFDKLKEKLKTFYQKLVEKAEDLKGDLKAKLS | Ltc7 | Free | Free | Linear | L | None | 34 | Antibacterial | 2 % Hemolysis at 256 μg/ml | Human | Spider Lachesana Tarabaevi | vesicles composed of DMPC/DMPG (7/3) = α-Helix | Low hemolytic | ||
| 34028137 | 2021 | VRLLRRRI{nt:H}{ct:Amid} | SAMP-A4 | Amidation | H | Linear | L | None | 8 | Antibacterial, Antifungal, Antibiofilm | 5 % Hemolysis at 69.26 μg/ml | Human | Synthesized Antimicrobial Peptide A4 | NA | Low hemolytic | ||
| 34028137 | 2021 | VRLLRRRI{nt:Acet}{ct:Amid} | SAMP-A4-C2 | Amidation | Acetylation | Linear | L | None | 8 | Antibacterial, Antifungal, Antibiofilm | 5 % Hemolysis at 34.56 μg/ml | Human | Samp-A4 Analogue | NA | Low hemolytic | ||
| 34028137 | 2021 | VRLLRRRI{nt:Butyryl}{ct:Amid} | SAMP-A4-C4 | Amidation | Butyryl | Linear | L | None | 8 | Antibacterial, Antifungal, Antibiofilm | 5 % Hemolysis at 73.84 μg/ml | Human | Samp-A4 Analogue | NA | Low hemolytic | ||
| 34028137 | 2021 | VRLLRRRI{nt:Hexanoyl}{ct:Amid} | SAMP-A4-C6 | Amidation | Hexanoyl | Linear | L | None | 8 | Antibacterial, Antifungal, Antibiofilm | 5 % Hemolysis at 84.98 μg/ml | Human | Samp-A4 Analogue | NA | Low hemolytic | ||
| 34028137 | 2021 | VRLLRRRI{nt:PEG}{ct:Amid} | SAMP-A4-PEG3 | Amidation | PEG | Linear | L | None | 8 | Antibacterial, Antifungal, Antibiofilm | 5 % Hemolysis at 19.95 μg/ml | Human | Samp-A4 Analogue | NA | Low hemolytic | ||
| 34028137 | 2021 | VRLLRRRI{nt:Gluconyl}{ct:Amid} | SAMP-A4-GlcA | Amidation | Gluconyl | Linear | L | None | 8 | Antibacterial, Antifungal, Antibiofilm | 5 % Hemolysis at 22.16 μg/ml | Human | Samp-A4 Analogue | NA | Low hemolytic | ||
| 34037941 | 2021 | KRNGFRKFMRRLKKFFAGGGSSIAHIKLH{ct:Amid} | CATHPb2 | Amidation | Free | Linear | L | None | 29 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Cathelicidin In Snake Python Bivittatus | α-Helical | Non-hemolytic | ||
| 34037941 | 2021 | GFRKFMRRLKKFF{ct:Amid} | Pb2-1 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Mutant Of Cathpb2 | α-Helical | Non-hemolytic | ||
| 34037941 | 2021 | GFRKFMRRLKK{ct:Amid} | Pb2-2 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Mutant Of Cathpb2 | NA | Non-hemolytic | ||
| 34037941 | 2021 | FFRKFFRRFKK{ct:Amid} | Pb2-3F | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Mutant Of Cathpb2 | NA | Non-hemolytic | ||
| 34037941 | 2021 | GFRKFWRRWKK{ct:Amid} | Pb2-2W | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Mutant Of Cathpb2 | NA | Non-hemolytic | ||
| 34037941 | 2021 | GWRKWWRRWKK{ct:Amid} | Pb2-4W | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Mutant Of Cathpb2 | NA | Non-hemolytic | ||
| 34037941 | 2021 | WWRKWWRRWKK{ct:Amid} | Pb2-5W | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Mutant Of Cathpb2 | NA | Non-hemolytic | ||
| 34482475 | 2021 | {nnr:Z}QPVSSPK | Pep-Bax8 | Free | Free | Linear | L | Z = pyroglutamic acid | 8 | Antibacterial | 1.6 % Hemolysis at 250 μg/mL | Human | Snake Venom Of Bothrops Atrox | NA | Non-hemolytic | ||
| 34482475 | 2021 | {nnr:Z}KW | SVMPi-Bax/Bj | Free | Free | Linear | L | Z = pyroglutamic acid | 3 | Antibacterial | 1.7 % Hemolysis at 250 μg/mL | Human | Snake Venoms Of Bothrops Atrox And Bothrops Jararacussu | NA | Non-hemolytic | ||
| 34482475 | 2021 | GRVPDNPKAPP | BPP-Bax11 | Free | Free | Linear | L | None | 11 | Antibacterial | 1.8 % Hemolysis at 250 μg/mL | Human | Snake Venom Of Bothrops Atrox | NA | Non-hemolytic | ||
| 34680789 | 2021 | INLLKIAKGIIKSL{ct:Amid} | EMP-AF-OR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 100 % Hemolysis at 100 μg/mL | Human | Wasp Eumenine Anterhynchium Flavomarginatum Micado | water = 17.73% Helical, 50% TFE = Helical | NA | ||
| 34680789 | 2021 | FKI{nnr:M*}GLIKKVAGAL{ct:Amid} | EMP-ER-D2K2 | Amidation | Free | Linear | L | M* = Methionine in sulfoxide form | 14 | Antibacterial, Antifungal | ~50 % Hemolysis at 100 μg/mL | Human | Emp-Er Analog | 50% TFE = Helical | NA | ||
| 34721331 | 2021 | VKKLVKKAVKKLVKKA{ct:Amid} | VL1 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKLVKKLVKKAVKKA{ct:Amid} | VL2 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKLVKKLVKKLVKKA{ct:Amid} | VL3 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKLVKKLVKKAVKKL{ct:Amid} | VL4 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKLVKKLVKKLVKKL{ct:Amid} | VL5 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKWVKKAVKKWVKKA{ct:Amid} | VW1 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKWVKKWVKKAVKKA{ct:Amid} | VW2 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKWVKKWVKKAVKKW{ct:Amid} | VW3 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKWVKKWVKKWVKKA{ct:Amid} | VW4 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | NA | Low hemolytic | ||
| 34721331 | 2021 | VKKWVKKWVKKWVKKW{ct:Amid} | VW5 | Amidation | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at >128 μM | Human | Synthetic Trp-Rich Peptides | sodium phosphate buffer = unordered, 50% TFE = α-Helical | Low hemolytic | ||
| 34721331 | 2021 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial | 5 % Hemolysis at 1 μM | Human | Honeybee Venom | α-Helical | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | 13.03±0.00 % Hemolysis at 400 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | 11.44±0.25 % Hemolysis at 200 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | 10.74±0.75 % Hemolysis at 100 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | 9.15±1.99 % Hemolysis at 50 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | 6.34±4.98 % Hemolysis at 25 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | 4.58±4.48 % Hemolysis at 12.5 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKKY | S61 | Free | Free | Linear | L | None | 17 | Antibacterial | -0.18±0.75 % Hemolysis at 6.25 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 11.44±1.24 % Hemolysis at 400 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 9.33±1.74 % Hemolysis at 200 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 8.63±3.24 % Hemolysis at 100 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 7.22±3.73 % Hemolysis at 50 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 5.99±3.98 % Hemolysis at 25 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 4.05±3.24 % Hemolysis at 12.5 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWKK | S62 | Free | Free | Linear | L | None | 16 | Antibacterial | 0.35±0.50 % Hemolysis at 6.25 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | 10.56±1.99 % Hemolysis at 400 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | 9.68±2.74 % Hemolysis at 200 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | 8.27±3.73 % Hemolysis at 100 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | 7.04±3.98 % Hemolysis at 50 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | 5.81±3.73 % Hemolysis at 25 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | 3.52±4.98 % Hemolysis at 12.5 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | GGLRSLGRKILRAWK | S63 | Free | Free | Linear | L | None | 15 | Antibacterial | -0.53±0.75 % Hemolysis at 6.25 µg/ml | Human | Bovine Myeloid Cells | NA | Low hemolytic | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 22.18±1.99 % Hemolysis at 400 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 18.13±0.25 % Hemolysis at 200 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 15.85±1.49 % Hemolysis at 100 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 12.15±0.25 % Hemolysis at 50 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 8.27±1.74 % Hemolysis at 25 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 4.93±2.49 % Hemolysis at 12.5 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34780520 | 2021 | KLKLLLLLKL | KLK1 | Free | Free | Linear | L | None | 10 | Antibacterial | 0.7±0.50 % Hemolysis at 6.25 µg/ml | Human | Sarcophaga Peregrina (Flesh Fly) | NA | NA | ||
| 34867843 | 2021 | FLLKIVALLKKKLL | PHNX-1 | Free | Free | Linear | L | None | 14 | Antibacterial | ~40 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | Helical | NA | ||
| 34867843 | 2021 | FLLKLGLGKKKLL | PHNX-4 | Free | Free | Linear | L | None | 13 | Antibacterial | ~10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | Random coil | NA | ||
| 34867843 | 2021 | FLIKILKGGKGGK | PHNX-5 | Free | Free | Linear | L | None | 13 | Antibacterial | ~10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | Random coil | NA | ||
| 34867843 | 2021 | FIGAIASYLKKFR | PHNX-6 | Free | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | Random coil Helical | Low hemolytic | ||
| 34867843 | 2021 | GVVDIIKGAGKKFAKGLAGKIANKK | PHNX-7 | Free | Free | Linear | L | None | 25 | Antibacterial | ~10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | Helical | NA | ||
| 34867843 | 2021 | GLMDTVKNAAKNLAGQLLDKIKCKITG | PHNX-8 | Free | Free | Linear | L | None | 27 | Antibacterial | ~10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | Helical | NA | ||
| 34959645 | 2021 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antibacterial | 70 % Hemolysis at 200 μM | Human | Host Defense Peptide | PBS, 60mMSDS = Helical | NA | ||
| 34959645 | 2021 | SKEKIGKEFKRIVQRIKDFLRNLV{ct:Amid} | SK-24 | Amidation | Free | Linear | L | None | 24 | Antibacterial, Antibiofilm | <25 % Hemolysis at 200 μM | Human | Ll-37 Derived Peptide | PBS, 60mMSDS = Helical | Low hemolytic | ||
| 34959645 | 2021 | GIKEFKRIVQRIKDFLRNLV{ct:Amid} | GI-20 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 50 % Hemolysis at ~160 μM | Human | Ll-37 Derived Peptide | PBS, 60mMSDS = Helical | NA | ||
| 34959645 | 2021 | GFKRIVQRIKDFLRNLV{ct:Amid} | GF-17 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 50 % Hemolysis at 175 μM | Human | Ll-37 Derived Peptide | PBS, 60mMSDS = Helical | NA | ||
| 34959645 | 2021 | G{nnr:X}KRlVQRlKD{nnr:X}LRNLV{ct:Amid} | 17BIPHE2 | Amidation | Free | Linear | Mix | X = biphenylalanines | 17 | Antibacterial, Antibiofilm | 50 % Hemolysis at ~200 μM | Human | Ll-37 Derived Peptide | PBS = distorted, 60mMSDS = Helical | NA | ||
| 34959645 | 2021 | RIVQRIKDFL{ct:Amid} | RI-10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | <25 % Hemolysis at 200 μM | Human | Ll-37 Derived Peptide | PBS = distorted, 60mMSDS = Helical | Low hemolytic | ||
| 34164880 | 2021 | KLLKKAGKLLKKAGKLLKKAG{nt:H}{ct:Amid} | Stripe | Amidation | H | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Synthetic Amp | phosphate buffer solution (pH 7.4) contain 1%SDS = right-handed Helical | Non-hemolytic | ||
| 34164880 | 2021 | KLLKKA{nnr:X}KLLKKA{nnr:X}KLLKKA{nnr:X}{nt:H}{ct:Amid} | Stripe1 | Amidation | H | Linear | L | X = sarcosine | 21 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Stripe Modification With Sarcosine | phosphate buffer solution (pH 7.4) contain 1%SDS = Random coil | Non-hemolytic | ||
| 34164880 | 2021 | KLLKK{nnr:X}GKLLKK{nnr:X}GKLLKK{nnr:X}G{nt:H}{ct:Amid} | Stripe2 | Amidation | H | Linear | L | X = sarcosine | 21 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Stripe Modification With Sarcosine | phosphate buffer solution (pH 7.4) contain 1%SDS = Random coil | Non-hemolytic | ||
| 34164880 | 2021 | KLLKK{nnr:X}{nnr:X}KLLKK{nnr:X}{nnr:X}KLLKK{nnr:X}{nnr:X}{nt:H}{ct:Amid} | Stripe3 | Amidation | H | Linear | L | X = sarcosine | 21 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Stripe Modification With Sarcosine | phosphate buffer solution (pH 7.4) contain 1%SDS = Random coil | Non-hemolytic | ||
| 34977576 | 2021 | {nnr:B}KKLLKCLKCL{cyc:7-10} | bp3 | Free | Free | Bicyclic | L | B = 3,5-bis(methylene)toluoyl | 11 | Antibacterial | MHC at 500 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | Low hemolytic | ||
| 34977576 | 2021 | {nnr:B}KKLLKCLKCLL{cyc:7-10} | bp65 | Free | Free | Bicyclic | L | B = 3,5-bis(methylene)toluoyl | 12 | Antibacterial | MHC at 16.6 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | NA | ||
| 34977576 | 2021 | {nnr:B}K{d}KL{d}LK{d}CL{d}KC{d}LL{d}{cyc:7-10} | bp67 | Free | Free | Bicyclic | Mix | B = 3,5-bis(methylene)toluoyl | 12 | Antibacterial | MHC at >2000 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | Low hemolytic | ||
| 34977576 | 2021 | {nnr:B}KKLLKC{d}LKC{d}LL{cyc:7-10} | bp68 | Free | Free | Bicyclic | Mix | B = 3,5-bis(methylene)toluoyl | 12 | Antibacterial | MHC at 16.6 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | NA | ||
| 34977576 | 2021 | {nnr:B}K{d}K{d}LLK{d}CLK{d}CLL{cyc:7-10} | bp69 | Free | Free | Bicyclic | Mix | B = 3,5-bis(methylene)toluoyl | 12 | Antibacterial | MHC at 16.6 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | NA | ||
| 34977576 | 2021 | KKLLKLLKLLL | ln65 | Free | Free | Linear | L | None | 12 | Antibacterial | MHC at 125 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | NA | ||
| 34977576 | 2021 | {nnr:Tol}-KKLLK-{nnr:Cm}-LK-{nnr:Cm}-LL | ln65b | Free | Free | Linear | L | Tol = toluoyl group, Cm = S-methyl cysteine | 12 | Antibacterial | MHC at 16.6 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | NA | ||
| 34977576 | 2021 | K{d}K{d}LLK{d}LLK{d}LLL | ln69 | Free | Free | Linear | Mix | None | 12 | Antibacterial | MHC at 1000 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | Low hemolytic | ||
| 34977576 | 2021 | {nnr:Tol}-K{d}K{d}LLK{d}-{nnr:Cm}-LK{d}-{nnr:Cm}-LL | ln69b | Free | Free | Linear | Mix | Tol = toluoyl group, Cm = S-methyl cysteine | 12 | Antibacterial | MHC at 1000 μg/ml | Human | Synthetic Peptide | 5 mM DPC = α-Helical | Low hemolytic | ||
| 34966279 | 2021 | KIILRIRWR{ct:Amid} | optP1 | Amidation | Free | Linear | L | None | 9 | Antibacterial | 50 % Hemolysis at 205 μM | Human | Optimized 9Mer | NA | Low hemolytic | ||
| 34966279 | 2021 | KRRVRWIIW{ct:Amid} | optP7 | Amidation | Free | Linear | L | None | 9 | Antibacterial | 50 % Hemolysis at >195 μM | Human | Optimized 9Mer | NA | Low hemolytic | ||
| 34966279 | 2021 | VRKPPYLPRPRPRPL{ct:Amid} | consP1 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at >139 μM | Human | Consensus Sequence Derived From Multiple Alignment | NA | Low hemolytic | ||
| 34966279 | 2021 | KIILRIRWRGGGVRKPPYLPRPRPRPL{ct:Amid} | hyP1CoG1 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at >157 μM | Human | Hybrid Peptide With Gly Linker, Optp1 C-Terminal | NA | Low hemolytic | ||
| 34966279 | 2021 | VRKPPYLPRPRPRPLGGGKIILRIRWR{ct:Amid} | hyP1CoG2 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at >157 μM | Human | Hybrid Peptide With Gly Linker, Optp1 C-Terminal | NA | Low hemolytic | ||
| 34966279 | 2021 | VRKPPYLPRPRPRPLGGGKRRVRWIIW{ct:Amid} | hyP7CoG1 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at >154 μM | Human | Hybrid Peptide With Gly Linker, Optp7 C-Terminal | NA | Low hemolytic | ||
| 34966279 | 2021 | KRRVRWIIWGGGVRKPPYLPRPRPRPL{ct:Amid} | hyP7CoG2 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at >154 μM | Human | Hybrid Peptide With Gly Linker, Optp7 N-Terminal | NA | Low hemolytic | ||
| 34966279 | 2021 | RWRRPIRRRPIRPPFWR{ct:Amid} | Bac5-v291 | Amidation | Free | Linear | L | None | 17 | Antibacterial | 50 % Hemolysis at >278 μM | Human | Optimized Bac5(1–17) Variant 291 | NA | Low hemolytic | ||
| 34966279 | 2021 | RWRRPIRRRPIRPPFWRGGGKRRVRWIIW{ct:Amid} | hyP7B5G | Amidation | Free | Linear | L | None | 29 | Antibacterial | 50 % Hemolysis at 102 μM | Human | Hybrid Peptide With Gly Linker, Optp7 C-Terminal | NA | NA | ||
| 34966279 | 2021 | RWRRPIRRRPIRPPFWRKKKKRRVRWIIW{ct:Amid} | hyP7B5K | Amidation | Free | Linear | L | None | 29 | Antibacterial | 50 % Hemolysis at 82 μM | Human | Hybrid Peptide With Lys Linker, Optp7 C-Terminal | NA | NA | ||
| 34966279 | 2021 | RWRRPIRRRPIRPPFWRKGKGKGKRRVRWIIW{ct:Amid} | hyP7B5GK | Amidation | Free | Linear | L | None | 32 | Antibacterial | 50 % Hemolysis at >120 μM | Human | Hybrid Peptide With Gly-Lys Linker, Optp7 C-Terminal | NA | Low hemolytic | ||
| 34966279 | 2021 | RWRRPIRRRPIRPPFWRKGKC-S-S-CKGKRRVRWIIW{ct:Amid} | hyP7B5Cys | Amidation | Free | Linear | L | None | 35 | Antibacterial | 50 % Hemolysis at 102 μM | Human | Hybrid Peptide With Disulfide Bridge, Designed To Be Cleaved In The Cytosol, Optp7 C-Terminal | NA | NA | ||
| 34966367 | 2021 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial | 2.3 % Hemolysis at 64 μM | Sheep | Venom Sac Of The Solitary Wasp | phosphate buffer = Random coil, membrane-mimicking environments = α-Helical | Low hemolytic | ||
| 34966367 | 2021 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial | 0.6 % Hemolysis at 32 μM | Sheep | Venom Sac Of The Solitary Wasp | phosphate buffer = Random coil, membrane-mimicking environments = α-Helical | Low hemolytic | ||
| 34966367 | 2021 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial | 0.7 % Hemolysis at 16 μM | Sheep | Venom Sac Of The Solitary Wasp | phosphate buffer = Random coil, membrane-mimicking environments = α-Helical | Low hemolytic | ||
| 34966367 | 2021 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial | 1.3 % Hemolysis at 8 μM | Sheep | Venom Sac Of The Solitary Wasp | phosphate buffer = Random coil, membrane-mimicking environments = α-Helical | Low hemolytic | ||
| 34966367 | 2021 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial | 0.5 % Hemolysis at 4 μM | Sheep | Venom Sac Of The Solitary Wasp | phosphate buffer = Random coil, membrane-mimicking environments = α-Helical | Low hemolytic | ||
| 34966367 | 2021 | G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid} | Anoplin[2-6] | Amidation | Free | Stapled | L | S5 = Olefinic | 8 | Antibacterial | 9.1 % Hemolysis at 64 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid} | Anoplin[2-6] | Amidation | Free | Stapled | L | S5 = Olefinic | 8 | Antibacterial | 4 % Hemolysis at 32 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid} | Anoplin[2-6] | Amidation | Free | Stapled | L | S5 = Olefinic | 8 | Antibacterial | 2.8 % Hemolysis at 16 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid} | Anoplin[2-6] | Amidation | Free | Stapled | L | S5 = Olefinic | 8 | Antibacterial | 2.4 % Hemolysis at 8 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid} | Anoplin[2-6] | Amidation | Free | Stapled | L | S5 = Olefinic | 8 | Antibacterial | 2.1 % Hemolysis at 4 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid} | Anoplin[5-9] | Amidation | Free | Stapled | L | S5 = Olefinic | 8 | Antibacterial | 62.7 % Hemolysis at 64 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid} | Anoplin[5-9] | Amidation | Free | Stapled | L | S5 = Olefinic | 8 | Antibacterial | 43.2 % Hemolysis at 32 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid} | Anoplin[5-9] | Amidation | Free | Stapled | L | S5 = Olefinic | 8 | Antibacterial | 29.8 % Hemolysis at 16 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid} | Anoplin[5-9] | Amidation | Free | Stapled | L | S5 = Olefinic | 8 | Antibacterial | 16.6 % Hemolysis at 8 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid} | Anoplin[5-9] | Amidation | Free | Stapled | L | S5 = Olefinic | 8 | Antibacterial | 6.5 % Hemolysis at 4 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid} | AnoplinS5(5,9) | Amidation | Free | Linear | L | S5 = Olefinic | 8 | Antibacterial | 14.2 % Hemolysis at 64 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid} | AnoplinS5(5,9) | Amidation | Free | Linear | L | S5 = Olefinic | 8 | Antibacterial | 11.9 % Hemolysis at 32 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid} | AnoplinS5(5,9) | Amidation | Free | Linear | L | S5 = Olefinic | 8 | Antibacterial | 8.9 % Hemolysis at 16 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid} | AnoplinS5(5,9) | Amidation | Free | Linear | L | S5 = Olefinic | 8 | Antibacterial | 7.2 % Hemolysis at 8 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34966367 | 2021 | GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid} | AnoplinS5(5,9) | Amidation | Free | Linear | L | S5 = Olefinic | 8 | Antibacterial | 6.7 % Hemolysis at 4 μM | Sheep | Anoplin Analogs | phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 50 % Hemolysis at 76.55 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 2.73 % Hemolysis at 2 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 4.31 % Hemolysis at 4 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 7.47 % Hemolysis at 8 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34825276 | 2022 | INWLKLGKMVIDAL{ct:Amid} | MPII | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 100 % Hemolysis at 256 μM | Mouse | Social Wasp Polybia Paulista | α-Helix | NA | ||
| 34825276 | 2022 | INWLHLGHMVIDAL{ct:Amid} | HMPII | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | >30 % Hemolysis at 256 μM | Mouse | Mpii Analogs | 10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical | NA | ||
| 34825276 | 2022 | INWLRLGRMVIDAL{ct:Amid} | RMPII | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 100 % Hemolysis at 256 μM | Mouse | Mpii Analogs | 10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical | NA | ||
| 34825276 | 2022 | INWL{nnr:O}LG{nnr:O}MVIDAL{ct:Amid} | OMPII | Amidation | Free | Linear | L | O = L-Ornithine | 14 | Antibacterial, Antifungal | 100 % Hemolysis at 256 μM | Mouse | Mpii Analogs | 10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical | NA | ||
| 34825276 | 2022 | INWL-{nnr:Dab}-LG-{nnr:Dab}-MVIDAL{ct:Amid} | BMPII | Amidation | Free | Linear | L | Dab = L-2, 4-Diamino butyric acids | 14 | Antibacterial, Antifungal | 100 % Hemolysis at 256 μM | Mouse | Mpii Analogs | 10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical | NA | ||
| 34825276 | 2022 | INWL-{nnr:Dap}-LG-{nnr:Dap}-MVIDAL{ct:Amid} | PMPII | Amidation | Free | Linear | L | Dap = L-2,3-Diamino-propionic | 14 | Antibacterial, Antifungal, Antibiofilm | 0 % Hemolysis at 256 μM | Mouse | Mpii Analogs | 10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical | Non-hemolytic | ||
| 35013238 | 2022 | KK WRK WLK WLA KK | W3_p1 | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 5 % Hemolysis at 120 μg/ml | Human | Synthetic Peptide | Helical | NA | ||
| 35013238 | 2022 | KK WLK WLK WLK KK | W3_p2 | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 5 % Hemolysis at 90 μg/ml | Human | Synthetic Peptide | Helical | NA | ||
| 35013238 | 2022 | KK WKC WAR WRL KK | W3_db5 | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 5 % Hemolysis at >>240 μg/ml | Human | Synthetic Peptide | Helical | Non-hemolytic | ||
| 35056876 | 2022 | INLKAIAAFAKKLI | MpVT | Free | Free | Linear | L | None | 14 | Antibacterial | <10 % Hemolysis at 50 μg/ml | Human | Vespa Tropica, The Greater Banded Horne | Water = unordered, 40% TFE, = α-Helix | Low hemolytic | ||
| 35056876 | 2022 | INLKAIAAFAKKFI | MpVT1 | Free | Free | Linear | L | None | 14 | Antibacterial | <10 % Hemolysis at 50 μg/ml | Human | Mpvt Analog | Water = unordered, 40% TFE, = α-Helix | Low hemolytic | ||
| 35056876 | 2022 | INLKAIAAFAKALI | MpVT3 | Free | Free | Linear | L | None | 14 | Antibacterial | 50 % Hemolysis at 100 μg/ml | Human | Mpvt Analog | Water = unordered, 40% TFE, = α-Helix | NA | ||
| 35056876 | 2022 | KAIAAFAKKFI | MpVT4 | Free | Free | Linear | L | None | 11 | Antibacterial | <10 % Hemolysis at 50 μg/ml | Human | Mpvt Analog | Water = unordered, 40% TFE, = Random coil | Low hemolytic | ||
| 35056876 | 2022 | KAIAAFAKKFFI | MpVT5 | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 50 μg/ml | Human | Mpvt Analog | Water = unordered, 40% TFE, = Random coil | Low hemolytic | ||
| 35056876 | 2022 | KAIAAFAKALFI | MpVT6 | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 50 μg/ml | Human | Mpvt Analog | Water = unordered, 40% TFE, = Random coil | Low hemolytic | ||
| 35056876 | 2022 | KAIAAFAAKLFI | MpVT7 | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 50 μg/ml | Human | Mpvt Analog | Water = unordered, 40% TFE, = Random coil | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{ct:Amid} | RW-BP-100 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal, Antibiofilm | 3.10 ± 0.77 % Hemolysis at 50 μg/mL | Sheep | Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues | NA | NA | ||
| 35145500 | 2022 | R{d}RLFRRILRWL{ct:Amid} | RW-BP100-1D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 4.61 ± 0.47 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RR{d}LFRRILRWL{ct:Amid} | RW-BP100-2D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 4.83 ± 1.08 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRL{d}FRRILRWL{ct:Amid} | RW-BP100-3D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 3.49 ± 0.76 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLF{d}RRILRWL{ct:Amid} | RW-BP100-4D* | Amidation | Free | Linear | Mix | None | 11 | Antibacterial, Antifungal, Antibiofilm | 0.11 ± 0.19 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFR{d}RILRWL{ct:Amid} | RW-BP100-5D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 1.26 ± 0.54 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRR{d}ILRWL{ct:Amid} | RW-BP100-6D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 2.33 ± 1.51 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRI{d}LRWL{ct:Amid} | RW-BP100-7D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 0.53 ± 1.12 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRIL{d}RWL{ct:Amid} | RW-BP100-8D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 0.91 ± 0.38 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILR{d}WL{ct:Amid} | RW-BP100-9D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 0.63 ± 0.24 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRW{d}L{ct:Amid} | RW-BP100-10D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 0.31 ± 0.37 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{d}{ct:Amid} | RW-BP100-11D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 0.65 ± 0.60 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid} | RW-BP100-All-D | Amidation | Free | Linear | D | None | 11 | Antibacterial | 1.94 ± 0.94 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{cyc:N-C}{ct:Amid} | RW-BP100-cycle | Amidation | Free | Cyclic | L | None | 11 | Antibacterial | 0.47 ± 0.61 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{ct:Amid} | RW-BP-100 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal, Antibiofilm | 4.70 ± 0.49 % Hemolysis at 100 μg/mL | Sheep | Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues | NA | NA | ||
| 35145500 | 2022 | R{d}RLFRRILRWL{ct:Amid} | RW-BP100-1D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 5.49 ± 0.23 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RR{d}LFRRILRWL{ct:Amid} | RW-BP100-2D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 5.99 ± 0.79 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRL{d}FRRILRWL{ct:Amid} | RW-BP100-3D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 4.04 ± 0.20 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLF{d}RRILRWL{ct:Amid} | RW-BP100-4D* | Amidation | Free | Linear | Mix | None | 11 | Antibacterial, Antifungal, Antibiofilm | 3.69 ± 0.01 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFR{d}RILRWL{ct:Amid} | RW-BP100-5D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 2.49 ± 0.72 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRR{d}ILRWL{ct:Amid} | RW-BP100-6D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 3.25 ± 0.23 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRI{d}LRWL{ct:Amid} | RW-BP100-7D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 1.11 ± 0.19 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRIL{d}RWL{ct:Amid} | RW-BP100-8D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 1.38 ± 0.58 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILR{d}WL{ct:Amid} | RW-BP100-9D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 1.53 ± 0.09 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRW{d}L{ct:Amid} | RW-BP100-10D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 1.28 ± 0.19 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{d}{ct:Amid} | RW-BP100-11D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 1.42 ± 0.15 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid} | RW-BP100-All-D | Amidation | Free | Linear | D | None | 11 | Antibacterial | 2.75 ± 0.23 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{cyc:N-C}{ct:Amid} | RW-BP100-cycle | Amidation | Free | Cyclic | L | None | 11 | Antibacterial | 1.19 ± 0.05 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{ct:Amid} | RW-BP-100 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal, Antibiofilm | 41.82 ± 2.27 % Hemolysis at 150 μg/mL | Sheep | Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues | NA | NA | ||
| 35145500 | 2022 | R{d}RLFRRILRWL{ct:Amid} | RW-BP100-1D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 39.81 ± 0.20 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RR{d}LFRRILRWL{ct:Amid} | RW-BP100-2D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 39.16 ± 1.75 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRL{d}FRRILRWL{ct:Amid} | RW-BP100-3D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 38.13 ± 3.12 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLF{d}RRILRWL{ct:Amid} | RW-BP100-4D* | Amidation | Free | Linear | Mix | None | 11 | Antibacterial, Antifungal, Antibiofilm | 18.75 ± 0.42 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFR{d}RILRWL{ct:Amid} | RW-BP100-5D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 29.72 ± 0.94 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRR{d}ILRWL{ct:Amid} | RW-BP100-6D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 32.57 ± 1.20 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRI{d}LRWL{ct:Amid} | RW-BP100-7D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 16.17 ± 3.36 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRIL{d}RWL{ct:Amid} | RW-BP100-8D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 26.19 ± 0.10 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILR{d}WL{ct:Amid} | RW-BP100-9D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 18.14 ± 0.20 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRW{d}L{ct:Amid} | RW-BP100-10D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 19.20 ± 2.16 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRWL{d}{ct:Amid} | RW-BP100-11D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 17.36 ± 1.92 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid} | RW-BP100-All-D | Amidation | Free | Linear | D | None | 11 | Antibacterial | 30.39 ± 2.11 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRWL{cyc:N-C}{ct:Amid} | RW-BP100-cycle | Amidation | Free | Cyclic | L | None | 11 | Antibacterial | 17.23 ± 3.08 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRWL{ct:Amid} | RW-BP-100 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal, Antibiofilm | 56.67 ± 6.33 % Hemolysis at 300 μg/mL | Sheep | Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues | NA | NA | ||
| 35145500 | 2022 | R{d}RLFRRILRWL{ct:Amid} | RW-BP100-1D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 52.88 ± 3.06 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RR{d}LFRRILRWL{ct:Amid} | RW-BP100-2D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 62.12 ± 6.27 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRL{d}FRRILRWL{ct:Amid} | RW-BP100-3D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 55.73 ± 5.27 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLF{d}RRILRWL{ct:Amid} | RW-BP100-4D* | Amidation | Free | Linear | Mix | None | 11 | Antibacterial, Antifungal, Antibiofilm | 48.55 ± 2.53 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFR{d}RILRWL{ct:Amid} | RW-BP100-5D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 51.41 ± 4.64 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRR{d}ILRWL{ct:Amid} | RW-BP100-6D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 55.81 ± 2.87 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRI{d}LRWL{ct:Amid} | RW-BP100-7D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 45.65 ± 5.13 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRIL{d}RWL{ct:Amid} | RW-BP100-8D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 50.11 ± 3.17 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILR{d}WL{ct:Amid} | RW-BP100-9D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 45.18 ± 2.41 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRW{d}L{ct:Amid} | RW-BP100-10D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 45.08 ± 4.70 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRWL{d}{ct:Amid} | RW-BP100-11D | Amidation | Free | Linear | Mix | None | 11 | Antibacterial | 46.97 ± 6.45 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid} | RW-BP100-All-D | Amidation | Free | Linear | D | None | 11 | Antibacterial | 51.40 ± 1.94 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRWL{cyc:N-C}{ct:Amid} | RW-BP100-cycle | Amidation | Free | Cyclic | L | None | 11 | Antibacterial | 48.67 ± 2.17 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 34506798 | 2022 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 1 % Hemolysis at 2 μM | Sheep | Venom Of The Spider Lycosa Singoriensis | 30 mM SDS and 50% TFE = α-Helical | Low hemolytic | ||
| 34506798 | 2022 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | <5 % Hemolysis at 16 μM | Sheep | Venom Of The Spider Lycosa Singoriensis | 30 mM SDS and 50% TFE = α-Helical | Low hemolytic | ||
| 33749557 | 2022 | {conj:RhoB}-KRFKKFFKK{ct:Amid} | RhoB-Ctn[1-9] | Amidation | RhoB | Linear | L | RhoB = rhodamine B (N termianl conjugate) Crotalicidin fragment, residues 1 to 9, with a N-terminal conjugated rhodamine B | 9 | Antibacterial, Antifungal | 0.6 % Hemolysis at 12.5 μM | Human | Crotalicidin (Rattlesnake (Crotalus Durissus Terrificus))-Derived Peptides | Helical | Low hemolytic | ||
| 33749557 | 2022 | {conj:RhoB}-KRFKKFFKK{ct:Amid} | RhoB-Ctn[1-9] | Amidation | RhoB | Linear | L | RhoB = rhodamine B (N termianl conjugate) Crotalicidin fragment, residues 1 to 9, with a N-terminal conjugated rhodamine B | 9 | Antibacterial, Antifungal | 1.6 % Hemolysis at 25 μM | Human | Crotalicidin (Rattlesnake (Crotalus Durissus Terrificus))-Derived Peptides | Helical | Low hemolytic | ||
| 35100952 | 2022 | KFVRSRRPRTASCALAFVN | ARF (26-44) | Free | Free | Linear | L | None | 19 | Antibacterial, Anticancer | 5 % Hemolysis at 250 μM | Mouse | Arf(Alternative Reading Frame) Proteins Are P19Arf In Mice | phosphate buffer = Random coil, 50% v/v TFE = α-Helix | Low hemolytic | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 0.6 % Hemolysis at 5 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 0.8 % Hemolysis at 10 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 2.5 % Hemolysis at 20 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 8.7 % Hemolysis at 40 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 10.1 % Hemolysis at 60 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 14.8 % Hemolysis at 80 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 37.2 % Hemolysis at 100 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 34978443 | 2022 | R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{nt:Amid}{ct:OH} | 1L | OH | Amidation | Linear | L | Bip = 4,4′-biphenyl-L-alanine | 6 | Antibacterial | 50 % Hemolysis | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH} | 2L | OH | Amidation | Linear | L | Dip = 3,3-diphenyl-L-alanine | 6 | Antibacterial | 50 % Hemolysis at 120 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{nt:Amid}{ct:OH} | 3L | OH | Amidation | Linear | L | Nal = 3-(2-naphthyl)-L-alanine | 6 | Antibacterial | 50 % Hemolysis at 105 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{nt:Amid}{ct:OH} | 4L | OH | Amidation | Linear | L | Bip = 4,4′-biphenyl-L-alanine | 8 | Antibacterial | 50 % Hemolysis | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH} | 5L | OH | Amidation | Linear | L | Dip = 3,3-diphenyl-L-alanine | 8 | Antibacterial | 50 % Hemolysis at 75 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{nt:Amid}{ct:OH} | 6L | OH | Amidation | Linear | L | Nal = 3-(2-naphthyl)-L-alanine | 8 | Antibacterial | 50 % Hemolysis at 70 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{nt:Amid}{ct:OH} | 7L | OH | Amidation | Linear | L | Bip = 4,4′-biphenyl-L-alanine | 7 | Antibacterial | 50 % Hemolysis | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH} | 8L | OH | Amidation | Linear | L | Dip = 3,3-diphenyl-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 145 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{nt:Amid}{ct:OH} | 9L | OH | Amidation | Linear | L | Nal = 3-(2-naphthyl)-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 130 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH} | 10L | OH | Amidation | Linear | L | Dip = 3,3-diphenyl-L-alanine | 6 | Antibacterial | 50 % Hemolysis at 185 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Nal}-{nnr:Nal}{nt:Amid}{ct:OH} | 11L | OH | Amidation | Linear | L | Nal = 3-(2-naphthyl)-L-alanine | 6 | Antibacterial | 50 % Hemolysis at 180 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH} | 12L | OH | Amidation | Linear | L | Dip = 3,3-diphenyl-L-alanine | 8 | Antibacterial | 50 % Hemolysis at 165 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{nt:Amid}{ct:OH} | 13L | OH | Amidation | Linear | L | Nal = 3-(2-naphthyl)-L-alanine | 8 | Antibacterial | 50 % Hemolysis at 190 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | K-K-K-K-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH} | 14L | OH | Amidation | Linear | L | Dip = 3,3-diphenyl-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 255 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | K-K-K-K-K-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{nt:Amid}{ct:OH} | 15L | OH | Amidation | Linear | L | Dip = 3,3-diphenyl-L-alanine | 8 | Antibacterial | 50 % Hemolysis at 280 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-{nnr:Dip}-R-R-{nnr:Dip}-{nnr:Dip}-R{nt:Amid}{ct:OH} | 16L | OH | Amidation | Linear | L | Dip = 3,3-diphenyl-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 220 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-{nnr:Dip}-{nnr:Dip}-R-R-{nnr:Dip}{nt:Amid}{ct:OH} | 17L | OH | Amidation | Linear | L | Dip = 3,3-diphenyl-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 240 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-{nnr:Nal}-R-R-{nnr:Nal}-{nnr:Nal}-R{nt:Amid}{ct:OH} | 18L | OH | Amidation | Linear | L | Nal = 3-(2-naphthyl)-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 205 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-{nnr:Nal}-{nnr:Nal}-R-R-{nnr:Nal}{nt:Amid}{ct:OH} | 19L | OH | Amidation | Linear | L | Nal = 3-(2-naphthyl)-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 195 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{cyc:N-C} | 1C | Free | Free | Cyclic | L | Bip = 4,4′-biphenyl-L-alanine | 6 | Antibacterial | 50 % Hemolysis | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C} | 2C | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 6 | Antibacterial | 50 % Hemolysis at 45 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C} | 3C | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 6 | Antibacterial | 50 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{cyc:N-C} | 4C | Free | Free | Cyclic | L | Bip = 4,4′-biphenyl-L-alanine | 8 | Antibacterial | 50 % Hemolysis | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C} | 5C | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 8 | Antibacterial | 50 % Hemolysis at 40 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C} | 6C | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 8 | Antibacterial | 50 % Hemolysis at 30 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{cyc:N-C} | 7C | Free | Free | Cyclic | L | Bip = 4,4′-biphenyl-L-alanine | 7 | Antibacterial | 50 % Hemolysis | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C} | 8C | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 70 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C} | 9C | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 80 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Dip}-{nnr:Dip}{cyc:N-C} | 10C | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 6 | Antibacterial | 50 % Hemolysis at 110 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-{nnr:Nal}-{nnr:Nal}{cyc:N-C} | 11C | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 6 | Antibacterial | 50 % Hemolysis at 125 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C} | 12C | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 8 | Antibacterial | 50 % Hemolysis at 100 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C} | 13C | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 8 | Antibacterial | 50 % Hemolysis at 90 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | K-K-K-K-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C} | 14C | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 165 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | K-K-K-K-K-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C} | 15C | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 8 | Antibacterial | 50 % Hemolysis at 180 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-{nnr:Dip}-R-R-{nnr:Dip}-{nnr:Dip}-R{cyc:N-C} | 16C | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 130 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-{nnr:Dip}-{nnr:Dip}-R-R-{nnr:Dip}{cyc:N-C} | 17C | Free | Free | Cyclic | L | Dip = 3,3-diphenyl-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 145 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-{nnr:Nal}-R-R-{nnr:Nal}-{nnr:Nal}-R{cyc:N-C} | 18C | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 105 μM | Human | Synthetic Peptide | NA | NA | ||
| 34978443 | 2022 | R-R-{nnr:Nal}-{nnr:Nal}-R-R-{nnr:Nal}{cyc:N-C} | 19C | Free | Free | Cyclic | L | Nal = 3-(2-naphthyl)-L-alanine | 7 | Antibacterial | 50 % Hemolysis at 110 μM | Human | Synthetic Peptide | NA | NA | ||
| 36465844 | 2022 | GVKFAKRFWRFAKKAFKRFEK{nt:Amid} | HAZ | Free | Amidation | Linear | L | None | 21 | Antibacterial, Antibiofilm, Anticancer | 20 % Hemolysis at 120 μM | Human | Synthetic Hybride (Palustrin-1D And Hp(2–20)) Peptide | α-Helical | NA | ||
| 36350889 | 2022 | RKSKEKIGKEFKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-1 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤5 % Hemolysis at 1.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-2 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤5 % Hemolysis at 1.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid} | DLL37-1 | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acid | 23 | Antibacterial, Antibiofilm | ≤5 % Hemolysis at 1.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | RKSKEKIGKEFKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-1 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤5 % Hemolysis at 2.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-2 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤5 % Hemolysis at 2.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid} | DLL37-1 | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acid | 23 | Antibacterial, Antibiofilm | ≤5 % Hemolysis at 2.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | RKSKEKIGKEFKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-1 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤5 % Hemolysis at 5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-2 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤5 % Hemolysis at 5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid} | DLL37-1 | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acid | 23 | Antibacterial, Antibiofilm | ≤5 % Hemolysis at 5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | RKSKEKIGKEFKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-1 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤20 % Hemolysis at 10 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-2 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤20 % Hemolysis at 10 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid} | DLL37-1 | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acid | 23 | Antibacterial, Antibiofilm | ≤20 % Hemolysis at 10 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36358242 | 2022 | WLKKWLKKLL{ct:Amid} | WALK244.01 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 16 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | KWLLKWLKKL{ct:Amid} | WALK244.02 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | LKWLLKWLKK{ct:Amid} | WALK244.03 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 64 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | Low hemolytic | ||
| 36358242 | 2022 | LLKWLKKWLK{ct:Amid} | WALK244.04 | Amidation | Free | Linear | L | None | 10 | Antibacterial, Anti-inflammatory | 5 % Hemolysis at 64 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | Low hemolytic | ||
| 36358242 | 2022 | KLLKWLKKWL{ct:Amid} | WALK244.05 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | KKLLKWLLKW{ct:Amid} | WALK244.06 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | LKKWLKWLLK{ct:Amid} | WALK244.07 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | WLKKLLKWLK{ct:Amid} | WALK244.08 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 8 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | KWLKKLLKWL{ct:Amid} | WALK244.09 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 8 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | LKWLKKLLKW{ct:Amid} | WALK244.10 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | WLLKWLKKL{ct:Amid} | WALK243.01 | Amidation | Free | Linear | L | None | 9 | Antibacterial | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | KWLLKWLLK{ct:Amid} | WALK243.02 | Amidation | Free | Linear | L | None | 9 | Antibacterial | 5 % Hemolysis at 64 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | Low hemolytic | ||
| 36358242 | 2022 | LKWLLKWLK{ct:Amid} | WALK243.03 | Amidation | Free | Linear | L | None | 9 | Antibacterial, Anti-inflammatory | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | LLKWLKKWL{ct:Amid} | WALK243.04 | Amidation | Free | Linear | L | None | 9 | Antibacterial, Anti-inflammatory | 5 % Hemolysis at 64 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | Low hemolytic | ||
| 36358242 | 2022 | KLLKWLLKW{ct:Amid} | WALK243.05 | Amidation | Free | Linear | L | None | 9 | Antibacterial | 5 % Hemolysis at 64 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | Low hemolytic | ||
| 36358242 | 2022 | LKWLKWLLK{ct:Amid} | WALK243.06 | Amidation | Free | Linear | L | None | 9 | Antibacterial | 5 % Hemolysis at 32 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | LKKWLKWLL{ct:Amid} | WALK243.07 | Amidation | Free | Linear | L | None | 9 | Antibacterial | 5 % Hemolysis at 16 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | WLKKLLKWL{ct:Amid} | WALK243.08 | Amidation | Free | Linear | L | None | 9 | Antibacterial | 5 % Hemolysis at 8 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | NA | ||
| 36358242 | 2022 | KWLLKLLKW{ct:Amid} | WALK243.09 | Amidation | Free | Linear | L | None | 9 | Antibacterial | 5 % Hemolysis at 64 μg/mL | Human | Synthetic Walk Peptides | 10 mM sodium phosphate buffer = Disordered, 50% TFE or 10 mM SDS micelles = α-Helix | Low hemolytic | ||
| 36430320 | 2022 | (CGKKWWGWKC)KL{cyc:N-C}{ct:Amid} | cTurg-2 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >1045 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGKKWGWWKC)KL{cyc:N-C}{ct:Amid} | cTurg-3 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 849 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGKKPWWWKC)KL{cyc:N-C}{ct:Amid} | cTurg-4 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >1065 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGRRWWGWRC)RL{cyc:N-C}{ct:Amid} | cTurg-5 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >1101 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGRRWGWWRC)RL{cyc:N-C}{ct:Amid} | cTurg-6 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 1101 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGRRPWWWRC)RL{cyc:N-C}{ct:Amid} | cTurg-7 | Amidation | Free | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 197 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | CGKKPGGWKCKL{nt:C8}{ct:Amid} | C8-Turg-1 | Amidation | C8 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >943 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | CGKKPGGWKCKL{nt:C10}{ct:Amid} | C10-Turg-1 | Amidation | C10 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >957 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | CGKKPGGWKCKL{nt:C12}{ct:Amid} | C12-Turg-1 | Amidation | C12 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >971 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | CGKKWWGWKCKL{nt:C8}{ct:Amid} | C8-Turg-2 | Amidation | C8 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 198 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | CGKKWWGWKCKL{nt:C10}{ct:Amid} | C10-Turg-2 | Amidation | C10 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 64 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | CGKKWWGWKCKL{nt:C12}{ct:Amid} | C12-Turg-2 | Amidation | C12 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 55 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | CGRRWGWWRCRL{nt:C8}{ct:Amid} | C8-Turg-6 | Amidation | C8 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 54 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | CGRRWGWWRCRL{nt:C10}{ct:Amid} | C10-Turg-6 | Amidation | C10 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 21 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | CGRRWGWWRCRL{nt:C12}{ct:Amid} | C12-Turg-6 | Amidation | C12 | Linear | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 39 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | (CGKKPGGWKC)KL{cyc:N-C}{nt:C8}{ct:Amid} | C8-cTurg-1 | Amidation | C8 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >942 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGKKPGGWKC)KL{cyc:N-C}{nt:C10}{ct:Amid} | C10-cTurg-1 | Amidation | C10 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at >956 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGKKPGGWKC)KL{cyc:N-C}{nt:C12}{ct:Amid} | C12-cTurg-1 | Amidation | C12 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 219 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | (CGKKWWGWKC)KL{cyc:N-C}{nt:C8}{ct:Amid} | C8-cTurg-2 | Amidation | C8 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 439 μg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36430320 | 2022 | (CGKKWWGWKC)KL{cyc:N-C}{nt:C10}{ct:Amid} | C10-cTurg-2 | Amidation | C10 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 106 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | (CGKKWWGWKC)KL{cyc:N-C}{nt:C12}{ct:Amid} | C12-cTurg-2 | Amidation | C12 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 32 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | (CGRRWGWWRC)RL{cyc:N-C}{nt:C8}{ct:Amid} | C8-cTurg-6 | Amidation | C8 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 30 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | (CGRRWGWWRC)RL{cyc:N-C}{nt:C10}{ct:Amid} | C10-cTurg-6 | Amidation | C10 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 16 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36430320 | 2022 | (CGRRWGWWRC)RL{cyc:N-C}{nt:C12}{ct:Amid} | C12-cTurg-6 | Amidation | C12 | Cyclic | L | None | 12 | Antibacterial, Antifungal | 50 % Hemolysis at 9 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 36432731 | 2022 | TGLGKIGYLMKKLLSKAKV | LS-AMP-F1 | Free | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm | 17 % Hemolysis at 200 μM | Mouse | Spider Lycosa Sinensis | α-Helical | Low hemolytic | ||
| 36432731 | 2022 | AGMKNIIDAIKKKLGGKL | LS-AMP-E1 | Free | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | <37.5 % Hemolysis at 200 μM | Mouse | Spider Lycosa Sinensis | α-Helical | Low hemolytic | ||
| 36559073 | 2022 | GWFSLVRKVVGGVGSL{ct:Amid} | Ramosin | Amidation | Free | Linear | L | None | 16 | Antibacterial | 0 % Hemolysis at 128 μM | Human | Colombian Salamander Bolitoglossa Ramosi | TFE 30% = α-Helical, water = Random coil | Non-hemolytic | ||
| 36704429 | 2022 | {conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid} | naprolyginine | Amidation | 2-(6-Methoxy-2-naphthyl)propionic acid | Linear | L | 2-(6-Methoxy-2-naphthyl)propionic acid | 5 | Antibacterial | 0 % Hemolysis at 5 μM | Human | Synthetic Conjugated Ultrashort Antimicrobial Peptide | NA | Non-hemolytic | ||
| 36704429 | 2022 | {conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid} | naprolyginine | Amidation | 2-(6-Methoxy-2-naphthyl)propionic acid | Linear | L | 2-(6-Methoxy-2-naphthyl)propionic acid | 5 | Antibacterial | 0 % Hemolysis at 10 μM | Human | Synthetic Conjugated Ultrashort Antimicrobial Peptide | NA | Non-hemolytic | ||
| 36704429 | 2022 | {conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid} | naprolyginine | Amidation | 2-(6-Methoxy-2-naphthyl)propionic acid | Linear | L | 2-(6-Methoxy-2-naphthyl)propionic acid | 5 | Antibacterial | 0 % Hemolysis at 20 μM | Human | Synthetic Conjugated Ultrashort Antimicrobial Peptide | NA | Non-hemolytic | ||
| 36704429 | 2022 | {conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid} | naprolyginine | Amidation | 2-(6-Methoxy-2-naphthyl)propionic acid | Linear | L | 2-(6-Methoxy-2-naphthyl)propionic acid | 5 | Antibacterial | 0 % Hemolysis at 40 μM | Human | Synthetic Conjugated Ultrashort Antimicrobial Peptide | NA | Non-hemolytic | ||
| 36704429 | 2022 | {conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid} | naprolyginine | Amidation | 2-(6-Methoxy-2-naphthyl)propionic acid | Linear | L | 2-(6-Methoxy-2-naphthyl)propionic acid | 5 | Antibacterial | 0 % Hemolysis at 60 μM | Human | Synthetic Conjugated Ultrashort Antimicrobial Peptide | NA | Non-hemolytic | ||
| 36704429 | 2022 | {conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid} | naprolyginine | Amidation | 2-(6-Methoxy-2-naphthyl)propionic acid | Linear | L | 2-(6-Methoxy-2-naphthyl)propionic acid | 5 | Antibacterial | 0 % Hemolysis at 80 μM | Human | Synthetic Conjugated Ultrashort Antimicrobial Peptide | NA | Non-hemolytic | ||
| 36704429 | 2022 | {conj:2-(6-Methoxy-2-naphthyl)propionic acid}RBRBR{ct:Amid} | naprolyginine | Amidation | 2-(6-Methoxy-2-naphthyl)propionic acid | Linear | L | 2-(6-Methoxy-2-naphthyl)propionic acid | 5 | Antibacterial | 1 % Hemolysis at 100 μM | Human | Synthetic Conjugated Ultrashort Antimicrobial Peptide | NA | Non-hemolytic | ||
| 36500545 | 2022 | VVVNVLVKVLPPPVV{nt:Amid} | P1 | Free | Amidation | Linear | L | None | 15 | Anti-MRSA, Antibacterial | 3.40 ± 0.29 % Hemolysis at 2 μg/mL | Human | Soil Bacterium Brevibacillus Sp. Spr-20 | H2O = β-Strand and Random coil, 50 mM SDS = β-Strand, Random coil and α-Helical | NA | ||
| 36500545 | 2022 | VVVNVLVKVLPPPVV{nt:Amid} | P1 | Free | Amidation | Linear | L | None | 15 | Anti-MRSA, Antibacterial | 62.23 ± 0.69 % Hemolysis at 64 μg/mL | Human | Soil Bacterium Brevibacillus Sp. Spr-20 | H2O = β-Strand and Random coil, 50 mM SDS = β-Strand, Random coil and α-Helical | NA | ||
| 36500545 | 2022 | VVVNVLVKVLPPPVV{nt:Amid} | P1 | Free | Amidation | Linear | L | None | 15 | Anti-MRSA, Antibacterial | 1.64 ± 0.17 % Hemolysis at 0.25 μg/mL | Human | Soil Bacterium Brevibacillus Sp. Spr-20 | H2O = β-Strand and Random coil, 50 mM SDS = β-Strand, Random coil and α-Helical | NA | ||
| 36500545 | 2022 | VVVNVLVKVLPPPVV{nt:Amid} | P1 | Free | Amidation | Linear | L | None | 15 | Anti-MRSA, Antibacterial | 5.52 ± 0.92 % Hemolysis at 32 μg/mL | Human | Soil Bacterium Brevibacillus Sp. Spr-20 | H2O = β-Strand and Random coil, 50 mM SDS = β-Strand, Random coil and α-Helical | NA | ||
| 36548751 | 2022 | MVWLLPLKFLASHVAMEQLSKLGSKIATKL{ct:Amid} | M-lycotoxin-Lp1a | Amidation | Free | Linear | L | None | 30 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36548751 | 2022 | VIWLPALKFLASHIAMEQLSKL{ct:Amid} | M-lycotoxin-Lp1b | Amidation | Free | Linear | L | None | 22 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36548751 | 2022 | IWLTALKFIGKNLGKHFAKQQLSKL{ct:Amid} | M-lycotoxin-Lp3a | Amidation | Free | Linear | L | None | 25 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36548751 | 2022 | KIKWFKAMKSIAKVAKKQLKKHLGGEN{ct:Amid} | M-lycotoxin-Lp4 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36548751 | 2022 | AGLGKIGAFIKKAAIKAKAA{ct:Amid} | M-lycotoxin-Lp5a | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36548751 | 2022 | AGLGKIGALIKKAAIKAKAA{ct:Amid} | M-lycotoxin-Lp5b | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36548751 | 2022 | SKWKAFLAKMKEIASEAL{ct:Amid} | M-lycotoxin-Lp6 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36442155 | 2022 | RRRRWWWW{cyc:N-C} | 1 | Free | Free | Cyclic | L | None | 8 | Antibacterial | 50 % Hemolysis at 175 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRWWW{cyc:N-C} | 2a | Free | Free | Cyclic | L | None | 5 | Antibacterial | 50 % Hemolysis at 120 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRWWWW{cyc:N-C} | 2b | Free | Free | Cyclic | L | None | 6 | Antibacterial | 50 % Hemolysis at 85 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRWWW{cyc:N-C} | 3a | Free | Free | Cyclic | L | None | 6 | Antibacterial | 50 % Hemolysis at 155 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRWWWW{cyc:N-C} | 3b | Free | Free | Cyclic | L | None | 7 | Antibacterial | 50 % Hemolysis at 105 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRWWWWW{cyc:N-C} | 3c | Free | Free | Cyclic | L | None | 8 | Antibacterial | 50 % Hemolysis at 80 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRWWWWWW{cyc:N-C} | 3d | Free | Free | Cyclic | L | None | 9 | Antibacterial | 50 % Hemolysis at 65 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRWWWWWWW{cyc:N-C} | 3e | Free | Free | Cyclic | L | None | 10 | Antibacterial | 50 % Hemolysis at 60 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | R{d}R{d}R{d}R{d}WWWW{cyc:N-C} | 4a | Free | Free | Cyclic | Mix | r = D-Arginine | 8 | Antibacterial | 50 % Hemolysis at 110 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRWWWWW{cyc:N-C} | 4b | Free | Free | Cyclic | L | None | 9 | Antibacterial | 50 % Hemolysis at 100 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRWWWWWW{cyc:N-C} | 4c | Free | Free | Cyclic | L | None | 10 | Antibacterial | 50 % Hemolysis at 75 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRWWWWWWW{cyc:N-C} | 4d | Free | Free | Cyclic | L | None | 11 | Antibacterial | 50 % Hemolysis at 60 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRWWWW{cyc:N-C} | 5a | Free | Free | Cyclic | L | None | 9 | Antibacterial | 50 % Hemolysis at 340 μg/mL | Human | Synthetic Cyclic Peptide | NA | Low hemolytic | ||
| 36442155 | 2022 | RRRRRWWWWW{cyc:N-C} | 5b | Free | Free | Cyclic | L | None | 10 | Antibacterial | 50 % Hemolysis at 230 μg/mL | Human | Synthetic Cyclic Peptide | NA | Low hemolytic | ||
| 36442155 | 2022 | RRRRRWWWWWW{cyc:N-C} | 5c | Free | Free | Cyclic | L | None | 11 | Antibacterial | 50 % Hemolysis at 140 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRWWWWWWW{cyc:N-C} | 5d | Free | Free | Cyclic | L | None | 12 | Antibacterial | 50 % Hemolysis at 115 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRRWWWW{cyc:N-C} | 6a | Free | Free | Cyclic | L | None | 10 | Antibacterial | 50 % Hemolysis at 265 μg/mL | Human | Synthetic Cyclic Peptide | NA | Low hemolytic | ||
| 36442155 | 2022 | RRRRRRWWWWW{cyc:N-C} | 6b | Free | Free | Cyclic | L | None | 11 | Antibacterial | 50 % Hemolysis at 255 μg/mL | Human | Synthetic Cyclic Peptide | NA | Low hemolytic | ||
| 36442155 | 2022 | RRRRRRWWWWWW{cyc:N-C} | 6c | Free | Free | Cyclic | L | None | 12 | Antibacterial | 50 % Hemolysis at 170 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRRWWWWWWW{cyc:N-C} | 6d | Free | Free | Cyclic | L | None | 13 | Antibacterial | 50 % Hemolysis at 85 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRRRWWWW{cyc:N-C} | 7a | Free | Free | Cyclic | L | None | 11 | Antibacterial | 50 % Hemolysis at 190 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRRRWWWWW{cyc:N-C} | 7b | Free | Free | Cyclic | L | None | 12 | Antibacterial | 50 % Hemolysis at 175 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRRRWWWWWW{cyc:N-C} | 7c | Free | Free | Cyclic | L | None | 13 | Antibacterial | 50 % Hemolysis at 170 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36442155 | 2022 | RRRRRRRWWWWWWW{cyc:N-C} | 7d | Free | Free | Cyclic | L | None | 14 | Antibacterial | 50 % Hemolysis at 140 μg/mL | Human | Synthetic Cyclic Peptide | NA | NA | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 10.19 ± 2.29 % Hemolysis at 160 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 1.96 ± 0.13 % Hemolysis at 80 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.44 ± 0.44 % Hemolysis at 40 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.15 ± 0.23 % Hemolysis at 20 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.65 ± 0.22 % Hemolysis at 10 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.34 ± 0.31 % Hemolysis at 5 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.06 ± 0.08 % Hemolysis at 2.5 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.22 ± 0.20 % Hemolysis at 1.2 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.13 ± 0.23 % Hemolysis at 0.6 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36480332 | 2022 | WFKFFKKFFKKWK | Pm11 | Free | Free | Linear | L | None | 13 | Antibacterial | 0.09 ± 0.16 % Hemolysis at 0.3 μM | Sheep | Flatfish Pleuronecies Americanus | α-Helix | Low hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 5 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 10 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 20 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 40 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 60 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 80 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 100 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36668862 | 2023 | LLKKVLALLKKVL{nt:Amid} | Hp-MAP3 | Free | Amidation | Linear | L | None | 13 | Antibacterial, Antibiofilm, Antifungal, Anticancer | ~15 % Hemolysis at 10.8 μM | mouse | Temporin-Pta Analog | 50% TFE or SDS = α-Helix | NA | ||
| 36668862 | 2023 | LLKKVLALLKKVL{nt:Amid} | Hp-MAP3 | Free | Amidation | Linear | L | None | 13 | Antibacterial, Antibiofilm, Antifungal, Anticancer | 25 % Hemolysis at 21.6 μM | mouse | Temporin-Pta Analog | 50% TFE or SDS = α-Helix | NA | ||
| 36668862 | 2023 | LLKKVLALLKKVL{nt:Amid} | Hp-MAP3 | Free | Amidation | Linear | L | None | 13 | Antibacterial, Antibiofilm, Antifungal, Anticancer | ~85 % Hemolysis at 43.3 μM | mouse | Temporin-Pta Analog | 50% TFE or SDS = α-Helix | NA | ||
| 36760504 | 2023 | VNFKLLSHSLLVTLRSHL | HJH-3 | Free | Free | Linear | L | None | 18 | Antibacterial | 7.31 % Hemolysis at 100 μg/mL | Chicken | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 36760504 | 2023 | VNFKLLSHSLLVTLRSHL | HJH-3 | Free | Free | Linear | L | None | 18 | Antibacterial | 13.37 % Hemolysis at 400 μg/mL | Chicken | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 36327032 | 2023 | RNCKWLFKTWLKLPK{nt:Amid} | RN15m4 | Free | Amidation | Linear | L | None | 15 | Antibacterial | <12 % Hemolysis at 200 μg/mL | Human | Analog Of Rn15 (Cathelin Domain Of Crocodylus Siamensis) | 73.33% α-Helix | Low hemolytic | ||
| 36769243 | 2023 | MNLVDRAILIRKRRRAALQLRDKVLRYLK | AMP 1 | Free | Free | Linear | L | None | 29 | Antibacterial | 29.2 ± 32 % Hemolysis at 100 µM | Mouse | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MKRKKKILIKKVLKLKSSAY | AMP 2 | Free | Free | Linear | L | None | 20 | Antibacterial | 14.9 ± 14.9 % Hemolysis at 100 µM | Mouse | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MTDGRYLIKRVKKKKKAVLQLILKFL | AMP 3 | Free | Free | Linear | L | None | 26 | Antibacterial | 50.1 ± 14.4 % Hemolysis at 100 µM | Mouse | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MNLVDRAILIRKRRRAALQLRDKVLRYLK | AMP 1 | Free | Free | Linear | L | None | 29 | Antibacterial | 12.9 ± 1.7 % Hemolysis at 100 µM | Rat | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MKRKKKILIKKVLKLKSSAY | AMP 2 | Free | Free | Linear | L | None | 20 | Antibacterial | 5.2 ± 1.9 % Hemolysis at 100 µM | Rat | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MTDGRYLIKRVKKKKKAVLQLILKFL | AMP 3 | Free | Free | Linear | L | None | 26 | Antibacterial | 29.5 ± 8.2 % Hemolysis at 100 µM | Rat | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MNLVDRAILIRKRRRAALQLRDKVLRYLK | AMP 1 | Free | Free | Linear | L | None | 29 | Antibacterial | 7.1 ± 1.1 % Hemolysis at 100 µM | Rabbit | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MKRKKKILIKKVLKLKSSAY | AMP 2 | Free | Free | Linear | L | None | 20 | Antibacterial | 4.6 ± 0.7 % Hemolysis at 100 µM | Rabbit | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MTDGRYLIKRVKKKKKAVLQLILKFL | AMP 3 | Free | Free | Linear | L | None | 26 | Antibacterial | 53.2 ± 7.4 % Hemolysis at 100 µM | Rabbit | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MNLVDRAILIRKRRRAALQLRDKVLRYLK | AMP 1 | Free | Free | Linear | L | None | 29 | Antibacterial | 22.3 ± 4 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MKRKKKILIKKVLKLKSSAY | AMP 2 | Free | Free | Linear | L | None | 20 | Antibacterial | 8.5 ± 1.4 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MTDGRYLIKRVKKKKKAVLQLILKFL | AMP 3 | Free | Free | Linear | L | None | 26 | Antibacterial | 37 ± 5.1 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | NA | ||
| 36837754 | 2023 | INLKAIAALAKKLF{ct:Amid} | Mastoparan-AF | Amidation | Free | Linear | L | None | 14 | Antibacterial | <5 % Hemolysis at 256 μg/mL | Sheep | Hornet Venom Of Vespa Affinis | Water = Disordered, SDS = Helical | Low hemolytic | ||
| 36837754 | 2023 | INLKAIAALAKKLF{ct:Amid} | Mastoparan-AF | Amidation | Free | Linear | L | None | 14 | Antibacterial | >35 % Hemolysis at 256 μg/mL | Chicken | Hornet Venom Of Vespa Affinis | Water = Disordered, SDS = Helical | NA | ||
| 36903328 | 2023 | KRFKKFFKKLRKSVKKRVKKFFKKPKVIGVSIPF | Hydrostatin-AMP2 | Free | Free | Linear | L | None | 34 | Antibacterial, Antibiofilm | 4.6 % Hemolysis at 250 μg/mL | Human | Sea Snake Hydrophis Cyanocinctus | Water = Random coil, SDS = α-Helical | Low hemolytic | ||
| 36908510 | 2023 | RFRPPIRRPPIRPPFRPPFRPPVR | OaBac5mini | Free | Free | Linear | L | None | 24 | Antibacterial | −1.26 to 1.59 % Hemolysis at 400 μg/mL | Rabbit | Active Fragment Of The Sheep-Derived | Random coil | Non-hemolytic | ||
| 36979401 | 2023 | KWKWRPLKRKLVLRM | PAM-5 | Free | Free | Linear | L | None | 15 | Antibacterial | <1 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 36914718 | 2023 | LGIKILWSAYKHRKTI{ct:CH3-(CH2)3-CONH} | L-6-C5 | CH3-(CH2)3-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at > 100 µM | Human | Synthetic Lippopeptide | NA | Low hemolytic | ||
| 36914718 | 2023 | LGIKILWSAYKHRKTI{ct:CH3-(CH2)3-CONH} | D-6-C5 | CH3-(CH2)3-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at > 100 µM | Human | Synthetic Lippopeptide | NA | Low hemolytic | ||
| 36914718 | 2023 | LGLKLLWSAYKHRKTL{ct:CH3-(CH2)3-CONH} | L-6-C5-Leu | CH3-(CH2)3-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at > 100 µM | Human | Synthetic Lippopeptide | NA | Low hemolytic | ||
| 36914718 | 2023 | LGLKLLWSAYKHRKTL{ct:CH3-(CH2)3-CONH} | D-6-C5-Leu | CH3-(CH2)3-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at > 100 µM | Human | Synthetic Lippopeptide | NA | Low hemolytic | ||
| 36914718 | 2023 | LGIKILWSAYKHRKTI{ct:CH3-(CH2)4-CONH} | L-6-C6 | CH3-(CH2)4-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at > 100 µM | Human | Synthetic Lippopeptide | NA | Low hemolytic | ||
| 36914718 | 2023 | LGIKILWSAYKHRKTI{ct:CH3-(CH2)4-CONH} | D-6-C6 | CH3-(CH2)4-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at > 100 µM | Human | Synthetic Lippopeptide | NA | Low hemolytic | ||
| 36914718 | 2023 | LGLKLLWSAYKHRKTL{ct:CH3-(CH2)4-CONH} | L-6-C6-Leu | CH3-(CH2)4-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 60 µM | Human | Synthetic Lippopeptide | NA | NA | ||
| 36914718 | 2023 | LGLKLLWSAYKHRKTL{ct:CH3-(CH2)4-CONH} | D-6-C6-Leu | CH3-(CH2)4-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 65 µM | Human | Synthetic Lippopeptide | NA | NA | ||
| 36914718 | 2023 | LGIKILWSAYKHRKTI{ct:CH3-(CH2)5-CONH} | L-6-C7 | CH3-(CH2)5-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 80 µM | Human | Synthetic Lippopeptide | NA | NA | ||
| 36914718 | 2023 | LGIKILWSAYKHRKTI{ct:CH3-(CH2)5-CONH} | D-6-C7 | CH3-(CH2)5-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 65 µM | Human | Synthetic Lippopeptide | NA | NA | ||
| 36914718 | 2023 | LGLKLLWSAYKHRKTL{ct:CH3-(CH2)5-CONH} | L-6-C7-Leu | CH3-(CH2)5-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 30 µM | Human | Synthetic Lippopeptide | NA | NA | ||
| 36914718 | 2023 | LGLKLLWSAYKHRKTL{ct:CH3-(CH2)5-CONH} | D-6-C7-Leu | CH3-(CH2)5-CONH | Free | Linear | L | None | 16 | Antibacterial | 5 % Hemolysis at 35 µM | Human | Synthetic Lippopeptide | NA | NA | ||
| 36982579 | 2023 | KRIVQRIKDFLR{ct:Amid} | KR12-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Ll-37-Derived Peptide Fragment | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C8}{ct:Amid} | C8α-KR12-NH2 | Amidation | C8 | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 64 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | K({nnr:C8})RIVQRIKDFLR{ct:Amid} | C8ε-KR12-NH2 | Amidation | Free | Linear | L | C8 = C8 | 12 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | KKRIVQRIKDFLR{nt:C8}{ct:Amid} | C8α-Lys-KR12-NH2 | Amidation | C8 | Linear | L | C8 = C8 | 13 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | K({nnr:C8})KRIVQRIKDFLR{ct:Amid} | C8ε-Lys-KR12-NH2 | Amidation | Free | Linear | L | C8 = C8 | 13 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLRK({nnr:C8}){ct:Amid} | KR12-Lysε(C8)-NH2 | Amidation | Free | Linear | L | C8 = C8 | 13 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLK({nnr:C8}){ct:Amid} | [Lysε(C8)]12KR12-NH2 | Amidation | Free | Linear | L | C8 = C8 | 12 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | KRIVQRIK({nnr:C8})DFLR{ct:Amid} | [Lysε(C8)]8KR12-NH2 | Amidation | Free | Linear | L | C8 = C8 | 12 | Antibacterial | 5 % Hemolysis at 64 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | K({nnr:C8})RIVQRIKDFLR{nt:C8}{ct:Amid} | C8α,C8ε-KR12-NH2 | Amidation | C8 | Linear | L | C8 = C8 | 12 | Antibacterial | 5 % Hemolysis at 8 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | K({nnr:C4})RIVQRIKDFLR{nt:C4}{ct:Amid} | C4α, C4ε-KR12-NH2 | Amidation | C4 | Linear | L | C4 = C4 | 12 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | RLFDKIRQVIRK({nnr:C8}){ct:Amid} | retro-KR12-C8ε-NH2 | Amidation | Free | Linear | L | C8 = C8 | 12 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | RLFDKIRQVIRK{nt:C8}{ct:Amid} | C8α-retro-KR12-NH2 | Amidation | C8 | Linear | L | C8 = C8 | 12 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:CH3-(CH2)5-CH(C4H9)-CO}{ct:Amid} | 2-Buthyloctanoic acid-KR12-NH2 | Amidation | CH3-(CH2)5-CH(C4H9)-CO | Linear | L | CH3-(CH2)5-CH(C4H9)-CO | 12 | Antibacterial | 5 % Hemolysis at 16 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:CH3-(CH2)3-CH(C2H5)-CO}{ct:Amid} | 2-Ethylhexanoic acid-KR12-NH2 | Amidation | CH3-(CH2)3-CH(C2H5)-CO | Linear | L | CH3-(CH2)3-CH(C2H5)-CO | 12 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-CO}{ct:Amid} | Benzoic acid-KR12-NH2 | Amidation | C6H5-CO | Linear | L | C6H5-CO | 12 | Antibacterial | 5 % Hemolysis at ≥512 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Non-hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-CH2-CO}{ct:Amid} | Phenylacetic acid-KR12-NH2 | Amidation | C6H5-CH2-CO | Linear | L | C6H5-CH2-CO | 12 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-CH2-CH2-CO}{ct:Amid} | 3-Phenylpropionic acid- KR12-NH2 | Amidation | C6H5-CH2-CH2-CO | Linear | L | C6H5-CH2-CH2-CO | 12 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-(CH2)3-CO}{ct:Amid} | 4-Phenylbutanoic acid-KR12-NH2 | Amidation | C6H5-(CH2)3-CO | Linear | L | C6H5-(CH2)3-CO | 12 | Antibacterial | 5 % Hemolysis at 128 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-CH=CH-CO}{ct:Amid} | trans-cinnamic acid-KR12-NH2 | Amidation | C6H5-CH=CH-CO | Linear | L | C6H5-CH=CH-CO | 12 | Antibacterial | 5 % Hemolysis at 128 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-C≡C-CO}{ct:Amid} | Phenylpropiolic acid-KR12-NH2 | Amidation | C6H5-C≡C-CO | Linear | L | C6H5-C≡C-CO | 12 | Antibacterial | 5 % Hemolysis at 256 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | Low hemolytic | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C6H5-C6H4-CO}{ct:Amid} | 4-Phenylbenzoic acid- KR12-NH2 | Amidation | C6H5-C6H4-CO | Linear | L | C6H5-C6H4-CO | 12 | Antibacterial | 5 % Hemolysis at 32 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 36982579 | 2023 | KRIVQRIKDFLR{nt:C24H39O3}{ct:Amid} | Deoxycholic acid- KR12-NH2 | Amidation | C24H39O3 | Linear | L | C24H39O3 | 12 | Antibacterial | 5 % Hemolysis at 8 µg/mL | Human | Kr12-Nh2 Lipidated Analogs | POPG and POPC = α-Helical | NA | ||
| 37007486 | 2023 | VFRLKKWIQKVI | FD10 | Free | Free | Linear | L | None | 12 | Antibacterial, Antifungal | 0.31 % Hemolysis at 256 μg/mL | Mouse | Protaetia Brevitarsis Lewis Larvae | α-Helix | Non-hemolytic | ||
| 37007486 | 2023 | KIYVLLRRQA | FD12 | Free | Free | Linear | L | None | 10 | Antibacterial | 0.4 % Hemolysis at 256 μg/mL | Mouse | Protaetia Brevitarsis Lewis Larvae | α-Helix | Non-hemolytic | ||
| 37007486 | 2023 | STLHLVLRLR{ct:Amid} | FD15 | Amidation | Free | Linear | L | None | 10 | Antibacterial | 0.55 % Hemolysis at 256 μg/mL | Mouse | Protaetia Brevitarsis Lewis Larvae | α-Helix | Non-hemolytic | ||
| 36979510 | 2023 | AWLDKLKSIGKVVGKVAIGVAKNLLNPQ | Raniseptins-3 | Free | Free | Linear | L | None | 28 | Antibacterial, Antifungal | ≤20 % Hemolysis at 128 µM | Human | Frog Boana Raniceps Skin Secretion | SDS = α-Helix | NA | ||
| 36979510 | 2023 | ALLDKLKSLGKVVGKVALGVVQNYLNPRQ | Raniseptins-6 | Free | Free | Linear | L | None | 29 | Antibacterial, Antifungal | ≤20 % Hemolysis at 128 µM | Human | Frog Boana Raniceps Skin Secretion | SDS = α-Helix | NA | ||
| 36426386 | 2023 | GIFDVLKNLAKGVITSLAS{ct:Amid} | OCN-3N | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolysis at 56 ± 7 µM | Mouse | Caribbean Frog Leptodactylus Nesiotus | α-Helix | NA | ||
| 36426386 | 2023 | GIFKVLKNLAKGVITSLAS{ct:Amid} | [D4K]OCN-3N | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolysis at 107 ± 8 µM | Mouse | Ocellatin-3N Analogs | NA | NA | ||
| 36426386 | 2023 | GIFDVLKNLAKGVITSLKS{ct:Amid} | [A18K]OCN-3N | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolysis at >128 µM | Mouse | Ocellatin-3N Analogs | NA | NA | ||
| 36426386 | 2023 | GIFKVLKNLAKGVITSLKS{ct:Amid} | [D4K,A18K]OCN-3N | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolysis at >128 µM | Mouse | Ocellatin-3N Analogs | NA | NA | ||
| 37242633 | 2023 | VRLIVAVRIWRR{ct:Amid} | IDR1018 | Amidation | Free | Linear | L | None | 12 | Wound healing, Antibiofilm, Antibacterial | 20 % Hemolysis at 128 μg/mL | Human | Cationic Host Defense Peptides | NA | NA | ||
| 37242633 | 2023 | VRLIVAVRIWRR{nt:PEG6}{ct:Amid} | PEG6-IDR1018 | Amidation | PEG6 | Linear | L | None | 12 | Wound healing, Antibiofilm, Antibacterial | 0 % Hemolysis at 128 μg/mL | Human | Cationic Host Defense Peptides | NA | Non-hemolytic | ||
| 37242633 | 2023 | T({nnr:GlcNAc})VRLIVAVRIWRR{ct:Amid} | Glc-IDR1018 | Amidation | Free | Linear | L | GlcNAc = N-acetyl glucosamine | 13 | Wound healing, Antibiofilm, Antibacterial | 0 % Hemolysis at 128 μg/mL | Human | Cationic Host Defense Peptides | NA | Non-hemolytic | ||
| 36951612 | 2023 | AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5} | GLP6 | C6H12NO5 | C8H15O | Linear | L | None | 14 | Antibacterial, Antibiofilm | 5.15 % Hemolysis at 8 µM | mouse | Synthetic Glycosylated Lp6 Lipopeptide | SDS = 67.5% α-Helical, pure water =7 .38% α-Helical | NA | ||
| 36951612 | 2023 | AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5} | GLP6 | C6H12NO5 | C8H15O | Linear | L | None | 14 | Antibacterial, Antibiofilm | 15.6 % Hemolysis at 16 µM | mouse | Synthetic Glycosylated Lp6 Lipopeptide | SDS = 67.5% α-Helical, pure water =7 .38% α-Helical | NA | ||
| 36951612 | 2023 | AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5} | GLP6 | C6H12NO5 | C8H15O | Linear | L | None | 14 | Antibacterial, Antibiofilm | 60.67 % Hemolysis at 64 µM | mouse | Synthetic Glycosylated Lp6 Lipopeptide | SDS = 67.5% α-Helical, pure water =7 .38% α-Helical | NA | ||
| 37107149 | 2023 | FGFGCNGPWNEDDLRCHNHCKSIKGYKGGYCAKGGFVCKCY | FNZ | Free | Free | Linear | L | None | 41 | Antibacterial | 0 % Hemolysis at 128 μg/mL | Mouse | Analogs Of Nz2114, A Mutant Of Plectasin | SDS = β-Sheet | Non-hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 2.78 % Hemolysis at 4 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 2.98 % Hemolysis at 8 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 3.15 % Hemolysis at 16 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 3.83 % Hemolysis at 32 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 5.79 % Hemolysis at 64 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 6.64 % Hemolysis at 128 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 15.5 % Hemolysis at 256 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37093361 | 2023 | WRLFRRILRVL{nt:Amid}{ct:Amid} | mCM11 | Amidation | Amidation | Linear | L | None | 11 | Antibacterial, Antibioflm | 24.53 % Hemolysis at 512 μg/mL | Human | Modifed Cecropin–Melittin | SDS = α-Helix | Low hemolytic | ||
| 37275897 | 2023 | CDFIETHYLDEQVKSIKELADWVTNLRRMGAPQNGMAEYLFD-KHTLGKESS{ct:Ferritin H} | Lc1687 | Ferritin H | Free | Linear | L | None | 51 | Antibacterial, Anti-parasitic | 2.5 % Hemolysis at 1000 mg/L | Fish | Fish Large Yellow Croaker Larimichthys Crocea With Ferritin H | PBS solution = α-Helical | Non-hemolytic | ||
| 37251186 | 2023 | KKKKKGIGFLAFGAFVILKKKK{ct:Amid} | MSI-Seg | Amidation | Free | Linear | L | None | 22 | Antibacterial | 16.6 ± 4.2 % Hemolysis at 100 µM | Pig | Msi-78 Analogues | LPC = α-Helical | NA | ||
| 37251186 | 2023 | KKKKKFIGLFAGGIVLAFKKKK{ct:Amid} | MSI-Seg-Scr | Amidation | Free | Linear | L | None | 22 | Antibacterial | 3.9 ± 1.4 % Hemolysis at 100 µM | Pig | Msi-78 Analogues | LPC = α-Helical | NA | ||
| 37251186 | 2023 | KKKKKGIGGLAGGAFVILKKKK{ct:Amid} | MSI-Seg-F2G | Amidation | Free | Linear | L | None | 22 | Antibacterial | 1.2 ± 30.2 % Hemolysis at 100 µM | Pig | Msi-78 Analogues | LPC = Random coil | NA | ||
| 37251186 | 2023 | KKKKKGIGF{d}LAF{d}GAFVILKKKK{ct:Amid} | MSI-Seg-F2F | Amidation | Free | Linear | Mix | None | 22 | Antibacterial | 8.1 ± 3.2 % Hemolysis at 100 µM | Pig | Msi-78 Analogues | LPC and LPS = β-Sheet | NA | ||
| 37251186 | 2023 | KKKKKKKGIGFLAFGAFVKILK{ct:Amid} | MSI-N7K | Amidation | Free | Linear | L | None | 22 | Antibacterial | 10 ± 5.6 % Hemolysis at 100 µM | Pig | Msi-78 Analogues | LPC and LPS = Random coil | NA | ||
| 36868141 | 2023 | FLPLIAGKIFCAISKKC | Des(8–14)brevinin-1PMa | Free | Free | Linear | L | None | 17 | Antibacterial | 50 % Hemolysis at >200 µM | Mouse | Amazon River Frog Lithobates Palmipes | NA | Low hemolytic | ||
| 36868141 | 2023 | FLPLIAGVAAKVLPKIFCAISKKC | Brevinin-1PMa | Free | Free | Linear | L | None | 24 | Antibacterial | 50 % Hemolysis at 4 µM | Mouse | Amazon River Frog Lithobates Palmipes | NA | NA | ||
| 36868141 | 2023 | FLPFLGKLLSGIF{ct:Amid} | Temporin-PMa | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 8 µM | Mouse | Amazon River Frog Lithobates Palmipes | NA | NA | ||
| 36868141 | 2023 | FLPFLGKLLSGIF | Temporin-PMa non-amidated | Free | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolysis at 110 µM | Mouse | Amazon River Frog Lithobates Palmipes | NA | NA | ||
| 37446618 | 2023 | YA{d}FGYPSGHFM | LENART01 | Free | Free | Linear | Mix | a = D-alanine | 11 | Antibacterial | 4.8 % Hemolysis at 200 µM (1 hour) | Human | Opioid–Ranatensin Hybrid Peptide | NA | Low hemolytic | ||
| 37446618 | 2023 | YA{d}FGYPSGHFM | LENART01 | Free | Free | Linear | Mix | a = D-alanine | 11 | Antibacterial | 8.3 % Hemolysis at 200 µM (2 hour) | Human | Opioid–Ranatensin Hybrid Peptide | NA | Low hemolytic | ||
| 37446618 | 2023 | YA{d}FGYPSGHFM | LENART01 | Free | Free | Linear | Mix | a = D-alanine | 11 | Antibacterial | 16.4 % Hemolysis at 200 µM (4 hour) | Human | Opioid–Ranatensin Hybrid Peptide | NA | Low hemolytic | ||
| 37300579 | 2023 | HIDWKKLLDAAKQIL{ct:Amid} | MP1 | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm, Antifungal | 50 % Hemolysis at 221.4 µM | Human | Mastoparan Family | α-Helix | Low hemolytic | ||
| 37300579 | 2023 | HIDWKKLLDAAKKIL{ct:Amid} | MP1-Q12K | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm, Antifungal | 50 % Hemolysis at 187.4 µM | Human | Mp1 Analog | α-Helix | Low hemolytic | ||
| 37513276 | 2023 | GPKTKAACKMACKLATCGKKPGGWKCKLCELGCDAV | Turgencin A | Free | Free | Linear | L | None | 36 | Antibacterial | 0 % Hemolysis at 10 μg/mL | Human | Fungi Pichia Pastoris | α-Helix and Random coil | Non-hemolytic | ||
| 37631261 | 2023 | RGGRLCYCRRRFCVCVGR | Protegrin-1 (PG-1) | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 0.7 µM | Human | Porcine (Sus Scrofa) Leukocytes | β-Hairpin | NA | ||
| 37631261 | 2023 | RGG-LCYCRGRFCVCVGR | Iseganan | Free | Free | Linear | L | None | 17 | Antibacterial | 2 % Hemolysis at 1 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37631261 | 2023 | RGGRRCYCRRRFCVCVGR | [L5R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 4.1 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37631261 | 2023 | RGGRACYCRRRFCVCVGR | [L5A] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 4.1 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37631261 | 2023 | RGGRLCYCRRRFCVCRGR | [V16R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 49.2 µM | Human | Protegrin-1 Analogs | β-Hairpin | Low hemolytic | ||
| 37631261 | 2023 | RGGRLCYCRRRFCVCAGR | [V16A] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 4.3 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37631261 | 2023 | RGGRLCYCRRRFCRCVGR | [V14R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at >64 µM | Human | Protegrin-1 Analogs | NA | Low hemolytic | ||
| 37631261 | 2023 | RGGRLCYCRRRFCACVGR | [V14A] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 5.5 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37631261 | 2023 | RGGRLCRCRRRFCVCVGR | [Y7R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 61.4 µM | Human | Protegrin-1 Analogs | NA | Low hemolytic | ||
| 37631261 | 2023 | RGGRLCTCRRRFCVCVGR | [Y7T] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 33.5 µM | Human | Protegrin-1 Analogs | NA | Low hemolytic | ||
| 37631261 | 2023 | RGGRLCTCRRRFCVCRGR | [Y7T,V16R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at >64 µM | Human | Protegrin-1 Analogs | NA | Low hemolytic | ||
| 37631261 | 2023 | RGGRLCYCRRRFCACRGR | [V14A,V16R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at >64 µM | Human | Protegrin-1 Analogs | NA | Low hemolytic | ||
| 37631261 | 2023 | RGGRACYCRRRFCVCRGR | [L5A, V16R] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at >64 µM | Human | Protegrin-1 Analogs | NA | Low hemolytic | ||
| 37631261 | 2023 | RGGRACYCRRRFCACVGR | [L5A, V14A] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 18.8 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37631261 | 2023 | RGGRACYCRRRFCVCAGR | [L5A,V16A] | Free | Free | Linear | L | None | 18 | Antibacterial | 2 % Hemolysis at 11.9 µM | Human | Protegrin-1 Analogs | NA | NA | ||
| 37310533 | 2023 | RIIDLLWRVRRPQKPKFVTVWVR | PMAP-23 | Free | Free | Linear | L | None | 23 | Antibacterial | <10 % Hemolysis at 100 µM | Human | Cathelicidin-Derived Amp | aqueous bufer = unordered structure, membrane-mimetic environments = Helix–hinge–Helix | Low hemolytic | ||
| 37310533 | 2023 | RIIDRLWLVRRPQKPKFVLVWVL | PMAP-NC | Free | Free | Linear | L | None | 23 | Antibacterial, Anticancer | 20 % Hemolysis at 64 µM | Human | Pmap-23 Analogs | Helix–hinge–Helix | NA | ||
| 37635252 | 2023 | GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS | PMAP-37(F34-R) | Free | Free | Linear | L | None | 37 | Antibacterial | ≤1.5 % Hemolysis at 0.36 μg/mL | Human | Pamp-37 (Pig Bone Marrow) Analogue | α-Helix | Low hemolytic | ||
| 37686259 | 2023 | RKYKEKKDKSQNKKKKRKCMIL | RK22 | Free | Free | Linear | L | None | 22 | Antibacterial, Antibiofilm | 0 % Hemolysis at 400 μg/mL | Mouse | Leech Hirudinaria Manillensis | NA | Non-hemolytic | ||
| 36508953 | 2023 | PFKLSLHL{ct:Amid} | Jelleine-I | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antibiofilm, Anti-Listeria monocytogenes | 26.25 % Hemolysis at 1000 μg/mL | Rabbit | Honeybees Royal Jelly | NA | Low hemolytic | ||
| 36736093 | 2023 | KF{nt:Fmoc = fluorenylmethyloxycarbonyl}{ct:Amid} | Fmoc-KF | Amidation | Fmoc = fluorenylmethyloxycarbonyl | Linear | L | None | 2 | Antibacterial | <5 % Hemolysis at 2.4 mM | Rabbit | Synthetic Peptide | NA | NA | ||
| 36736093 | 2023 | KKF{nt:Fmoc = fluorenylmethyloxycarbonyl}{ct:Amid} | Fmoc-KKF | Amidation | Fmoc = fluorenylmethyloxycarbonyl | Linear | L | None | 3 | Antibacterial | 0 % Hemolysis at 2.4 mM | Rabbit | Synthetic Peptide | NA | Non-hemolytic | ||
| 36736093 | 2023 | KKKF{nt:Fmoc = fluorenylmethyloxycarbonyl}{ct:Amid} | Fmoc-KKKF | Amidation | Fmoc = fluorenylmethyloxycarbonyl | Linear | L | None | 4 | Antibacterial | 0 % Hemolysis at 2.4 mM | Rabbit | Synthetic Peptide | NA | Non-hemolytic | ||
| 36870201 | 2023 | FVQWFSKFLGRIL{ct:Amid} | Temporin L | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 50 % Hemolysis at 15 µM | Human | European Frog Rana Temporaria | PC/PG (3:1 w/w) = 70.1% Helical, PC/Chol (8:1 w/w) vesicles = 61.7% Helical | NA | ||
| 36870201 | 2023 | FVQWFSKF(βL)RIL{ct:Amid} | L9βl-TL | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antibiofilm | 50 % Hemolysis at 33.3 µM | Human | Tl-Analogue | PC/PG (3:1 w/w) = 13.8% Helical, PC/Chol (8:1 w/w) vesicles = 7.2% Helical | NA | ||
| 37167720 | 2023 | RRWQWR{ct:Amid} | LfcinB6 (Lf6) | Amidation | Free | Linear | L | None | 6 | Antibacterial | 10 % Hemolysis at >512 µM | Sheep | Lactoferrin Bovine Milk | NA | Low hemolytic | ||
| 37167720 | 2023 | RRWQWRP{d}PRWQWRR{ct:Amid} | Lf6-pP | Amidation | Free | Linear | L | p = D-Proline | 14 | Antibacterial, Antibiofilm, Anti-inflammatory | 10 % Hemolysis at >512 µM | Sheep | Synthetic Amps | Phosphate buffer and 50% TFE = typical TrpZip Hairpin, 30 mM SDS = α-Helical | Low hemolytic | ||
| 37167720 | 2023 | RRWQWRGGRWQWRR{ct:Amid} | Lf6-GG | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 10 % Hemolysis at >512 µM | Sheep | Synthetic Amps | Phosphate buffer and 50% TFE = typical TrpZip Hairpin, 30 mM SDS = α-Helical | Low hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C2} | PE-2C-C2-DH | Free | C2 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C3} | PE-2C-C3-DH | Free | C3 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C4} | PE-2C-C4-DH | Free | C4 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C5} | PE-2C-C5-DH | Free | C5 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C6} | PE-2C-C6-DH | Free | C6 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C7} | PE-2C-C7-DH | Free | C7 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C8} | PE-2C-C8-DH | Free | C8 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:6-MC7} | PE-2C-6-MC7-DH | Free | 6-MC7 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:6-MC8} | PE-2C-6-MC8-DH | Free | 6-MC8 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at >1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 36941353 | 2023 | {nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:LB-8} | PE-2C-LB-8-DH) | Free | LB-8 | Cyclic | Mix | Dab = L-2,4-diaminobutyric acid | 10 | Antibacterial | 0 % Hemolysis at 1500 μg/mL | Rabbit | Synthetic Cyclic Peptide | NA | Non-hemolytic | ||
| 31608030 | 2019 | FKRIVQRIKDFLRNLV | FK16 | Free | Free | Linear | L | None | 16 | Antibacterial | <10% (1 hr) % Hemolysis at 256 μg/mL | Human | Cathelicidin-Derived Peptides | NA | Low hemolytic | ||
| 23409125 | 2013 | RLLFRKIRRLKR | EC5 | Free | Free | Linear | L | None | 12 | Antibacterial | 5 % Hemolysis at 500 μg/mL | Chicken | Peptide Synergists From Phage Display | NA | Low hemolytic | ||
| 19451300 | 2009 | FFSLLPSLIGGLVSAIK | imcroporin | Free | Free | Linear | L | None | 17 | Antibacterial | <50 % Hemolysis at 50 μg/ml | Human | Scorpion Isometrus Maculates | α-Helix | NA | ||
| 25626077 | 2015 | FLFSLIPSVIAGLVSAIRN{ct:Amid} | AaeAP1 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 100 % Hemolysis at 16 μg/ml | Horse | Scorpion Androctonus Aeneas | 21.05 % α-Helix | NA | ||
| 25626077 | 2015 | FLFSLIPSAIAGLVSAIRN{ct:Amid} | AaeAP2 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 100 % Hemolysis at 64 μg/ml | Horse | Scorpion Androctonus Aeneas | 21.05 % α-Helix | NA | ||
| 25626077 | 2015 | FLFKLIPKVIKGLVKAIRK{ct:Amid} | AaeAP1a | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal. Anticancer, Antiproliferative | 100 % Hemolysis at 32 μg/ml | Horse | Aaeap1 Analogues | 31.58% α-Helix | NA | ||
| 25626077 | 2015 | FLFKLIPKAIKGLVKAIRK{ct:Amid} | AaeAP2a | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal. Anticancer, Antiproliferative | 100 % Hemolysis at 64 μg/ml | Horse | Aaeap2 Analogues | 31.58% α-Helix | NA | ||
| 25633390 | 2015 | ARDGYIVDEKGCKFACFIN | Cm38 | Free | Free | Linear | L | None | 19 | Antibacterial | 0 % Hemolysis at 64 µM | Human | Scorpion Centruroides Margaritatus | NA | Non-hemolytic | ||
| 34971943 | 2022 | FIHHIIGGLFSAGKAIHRLIRRRRR | Oreoch-2 | Free | Free | Linear | L | None | 25 | Antibacterial | 40.33 % Hemolysis at 64 µg/mL | Mouse | Synthetic | α-Helix | Low hemolytic | ||
| 34971943 | 2022 | FIHHIIGGLFSAGKAIHRLIRRRRR | Oreoch-2 | Free | Free | Linear | L | None | 25 | Antibacterial | ∼10 % Hemolysis at 32 µg/mL | Mouse | Synthetic | α-Helix | NA | ||
| 34971943 | 2022 | FIIGGLFSAGKAIHRLIRRRRR | ZN-5 | Free | Free | Linear | L | None | 22 | Antibacterial | 4.84 % Hemolysis at 64 µg/mL | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 34971943 | 2022 | FLFSAGKAIHRLIRRRRR | ZN-6 | Free | Free | Linear | L | None | 18 | Antibacterial | 2.02 % Hemolysis at 64 µg/mL | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 35216177 | 2022 | FVQWFSKFLGRIL | Temporin L | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼70 % Hemolysis at 100 µM | Human | Rana Temporaria (Red Frog) | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3 , DLeu9 ] TL | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial, Antibiofilm | ∼50 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVQWFSKFLGRIL | Temporin L | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼43 % Hemolysis at 50 µM | Human | Rana Temporaria (Red Frog) | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3 , DLeu9 ] TL | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial, Antibiofilm | ∼25 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3,DLeu9] TL (TL1) | Amidation | Free | Linear | Mix | l=D-Leu | 13 | Antibacterial, Antibiofilm | 60 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}PRIL{ct:Amid} | [Pro3,DLeu9,Pro10] TL (TL2) | Amidation | Free | Linear | Mix | l=D-Leu | 14 | Antibacterial, Antibiofilm | 60 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}P{d}RIL{ct:Amid} | [Pro3,DLeu9,DPro10] TL (TL3) | Amidation | Free | Linear | Mix | l=D-Leu, p = D-Pro | 14 | Antibacterial, Antibiofilm | 20 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}{nnr:O}RIL{ct:Amid} | [Pro3,DLeu9,Hyp10] TL (TL4) | Amidation | Free | Linear | Mix | l=D-Leu, O = Hyp = hydroxyproline | 14 | Antibacterial, Antibiofilm | 80 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}{nnr:o}RIL{ct:Amid} | [Pro3,DLeu9,DHyp10] TL (TL5) | Amidation | Free | Linear | Mix | l=D-Leu, o = D-Hyp = hydroxyproline | 14 | Antibacterial, Antibiofilm | 20 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}{nnr:N=Nle}RIL{ct:Amid} | [Pro3,DLeu9,Nle10] TL (TL6) | Amidation | Free | Linear | Mix | l=D-Leu, N = Nle | 14 | Antibacterial, Antibiofilm | 60 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}{nnr:n=D-Nle}RIL{ct:Amid} | [Pro3,DLeu9,DNle10] TL (TL7) | Amidation | Free | Linear | Mix | l=D-Leu, n = D-Nle | 14 | Antibacterial, Antibiofilm | 40 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}KRIL{ct:Amid} | [Pro3,DLeu9,Lys10] TL (TL8) | Amidation | Free | Linear | Mix | l=D-Leu | 14 | Antibacterial, Antibiofilm | 80 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | [Pro3,DLeu9,DLys10] TL (TL9) | Amidation | Free | Linear | Mix | l=D-Leu, k = D-Lys | 14 | Antibacterial, Antibiofilm | 40 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}WRIL{ct:Amid} | [Pro3,DLeu9,Trp10] TL (TL10) | Amidation | Free | Linear | Mix | l=D-Leu | 14 | Antibacterial, Antibiofilm | 60 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}W{d}RIL{ct:Amid} | [Pro3,DLeu9,DTrp10] TL (TL11) | Amidation | Free | Linear | Mix | l=D-Leu, w = D-Trp | 14 | Antibacterial, Antibiofilm | 80 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFl{nnr:Aic}RIL{ct:Amid} | [Pro3,DLeu9,Aic10] TL (TL12) | Amidation | Free | Linear | Mix | Aic = 2-aminoindane-2-carboxylic acid | 14 | Antibacterial, Antibiofilm | 100 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216297 | 2022 | WFGKLYRGITK | Pep-A | Free | Free | Linear | L | None | 11 | Antibacterial | ∼3 % Hemolysis at 50 µM | Rabbit | Synthetic | α-Helix | Non-hemolytic | ||
| 35216297 | 2022 | WRGITKVVKKV | Pep-B | Free | Free | Linear | L | None | 11 | Antibacterial | ∼7 % Hemolysis at 50 µM | Rabbit | Synthetic | α-Helix | Non-hemolytic | ||
| 35216297 | 2022 | WVVKKVKGLLK | Pep-C | Free | Free | Linear | L | None | 11 | Antibacterial | ∼2 % Hemolysis at 50 µM | Rabbit | Synthetic | α-Helix | Non-hemolytic | ||
| 35216297 | 2022 | WFGKLYRGITK{nt:myristic acid} | Myr-A | Free | myristic acid | Linear | L | None | 11 | Antibacterial | ∼5.5 % Hemolysis at 50 µM | Rabbit | Synthetic | α-Helix | Non-hemolytic | ||
| 35216297 | 2022 | WRGITKVVKKV{nt:myristic acid} | Myr-B | Free | myristic acid | Linear | L | None | 11 | Antibacterial | ∼2.5 % Hemolysis at 50 µM | Rabbit | Synthetic | α-Helix | Non-hemolytic | ||
| 35216297 | 2022 | WVVKKVKGLLK{nt:myristic acid} | Myr-C | Free | myristic acid | Linear | L | None | 11 | Antibacterial | 28.5 % Hemolysis at 50 µM | Rabbit | Synthetic | α-Helix | NA | ||
| 35203875 | 2022 | RRLFRRILRWL | L6 | Free | Free | Linear | L | None | 11 | Antibacterial | 50 % Hemolysis at 50 µM | Sheep | Synthetic | α-Helix | NA | ||
| 35203875 | 2022 | RR{nnr:S5}FRR{nnr:S5}LRWL | L6S1 | Free | Free | Macrocyclized | L | (R8) and (S5) indicate stapled using 8- and 5-atom linkers, respectively. | 11 | Antibacterial | ∼5 % Hemolysis at 50 µM | Sheep | Synthetic | NA | Non-hemolytic | ||
| 35203875 | 2022 | RRLFRR{nnr:S5}LRW{nnr:S5} | L6S2 | Free | Free | Macrocyclized | L | (S5) and (S5) indicate stapled using 5- and 5-atom linkers, respectively. | 11 | Antibacterial | ∼55 % Hemolysis at 50 µM | Sheep | Synthetic | NA | NA | ||
| 35203875 | 2022 | RRL{nnr:R8}RRILRW{nnr:S5} | L6S3 | Free | Free | Macrocyclized | L | (R8) and (S5) indicate stapled using 8- and 5-atom linkers, respectively. | 11 | Antibacterial | <5 % Hemolysis at 50 µM | Sheep | Synthetic | NA | Non-hemolytic | ||
| 35203875 | 2022 | KRIVQRIKKWLR | L8 | Free | Free | Linear | L | None | 12 | Antibacterial | ∼1 % Hemolysis at 50 µM | Sheep | Synthetic | α-Helix | Non-hemolytic | ||
| 35203875 | 2022 | KR{nnr:S5}VQR{nnr:S5}KKWLR | L8S1 | Free | Free | Linear | L | macrocyclized, (S5) and (S5) indicate stapled using 5- and 5-atom linkers, respectively | 12 | Antibacterial | 0 % Hemolysis at 50 µM | Sheep | Synthetic | NA | Non-hemolytic | ||
| 35203875 | 2022 | KRIVQR{nnr:S5}KKW{nnr:S5}R | L8S2 | Free | Free | Linear | L | macrocyclized, (S5) and (S5) indicate stapled using 5- and 5-atom linkers, respectively | 12 | Antibacterial | 0 % Hemolysis at 50 µM | Sheep | Synthetic | NA | Non-hemolytic | ||
| 35203875 | 2022 | KRI{nnr:R8}QRIKKW{nnr:S5}R | L8S3 | Free | Free | Macrocyclized | L | (R8) and (S5) indicate stapled using 8- and 5-atom linkers, respectively | 12 | Antibacterial | ∼20 % Hemolysis at 50 µM | Sheep | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | SPRVCIRVCRNGVCYRRCWG | Capitellacin | Free | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 128 µM | Human | Capitella Teleta | NA | Low hemolytic | ||
| 35323465 | 2022 | RSPRVCIRVCRNGVCYRRCWG | CT2 | Free | Free | Linear | L | None | 21 | Antibacterial | >5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | SPRVCIRVCRNGVCYRRCW | CT3 | Free | Free | Linear | L | None | 19 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | RVCIRVCRNGVCYRRCW | CT4 | Free | Free | Linear | L | None | 17 | Antibacterial | <5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | KWCI RVCRNGVCYRRCR | CT5 | Free | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | <2.5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | RVC FRVCRNGVCYRRCW | CT6 | Free | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | <2.5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | RVCIRVCYRGVCYRRCW | CT7 | Free | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 50 % Hemolysis at 128 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35323465 | 2022 | KWCFRVCYRGICYRRCR | Tachyplesin-1 | Free | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | <5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 96 ± 2.1 % Hemolysis at 5 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 80.5 ± 2.3 % Hemolysis at 2.5 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 74.2 ± 2.2 % Hemolysis at 1.25 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 59.5 ± 1.8 % Hemolysis at 0.625 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 25 ± 1.2 % Hemolysis at 0.312 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 6 ± 0.8 % Hemolysis at 0.156 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.078 µg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.039 µg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 35335979 | 2022 | FVDLKKIANILNSIF{ct:Amid} | Temporin-1CEh | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 50 % Hemolysis at 152.6 µM | Horse | Rana Chensinensis | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANILNSIF{ct:Amid} | Temporin-1CEh | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 92.3 % Hemolysis at 256 µM | Horse | Rana Chensinensis | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANIINSIF{ct:Amid} | Temporin-1CEa | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 50 % Hemolysis at 160 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANIL{ct:Amid} | T1CEh-t | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antibiofilm | <5 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANII{ct:Amid} | T1CEa-t | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antibiofilm | 0 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKFVDLKKIANIL{ct:Amid} | T1CEh-KK | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKFVPLKKIANIL{ct:Amid} | T1CEh-KKP | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼1 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKWVPLKKIANIL{ct:Amid} | T1CEh-KKPW | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <10 % Hemolysis at 256 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKWVPWKKIANIL{ct:Amid} | T1CEh-KKPWW | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 6 % Hemolysis at 256 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKWVPWKKKWVPWKKIANIL{ct:Amid} | T1CEh-KKPWW2 | Amidation | Free | Branched | L | None | 20 | Antibacterial, Antibiofilm | 63 % Hemolysis at 256 µM | Horse | Synthetic | α-Helix | NA | ||
| 35326879 | 2022 | RRRRWWWW{cyc:N-C} | [R4W4] | Free | Free | Cyclic | L | None | 8 | Antibacterial, Cytotoxic | 80 % Hemolysis at 500 µg/mL | Human | Synthetic | NA | NA | ||
| 35326879 | 2022 | RRRRWWWW | (R4W4) | Free | Free | Linear | L | None | 8 | Antibacterial, Cytotoxic | 38 % Hemolysis at 500 µg/mL | Human | Synthetic | NA | NA | ||
| 35326879 | 2022 | ({conj:Levo}-{conj:C10}-KRRRWWWW) | (Levo-C10-KR3W4) | Free | Free | Linear | L | Levo = Levofloxacin covalent conjugates, C10 = 10-hydroxy decanoic acid(linker) | 8 | Antibacterial, Cytotoxic | ∼9 % Hemolysis at 500 µg/mL | Human | Synthetic | NA | NA | ||
| 35326879 | 2022 | [{conj:Levo}-{conj:C10}-KRRRWWWW]{cyc:N-C} | [Levo-C10-KR3W4] | Free | Free | Cyclic | L | Levo = Levofloxacin covalent conjugates, C10 = 10-hydroxy decanoic acid(linker) | 8 | Antibacterial, Cytotoxic | ∼30 % Hemolysis at 500 µg/mL | Human | Synthetic | NA | NA | ||
| 35326879 | 2022 | {conj:Levo}+ (RRRRWWWW) | Levo + (R4W4) | Free | Free | Linear | L | Levo = Levofloxacin, physical mixture of Levofloxacin and peptides (500 µg/mL (1:1; w/w)) | 8 | Antibacterial, Cytotoxic | ∼10 % Hemolysis at 500 µg/mL | Human | Synthetic | NA | NA | ||
| 35326879 | 2022 | {conj:Levo}+ [RRRRWWWW]{cyc:N-C} | Levo + [R4W4] | Free | Free | Cyclic | L | Levo = Levofloxacin, physical mixture of Levofloxacin and peptides (500 µg/mL (1:1; w/w)) | 8 | Antibacterial, Cytotoxic | ∼22 % Hemolysis at 500 µg/mL | Human | Synthetic | NA | NA | ||
| 35290038 | 2022 | LKLLKKLLKKLLKLL{ct:Amid} | Amp1L | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | ∼55 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | NA | ||
| 35290038 | 2022 | L{nnr:k}LLKKLLKKLLKLL{ct:Amid} | Amp1EP2 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | ∼35 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLL{nnr:k}KLLKKLLKLL{ct:Amid} | Amp1EP5 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | <10 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLLK{nnr:k}LLKKLLKLL{ct:Amid} | Amp1EP6 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | <5 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLLKKLL{nnr:k}KLLKLL{ct:Amid} | Amp1EP9 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | <5 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35290038 | 2022 | LKLLKKLLK{nnr:k}LLKLL{ct:Amid} | Amp1EP10 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | <5 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35290038 | 2022 | LKLLKKLLKKLL{nnr:k}LL{ct:Amid} | Amp1EP13 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | < 10 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLLKKLLKKLLKLL{ct:Amid} | Amp1L | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | 100 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | NA | ||
| 35290038 | 2022 | L{nnr:k}LLKKLLKKLLKLL{ct:Amid} | Amp1EP2 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | 100 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLL{nnr:k}KLLKKLLKLL{ct:Amid} | Amp1EP5 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | ∼85 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLLK{nnr:k}LLKKLLKLL{ct:Amid} | Amp1EP6 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | ∼60 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35290038 | 2022 | LKLLKKLL{nnr:k}KLLKLL{ct:Amid} | Amp1EP9 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | >35 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35290038 | 2022 | LKLLKKLLK{nnr:k}LLKLL{ct:Amid} | Amp1EP10 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | <10 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35290038 | 2022 | LKLLKKLLKKLL{nnr:k}LL{ct:Amid} | Amp1EP13 | Amidation | Free | Linear | L | k = involved in isopeptide bond formation | 15 | Antibacterial | < 10 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 3.1 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 6.2 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 12.5 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 200 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | >85 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 50 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | >100 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼1 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <10 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <25 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <50 % Hemolysis at 200 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 12.5 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼10 % Hemolysis at 37.5 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 62.5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | >100 % Hemolysis at 200 µM | Human | Synthetic | α-Helix | NA | ||
| 35050481 | 2022 | TTLRLNTLAYKVAWLVNVKAFWAAGRALKKVGR | dendrocin-ZM1 | Free | Free | Linear | L | None | 34 | Antibacterial | >5 % Hemolysis at 16 μg/mL | Human | Zataria Multifora | α-Helix | Low hemolytic | ||
| 35050481 | 2022 | TTLRLNTLAYKVAWLVNVKAFWAAGRALKKVGR | dendrocin-ZM1 | Free | Free | Linear | L | None | 34 | Antibacterial | 17 % Hemolysis at 128 μg/mL | Human | Zataria Multifora | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLGKLF{ct:Amid} | SHa | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 50 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 2.812 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 2.812 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 2.812 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 1±0.62 % Hemolysis at 5.625 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 5.625 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 5.625 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 7±0.55 % Hemolysis at 11.25 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 11.25 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 1.8±0.9 % Hemolysis at 11.25 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 52.74 ± 5.94 % Hemolysis at 22.5 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 2.88 ± 1.24 % Hemolysis at 22.5 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 2 ± 0.94 % Hemolysis at 22.5 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 55.07 ± 5.23 % Hemolysis at 45 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 18.18 ± 7.65 % Hemolysis at 45 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 7.49 ± 1.20 % Hemolysis at 45 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 58.93 ± 6.02 % Hemolysis at 90 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 42.93 ± 4.75 % Hemolysis at 90 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 44.69 ± 3.73 % Hemolysis at 90 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 61.64 ± 13.83 % Hemolysis at 180 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 47.60 ± 7.88 % Hemolysis at 180 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 57.01 ± 8.50 % Hemolysis at 180 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 64.71 ± 11.34 % Hemolysis at 360 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 51.15 ± 10.41 % Hemolysis at 360 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 58.97 ± 5.51 % Hemolysis at 360 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35464194 | 2022 | VKRFKKFFRKLKKSV{ct:Amid} | B1 | Amidation | Free | Linear | L | None | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | VKRFKKFFRKLKKLV{ct:Amid} | B1-Leu | Amidation | Free | Linear | L | None | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | V{nnr:S5}RFK{nnr:S5}FFRKLKKLV{ct:Amid} | B1-L-1 | Amidation | Free | Linear | L | S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | VKRF{nnr:S5}KFF{nnr:S5}KLKKLV{ct:Amid} | B1-L-2 | Amidation | Free | Stapled | L | S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | VKRFK{nnr:S5}FFR{nnr:S5}LKKLV{ct:Amid} | B1-L-3 | Amidation | Free | Stapled | L | S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | VKRFKKFF{nnr:S5}KLK{nnr:S5}LV{ct:Amid} | B1-L-4 | Amidation | Free | Stapled | L | S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | V{nnr:R8}RFKKFF{nnr:S5}KLKKLV{ct:Amid} | B1-L-5 | Amidation | Free | Stapled | L | S5 = (S)-2-(4-pentenyl) alanine, stapled b/w R8 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | VKRF{nnr:R8}KFFRKL{nnr:S5}KLV{ct:Amid} | B1-L-6 | Amidation | Free | Stapled | L | R8 = (R)-2-(7-octenyl) alanine, S5 = (S)-2-(4-pentenyl) alanine, stapled b/w R8 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35464194 | 2022 | VKRFK{nnr:R8}FFRKLK{nnr:S5}LV{ct:Amid} | B1-L-7 | Amidation | Free | Stapled | L | R8 = (R)-2-(7-octenyl) alanine, S5 = (S)-2-(4-pentenyl) alanine, stapled b/w R8 and S5 | 15 | Antibacterial, Cytotoxic | 50 % Hemolysis at > 80 µM | Rabbit | Bungarus Fasciatus | NA | Low hemolytic | ||
| 35563004 | 2022 | LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV | CgR2150 | Free | Free | Linear | L | None | 115 | Antibacterial | ∼0 % Hemolysis at 10 µg/mL | Porcine | Bacillus Subtilis | α-Helix Random coil | Low hemolytic | ||
| 35563004 | 2022 | LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV | CgR2150 | Free | Free | Linear | L | None | 115 | Antibacterial | ∼0 % Hemolysis at 20 µg/mL | Porcine | Bacillus Subtilis | α-Helix Random coil | Low hemolytic | ||
| 35563004 | 2022 | LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV | CgR2150 | Free | Free | Linear | L | None | 115 | Antibacterial | ∼0 % Hemolysis at 30 µg/mL | Porcine | Bacillus Subtilis | α-Helix Random coil | Low hemolytic | ||
| 35563004 | 2022 | LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV | CgR2150 | Free | Free | Linear | L | None | 115 | Antibacterial | ∼0 % Hemolysis at 40 µg/mL | Porcine | Bacillus Subtilis | α-Helix Random coil | Low hemolytic | ||
| 35563004 | 2022 | LAVHHLHSIRGRHHSCTIAQTQANHRHNSYQPNNSSCLAKETDLPTTRSTPATTSSTAPARKSPPASPAPTRQRLCPSPPRGPVSSRHPRRRGQARGRTRAAGVRRTKGYGGKCV | CgR2150 | Free | Free | Linear | L | None | 115 | Antibacterial | 0.32 % Hemolysis at 50 µg/mL | Porcine | Bacillus Subtilis | α-Helix Random coil | Low hemolytic | ||
| 35563004 | 2022 | LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR | CgR3101 | Free | Free | Linear | L | None | 46 | Antibacterial | ∼0 % Hemolysis at 10 µg/mL | Porcine | Bacillus Subtilis | Random coil | Low hemolytic | ||
| 35563004 | 2022 | LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR | CgR3101 | Free | Free | Linear | L | None | 46 | Antibacterial | ∼0 % Hemolysis at 20 µg/mL | Porcine | Bacillus Subtilis | Random coil | Low hemolytic | ||
| 35563004 | 2022 | LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR | CgR3101 | Free | Free | Linear | L | None | 46 | Antibacterial | ∼0 % Hemolysis at 30 µg/mL | Porcine | Bacillus Subtilis | Random coil | Low hemolytic | ||
| 35563004 | 2022 | LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR | CgR3101 | Free | Free | Linear | L | None | 46 | Antibacterial | ∼0 % Hemolysis at 40 µg/mL | Porcine | Bacillus Subtilis | Random coil | Low hemolytic | ||
| 35563004 | 2022 | LAVPNFEPPTRTTCPAPTSPGNPCGPPPPASQTRRPPFHPTSPLRR | CgR3101 | Free | Free | Linear | L | None | 46 | Antibacterial | 0.46 % Hemolysis at 50 µg/mL | Porcine | Bacillus Subtilis | Random coil | Low hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 1 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | <5 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | ∼1 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | <5 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Hairpin | Low hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | <1 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | <1 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35616397 | 2022 | GAIPKCCVGTSRNIPLSILMRVERYDVOHNHGACEIDAWLHANGRKYCADPRVKKVLGVAMQIRKAQLMREKLNSIMRR | omCK11 | Free | Free | Linear | L | None | 79 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Oncorhynchus Mykiss | α-Helix | NA | ||
| 35616397 | 2022 | AHPKVKRKLKRMQRKKDGKQKRH | omCCL28-like-23 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | ATPKMEQFLQKLMKRMARLKASAV | drCCL27b-24 | Free | Free | Linear | L | None | 24 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | AHPKWMEVRSRQRKKKHNKRRATY | IcCCL28-25 | Free | Free | Linear | L | None | 24 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | APLKMKAILEIVHRRMKQNKMKAAF | smCCL27b-25 | Free | Free | Linear | L | None | 25 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | VDQTVFKDIWWRMKQWKQRVKKRAAKYNV | trCCL28-29 | Free | Free | Linear | L | None | 29 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | AHPRIKKHLDLLMKKKRHLAMKIAAP | chCCL27a-26 | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35377553 | 2022 | FFGSVLKLIPKIL | temporin-PTa | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 13 % Hemolysis at 87 µM | Mus musculus | Hylarana Picturata | α-Helix | NA | ||
| 35377553 | 2022 | AAGKVLKLLKKLL | Hp-MAP1 | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | Hemolytic | Mus musculus | Synthetic; Temporin-Pta | α-Helix | NA | ||
| 35377553 | 2022 | AAKKVLKLLKKLL | Hp-MAP2 | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | Hemolytic | Mus musculus | Synthetic; Temporin-Pta | α-Helix | NA | ||
| 35526666 | 2022 | FFSLIPSLVGGLISAFK{ct:Amid} | Stig (stigmurin) | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 0 % Hemolysis at 150–1.17 µM | Human | Tityus Stigmurus | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPKLVGKLISAFK{ct:Amid} | StigA8 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 11.5 % Hemolysis at 9.17 µM | Human | Synthetic; Analog Of Stigmurin | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPKLVGKLIKAFK{ct:Amid} | StigA18 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 14 % Hemolysis at 9.17 µM | Human | Synthetic; Analog Of Stigmurin | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPKLVGKLISAFK{ct:Amid} | StigA8 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 15 % Hemolysis at 150 µM | Human | Synthetic; Analog Of Stigmurin | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPKLVGKLIKAFK{ct:Amid} | StigA18 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 22 % Hemolysis at 150 µM | Human | Synthetic; Analog Of Stigmurin | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPSLVKKLIKAFK{ct:Amid} | StigA25 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 100 % Hemolysis at 150 µM | Human | Synthetic; Analog Of Stigmurin | NA | NA | ||
| 35526666 | 2022 | FFKLIPKLVKKLIKAFK{ct:Amid} | StigA31 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 80 % Hemolysis at 150 µM | Human | Synthetic; Analog Of Stigmurin | NA | NA | ||
| 35526666 | 2022 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 5 % Hemolysis at 160 µM | Human | T. Serrulatus Scorpion | NA | NA | ||
| 35526666 | 2022 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 86 % Hemolysis at 40 µM | Human | T. Serrulatus Scorpion | NA | NA | ||
| 35891269 | 2022 | KLFGKVGNLLQKGWQKIKNIGRRIKDFFRNIRPMQEA{ct:Amid} | To-KL37 | Amidation | Free | Linear | L | None | 37 | Antibacterial, Antifungal | 16 % Hemolysis at 50 µM | Human | Cathelicidin-Derived | NA | Low hemolytic | ||
| 35887160 | 2022 | AGDKKIKIGINGFGRIGRL | NP-6 | Free | Free | Linear | L | None | 19 | Antibacterial | 2.39 ± 0.13 % Hemolysis at 512 µg/mL | Mouse | Synthetic | NA | Non-hemolytic | ||
| 35966656 | 2022 | KWKLFKKIHKVGQNIRKGIIKAGPAVAVVGQAAQIAK | PEW300 | Free | Free | Linear | L | None | 37 | Antibacterial, Antibiofilm | 0 % Hemolysis at 50 to 250 μg/ml | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 35978681 | 2022 | KWKLFKKIGAVLKVL{ct:Amid} | CAM (CA(1–7)M(2–9)) | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 690 μg/mL | Sheep | Synthetic | NA | NA | ||
| 35978681 | 2022 | RWKLFKKIGAVLKVL{ct:Amid} | R1-CAM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 450 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | KWRLFKKIGAVLKVL{ct:Amid} | R3-CAM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 750 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | KWKLFRKIGAVLKVL{ct:Amid} | R6-CAM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 935 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | KWKLFKRIGAVLKVL{ct:Amid} | R7-CAM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at >1000 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | KWKLFKKIGAVLRVL{ct:Amid} | R13-CAM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 280 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | RWRLFRRIGAVLRVL{ct:Amid} | R-CAM | Amidation | Free | Linear | L | No subscript indicates that all Lys residues were replaced by either Arg or Orn | 15 | Antibacterial | 50 % Hemolysis at 230 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | {nnr:O}W{nnr:O}LF{nnr:O}{nnr:O}IGAVL{nnr:O}VL{ct:Amid} | O-CAM | Amidation | Free | Linear | L | O = L-Ornithine, No subscript indicates that all Lys residues were replaced by either Arg or Orn | 15 | Antibacterial | 50 % Hemolysis at >1000 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 35978681 | 2022 | CKWKLFKKIGAVLKVL{cyc:N-C}{ct:Amid} | Cyc-CAM | Amidation | Free | Cyclic | L | None | 16 | Antibacterial | 50 % Hemolysis at >1000 μg/mL | Sheep | Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9) | NA | NA | ||
| 36145681 | 2022 | GFLFKLIPKAIKKLISKFK | GK-19 | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal | <5 % Hemolysis at 100 μM | Rat | Synthetic | NA | Low hemolytic | ||
| 36145681 | 2022 | GFLFKLIPKAIKKLISKFK | GK-19 | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 15 % Hemolysis at 200 μM | Rat | Synthetic | NA | Low hemolytic | ||
| 36145681 | 2022 | GFLFKLIPKAIKKLISKFK | GK-19 | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 40 % Hemolysis at 400 μM | Rat | Synthetic | NA | Low hemolytic | ||
| 25561178 | 2015 | {nnr:x}ISQ{d}I{d}IST{d}A{nnr:X}I | Teixobactin | Free | Free | Linear | Mix | x = NmPhe(N-methylated phenylalanine), X = End (Enduracididine) | 11 | Anticancer, Antibacterial | No Hemolysis | Human | Eleftheria Terrae | NA | Non-hemolytic | ||
| 25329706 | 2014 | RFPGLMMKLLV | LBP/BPI (324334), ofLBP1N | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 45 % Hemolysis at 100μg/mL | Human | Synthetic Construct | NA | NA | ||
| 25329706 | 2014 | RFPKLMMKLLV | LBP/BPI (324334)[G4K], ofLBP2A | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 30 % Hemolysis at 100μg/mL | Human | Synthetic Construct | NA | NA | ||
| 25329706 | 2014 | KLVKTQLKVLK | LBP/BPI (450460), ofLBP4N | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 0 % Hemolysis at 100μg/mL | Human | Synthetic Construct | NA | Non-hemolytic | ||
| 25329706 | 2014 | KLVKTWLKVLK | LBP/BPI (450460)[Q6W], ofLBP5A | Free | Free | Linear | L | None | 11 | Antibacterial, Antifungal | 0 % Hemolysis at 100μg/mL | Human | Synthetic Construct | NA | Non-hemolytic | ||
| 25329706 | 2014 | MKLVKTWLKVLK | LBP/BPI (449460)[Q7W], ofLBP6A | Free | Free | Linear | L | None | 12 | Antibacterial, Antifungal | 28 % Hemolysis at 100μg/mL | Human | Synthetic Construct | NA | NA | ||
| 25485686 | 2015 | TR{d}SG{nnr:x}LR{d}EQ{d}W{d}IT | Lysocin E | Free | Free | Linear | Mix | x = D-N-Methylphenylalanine | 12 | Antibacterial, Antifungal | <1 % Hemolysis at 100μg/mL | Sheep | Lysobacter | NA | Non-hemolytic | ||
| 25485686 | 2015 | TR{d}SG{nnr:x}LR{d}EQ{d}W{d}IT | Lysocin E | Free | Free | Linear | Mix | x = D-N-Methylphenylalanine | 12 | Antibacterial, Antifungal | <1 % Hemolysis at 100μg/mL | Horse | Lysobacter | NA | Non-hemolytic | ||
| 21884742 | 2011 | IKWKAILDAVKKVI{ct:Amid} | Mastoparan-A | Amidation | Free | Linear | L | None | 14 | Antibacterial | 4 % Hemolysis at 32μg/mL | Sheep | Vespa Analis | 40%TFE= α-Helix | NA | ||
| 21884742 | 2011 | INLKAIAALAKKLL{ct:Amid} | Mastoparan M | Amidation | Free | Linear | L | None | 14 | Antibacterial | 7 % Hemolysis at 64μg/mL | Sheep | Vespa Mandarinia | 40%TFE= α-Helix | NA | ||
| 21884742 | 2011 | INLKAIAALAKKLF{ct:Amid} | Mastoparan-AF | Amidation | Free | Linear | L | None | 14 | Antibacterial | 2.5 % Hemolysis at 32μg/mL | Sheep | Vespa Affinis | 40%TFE= α-Helix | NA | ||
| 28002968 | 2016 | WGEAFSAGVHRLANGGNG{ct:Amid} | Leucocin A (18-35)/ WG18 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >71.15μM | Human | Synthetic Construct | TFE = α-Helix | NA | ||
| 28002968 | 2016 | WGRAFSAGVHRLANGGNG{ct:Amid} | WR1 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >70.09μM | Human | Synthetic Construct | TFE = Random coil | NA | ||
| 28002968 | 2016 | WGRAFSAGVHRLARGGRG{ct:Amid} | WR3 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >67.01μM | Human | Synthetic Construct | TFE = α-Helix | NA | ||
| 28002968 | 2016 | WGRAFSRGVRRLARGGRG{ct:Amid} | WR5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >63.54μM | Human | Synthetic Construct | TFE = Random coil | NA | ||
| 28002968 | 2016 | WGRAFRRGVRRLARGGRR{ct:Amid} | WR7 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >58.64μM | Human | Synthetic Construct | TFE = Random coil | NA | ||
| 28002968 | 2016 | WGRAFRRLVRRLARGLRR{ct:Amid} | WRL2 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >55.78μM | Human | Synthetic Construct | TFE = α-Helix | NA | ||
| 28002968 | 2016 | WLRAFRRLVRRLARGLRR{ct:Amid} | WRL3 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at 27.22μM | Human | Synthetic Construct | TFE = α-Helix | NA | ||
| 28002968 | 2016 | WLRAFRRLVRRLARLLRR{ct:Amid} | WRL4 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at 53.18μM | Human | Synthetic Construct | TFE = α-Helix | NA | ||
| 11600395 | 2001 | KNIRRIIRKIIHIIKKYG | OV-5 | Free | Free | Linear | L | None | 18 | Antibacterial | 76 % Hemolysis at 100μM | Human | Synthetic Construct | NA | NA | ||
| 28741926 | 2017 | {nnr:Z}CRRLCYKQRCVTYCRGR{ct:Amid} | Gomesin | Amidation | Free | Linear | L | Z = pyroglutamic acid | 18 | Antibacterial, Antifungal | 47.2±6 % Hemolysis at 64μM | Human | Acanthoscurria Gomesiana [Tarantula Spider] | NA | NA | ||
| 24269514 | 2014 | GLLKKWLKKWKEFKRIVGY{ct:Amid} | peptide2 | Amidation | Free | Linear | L | None | 19 | Antibacterial | 20 % Hemolysis at 160μg/mL | Human | Synthetic Construct | α-Helix | NA | ||
| 28433718 | 2017 | FFFHIVKGLFHAGRMIHGLV | Piscidin-2 (1-20), ecPis-2 (1-20) | Free | Free | Linear | L | None | 20 | Antibacterial, Antiparasitic, Antifungal | 5.12±0.37 % Hemolysis at 2.5μM | Rabbit | Synthetic Construct | α-Helix | NA | ||
| 15019209 | 2003 | GIFSKLAGKKLKNLLISGL{ct:Amid} | Esculentin-1B (1-18) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 7 % Hemolysis at 15μM | Human | Synthetic Construct | NA | NA | ||
| 32828795 | 2020 | WPKWWKWKRRWGRKKAKKRRG | Peptide 1 | Free | Free | Linear | L | None | 21 | Antibacterial | 3.4 % Hemolysis at 100μM | Human | Synthetic Construct | NA | Low hemolytic | ||
| 19113844 | 2009 | GLWSKIKEVGKEAAKAAAKAAGK | Dermaseptin B2 (1-23) | Free | Free | Linear | L | None | 23 | Antibacterial | 0 % Hemolysis at 50μM | Rat | Synthetic Construct | NA | Non-hemolytic | ||
| 28433718 | 2017 | IFGLLLHGAIHVGKLIHGLVRRH | Piscidin-3 (1-23), ecPis-3 (1-23) | Free | Free | Linear | L | None | 23 | Antibacterial, Antiparasitic, Antifungal | 0.22±0.06 % Hemolysis at 1.25μM | Rabbit | Synthetic Construct | α-Helix | NA | ||
| 24495783 | 2014 | TQQAFQKFLAAVTSALGKQYH{ct:Amid} | SHbetaAP-NH2 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 100μg/mL | Human | C-Terminus Of Katsuwonus Pelamis Hemoglobin Beta Synthetic Construct | α-Helix Random coil | Non-hemolytic | ||
| 24495783 | 2014 | TQQAFQKFLAAVTSALGKQYH{ct:OH} | SHbetaAP-OH | OH | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 100μg/mL | Human | Synthetic Construct | α-Helix Random coil | Non-hemolytic | ||
| 24412436 | 2014 | VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND | SJGAP (Skipjack tuna GAPDH-related AMP) | Free | Free | Linear | L | None | 32 | Antibacterial, Antifungal | 0 % Hemolysis at <100μg/mL | Human | Fish Skipjack Tuna Katsuwonus Pelamis | one Alphα-Helix Strand, two parallel Betα-Strands, and 2 Loop regions | Non-hemolytic | ||
| 33179211 | 2021 | QGWEAVAAAVASKIVGLWRNETTELLGHECKFTVKPYIKRFQLNYKGGRLWC | Cf-ALF2 | Free | Free | Linear | L | None | 52 | Antibacterial | 0 % Hemolysis at 20μM | Human | Charybdis Feriatus [Crucifix Crab] | NA | Non-hemolytic | ||
| 28433718 | 2017 | FFFHIVKGLFHAGRMIHGLVNRRRHRHGMEELDLDQRAFEREKAFA | Piscidin-2, ecPis-2 | Free | Free | Linear | L | None | 46 | Antibacterial, Antiparasitic, Antifungal | 4.03±0.31 % Hemolysis at 2.5μM | Rabbit | Epinephelus Coioides | α-Helix | NA | ||
| 28433718 | 2017 | IFGLLLHGAIHVGKLIHGLVRRHGEEQLDDLEQLDKRALDYNPGRPGFD | Piscidin-3, ecPis-3 | Free | Free | Linear | L | None | 49 | Antibacterial, Antiparasitic, Antifungal | 9.30±3.40 % Hemolysis at 20μM | Rabbit | Epinephelus Coioides | α-Helix | NA | ||
| 28433718 | 2017 | FFRHIKSFWKGAKAIFRGARQGWREHRALSKQRKMDQGGGGNEVDNGTPPYWQK | Piscidin-4, ecPis-4 | Free | Free | Linear | L | None | 54 | Antibacterial, Antiparasitic, Antifungal | 9.29±1.06 % Hemolysis at 1.25μM | Rabbit | Epinephelus Coioides | α-Helix | NA | ||
| 23711469 | 2013 | AATAKKGAKKADAPAKPKKATKPKSPKKAAKKAGAKKGVKRAGKKGAKKTTKAKK | Molluscidin-1, cgMolluscidin | Free | Free | Linear | L | None | 55 | Antibacterial, Antifungal | 0 % Hemolysis at 100μg/mL | Human | Pacific Oyster Crassostrea Gigas | α-Helix and Random coil | Non-hemolytic | ||
| 8223491 | 1993 | IIGPVLGMVGSALGGLLKKI{ct:Amid} | Peptide B Bombinin H1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, hemolytic | Hemolysis at 17μM | Human | Yellow-Bellied Toad, Bombina Variegata L, Europe | NA | NA | ||
| 8223491 | 1993 | I{nnr:l}GPVLGLVGSALGGLLKKI | Bombinin H4 | Free | Free | Linear | Mix | l = D-aILe(D-alloisoleucine) | 20 | Antibacterial, hemolytic, Antifungal, candidacidal, Antiparasitic | Hemolysis at 14.6μM | Human | Yellow-Bellied Toad, Bombina Variegata L, Europe | Helix | NA | ||
| 11835991 | 2002 | GIGTKILGGVKTALKGALKELASTYAN{ct:Amid} | Maximin 1 | Amidation | Free | Linear | L | None | 27 | Antibacterial, Antiviral, Antifungal, candidacidal, Spermicidal, Anti-HIV, Hemolytic, Anticancer | Low Hemolysis at 50μg/mL | Rabbit | Chinese Red Belly Toad, Bombina Maxima | Helix | Low hemolytic | ||
| 8163497 | 1994 | GIFSKLAGKKLKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC | Esculentin-1B | Free | Free | Linear | L | None | 46 | Antibacterial, Anti-diabetes, Hemolytic | Hemolytic | Human | Edible Frog, Rana Esculenta , Europe | Helix | NA | ||
| 10931184 | 2000 | GILDTIKSIASKVWNSKTVQDLKRKGINWVANKLGVSPQAA | Hadrurin | Free | Free | Linear | L | None | 41 | Antibacterial, hemolytic | 80 % Hemolysis at 20μM | Human | Venom, Hadrurus Aztecus, Mexico, North America | NA | NA | ||
| 10931184 | 2000 | GILDTIKSIASKVWNSKTVQDLKRKGINWVANKLGVSPQAA | Hadrurin | Free | Free | Linear | L | None | 41 | Antibacterial, hemolytic | 50 % Hemolysis at <10μM | Human | Venom, Hadrurus Aztecus, Mexico, North America | NA | NA | ||
| 10931184 | 2000 | G{d}I{d}L{d}D{d}T{d}I{d}K{d}S{d}I{d}A{d}S{d}K{d}V{d}W{d}N{d}S{d}K{d}T{d}V{d}Q{d}D{d}L{d}K{d}R{d}K{d}G{d}I{d}N{d}W{d}V{d}A{d}N{d}K{d}L{d}G{d}V{d}S{d}P{d}Q{d}A{d}A{d} | D-isomer Hadrurin | Free | Free | Linear | D | None | 41 | Antibacterial, hemolytic | 100 % Hemolysis at 5μM | Human | Venom, Hadrurus Aztecus, Mexico, North America | NA | NA | ||
| 9257708 | 1997 | GWLRKAAKSVGKFYYKHKYYIKAAWQIGKHAL | Styelin D | Free | Free | Linear | L | None | 32 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolysis at <10μg/mL | Human | Sea Squirt, Styela Clava | Helix | NA | ||
| 9257708 | 1997 | GWLRKAAKSVGKFYYKHKYYIKAAWQIGKHAL | Styelin D | Free | Free | Linear | L | None | 32 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolysis at 40μg/mL | Sheep | Sea Squirt, Styela Clava | Helix | NA | ||
| 8353519 | 1993 | SIGSAFKKALPVAKKIGKAALPIAKAALP | Ceratotoxin B | Free | Free | Linear | L | None | 29 | Antibacterial Gram-, Hemolytic | Hemolytic | Human | Female Reproductive Accessory Glands, Medfly, Ceratitis Capitata | Helix | NA | ||
| 15648972 | 2004 | GVVDILKGAGKDLLAHLVGKISEKV{ct:Amid} | Ocellatin-1 | Amidation | Free | Linear | L | None | 25 | Antibacterial Gram-, Hemolytic | Hemolytic | Human | Frog Skin South American Leptodactylus Ocellatus | NA | NA | ||
| 15648972 | 2004 | GVLDIFKDAAKQILAHAAEKQI{ct:Amid} | Ocellatin-2 | Amidation | Free | Linear | L | None | 22 | Antibacterial Gram-, Hemolytic | Hemolytic | Human | Frog Skin South American Leptodactylus Ocellatus | NA | NA | ||
| 15648972 | 2004 | GVLDILKNAAKNILAHAAEQI{ct:Amid} | Ocellatin-3 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Hemolytic | Hemolytic | Human | South American Frog Leptodactylus Ocellatus | NA | NA | ||
| 17698251 | 2004 | VWPLGLVICKALKIC | Dybowskin-4 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal, candidacidal, Hemolytic | 47.58 % Hemolysis | Human | Frog Rana Dybowskii , Asia | NA | NA | ||
| 17698251 | 2004 | FLPLLLAGLPLKLCFLFKKC | Dybowskin-6 | Free | Free | Linear | L | None | 20 | Antibacterial Gram+, Antifungal, candidacidal, Hemolytic | 59.39 % Hemolysis | Human | Frog Rana Dybowskii , Asia | NA | NA | ||
| 14978112 | 2004 | RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | human RK-31 | Free | Free | Linear | L | None | 31 | Antibacterial, Antifungal, candidacidal, Hemolytic | 6 % Hemolysis at 100µM | Human | Human Protease Truncation; Human Sweat, Homo Sapiens | NA | Low hemolytic | ||
| 9022710 | 1993 | I{nnr:l}GPVLGMVGSALGGLLKKI | Bombinin H3 | Free | Free | Linear | Mix | l = D-alloisoleucine | 20 | Antibacterial, Hemolytic | Hemolytic at 15.7µM | Human | Toad, Bombina Variegata, Europe | NA | NA | ||
| 10477123 | 1999 | ALWKTMLKKLGTMALHAGKAAFGAAADTISQ | Dermaseptin-DI3 (DD M) | Free | Free | Linear | L | None | 31 | Antibacterial, Hemolytic | Hemolytic at >33µM | Human | Brazilian Frog, Phyllomedusa Distincta, South America | NA | NA | ||
| 10477123 | 1999 | ALWKTLLKNVGKAAGKAALNAVTDMVNQ | Dermaseptin-DI2 (Dermaseptin DI2, DRS-DI2, DD L) | Free | Free | Linear | L | None | 28 | Antibacterial, Antiparasitic, Hemolytic | Hemolytic at 12.5µM | Human | Brazilian Frog, Phyllomedusa Distincta, South America | NA | NA | ||
| 17272268 | 2007 | GFMDTAKNVAKNVAVTLIDNLKCKITKAC | Odorranain-F1 | Free | Free | Linear | L | None | 29 | Antibacterial, Antifungal, candidacidal, Hemolytic | 15.4 % Hemolytic at 50µg/ml | Rabbit | Frog Skin, Odorrana Grahami, China, Asia | Helix | NA | ||
| 17272268 | 2007 | GIFGKILGVGKKVLCGLSGWC | Odorranain-H1 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal, candidacidal, Hemolytic | 21.6 % Hemolytic at 50µg/ml | Rabbit | Frog Skin, Odorrana Grahami, China, Asia | Helix | NA | ||
| 17272268 | 2007 | VIPFVASVAAEMMQHVYCAASKKC | Odorranain-P1a (OdP1a) | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 11.2 % Hemolytic at 50µg/ml | Rabbit | Frog Skin, Odorrana Grahami, China, Asia | NA | NA | ||
| 17272268 | 2007 | GLFGKSSVVGRKYYVDLAGCAKA | Odorranain-W1 | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal, candidacidal, Hemolytic | 17.6 % Hemolytic at 50µg/ml | Rabbit | Frog Skin, Odorrana Grahami, China, Asia | NA | NA | ||
| 17272268 | 2007 | GLLSGVLGVGKKVDCGLSGLC | Nigrocin-OG21 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal, candidacidal, Hemolytic | 100 % Hemolytic at 50µg/ml | Rabbit | Frog Skin, Odorrana Grahami, China, Asia | NA | NA | ||
| 19022312 | 2009 | FFGTALKIAANVLPTAICKILKKC | Brevinin-1LTa | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 1.5µg/ml | Rabbit | Chinese Broad-Folded Frog, Hylarana Latouchii (Anura:Ranidae), China, Asia | NA | NA | ||
| 19022312 | 2009 | FFPLVLGALGSILPKIF{ct:Amid} | Temporin-LTa | Amidation | Free | Linear | L | None | 17 | Antibacterial Gram+, Hemolytic | 50 % Hemolytic at 9µg/ml | Rabbit | Chinese Broad-Folded Frog, Hylarana Latouchii (Anura:Ranidae), China, Asia | NA | NA | ||
| 19254736 | 2009 | FLPAIVGAAAKFLPKIFCAISKKC | Brevinin-1BLa | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic, Anticancer | 50 % Hemolytic at 14µM | Human | Leopard Frog, Lithobates Yavapaiensis, North America | NA | NA | ||
| 19254736 | 2009 | FLPIIAGVAAKVLPKIFCAISKKC | Brevinin-1BLb | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, Hemolytic, Anticancer | Hemolytic | Human | Leopard Frog, Lithobates Yavapaiensis, North America | NA | NA | ||
| 19254736 | 2009 | FLPIIAGIAAKFLPKIFCTISKKC | Brevinin-1BLc | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic, Anticancer | 50 % Hemolytic at 9µM | Human | Leopard Frog, Lithobates Yavapaiensis, North America | NA | NA | ||
| 19254736 | 2009 | FLPVIAGVAANFLPKLFCAISKKC | Brevinin-1Ya | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic, Anticancer | 50 % Hemolytic at 18µM | Human | Leopard Frog, Lithobates Yavapaiensis, North America | NA | NA | ||
| 19254736 | 2009 | FLPIIAGAAAKVVEKIFCAISKKC | Brevinin-1Yc | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic, Anticancer | 50 % Hemolytic at 13µM | Human | Leopard Frog, Lithobates Yavapaiensis, North America | NA | NA | ||
| 15556063 | 2004 | FFPIIAGMAAKLIPSLFCKITKKC | Brevinin-1SPa | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 7µM | Human | Frog Rana Septentrionalis , North America | NA | NA | ||
| 15556063 | 2004 | FLPIIAGMAAKVICAITKKC | Brevinin-1SPb | Free | Free | Linear | L | None | 20 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 25µM | Human | Frog Rana Septentrionalis , North America | NA | NA | ||
| 15556063 | 2004 | FFPIIAGMAAKVICAITKKC | Brevinin-1SPd | Free | Free | Linear | L | None | 20 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 8µM | Human | Frog Rana Septentrionalis , North America | NA | NA | ||
| 20451254 | 2010 | FLSLIPHIVSGVASIAKHF{ct:Amid} | Phylloseptin-1 (PSN-1) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Antiparasitic, Hemolytic, Antibiofilm | 6.7 % Hemolytic at 5µM | Horse | The Waxy Monkey Frog, Phyllomedusa Sauvagei, South America | Helix | NA | ||
| 21295070 | 2011 | GIFSALAAGVKLLGNTLFKMAGKAGAEHLACKATNQC | Esculentin-2PRb | Free | Free | Linear | L | None | 37 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 35µM | Human | Frog North America, The Oregon Spotted Rana Pretiosa | NA | NA | ||
| 21295070 | 2011 | FLPVLTGLTPSIVPKLVCLLTKKC | Brevinin-1PRa | Free | Free | Linear | L | None | 24 | Antibacterial Gram+, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 7µM | Human | Frog North America, The Oregon Spotted Rana Pretiosa | NA | NA | ||
| 21295070 | 2011 | FLPIITNLLGKLL{ct:Amid} | Temporin-PRb | Amidation | Free | Linear | L | None | 13 | Antibacterial Gram+, Hemolytic | 50 % Hemolytic at 35µM | Human | Frog North America, The Oregon Spotted Rana Pretiosa | NA | NA | ||
| 21338048 | 2011 | ILGPVLGLVGNALGGLIKKL{ct:Amid} | Maximin H39 | Amidation | Free | Linear | L | None | 20 | Antibacterial Gram+, Hemolytic | 50 % Hemolytic at 100µg/ml | Human | Toad Brain, Bombina Maxima, China, Asia | NA | NA | ||
| 21596752 | 2011 | GIPCGESCVFIPCITGAIGCSCKSKVCYRN{cyc:N-C} | Cliotide T1 | Free | Free | Cyclic | L | None | 30 | Antibacterial, Hemolytic, Anticancer | 50 % Hemolytic at 7.1µM | Human | Plant Clitoria Ternatea | NA | NA | ||
| 21596752 | 2011 | GIPCGESCVFIPCITAAIGCSCKSKVCYRN{cyc:N-C} | Cliotide T4 | Free | Free | Cyclic | L | None | 30 | Antibacterial, Hemolytic, Anticancer | 50 % Hemolytic at 8.4µM | Human | Plant Clitoria Ternatea | NA | NA | ||
| 21303203 | 2011 | GLWDSIKNFGKTIALNVMDKIKCKIGGGCPP | Palustrin-2CE | Free | Free | Linear | L | None | 31 | Antibacterial, hemolytic | 50 % Hemolytic at 64µM | Human | The Chinese Brown Frog, Rana Chensinensis, China, Asia | NA | NA | ||
| 19778602 | 2010 | FLPLVLGALSGILPKIL{ct:Amid} | Temporin-RN1 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 6.69±1.51 % Hemolytic at 100µg/ml | Rabbit | Frog Skin Secretions, Rana Nigrovittata , China, Asia | NA | NA | ||
| 19778602 | 2010 | FFPLLFGALSSHLPKLF{ct:Amid} | Temporin-RN3 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | Hemolytic | Rabbit | Frog Skin Secretions, Rana Nigrovittata , China, Asia | NA | NA | ||
| 22306820 | 2012 | FALGAVTKLLPSLLCMITRKC | Hainanenin 1 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal, hemolytic, candidacidal | 20.72 % Hemolytic at 25µg/ml | Human | Skin Secretions, Hainan Cascade-Frog, Amolops Hainanensis; China, Asia | NA | NA | ||
| 22306820 | 2012 | FALGAVTKLLPSLLCMITRKC | Hainanenin 1 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal, hemolytic, candidacidal | 42.34 % Hemolytic at 50µg/ml | Human | Skin Secretions, Hainan Cascade-Frog, Amolops Hainanensis; China, Asia | NA | NA | ||
| 22306820 | 2012 | FALGAVTKRLPSLFCLITRKC | Hainanenin 5 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal, hemolytic, candidacidal | 23.31 % Hemolytic at 25µg/ml | Human | Skin Secretions, Hainan Cascade-Frog, Amolops Hainanensis; China, Asia | NA | NA | ||
| 22306820 | 2012 | FALGAVTKRLPSLFCLITRKC | Hainanenin 5 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal, hemolytic, candidacidal | 49.14 % Hemolytic at 50µg/ml | Human | Skin Secretions, Hainan Cascade-Frog, Amolops Hainanensis; China, Asia | NA | NA | ||
| 22467870 | 2012 | IPCGESCVWIPCITAIAGCSCKNKVCYT | ChaC7 (chassatide C7) | Free | Free | Linear | L | None | 28 | Antibacterial, Hemolytic, Anticancer | 50 % Hemolytic at 11.6µM | Human | Plant Chassalia Chartacea (Or Chassalia Curviflora) | Bridge | NA | ||
| 22467870 | 2012 | AIPCGESCVWIPCISTVIGCSCSNKVCYR | ChaC8 (chassatide C8) | Free | Free | Linear | L | None | 29 | Antibacterial, Hemolytic, Anticancer | 50 % Hemolytic at 25.5µM | Human | Plant Chassalia Chartacea (Or Chassalia Curviflora) | Bridge | NA | ||
| 22467870 | 2012 | IPCGESCVWIPCISGMFGCSCKDKVCYS | ChaC11 (chassatide C11) | Free | Free | Linear | L | None | 28 | Antibacterial, Hemolytic, Anticancer | 50 % Hemolytic at 13.3µM | Human | Plant Chassalia Chartacea (Or Chassalia Curviflora) | Bridge | NA | ||
| 22828809 | 2013 | FLSTLLKVAFKVVPTLFCPITKKC | Brevinin-1-AJ1 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic, candidacidal | 50 % Hemolytic at 50-100µM | Rabbit | Skin, The Torrent Frog, Amolops Jingdongensis, South China, Asia | NA | NA | ||
| 22828809 | 2013 | FLSTLLKVAFKVVPTLFCPITKKC | Brevinin-1-AJ1 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic, candidacidal | 83.05 % Hemolytic at 100µM | Rabbit | Skin, The Torrent Frog, Amolops Jingdongensis, South China, Asia | NA | NA | ||
| 22828809 | 2013 | FLSTLLKVAFKVVPTLFCPITKKC | Brevinin-1-AJ1 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic, candidacidal | 24.58 % Hemolytic at 50µM | Rabbit | Skin, The Torrent Frog, Amolops Jingdongensis, South China, Asia | NA | NA | ||
| 22951323 | 2012 | SLFSIFKTAAKFVGKNLLKQAGKAGLETLACKAKNEC | Esculentin-2CG1 | Free | Free | Linear | L | None | 37 | Antibacterial, Antifungal, hemolytic | 50 % Hemolytic at 75µM | Human | Frog Skin Secretions, Amolops Chunganensis, China, Asia | NA | NA | ||
| 22951323 | 2012 | GLWNTIKEAGKKFAINVLDKIRCGIAGGCKT | Palustrin-2CG1 | Free | Free | Linear | L | None | 31 | Antibacterial, Antifungal, hemolytic | 50 % Hemolytic at 75µM | Human | Frog Skin Secretions, Amolops Chunganensis, China, Asia | NA | NA | ||
| 22951323 | 2012 | FLPIVAGLAANFLPKIVCKITKKC | Brevinin-1CG2 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic | 50 % Hemolytic at 19µM | Human | Frog Skin Secretions, Amolops Chunganensis, China, Asia | NA | NA | ||
| 22951323 | 2012 | FLSTLLNVASNVVPTLICKITKKC | Brevinin-1CG3 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic | 50 % Hemolytic at 19µM | Human | Frog Skin Secretions, Amolops Chunganensis, China, Asia | NA | NA | ||
| 22951323 | 2012 | FLSTLLNVASKVVPTLFCKITKKC | Brevinin-1CG4 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic | 50 % Hemolytic at 37.5µM | Human | Frog Skin Secretions, Amolops Chunganensis, China, Asia | NA | NA | ||
| 22951323 | 2012 | FLPMLAGLAANFLPKIVCKITKKC | Brevinin-1CG5 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic, candidacidal | 50 % Hemolytic at 19µM | Human | Frog Skin Secretions, Amolops Chunganensis, China, Asia | NA | NA | ||
| 22951323 | 2012 | GILDKLKEFGISAARGVAQSLLNTTASCKLAKTC | Brevinin-2CG1 | Free | Free | Linear | L | None | 34 | Antibacterial, Antifungal, hemolytic | 50 % Hemolytic at 75µM | Human | Frog Skin Secretions, Amolops Chunganensis, China, Asia | NA | NA | ||
| 23000095 | 2012 | SGTSEKERESGRLLGVVKRLIVCFRSPFP{ct:Amid} | HsAp1 | Amidation | Free | Linear | L | None | 29 | Antibacterial, Antifungal, hemolytic | 95 % Hemolytic at 3.2µM | Human | Scorpions Venom, Heterometrus Spinifer, Asia | NA | NA | ||
| 23000095 | 2012 | SGTSEKERESGRLLGVVKRLIVCFRSPFP{ct:Amid} | HsAp1 | Amidation | Free | Linear | L | None | 29 | Antibacterial, Antifungal, hemolytic | 100 % Hemolytic at 6.4µM | Human | Scorpions Venom, Heterometrus Spinifer, Asia | NA | NA | ||
| 23000095 | 2012 | SGTSEKERESGRLLGVVKRLIVCFRSPFP{ct:Amid} | HsAp1 | Amidation | Free | Linear | L | None | 29 | Antibacterial, Antifungal, hemolytic | 35 % Hemolytic at 1.6µM | Human | Scorpions Venom, Heterometrus Spinifer, Asia | NA | NA | ||
| 18339450 | 2008 | MAADIISTIGDLVKLIINTVKKFQK | delta-lysin I | Free | Free | Linear | L | None | 25 | Antibacterial, hemolytic | 50 % Hemolytic at ~12.5µM | Human | Bacteria Staphylococcus Warneri Rk | NA | NA | ||
| 21262304 | 2011 | FLPIIAGVAAKVLPKLFCAITKKC | Brevinin-1CHa | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 5µM | Human | Skin Secretions, Chiricahua Leopard Frog, Lithobates Chiricahuensis, Arizona, Usa, North America | NA | NA | ||
| 21262304 | 2011 | FLPVIAGLAAKVLPKLFCAITKKC | Brevinin-1CHb | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 5µM | Human | Skin Secretions, Chiricahua Leopard Frog, Lithobates Chiricahuensis, Arizona, Usa, North America | NA | NA | ||
| 20308076 | 2010 | FLPAALAGIGGILGKLF | Temporin-SHd (Temp-SHd) | Free | Free | Linear | L | None | 17 | Antibacterial, Antiparasitic, Anti-MRSA, Hemolytic | 50 % Hemolytic at 44µM | Human | Skin, Pelophylax Saharica, Africa | Helix | NA | ||
| 22342498 | 2012 | FLSTLWNAAKSIF{ct:Amid} | VmCT2 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Hemolytic | 50 % Hemolytic at 35µM | Human | Scorpions Vaejovis Mexicanus Smithi | Helix | NA | ||
| 19633086 | 2009 | NKGCAICSIGAACLVDGPIPDFEIAGATGLFGLWG | Subtilosin A1 | Free | Free | Linear | L | None | 35 | Antibacterial Gram+, Hemolytic | Hemolytic at 16µM | Rabbit | Bacteria Mutant Produced In B. Subtilis | NA | NA | ||
| 23935531 | 2013 | SLFGTFAKMALKGASKLIPHLLPSRQQ | CPF-St4 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal, Antiparasitic, Hemolytic | 50 % Hemolytic at 64µM | Mouse | African Clawed Frog Silurana Tropicalis | NA | NA | ||
| 23935531 | 2013 | GVFGLLAKAALKGASKLIPHLLPSRQQ | CPF-St5 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal, Antiparasitic, Hemolytic | 50 % Hemolytic at 64µM | Mouse | African Clawed Frog Silurana Tropicalis | NA | NA | ||
| 23935531 | 2013 | GVWSTILGGLKKFAKGGLDAIVNPK | XPF-St6 | Free | Free | Linear | L | None | 25 | Antibacterial, Antifungal, Antiparasitic, Hemolytic | 50 % Hemolytic at 64µM | Mouse | African Clawed Frog Silurana Tropicalis | NA | NA | ||
| 23935531 | 2013 | GFMSKVANFAKKFAKGGVNAIMNQK | XPF-St8 | Free | Free | Linear | L | None | 25 | Antibacterial, Antifungal, Antiparasitic, Hemolytic | 50 % Hemolytic at 64µM | Mouse | African Clawed Frog Silurana Tropicalis | NA | NA | ||
| 22426384 | 2012 | FLAGLIGGLAKML | Temporin-LTe | Free | Free | Linear | L | None | 13 | Antibacterial Gram+, Hemolytic | 50 % Hemolytic at 40µM | Human | Broad-Folded Frog, Hylarana Latouchii, China, Asia | NA | NA | ||
| 22484288 | 2012 | FLFSLIPSAISGLISAF{ct:Amid} | AamAP2 | Amidation | Free | Linear | L | None | 17 | Antibacterial Gram+,Antifungal, candidacidal, Hemolytic | ~50 % Hemolytic at 100µM | Horse | Scorpion Venom, The North African Scorpion, Androctonus Amoreuxi | NA | NA | ||
| 25066917 | 2014 | FLPLLVGAISSILPKIF{ct:Amid} | Temporin-TP2 | Amidation | Free | Linear | L | None | 17 | Antibacterial Gram+, Hemolytic | 50 % Hemolytic at 59.4µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPLLFGALSTLLPKIF{ct:Amid} | Temporin-TP3 | Amidation | Free | Linear | L | None | 17 | Antibacterial Gram+, Hemolytic | 50 % Hemolytic at 94.6µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPGLIKAAVGVGSTILCKITKKC | Brevinin-1TP1 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, Antioxidant, Hemolytic | 50 % Hemolytic at 44.4µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPGLIKAAVGIGSTIFCKISKKC | Brevinin-1TP2 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Antioxidant, Hemolytic | 50 % Hemolytic at 43.1µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPGLIKVAVGVGSTILCKITKKC | Brevinin-1TP3 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, Antioxidant, Hemolytic | 50 % Hemolytic at 65.4µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPGLIKAAVGIGSTIFCKISRKC | Brevinin-1TP4 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 82µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | SILSTLKDVGISAIKSAGSGVLSTLLCKLNKNC | Brevinin-2TP1 | Free | Free | Linear | L | None | 33 | Antibacterial, Hemolytic | 50 % Hemolytic at 18.2µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPFVGKLLSGLL{ct:Amid} | Temporin-LF1 | Amidation | Free | Linear | L | None | 13 | Antibacterial Gram+, Antifungal, Hemolytic | 50 % Hemolytic at 34.2µM | Human | Frog Skin Secretions, Amolops Lifanensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPMLAGLAANFLPKIICKITKKC | Brevinin-1LF1 | Free | Free | Linear | L | None | 24 | Antibacterial Gram+, Antifungal, Antioxidant, Hemolytic | 50 % Hemolytic at 100µM | Human | Frog Skin Secretions, Amolops Lifanensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPIVASLAANFLPKIICKITKKC | Brevinin-1LF2 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 68µM | Human | Frog Skin Secretions, Amolops Lifanensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | GLWNTIKEAGKKFALNLLDKIRCGIAGGCKG | Palustrin-2GN1 | Free | Free | Linear | L | None | 31 | Antibacterial, Antioxidant, Hemolytic | 50 % Hemolytic at 46.4µM | Human | Frog Skin Secretions, Amolops Granulosus, China, Asia | NA | NA | ||
| 25066917 | 2014 | GILDTLKQLGKAAAQSLLSKAACKLAKTC | Palustrin-2GN3 | Free | Free | Linear | L | None | 29 | Antibacterial, Antifungal, Hemolytic | 50 % Hemolytic at 52.2µM | Human | Frog Skin Secretions, Amolops Granulosus, China, Asia | NA | NA | ||
| 30802593 | 2019 | FIVPSIFLLKKAFCIALKKC | Japonicin-2LF | Free | Free | Linear | L | None | 20 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm | >80 % Hemolytic at 64µM | Horse | Fujian Large-Headed Frog Skin Secretion, Limnonectes Fujianensis, China, Asia | Helix | NA | ||
| 32933215 | 2020 | FLPALAGIAGLLGKIF{ct:Amid} | Temporin-SHe | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal, Antiparasitic, Hemolytic | 84 % Hemolytic at 25µM | Human | Sahara Frog, Pelophylax Saharicus, Africa | Helix | NA | ||
| 31328553 | 2021 | SIFSLFKMGAKALGKTLLKQAGKAGAEYAACKATNQC{ct:Amid} | Esculentin-2 HYba1 | Amidation | Free | Linear | L | None | 37 | Antibacterial, Anti-MRSA, Hemolytic, Anticancer | 50 % Hemolytic at 15µM | Human | Frog Skin Secretion, Hydrophylax Bahuvistara, India, Asia | NA | NA | ||
| 31328553 | 2021 | SILSLFKMGAKALGKTLIKQAGKAGAEYVACKATNQC{ct:Amid} | Esculentin-2 HYba2 | Amidation | Free | Linear | L | None | 37 | Antibacterial, Anti-MRSA, Hemolytic, Anticancer | 50 % Hemolytic at 12µM | Human | Frog Skin Secretion, Hydrophylax Bahuvistara, India, Asia | NA | NA | ||
| 31328553 | 2021 | SIFSLFKMGAKALGKTLLKQAGKAGAEYAACKATNQC | Esculentin-2 HYba1 | Free | Free | Linear | L | None | 37 | Antibacterial, Anti-MRSA, Hemolytic, Anticancer | 50 % Hemolytic at 10µM | Human | Frog Skin Secretion, Hydrophylax Bahuvistara, India, Asia | NA | NA | ||
| 31328553 | 2021 | SILSLFKMGAKALGKTLIKQAGKAGAEYVACKATNQC | Esculentin-2 HYba2 | Free | Free | Linear | L | None | 37 | Antibacterial, Anti-MRSA, Hemolytic, Anticancer | 50 % Hemolytic at 10µM | Human | Frog Skin Secretion, Hydrophylax Bahuvistara, India, Asia | NA | NA | ||
| 37228702 | 2023 | FLPLLAGLAANFLPQIICKIARKC | Brevinin-1-AW | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance | 50 % Hemolytic at 23.96µM | Horse | Skin Secretion, The Wuyi Torrent Frog, Amolops Wuyiensis, China, Asia | Helix | NA | ||
| 37228702 | 2023 | FLPLLAGLAANFLPKIICKIARKC | B1AW-K | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance | 50 % Hemolytic at 10.6µM | Horse | Synthetic Peptide | Helix | NA | ||
| 33508505 | 2021 | RIRIRIWRIRIRICTKSIPPIC | RI3 | Free | Free | Linear | L | None | 22 | Antibacterial, Anti-MRSA, Hemolytic | 10 % Hemolytic at 8µM | Human | Synthetic Peptide | NA | NA | ||
| 37516110 | 2023 | GSKPWWWSYFTSLSTHRPRWLLKY | CBPZ-GSK24 | Free | Free | Linear | L | None | 24 | Antibacterial Gram-, Hemolytic | 50 % Hemolytic at 19.42µM | Human | Synthetic Peptide | NA | NA | ||
| 31386688 | 2019 | LKMLGMLFHNIRNILKTV{ct:Amid} | Hs01 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at >128µM | Human | Human Prame Family Member 20 | Helix | NA | ||
| 31386688 | 2019 | KWAVRIIRKFIKGFIS{ct:Amid} | Hs02 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at >128µM | Human | Human Unconventional Myosin-Ih | Helix | NA | ||
| 31386688 | 2019 | FLREFHKWIERVVGWLGKVF{ct:Amid} | Hs03 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at >128µM | Human | Human Anaphase-Promoting Complex Subunit 2 | Helix | NA | ||
| 31386688 | 2019 | LFNNYITAALKLLEKLYKV{ct:Amid} | Hs04 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 64µM | Human | Human Unconventional Myosin 1H Protein, Intragenic Antimicrobial Peptide, Homo Sapiens (Probable E3 Ubiquitin-Protein Ligase Herc3 Isoform 1) | Helix | NA | ||
| 37938588 | 2023 | MRRKTPVKWKTFFKALKHKKKIFKKTFEKFKFLAKGPAFLKGFDQKLKS | CFPS_AMP_5 | Free | Free | Linear | L | None | 49 | Antibacterial, Hemolytic | 50 % Hemolytic at 82.9µM | Human | Synthetic Peptide | NA | NA | ||
| 37938588 | 2023 | MYLKKFLALKNSLKKLSPFKCAVKSWLKKCAEVTFYSKLLGRRGKKDGN | CFPS_AMP_6 | Free | Free | Linear | L | None | 49 | Antibacterial, Hemolytic | 50 % Hemolytic at 73.8µM | Human | Synthetic Peptide | NA | NA | ||
| 37938588 | 2023 | MWFDRKKFFWPGVCLFLLFFPKRFYKKGPEKVFSFRKKYKFARKCKCKL | CFPS_AMP_12 | Free | Free | Linear | L | None | 49 | Antibacterial, Hemolytic | 50 % Hemolytic at 17.1µM | Human | Synthetic Peptide | NA | NA | ||
| 37938588 | 2023 | MEAFKKKPRLPLFKVKLTRFLERARGLGSYRIFEFFKKFGVKKFVSSLR | CFPS_AMP_15 | Free | Free | Linear | L | None | 49 | Antibacterial, Hemolytic | 50 % Hemolytic at 24.8µM | Human | Synthetic Peptide | NA | NA | ||
| 37938588 | 2023 | MCFFPRRKSKVKVKGGLCRLLFIFFKTTFCFKAKTKKEIKKGTGKKIVR | CFPS_AMP_18 | Free | Free | Linear | L | None | 49 | Antibacterial, Hemolytic | 50 % Hemolytic at 4.7µM | Human | Synthetic Peptide | NA | NA | ||
| 37938588 | 2023 | MSTRSSSIRRLVEAVRTRFRAALRTVLFFALRTTKRRPRR | CFPS_AMP_23 | Free | Free | Linear | L | None | 40 | Antibacterial, Hemolytic | 50 % Hemolytic at 11.5µM | Human | Synthetic Peptide | NA | NA | ||
| 37938588 | 2023 | MKKKKKGILKQNNKKKKYTLFNRMVVFLFLGFIMIIFVQKYKKVIYHK | CFPS_AMP_29 | Free | Free | Linear | L | None | 48 | Antibacterial, Hemolytic | 50 % Hemolytic at 50.6µM | Human | Synthetic Peptide | NA | NA | ||
| 28161291 | 2017 | FWRIVRWIKRWLR{ct:Amid} | FK13-a2 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-inflammatory, Hemolytic | 50 % Hemolytic at 14µM | Human | Human Cathelicidin Analog | Helix | NA | ||
| 28161291 | 2017 | FWRIVRRIWRWLR{ct:Amid} | FK13-a3 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-inflammatory, Hemolytic | 50 % Hemolytic at 12.5µM | Human | Human Cathelicidin Analog | Helix | NA | ||
| 37812567 | 2023 | RRWWRWWL | W544 | Free | Free | Linear | L | None | 8 | Antibacterial, Hemolytic | 50 % Hemolytic at 80µM | Human | Human Cathelicidin Analog | NA | NA | ||
| 27915018 | 2017 | WWWLKRIW{ct:Amid} | TetraF2W-KR | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 30µM | Human | Synthetic Peptide | Rich | NA | ||
| 27915018 | 2017 | WWWLKRIW{ct:Amid} | TetraF2W-KR | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 50µM | Porcine | Synthetic Peptide | Rich | NA | ||
| 27915018 | 2017 | WWWLKRIW{ct:Amid} | TetraF2W-KR | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 35µM | Chicken | Synthetic Peptide | Rich | NA | ||
| 27915018 | 2017 | WWWLRKIW{ct:Amid} | TetraF2W-RK | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 30µM | Human | Synthetic Peptide | Helix | NA | ||
| 27915018 | 2017 | WWWLRKIW{ct:Amid} | TetraF2W-RK | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 40µM | Porcine | Synthetic Peptide | Helix | NA | ||
| 27915018 | 2017 | WWWLRKIW{ct:Amid} | TetraF2W-RK | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 35µM | Chicken | Synthetic Peptide | Helix | NA | ||
| 27915018 | 2017 | WWWLKKIW{ct:Amid} | TetraF2W-KK | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 40µM | Human | Synthetic Peptide | Rich | NA | ||
| 27915018 | 2017 | WWWLKKIW{ct:Amid} | TetraF2W-KK | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 55µM | Porcine | Synthetic Peptide | Rich | NA | ||
| 27915018 | 2017 | WWWLKKIW{ct:Amid} | TetraF2W-KK | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 50µM | Chicken | Synthetic Peptide | Rich | NA | ||
| 32723829 | 2020 | RRRWWWWL | WW306 (Horine-L) | Free | Free | Linear | L | None | 8 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 60µM | Human | Synthetic Peptide | Rich | NA | ||
| 9010936 | 1996 | GFFALIAKTISSPLFKTL{ct:Amid} | 18A | Amidation | Free | Linear | L | None | 18 | Antibacterial Gram+, Hemolytic | 100 % Hemolytic at 33µg/ml | Human | Synthetic Peptide | NA | NA | ||
| 38074470 | 2023 | FLGTVLKVAAKVLPAALCQIFKKC | Brevinin-1LTe | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 6.4µM | Human | Skin Secretion, The Broad-Folded Frog, Hylarana Latouchii | NA | NA | ||
| 38611812 | 2024 | FLPLLAGLAASFLPTIFCKISRKC{ct:C-terminus contains a Rana box: one disulfide bond.} | Brevinin-1BW | C-terminus contains a Rana box: one disulfide bond. | Free | Linear | L | None | 24 | Antibacterial, Anti-inflammatory, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 35.8µg/ml | Sheep | Skin, Pelophylax Nigromaculatus, East Asia | NA | NA | ||
| 36249542 | 2022 | FLSKILSTLRILL | YZ106 | Free | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 50µM | Human | Synthetic Peptide | NA | NA | ||
| 36249542 | 2022 | FLSKILSTLRILF | YZ107 | Free | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 25µM | Human | Synthetic Peptide | NA | NA | ||
| 36138742 | 2022 | FLKIIGKLLSGLL | VM-3K | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 11.2µM | Horse | Synthetic Peptide | Helix | NA | ||
| 36138742 | 2022 | FLGIIGKLLSGLL | VM-3G | Free | Free | Linear | L | None | 13 | Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 9.7µM | Horse | Synthetic Peptide | Helix | NA | ||
| 36138742 | 2022 | FLWIIGKLLSGLL | VM-3W | Free | Free | Linear | L | None | 13 | Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 9.7µM | Horse | Synthetic Peptide | Helix | NA | ||
| 38988311 | 2024 | HLLSLLKKAAKKLLKKLLKKLAKKL | DeNo1011 | Free | Free | Linear | L | None | 25 | Antibacterial Gram-, Hemolytic | 50 % Hemolytic at 32µg/ml | Porcine | Synthetic Peptide | NA | NA | ||
| 38988311 | 2024 | KIFGKILKKLLKKLLKKLLKKL | DeNo1013 | Free | Free | Linear | L | None | 22 | Antibacterial Gram-, Hemolytic | 50 % Hemolytic at 64µg/ml | Porcine | Synthetic Peptide | NA | NA | ||
| 38988311 | 2024 | FLPIIAGLAAKLLPKLFCKITKKC | DeNo1017 | Free | Free | Linear | L | None | 24 | Antibacterial, Hemolytic | 50 % Hemolytic at 16µg/ml | Porcine | Synthetic Peptide | NA | NA | ||
| 38988311 | 2024 | FLPIIAGLAAKFLPKIFCKITKKC | DeNo1016 | Free | Free | Linear | L | None | 24 | Antibacterial, Hemolytic | 50 % Hemolytic at 4-8 µg/ml | Porcine | Synthetic Peptide | NA | NA | ||
| 39141008 | 2024 | GLLKKLLKKLLKKLLKKI | LK4 | Free | Free | Linear | L | None | 18 | Antibacterial, Hemolytic | 50 % Hemolytic at 64µM | Human | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GLLKKLLKKLLKKLLKKI | LK4 | Free | Free | Linear | L | None | 18 | Antibacterial, Hemolytic | 10 % Hemolytic at 5.42µM | Human | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GFFKKFFKKFFKKFFKKI | FK4 | Free | Free | Linear | L | None | 18 | Antibacterial, Hemolytic | 50 % Hemolytic at 32-64µM | Human | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GFFKKFFKKFFKKFFKKI | FK4 | Free | Free | Linear | L | None | 18 | Antibacterial, Hemolytic | 10 % Hemolytic at 4.02µM | Human | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GWWKKWWKKWWKKI | WK3 | Free | Free | Linear | L | None | 14 | Antibacterial, Hemolytic | 50 % Hemolytic at 32-64µM | Human | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GWWKKWWKKWWKKI | WK3 | Free | Free | Linear | L | None | 14 | Antibacterial, Hemolytic | 10 % Hemolytic at 55.52µM | Human | Synthetic Peptide | Helix | NA | ||
| 39141008 | 2024 | GWWKKWWKKWWKKWWKKI | WK4 | Free | Free | Linear | L | None | 18 | Antibacterial, Hemolytic | 10 % Hemolytic at 4.38µM | Human | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPHAISAVSALAKHL | Phylloseptin-TO2 | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 64µM | Horse | Skin Secretion, Super Tiger Leg Monkey Tree Frog, Phyllomedusa Tomopterna, Central America, South America | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAISAVSALAKHL | PSTO2 7K | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 32-64µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAISAVSALAKKL | PSTO2 18K | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 64µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAIKAVSALAKKL | PSTO2 SR (Phylloseptin-TO2 analog) | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 64µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAIKAVKALAKKL | PSTO2 SR2 (Phylloseptin-TO2 analog) | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39138237 | 2024 | FLPFLASLALKIL{ct:Amid} | Temporin-WY2 (Natural AMPs, Leu-rich, frog, amphibians, animals, XXA, UCLL1c) | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 32-64µM | Horse | Cutaneous Secretion, The Ranidae Frog, Amolops Wuyiensis, China, Asia | Helix | NA | ||
| 39138237 | 2024 | FLPKLLSALAKIL{ct:Amid} | QUB-1426 (Synthetic AMPs, Temporin-WY2 analog, Leu-rich, XXA, UCLL1c | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 16-32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39138237 | 2024 | KKKKKKFLPFLASLALKIL{ct:Amid} | 6K-WY2 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39138237 | 2024 | KKKKKKFLPKLLSALAKIL{ct:Amid} | 6K-1426 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39345903 | 2024 | FFPIVAGVAAKVLKKIFCTISKKC | Brevinin-1pl (natural AMPs; frog, amphibians, animals; XXU; 1S=S, UCSS1a; BBL) | Free | Free | Linear | L | None | 24 | Antibacterial, Anticancer, Anti-MRSA, Hemolytic | 50 % Hemolytic at 37.64µM | Horse | Skin Secretions, The Northern Leopard Frog, Rana Pipiens, North America | Helix | NA | ||
| 39345903 | 2024 | FFPKVAGVAAKVLKKIFCTISKKC | [Lys4] brevinine-1pl (brevinine-1pl I4K analog, Synthetic AMPs, XXU; 1S=S, UCSS1a) | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 80.77µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39345903 | 2024 | FFPKVAGVAAKVAKKIFCTISKKC | [Lys4, Ala13] brevinine-1pl (brevinine-1pl I4K,L13A analog, Synthetic AMPs, XXU; 1S=S, UCSS1a) | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 41.34µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39345903 | 2024 | FFPKVAGVAAKVLKKAFCTISKKC | [Lys4, Ala16] brevinine-1pl (brevinine-1pl I4K,I16A analog, Synthetic AMPs, XXU; 1S=S, UCSS1a | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 84.86µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39427973 | 2025 | FLPFLGKLFSGIF{ct:Amid} | Temporin-PMb | Amidation | Free | Linear | L | None | 13 | Antibacterial, Hemolytic, Anticancer | 50 % Hemolytic at 32-64µM | Human | Skin Secretion, The Amazon River Frog, Lithobates Palmipes (Ranidae), Brazil, South America | NA | NA | ||
| 39357847 | 2025 | FLKLIGKVLSGIL{ct:Amid} | Temporin F P3K analog | Amidation | Free | Linear | L | None | 13 | Antibacterial, Hemolytic | 50 % Hemolytic at 70µM | Human | Synthetic Peptide | Helix | NA | ||
| 39357847 | 2025 | FLKLIGKVLSKIL{ct:Amid} | Temporin F P3K,G11K analog | Amidation | Free | Linear | L | None | 13 | Antibacterial, Hemolytic | 50 % Hemolytic at 30µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | IILLLLKKFLKKL{ct:Amid} | 2K4L | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 62.5µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | WILLLLKKFLKKL{ct:Amid} | 2K4L_W1 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 12.5µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | IWLLLLKKFLKKL{ct:Amid} | 2K4L_W2 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 50µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | IILLLLKKFWKKL{ct:Amid} | 2K4L_W10 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 12.5µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | IILLLLKKFLKKW{ct:Amid} | 2K4L_W13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 12.5µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | IILLLLKKFWKKW{ct:Amid} | 2K4L_2W | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 25µM | Human | Synthetic Peptide | Helix | NA | ||
| 34953322 | 2022 | IWLLLLKKFWKKW{ct:Amid} | 2K4L_3W (Temporin-1CEc analog) | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 6.25µM | Human | Synthetic Peptide | Helix | NA | ||
| 19944711 | 2010 | AHDGNPLEECFREDDEEFFLEIAKNGLTATSNPKRVVIV{ct:Amid} | L-amino-acid oxidase (BmarLAAO) (LAO) (EC 1.4.3.2) | Amidation | Free | Linear | L | None | 39 | Antibacterial and Antiparasitic | Hemolytic | NA | Bothrops Marajoensis (Marajo Lancehead) | NA | NA | ||
| 15142548 | 2004 | ADVRNPLEEFRETDYEVL | L-amino-acid oxidase (Balt-LAAO-I) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 18 | Antibacterial | Hemolytic | NA | Bothrops Alternatus (Urutu) (Rhinocerophis Alternatus) | NA | NA | ||
| 31671555 | 2019 | MAFLKKSLFLVLFLGLVSLSMCEEEKRENEVEEEQEDDEQSELRRSLRSSIKDMAAAAGRAALNAVNGIVNPGEQ{ct:Amid} | Dermaseptin-SP5 (DRS-SP5) | Amidation | Free | Linear | L | None | 75 | Antibacterial, Antifungal | <20 % Hemolytic at 256mg/L | Human | Agalychnis Spurrelli (Gliding Leaf Frog) (Agalychnis Litodryas) | Alpha Helix | Non-hemolytic | ||
| 31671555 | 2019 | MAFLKKSLFLVLFLGLVSLSMCEEEKRENEVEEEQEDDEQSELRRSLWSSIKDMAAAAGRAALNAVNGILNPGEQ{ct:Amid} | Dermaseptin-SP4 (DRS-SP4) | Amidation | Free | Linear | L | None | 75 | Antibacterial, Antifungal | <20 % Hemolytic at 256mg/L | Human | Agalychnis Spurrelli (Gliding Leaf Frog) (Agalychnis Litodryas) | Alpha Helix | Low hemolytic | ||
| 31671555 | 2019 | MAFLKKSLFLVLFLGLVSLSMCEEEKRENEVEEEQEDDEQSELRRSLWSSIKDMAAAAGRAALNAVNGIVNPGEQ{ct:Amid} | Dermaseptin-SP3 (DRS-SP3) | Amidation | Free | Linear | L | None | 75 | Antibacterial, Antifungal | <20 % Hemolytic at 256mg/L | Human | Agalychnis Spurrelli (Gliding Leaf Frog) (Agalychnis Litodryas) | Alpha Helix | Low hemolytic | ||
| 17000029 | 2006 | MFTLKKSLLLLFFLGTINLSLCEQERNAEEERRDEPDERNAEVEKRFLPIVGKLLSGLSGLLGK{ct:Amid} | Temporin-ALa (Amolopin-2a) | Amidation | Free | Linear | L | None | 64 | Antibacterial, Antifungal | Hemolytic | Rabbit | Amolops Loloensis (Lolokou Sucker Frog) (Staurois Loloensis) | NA | Low hemolytic | ||
| 22438972 | 2012 | IKFEPPLPPKKAHKKFWEDDGIYYPPNHNFP | L-amino-acid oxidase (Bm-LAO) (LAAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 31 | Antibacterial Antiparasitic | 12.5+-5.3 % Hemolytic at 512μg/mL | Human | Bothrops Mattogrossensis (Pitviper) (Bothrops Neuwiedi Mattogrossensis) | NA | NA | ||
| 19946788 | 2010 | IWLTALKFLGKNLGKHLAKQQLAKL{nt:H}{ct:Amid} | Toxin LyeTx 1 | Amidation | H | Linear | L | None | 25 | Antibacterial | 50 % Hemolytic at 1.3*10^-4M | Rabbit | Lycosa Erythrognatha (Wolf Spider) (Scaptocosa Raptoria) | α-Helix | Low hemolytic | ||
| 26322745 | 2015 | GKYTCGETCFKGKCYTPGCTCSYPICKKD{cyc:N-C} | Cyclotide mela-1 | Free | Free | Cyclic | L | None | 29 | Antibacterial | 50 % Hemolytic at >64µM | Human | Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia) | NA | Non-hemolytic | ||
| 26322745 | 2015 | GKPTCGETCFKGKCYTPGCTCSYPLCKKD{cyc:N-C} | Cyclotide mela-2 | Free | Free | Cyclic | L | None | 29 | Antibacterial | 50 % Hemolytic at >64µM | Human | Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia) | NA | Non-hemolytic | ||
| 26322745 | 2015 | GLPTCGETCFKGKCYTPGCSCSYPICKKD{cyc:N-C} | Cyclotide mela-6 | Free | Free | Cyclic | L | None | 29 | Antibacterial | 50 % Hemolytic at >64µM | Human | Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia) | NA | Non-hemolytic | ||
| 26322745 | 2015 | GLPTCGETCFKGKCYTPGCSCSYPICKKN{cyc:N-C} | Cyclotide mela-7 | Free | Free | Cyclic | L | None | 29 | Antibacterial | 50 % Hemolytic at >64µM | Human | Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia) | NA | Non-hemolytic | ||
| 25220871 | 2014 | FWGAVWKILSKVLPHIPGTVKWLQEKV | M-ectatotoxin-Eb2a (M-ECTX-Eb2a) (Ponericin-Q42) | Free | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolytic at 2.5+-0.1µM | Human | Ectatomma Brunneum (Ant) (Ectatomma Quadridens) | NA | NA | ||
| 30734396 | 2019 | FLSLIPKIAGGIASLVKNL{ct:Amid} | Phylloseptin-1.1TR (PLS-1.1TR) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolytic at 28µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | Helical | NA | ||
| 30734396 | 2019 | FLSLIPKIAGGIASLVKDL{ct:Amid} | Phylloseptin-1.2TR (PLS-1.2TR) (Phylloseptin-1.3TR) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolytic at 75µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | NA | NA | ||
| 30734396 | 2019 | FLSLIPHIATGIAALAKHL{ct:Amid} | Phylloseptin-2.1TR (PLS-2.1TR) (Phylloseptin-2.2TR) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 50 % Hemolytic at 41µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | Helical | NA | ||
| 30734396 | 2019 | FFSMIPKIATGIASLVKDL{ct:Amid} | Phylloseptin-3.2TR (PLS-3.2TR) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal, Anti-inflammatory | 50 % Hemolytic at 110µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | NA | NA | ||
| 30734396 | 2019 | LLGMIPVAITAISALSKL{ct:Amid} | Medusin-TR1 (MDS-TR1) (Phylloseptin-4TR) (PLS-4TR) | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal, Anti-inflammatory, Antibiofilm | 50 % Hemolytic at 65µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | Helical | NA | ||
| 18312859 | 2008 | NILSSIVNGINRALSFFG | Amolopin-P1 | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 3 % Hemolytic at 200μg/mL | Rabbit | Amolops Loloensis (Lolokou Sucker Frog) (Staurois Loloensis) | β-Sheet | Non-hemolytic | ||
| 19843479 | 2009 | MFTLKKSLLLLFFLGTINLSLCEQERNAEEERRDDLGERQAEVEKRFFPIVGKLLSG | Temporin-ALk (Amolopin-n1) | Free | Free | Linear | L | None | 57 | Antibacterial, Antifungal | 25 % Hemolytic at 100μg/mL | Rabbit | Amolops Loloensis (Lolokou Sucker Frog) (Staurois Loloensis) | NA | Low hemolytic | ||
| 22450466 | 2012 | FLPLIASVAANLVPKIFCKITKKC | Brevinin-1V | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal | 50 % Hemolytic at 75µM | Human | Odorrana Hainanensis (Odor Frog) (Rana Hainanensis) | Helical | NA | ||
| 22450466 | 2012 | FLPLIASLAANFVPKIFCKITKKC | Brevinin-1HN1 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal | 50 % Hemolytic at 75µM | Human | Odorrana Hainanensis (Odor Frog) (Rana Hainanensis) | Helical | NA | ||
| 22450466 | 2012 | SLLGTVKDLLIGAGKSAAQSVLKGLSCKLSKDC | Brevinin-2HS2 | Free | Free | Linear | L | None | 33 | Antibacterial, Antifungal | 50 % Hemolytic at 300µM | Human | Odorrana Hainanensis (Odor Frog) (Rana Hainanensis) | Helical | Low hemolytic | ||
| 22450466 | 2012 | AILTTLANWARKFL{ct:Amid} | temporin-HN1 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 50 % Hemolytic at 75µM | Human | Odorrana Hainanensis (Odor Frog) (Rana Hainanensis) | Helical | NA | ||
| 22450466 | 2012 | NILNTIINLAKKIL{ct:Amid} | temporin-HN2: | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 50 % Hemolytic at 300µM | Human | Odorrana Hainanensis (Odor Frog) (Rana Hainanensis) | Helical | Low hemolytic | ||
| 15274631 | 2004 | MSSRAGIAEGYEQIEVDVVAVWKEGYVYENRGSTSVEQKIKITKGMRNLNSETKTLTASHSIGSTISTGDLFEIATVDVSYSYSHEESQVSMTETEVYESKEIEHTITIPPTSKFTRWQLNADVGGADIEYMYLIDEVTPIGGTLSIPQVIKSRAKILVGREIYLGETEIRIKHADRKEYMTVVSRKSWPAATLGHSKLYKFVLYEDMYGFRIKTLNTMYSGYEYAYSSDQGGIYFDQGSDNPKQRWAINKSLPLRHGDVVTFMNKYFTRSGLCYYDGPATDVYCLDKREDKWILEVVKP | Lysenin-related protein 2 (LRP-2) (Fetidin) (Hemolysin) (Lysenin-3) (efL3) | Free | Free | Linear | L | None | 300 | Antibacterial | Hemolytic | Sheep | Eisenia Fetida (Red Wiggler Worm) | NA | NA | ||
| 16330062 | 2006 | FLPIIAKLLGGLL | Vespid chemotactic peptide 5e (VCP 5e) | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | Hemolytic at 50μg/mL | Rabbit | Vespa Magnifica (Hornet) | NA | NA | ||
| 19716842 | 2010 | FLPKMSTKLRVPYRRGTKDYH | Antimicrobial peptide scolopin-1 | Free | Free | Linear | L | None | 21 | Antibacterial, Antiyeast | 25±2 % Hemolytic at 50μg/mL | Human | Scolopendra Mutilans (Chinese Red-Headed Centipede) (Scolopendra Subspinipes Mutilans) | NA | NA | ||
| 19716842 | 2010 | GILKKFMLHRGTKVYKMRTLSKRSH | Antimicrobial peptide scolopin-2 | Free | Free | Linear | L | None | 25 | Antibacterial, Antiyeast | 32±7 % Hemolytic at 50μg/mL | Human | Scolopendra Mutilans (Chinese Red-Headed Centipede) (Scolopendra Subspinipes Mutilans) | NA | NA | ||
| 19716842 | 2010 | FLPKMSTKLRVPYRRGTKDYH | Antimicrobial peptide scolopin-1 | Free | Free | Linear | L | None | 21 | Antibacterial, Antiyeast | 21±5 % Hemolytic at 50μg/mL | Rabbit | Scolopendra Mutilans (Chinese Red-Headed Centipede) (Scolopendra Subspinipes Mutilans) | NA | NA | ||
| 19716842 | 2010 | GILKKFMLHRGTKVYKMRTLSKRSH | Antimicrobial peptide scolopin-2 | Free | Free | Linear | L | None | 25 | Antibacterial, Antiyeast | 37±6 % Hemolytic at 50μg/mL | Rabbit | Scolopendra Mutilans (Chinese Red-Headed Centipede) (Scolopendra Subspinipes Mutilans) | NA | NA | ||
| 15207717 | 2004 | GFRDVLKGAAKAFVKTVAGHIAN{ct:Amid} | Ascaphin-1 | Amidation | Free | Linear | L | None | 23 | Antibacterial | 50 % Hemolytic at >200µM | Human | Ascaphus Truei (Coastal Tailed Frog) | NA | NA | ||
| 15207717 | 2004 | GFRDVLKGAAKAFVKTVAGHIANI | Ascaphin-3 | Free | Free | Linear | L | None | 24 | Antibacterial | 50 % Hemolytic at >200µM | Human | Ascaphus Truei (Coastal Tailed Frog) | NA | NA | ||
| 15207717 | 2004 | GIKDWIKGAAKKLIKTVASHIANQ | Ascaphin-5 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal | 50 % Hemolytic at >200µM | Human | Ascaphus Truei (Coastal Tailed Frog) | NA | NA | ||
| 15207717 | 2004 | GFKDWIKGAAKKLIKTVASAIANQ | Ascaphin-7 | Free | Free | Linear | L | None | 24 | Antibacterial | 50 % Hemolytic at >200µM | Human | Ascaphus Truei (Coastal Tailed Frog) | NA | NA | ||
| 21549739 | 2011 | FDVMGIIKKIAGAL{ct:Amid} | Eumenine mastoparan-EF (EMP-EF) | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 50 % Hemolytic at 181.1µM | Mouse | Eumenes Fraterculus (Solitary Wasp) | Alphα-Helical | Low hemolytic | ||
| 15556063 | 2004 | FLSAITSLLGKLL{ct:Amid} | Temporin-1SPb | Amidation | Free | Linear | L | None | 13 | Antibacterial | 50 % Hemolytic at 60µM | Human | Lithobates Septentrionalis (Mink Frog) (Rana Septentrionalis) | NA | NA | ||
| 15556063 | 2004 | GIWDTIKSMGKVFAGKILQNL{ct:Amid} | Brevinin-2-related peptide | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal, Anti-HIV | 50 % Hemolytic at 70µM | Human | Lithobates Septentrionalis (Mink Frog) (Rana Septentrionalis) | NA | NA | ||
| 19463738 | 2009 | GLKDIFKAGLGSLVKGIAAHVAN{ct:Amid} | Alyteserin-1a | Amidation | Free | Linear | L | None | 23 | Antibacterial Gram- | 50 % Hemolytic at >100µM | Human | Alytes Obstetricans (Common Midwife Toad) (Bufo Obstetricans) | Alphα-Helical | NA | ||
| 19463738 | 2009 | GLKEIFKAGLGSLVKGIAAHVAN{ct:Amid} | Alyteserin-1b | Amidation | Free | Linear | L | None | 23 | Antibacterial Gram- | 50 % Hemolytic at 210µM | Human | Alytes Obstetricans (Common Midwife Toad) (Bufo Obstetricans) | Alphα-Helical | NA | ||
| 19463738 | 2009 | ILGKLLSTAAGLLSNL{ct:Amid} | Alyteserin-2a | Amidation | Free | Linear | L | None | 16 | Antibacterial | 50 % Hemolytic at 135µM | Human | Alytes Obstetricans (Common Midwife Toad) (Bufo Obstetricans) | NA | NA | ||
| 15809084 | 2005 | DICTNCCAGTKGCNTTSANGAFICEGQSDPKKPKACPLNCDPHIAYA{nt:Amid} | Potamin-1 (PT-1) | Free | Amidation | Linear | L | None | 47 | Antibacterial, Antifungal | 0 % Hemolytic at 40µM | Human | Solanum Tuberosum (Potato) | NA | Non-hemolytic | ||
| 18976634 | 2008 | MAFLKKSLFLVLFLGIVSLSICEEEKREGEEEEKQEEENEELSEEELRERRAWLDKLKSLGKVVGKVALGVAQNYLNPQQ | Raniseptin-1 (Rsp-1) | Free | Free | Linear | L | None | 80 | Antibacterial | 20 % Hemolytic at 80µM | Human | Boana Raniceps (Chaco Tree Frog) (Hyla Roeschmanni) | NA | NA | ||
| 21539875 | 2011 | MLLTISDFLFLSLTFSRYARMRDSRPWSDRKNNYSGPQFTYPPEKAPPEKLIKWNNEGSPIFEMPAEGGHIEP | Antimicrobial peptide lumbricin-PG (Lumbricin-PG) | Free | Free | Linear | L | None | 73 | Antibacterial, Antifungal | 1.5 % Hemolytic at 200μg/mL | Human | Metaphire Guillelmi (Earthworm) (Pheretima Guillelmi) | NA | Low hemolytic | ||
| 21539875 | 2011 | MLLTISDFLFLSLTFSRYARMRDSRPWSDRKNNYSGPQFTYPPEKAPPEKLIKWNNEGSPIFEMPAEGGHIEP | Antimicrobial peptide lumbricin-PG (Lumbricin-PG) | Free | Free | Linear | L | None | 73 | Antibacterial, Antifungal | 2.1 % Hemolytic at 200μg/mL | Rabbit | Metaphire Guillelmi (Earthworm) (Pheretima Guillelmi) | NA | Low hemolytic | ||
| 16087274 | 2006 | GLHKVMREVLGYERNSYKKFFLR | Ixosin | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal | Hemolytic at 50μg/mL | Rabbit | Ixodes Sinensis (Hard Tick) | NA | Non-hemolytic | ||
| 18312859 | 2008 | NVLSSVANGINRALSFFG | Amolopin-P2 | Free | Free | Linear | L | None | 18 | Antibacterial | 3 % Hemolytic at 200μg/mL | Rabbit | Amolops Loloensis (Lolokou Sucker Frog) (Staurois Loloensis) | NA | Non-hemolytic | ||
| 11682065 | 2001 | GLLDSIKGMAISAGKGALQNLLKVASCKLDKTC | Nigrocin-1 | Free | Free | Linear | L | None | 33 | Antibacterial, Antifungal | 1.1 % Hemolytic at 100μg/mL | Human | Pelophylax Nigromaculatus (Black-Spotted Frog) (Rana Nigromaculata) | α-Helical | Non-hemolytic | ||
| 11682065 | 2001 | GLLSKVLGVGKKVLCGVSGLC | Nigrocin-2 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0.9 % Hemolytic at 100μg/mL | Human | Pelophylax Nigromaculatus (Black-Spotted Frog) (Rana Nigromaculata) | α-Helical | Non-hemolytic | ||
| 26930596 | 2016 | AVAGEKLWLLPHLLKMLLTPTP | Polydim-I | Free | Free | Linear | L | None | 22 | Antibacterial | <2.6 % Hemolytic at 121.6μg/mL | Human | Polybia Dimorpha (Neotropical Wasp) | NA | Non-hemolytic | ||
| 15777955 | 2005 | IGGIISFFKRLF | Grammistin Gs B | Free | Free | Linear | L | None | 12 | Antibacterial | Hemolytic at <10HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | Non-hemolytic | ||
| 15777955 | 2005 | FIGGIISFFKRLF | Grammistin Gs D | Free | Free | Linear | L | None | 13 | Antibacterial | Hemolytic at 79HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | NA | ||
| 15777955 | 2005 | FIGGIISFIKKLF | Grammistin Gs E | Free | Free | Linear | L | None | 13 | Antibacterial | Hemolytic at 63HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | NA | ||
| 15777955 | 2005 | WWRELLKKLAFTAAGHLGSVLAAKQSGW | Grammistin Gs A | Free | Free | Linear | L | None | 28 | Antibacterial | Hemolytic at <10HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | Non-hemolytic | ||
| 15777955 | 2005 | NWRKILGKIAKVAAGLLGSMLAGYQV | Grammistin Gs C | Free | Free | Linear | L | None | 26 | Antibacterial | Hemolytic at <10HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | Non-hemolytic | ||
| 9784389 | 1998 | SMLSVLKNLGKVGLGFVACKINKQC | Ranatuerin-1 | Free | Free | Linear | L | None | 25 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | GLFLDTLKGAAKDVAGKLEGLKCKITGCKLP | Ranatuerin-2 | Free | Free | Linear | L | None | 31 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | GFLDIINKLGKTFAGHMLDKIKCTIGTCPPSP | Ranatuerin-3 | Free | Free | Linear | L | None | 32 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | FLPFIARLAAKVFPSIICSVTKKC | Ranatuerin-4 | Free | Free | Linear | L | None | 24 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | FLPIASLLGKYL | Ranatuerin-5 (Temporin) | Free | Free | Linear | L | None | 12 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | FISAIASMLGKFL | Ranatuerin-6 (Temporin) | Free | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | FLSAIASMLGKFL | Ranatuerin-7 (Temporin) | Free | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | FISAIASFLGKFL | Ranatuerin-8 (Temporin) | Free | Free | Linear | L | None | 13 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | FLFPLITSFLSKVL | Ranatuerin-9 (Temporin) | Free | Free | Linear | L | None | 14 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 19298834 | 2009 | GLLGGLLGPLLGGGGGGGGGLL | Leptoglycin | Free | Free | Linear | L | None | 22 | Antibacterial | 0 % Hemolytic at 2-200µM | Human | Leptodactylus Pentadactylus (Smokey Jungle Frog) (Rana Pentadactyla) | NA | Non-hemolytic | ||
| 21520894 | 2011 | PVVDTTGNNPLQQQEEYYV | Kunitz-type serine protease inhibitor 1 (Xb-KTI) | Free | Free | Linear | L | None | 19 | Antibacterial, trypsin inhibitor | 0 % Hemolytic at 250μg/mL | Human | Xanthosoma Sagittifolium (Arrowleaf Elephant'S Ear) (Arum Sagittifolium) | NA | Non-hemolytic | ||
| 15246874 | 2004 | MKLSCLLLTLAIIFVLTIVHAPNVKAKALADPESDAVGFADAVGEADPFDITKLNIKKLTKATCKVISKGASMCKVLFDKKKQE | M-myrmeciitoxin-Mb2a (M-MIITX-Mb2a) (M-myrmeciitoxin-Mp3a) (M-MIITX-Mp3a) (Pilosulin-4) | Free | Free | Linear | L | None | 84 | Antibacterial | 0 % Hemolysis at 50µM | Human | Myrmecia Banksi (Jack Jumper Ant) (Australian Jumper Ant) | NA | Non-hemolytic | ||
| 31209048 | 2019 | GLLSLLSLLGKLL{ct:Amid} | DFTamP1 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at <3.1µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GALSLLSLLGKLL{ct:Amid} | DFT506 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 4µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLASLLSLLGKLL{ct:Amid} | DFT507 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at <3.1µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSALSLLGKLL{ct:Amid} | DFT508 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 6µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLASLLGKLL{ct:Amid} | DFT509 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 4µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLLSALGKLL{ct:Amid} | DFT510 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 19µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLLSLAGKLL{ct:Amid} | DFT511 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 14µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLLSLLGKAL{ct:Amid} | DFT512 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 4µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLLSLLGKLA{ct:Amid} | DFT513 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at <3.1µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSALKALGKLL{ct:Amid} | DFT514 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 36µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSAL{nnr:O}ALGKLL{ct:Amid} | DFT515 | Amidation | Free | Linear | L | O = L-Ornithine | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 36µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSAL{nnr:O}ALG{nnr:O}LL{ct:Amid} | DFT516 | Amidation | Free | Linear | L | O = L-Ornithine | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 36µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSALKAAGKLL{ct:Amid} | DFT521 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at > 50µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GALSALKALGKLL{ct:Amid} | DFT528 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at > 50µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSALKALGKAL{ct:Amid} | DFT529 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at > 50µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSAAKAAGKLL{ct:Amid} | DFT522 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 50µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GALSALKALGKAL{ct:Amid} | DFT530 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >100µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLSLLGKLL{ct:Amid} | DFT523 | Amidation | Free | Linear | L | None | 12 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >50µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLSLGKLL{ct:Amid} | DFT524 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >300µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLGKLL{ct:Amid} | DFT525 | Amidation | Free | Linear | L | None | 9 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >300µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLSSLGKLL{ct:Amid} | DFT526 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >300µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLSLLLSLLGKLL{ct:Amid} | DFT502 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 3.1µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLSLLLSLGLKLL{ct:Amid} | DFT503 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >300µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLSLLLSLLLGKL{ct:Amid} | DFT504 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 8µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSSLLLLGKLL{ct:Amid} | DFT505 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 20µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GKLLSLLSLLGLL{ct:Amid} | DFT527 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 20µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | GLLSLLSLGLKLL{ct:Amid} | DFT531 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 7µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | LLGSLLSLGLKLL{ct:Amid} | DFT532 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at 13µM | Human | Synthetic Peptide | NA | NA | ||
| 31209048 | 2019 | G{d}L{d}S{d}L{d}L{d}L{d}S{d}L{d}G{d}L{d}K{d}L{d}L{d}{ct:Amid} | DFT503d | Amidation | Free | Linear | D | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >300µM | Human | Synthetic Peptide | NA | NA |